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ABSTRACT
EFFECT OF AGING ON GENE EXPRESSION BY GRANULOSA CELLS FROM MARES 
Changes in gene expression in granulosa cells from mares may result from aging or 
development of metabolic disease as well as from other causes.  We used qRT-PCR to quantify 
expression of equine insulin receptor (IR), insulin-like growth factor receptor (IGF-1R), glucose 
transporter type 4 (GLUT4) and adenosine monophosphate-activated protein kinase (AMPK) 
subunit genes in granulosa cells from young (4-9 years), middle-aged (10-16 years) and older 
(>16 years) mares.  Granulosa cells were isolated following follicular aspiration and incubated in 
the presence or absence of 10% fetal bovine serum (FBS) and 30mM glucose for 24 hrs.  Cells 
were then treated for 1 hr with insulin (100nM), IGF-1 (10nM), epidermal growth factor (EGF; 
1μM), progesterone (P4; 100 nM) or human chorionic gonadotropin (hCG; 100 nM).  ∆Ct, where 
Δct is equal to the CT value for the gene of interest minus the CT value for a house keeping 
gene, values for IGF-1R or IR expression did not differ significantly for any age group.  
However, there were statistically significant differences in the ratio of ∆Ct for IR relative to ∆Ct 
for IGF-1R for individual young, middle-aged and old mares.  Young animals expressed 
increased IGF-1R relative to IR after pre-incubation of cells in either – fetal bovine serum 
FBS/30mM glucose  or + FBS/30mM glucose  media followed by treatment with insulin, IGF-1, 
or EGF.  Conversely, middle-aged animals expressed increased IR relative to IGF-1R following 
preincubation in both medium and following treatment with insulin or IGF-1. Finally, older 
animals expressed approximately equal amounts of IR relative to IGF-1R (-FBS/-30mM 
glucose) or increased IR relative to IGF-1R.  
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When cells were pre-incubated in +FBS/+30mM glucose medium and treated with insulin or 
IGF-1, the ratio of IR expression relative to IGF1R expression changed and there was increased
IGF-1R relative to IR.  Changes in the relative numbers of IR and IGF-1R monomers expressed 
from IR and IGF-1R genes may affect the particular receptor dimers assembled from these 
monomers.  In evaluating fold change 2-∆∆Ct in gene expression, we observed increases in 
IGF-1R expression (+FBS/+30mM glucose; p<0.03), GLUT4 expression (+FBS/+30mM 
glucose; p<0.05) and AMPKα2 expression (-FBS/-30mM glucose; p<0.03) in older mares
relative to young animals.  Together, these results indicate that young animals differ from older 
animals in several ways.  Young animals maintain stable ratios of ∆CT for IGF-1R to ∆CT for IR 
and these ratios are not affected by treatment with insulin, IGF-1 or EGF.  Thus, it is likely that 
young animals maintain higher levels of IGF-1R homodimers and hybrid receptors formed from 
IGF-1R and insulin receptor monomers and that receptor numbers, including insulin receptors, 
remain stable, particularly when circulating glucose and insulin levels are high.  Older animals, 
on the other hand, are more labile with respect to ∆CT for IGF-1R relative to ∆CT for IR.  
Exposure of granulosa cells pre-incubated in +FBS/+30mM glucose  medium to high levels of 
glucose, insulin, IGF-1 or EGF demonstrated increased IGF-1R expression.  This may decrease 
numbers of insulin-responsive insulin homodimers, increasing hybrid receptors and IGF-1R 
homodimers and thus decreasing insulin responsiveness and insulin effects on metabolism.  
Moreover, when there are significant effects on expression of IR, IGF1R or GLUT4 in older 
animals, there are accompanying increases in expression of some AMPK subunit genes in older 
animals indicating additional effects of aging on overall metabolism. 
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CHAPTER 1:  BACKGROUND AND SIGNIFICANCE 
1.1:   Introduction 
The equine follicle and human follicle are finely-tuned microenvironments in which cell-
cell communication and exchange of soluble factors are essential to development of the dominant 
follicle and production of a fertilizable oocyte (1).  The effects of aging on follicular maturation 
and fertility in mares and women have led to suggestions that the equine model may be an 
appropriate model for studies of reproductive aging in women (2).  As in women, mare 
gonadotropins are secreted by the anterior pituitary gland and bind their respective receptors on 
granulosa cells in the follicle.  Activation of these receptors is necessary for follicle development 
and production of cell-secreted factors including epidermal growth factor (EGF)-like hormones 
that act locally on the oocyte or on cumulus cells associated with the oocyte (2).   Although 
gonadotropin responsiveness by bovine granulosa cells is enhanced in the presence of insulin and 
insulin like growth factor-1 (IGF-1) (3), very high concentrations of IGF-1 decrease embryo 
viability and increase apoptosis (4).  In addition, changes in the metabolic status of mares (and 
women) including reduced insulin sensitivity affect fertility at any age (5).  In mares, insulin 
insensitivity produces aberrant reproductive cycles (6) and is often associated with obesity. In 
humans, insulin resistance and obesity are correlated with polycystic ovarian syndrome (PCOS), 
a major cause of infertility in women (7).   
Because metabolic disorders are a common concern in aging mares, our goal in these 
studies was to examine the relationship between gene expression for insulin receptor (IR) and 
insulin-like growth factor-1 receptor (IGF-1R) and cellular metabolism in granulosa cells. These 
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studies used granulosa cells from young mares (4-9 years), middle aged mares (10-16 years) and 
older animals (>16years) and were conducted in medium containing either high levels of glucose 
(30 mM) and 10% fetal bovine serum as a source of growth factors (+FBS/+30 mM glucose) or 
in medium lacking additional glucose and FBS (-FBS/-30 mM glucose). We used real-time 
reverse transcription polymerase chain reaction (RT-PCR) to quantify expression of equine IR 
and IGF-1R genes in granulosa cells in response to epidermal growth hormone (EGF), 
IGF-1, insulin, progesterone (P4) and human chorionic gonadotropin (hCG).  We also examined 
effects of these hormones on the expression of the glucose transporter type 4 (GLUT4) gene 
which is up-regulated by insulin, and on the levels of adenosine monophosphate-activated 
protein kinase (AMPK) isoform genes which reflect the metabolic activity of granulosa cells.   
1. 2: Selection of the dominant follicle and hormonal effects on follicle function
Dominant follicle growth in an ovulatory phase is associated with follicular waves and 
processes that lead to continual growth of the dominant follicle and regression of other subordinate 
follicles (8,9).  The structure of the follicle and the relationship between granulosa cells and the 
oocyte are shown in Figure 1.1.  In women, ovulatory waves resulting from increasing follicle 
stimulating hormone (FSH) reach their peak when the largest follicle in size is about 13 mm in 
diameter.  Following the FSH surge, there is a decrease in FSH which is linked to increased levels 
of inhibin.  Circulating estradiol begin to increase about two days after the FSH peak and one day 
prior to the beginning of deviation. Follicle deviation occurs when one or two dominant follicles 
are apparent and where the dominant follicle is ≥ 28 mm in diameter (10,11).  One day before the 
beginning of diameter deviation, the intra-follicular concentrations of estradiol, IGF-1, inhibin A 
and activin A increase differentially in what will become the dominant follicle.  This follicle, the 
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dominant follicle, can grow to greater than 28 mm in mares.  The remaining follicles then undergo 
atresia (12).   
The appearance of follicular deviation and a dominant follicle is influenced by the IGF-1 
and are dose dependent.  Injection of a physiological dose of IGF-1 into the second largest follicle 
of the mare prior to deviation increased the concentration of inhibin A and activin A, but not 
estradiol within 24 hours post injection (PI). The 500- and 250-μg does stimulated follicle growth 
and ovulation growth.  Injection of IGF-1 binding protein into the dominant follicle at the expected 
beginning of deviation decreased the follicle size within 24 hours (13).   
 Members of the IGF-1 super family in mammals are reproductively important hormones.  
The IGF-1 super family in mammals includes IGF-1 and IGF-2 and their receptors.  In both equine 
and bovine species, accumulation of IGF-1 occurs in the dominant follicle and in larger amounts 
than in the regressing follicles.  IGF-1 in the dominant follicle leads to secretion of activin A, 
inhibin A, and vascular endothelial growth factor (VEGF).  These local IGF-1 effects are probably 
involved, at least in part, for selection of a dominant follicle in the mare (14).   Ginther et al. 
demonstrated that IGF-1 and its receptor played a critical role in expression of follicular-fluid 
factors leading to selection and growth of the dominant follicle in mares (15).  IGF-1 acts with 
FSH in granulosa cells to stimulate gonadal steroid production.  Knockout of IGF-1 or FSH leads 
to infertility and hypogonadism (16).  Thus IGF-1, in addition to FSH and LH, may play an 
important role in regulation of estradiol production in the human ovary (17).   
EGF and EGF-related proteins as growth promoting factors in the follicle by 
providing autocrine and/or paracrine signals that facilitate the LH stimulus. The EGF signaling 
system consists of EGF-related ligands and tyrosine kinase receptors called collectively described 
as the epidermal growth factor receptor (EGFR) family and also known as ErbB receptors. 
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Amphiregulin (AR), epiregulin (EPI), and beta cellulin (BTC), each with EGF-like motifs, are 
capable of binding the EGF receptor (18,19).  EGF-like growth factors appear to function as 
mediators of LH action in the dominant follicle.  LH regulates mRNA and protein synthesis and 
LH activation of the LH receptor leads to regulation of EGF-like growth factors at the 
transcriptional level and processing of ligand precursors. Soluble EGF-like growth factors then act 
as autocrine and paracrine hormones to activate EGFR and to increase metabolic activity within 
target cells.  One activated enzyme, AMPK, which is discussed later in this section, is necessary 
for LH- and EGF-mediated cumulus expansion and oocyte maturation. 
In addition to follicular growth, the oocyte and granulosa cells develop intimate 
intercellular connections (20,21).  Both the oocyte and granulosa cells have cytoplasmic 
projections and microvilli that interdigitate with each other to create a large surface area for 
diffusion (22).  In addition, some of the follicle cell microvilli and cytoplasmic projections 
physically penetrate deeply into the oocyte via invagination of the oocyte plasma membrane, 
occasionally reaching close to the nuclear membrane to control local FSH levels (11).   
1.3: Aging effects on follicular development 
Female reproductive organs show signs of aging earlier than tissues or organs in the body. 
In women, fertility begins to decrease in the late 30s. However, an ovulatory cycle continues to 
produce ova until menopause at a mean age of 50 years (23).  In most women, ovarian function 
diminishes between 50 and 55 years of age and the serum FSH concentration becomes higher 
than that seen in younger women (24).  Hormone levels of LH, FSH, estradiol (E2), and 
progesterone (P) also change with increasing age and the inter-menstrual interval increases. In 
women, cycle length is 28 days between the ages 25 and 40 years and the cycle length gradually 
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decreases until menopause (24). Changes in cycle length appear to be due to changes in follicular 
maturation. A shorter follicular phase in premenopausal women is accompanied by increased 
levels of FSH and decreased estradiol levels throughout the cycle. With aging, short cycles are 
interspersed with long cycles where there is no evidence of ovulation.  Aging follicles have fewer 
granulosa cells and these cells are less responsive to LH (25).    
Aging in mares also affects development of the dominant follicle.  In mares over 20 years 
of age, development of a dominant follicle and delayed emergence of subordinate follicles is a 
common occurrence (12).  Major anovulatory waves precede the wave that initiates ovulation.  
Similarly to women, the major anovulation wave has been reported to occur in horses and other 
monovular species.  Mares are also reported to have anovulatory and ovulatory seasons with the 
transition between these seasons occurring in the spring (13).   
Changes in the ovarian cycle in both humans and mares are associated with decreased 
pregnancy rates.  Healy et al. (1994) showed that fecundity in middle-aged women decreased 
about 50% as women aged from 25 to 35 years (26).  In Amish women who did not use 
contraceptives, the median age for the last birth was 38.5 years and only about 7% of births 
occurred in women between 40 and 44 years of age. The age of women at last delivery was 10 
years before the age at menopause (27).  In mares, overall fertility in mares begins to decrease in 
at approximately 12 years of age and then declines linearly until the late 20s. Madill (2002) 
showed that the conception rate per cycle was 57% in younger mares (2-11 years) and 31% in 
older mares (>14 years) while foaling rates per cycle were 51% and 13%, respectively, and foaling 
rates per season were 82% and 48%, respectively (28).   
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1.4: Metabolic disorders can accompany aging and affect follicular development 
 In addition to aging, fertility in women and mares may be affected by metabolic disorders.  
Obesity modifies the aging process through effects on energy homeostatic mechanisms. Obesity 
may contribute indirectly to the development of age-related diseases such as diabetes mellitus and 
atherosclerosis (29).  Aging is one of the most common causes of impaired leptin sensitivity (30).  
Leptin is a hormone secreted by adipocytes that can cause suppression of appetite.   
  Changes in fat distribution associated with the onset of metabolic disorders may cause the 
accumulation of lipids in the adipose tissue, particularly in the abdomen.  In women, menopause 
is associated with an increase in intra-abdominal fat, perhaps as a result of loss of ovarian function.  
Ovariectomy in rats resulted in weight gain and increased intra-abdominal fat deposition.  In 
knock-out mice that have aromatase defect or loss of estrogen receptor α, obesity and associated 
metabolic disorders are common (31,32).  Menopause does not seem to affect androgen production 
as adrenal glands continue to secrete androgen precursors such as dehydroepiandrosterone-sulfate 
(DHEA-S) and androstenedione (33). 
1.5: Cellular metabolism, AMP kinase activity and aging 
AMP-activated protein (AMP) kinases are active during decreases in overall cellular 
energy and increases ATP production while decreasing energy-utilization in anabolic processes 
(34,35).  AMP kinase (AMPK) is a heterotrimeric enzyme that is evolutionarily conserved from 
yeast to mammals and functions to maintain cellular and whole body energy homeostasis.  
The 5’ AMPK-activated protein kinase is serine/threonine protein kinase (34,36).  There 
are two genes encoding isoforms of both α and β subunits (α1, α2, β1 and β2) and three genes 
encoding isoforms  subunit 1, 2 and 3.  The AMPK holoenzyme consists of one catalytic 
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subunit α and two functionally and structurally different regulatory subunits (β, γ). Two isoforms 
have been identified for α, and β subunits α1, α2, β1, β2, and three isoforms have been identified for 
the γ -subunits, γ 1, γ 2, and γ 3 (37).  AMP binds AMPK via two cystathionine beta synthase (CBS) 
domains on the  subunit and activates AMPK by an allosteric mechanism (Figure 1.2).  AMP 
makes AMPK a better substrate for upstream kinase and poorer substrate for phosphatases 
(31,38,39) perhaps because binding of AMP to γ subunits is opposed by ATP.  Generally, the ratio 
of AMP to ATP ratio is an indicator of AMPK activity (31).  A decrease in the AMP to ATP ratio 
leads to increased AMPK activity during exercise (40-42).    
 AMP kinases play a number of roles in glucose utilization in tissues.  In mammals insulin 
promotes lipid, protein, and glycogen synthesis, whereas AMPK inhibits these biosynthetic 
pathways. The effect of insulin on protein synthesis is mediated in part by activation of mTOR 
pathway via phosphorylation of TSC2, whereas activation of AMPK causes phosphorylation of 
different sites on TSC2 and inhibits mTOR (43,44); (Figures 1.3 and 1.4).  Signaling via insulin 
or IGF-1 affect AMP kinase activity.  AKT, a protein kinase in the insulin and IGF-1 pathway, 
induces phosphorylation of AMPK at ser485/ser491 which subsequently inhibits the phosphorylation 
of AMPK at thr172 by LKB which suppresses AMPK activity.  In addition, AMPK activation 
suppresses the signaling by insulin and IGF-1 pathway by phosphorylating insulin receptor 
substrate (IRS) at ser794 and, as a result, inhibiting signaling of insulin and IGF-1 pathway to AKT 
mTOR in smooth muscle (45).  Winder and Hardie (46) have suggested that AMPK activators may 
be useful in the treatment of Type II diabetes.   
AMPK also stimulates glucose transport and glycolysis.  In the heart, glucose uptake is 
mediated primarily by GLUT4.  AMPK stimulates GLUT4 translocation to the sarcolemma (47) 
via an indirect mechanism.  Phosphorylation of Rab GTPase-activating proteins regulate Rab10, 
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which modulates docking and fusion of GLUT4 vesicles with the plasma membrane.  In addition, 
AMPK may inhibit endocytosis of GLUT4 in cardiomyocytes thus increasing sarcolemma GLUT4 
content and glucose transport (48). 
AMPK also affects glucose metabolism by indirectly increasing the activity of 
phosphofructokinase-1, the rate-limiting enzyme in glycolysis. Activated AMPK directly 
phosphorylates and stimulates phosphofructokinase-2 to synthesize fructose 2, 6-bisphosphate, 
which in turn allosterically activates phosphofructokinase-1.  Thus increases in myocardial glucose 
transport and glycolysis are important components of the metabolic response to ischemia or 
hypoxia.  Insulin and AMPK can also cooperate to regulate plasma glucose levels. In skeletal 
muscle, both insulin and AMPK activation stimulates glucose uptake via increased translocation 
of GLUT4 to the plasma membrane.   
AMPK activity is affected by aging, probably resulting from its interactions with mTOR 
(49).  With aging, there are reported increases in the AMP/ATP ratio (50-52), lower levels of 
AMPK in muscle (53,54) and a decrease in the responsiveness of AMPK signaling (55).  
Moreover, the baseline activity of AMPK was higher in older animals compared to younger 
animals (54).  Such changes may contribute to a decrease in AMPK responsiveness to metabolic 
stress.   These observations are also consistent with the “rate-of-living” theory of aging that 
hypothesizes that excessive consumption of energy enhances the aging process.   
1.6: Changes in metabolic hormones associated with aging and insulin resistance 
Changes in pancreatic function, insulin receptor numbers and post-receptor changes in 
insulin-mediated signaling contribute to insulin resistance seen in aging. Strategies for 
compensating for these aging-related changes include dietary changes, exercise, oral 
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hypoglycemic agents and, with more severe forms, use of insulin.  In addition, metabolic activity 
associated with thyroid function is also affected by aging which can result in lower plasma 
thyroxine (T4) and increased thyrotropin stimulating hormone (TSH).  This is seen in 
approximately 5 to 10% of older women (56) and may be the result of autoimmune disease rather 
that a direct consequence of aging (57,58).  There are also decreases in growth hormone release 
from the pituitary gland and, as a result, a decrease in IGF-I production by the liver.   
Reductions in growth hormone with aging have direct effects on ovarian function.  It binds 
receptors on granulosa, thecal and luteal cells.  Growth hormone and IGF-1 increase the sensitivity 
of ovaries to gonadotropin stimulation and enhance follicular development.   Both IGF-1 and IGF-
2 affect the maturation of the follicle and gamete as well (59).  When growth hormone levels 
decrease, low serum levels of IGF-I prevent the dominant follicle from forming and, in women, 
can result in multiple ovulatory follicles.  Increasing IGF-1 levels restores selection of a single 
dominant follicle (60).  
1.7: Do changes in metabolic function accompany aging in mares?  
These various studies suggest that aging in mares is accompanied by metabolic changes as well 
as changes in ovarian function. The goal of this study was to evaluate the effects of aging on 
expression of genes responsible for hormone responsiveness in granulosa cells in the dominant 
follicle and metabolic activity of those cells in response to both aging and hormone treatment.    
This involved selection of genes involved in insulin-mediated effects on aging and analysis of gene 
expression in granulosa cells from mares of various ages using RT-PCR.   
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1. 8: Hypothesis
We hypothesize that granulosa cells in older animals express less insulin receptor, 
insulin-like growth factor-1 receptor and GLUT4 genes when compared to younger animals. 
These changes in gene expression affect the ability of older animals to respond to insulin 
and alter overall metabolic activity of these animals. 
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Figure 1.1:  Signaling pathways and mediators of ovulation. Ovulatory surges of FSH and LH 
stimulate cells from multiple follicle compartments to transduce signals that collectively lead to 
ovulation. LH signaling is transduced by thecal and mural granulosa cells, whereas FSH signaling 
is transduced by mural granulosa and cumulus cells. Thecal cells secrete IL-1, a cytokine that 
stimulates cumulus cell expansion, and InsL3, a peptide that may trigger a reduction in oocyte 
cAMP levels. Mural granulosa cells secrete EGF-like ligands, growth factors that transduce the 
ovulatory response to the cumulus cells. In addition, they secrete versican and AdamTS-1, both of 
which become components of the cumulus cell matrix. PGE2 generated by cumulus cells promotes 
cAMP production that enhances ovulatory signaling cascades. Oocyte morphogens including 
GDF-9, BMP-15, and BMP-6, and other signaling molecules generated both within and outside 
the follicle, modulate cumulus cell, mural granulosa cell, and theca cell responses to ovulatory 
signals. FSH, follicle stimulating hormone; LH, luteinizing hormone; IL-1, interleukin-1; InsL3, 
insulin-like peptide 3; cAMP, cyclic adenosine mono phosphate; EGF-L, EGF-like ligands; II, 
inter-trypsin inhibitor; PGE2, prostaglandin E2; GDF-9, growth and differentiation factor‐9; 
BMP-15, bone morphogenetic protein‐15; and BMP-6, bone morphogenetic protein‐6. 
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Figure 1.2: Domain structure of α, β and γ subunits of AMPK and their isoforms.  α-subunits;
AID, autoinhibitory domain; α-CTD, alpha C-terminal domain; β-subunits; CBM, carbohydrate-
binding module; β-CTD, C-terminal domain; γ subunits; CBS1, CBS2, CBS3, and CBS4, 
cystathione β-synthase repeats; γ2- NTD, N-terminal extension of ‘‘long’’ version of γ2 subunit; 
γ 3-NTD, N-terminal extension of “long” version of γ 3 subunit. 
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Figure 1.3. AMPK modulates cell-cycle progression and cell growth through mTOR.
mTOR is also involved in changes in insulin receptor function with aging.
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Figure 1.4:  Changes in AMPK function including inhibition of mTOR with aging.   As shown 
here, AMPK activity can be stimulated by energy deficiency and several physiological and 
chemical agents including metformin which is used to treat insulin-resistance.  The decline in the 
sensitivity of AMPK activation with aging disturbs metabolic balance and is associated with 
development of metabolic diseases.  Abbreviations: AAK-2, AMP-activated kinase-2; AICAR, 
5-aminoimidazole-4-carboxamide riboside; AMPK, AMP-activated protein kinase; CaMKKβ,
Ca2+/calmodulin-dependent protein kinase kinase β; CRTC-1, cyclic AMP-regulated
transcriptional co-activator-1; DAF-16, abnormal dauer formation protein-16; FoxO, forkhead
box protein O; LKB1, serine/threonine kinase 11; mTOR, mammalian target of rapamycin; NF-
κB, nuclear factor-κB; Nrf2, nuclear factor-erythroid 2-related factor 2; PP, protein phosphatase;
SIRT1, silent information regulator 1; SKN-1, skinhead-1; TAK1, transforming growth factor-β-
activated kinase 1; ULK1, UNC-51-like kinase 1.
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Figure 1.5. Insulin and IGF-1 bind their receptors with high affinity and have effects on GLUT4 
translocation to the plasma membrane.  Increased signaling by these hormones promotes 
cell growth and energy metabolism.  As shown for insulin receptor in this figure, both IGF-1 
and insulin receptors are made up of two trans-membrane domain subunits with tyrosine-
kinase activity. Any changes in these receptors and signaling is associated with variety 
diseases like cancer and diabetes mellitus. 
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CHAPTER 2: MATERIALS AND METHODS 
2.1:   Introduction to RT-PCR 
Mares are seasonal breeders and limited numbers of granulosa cells are available from a 
single animal. However, robust assays for granulosa cell function are now available that do not 
require large numbers of granulosa cells, e.g. reverse transcription-polymerase chain reaction (RT-
PCR).   Gene expression in response to various ligands as well as changes in metabolic activity 
may result from aging or development of metabolic disease.  We used real-time reverse 
transcription polymerase chain reaction (RT-qPCR) to quantify gene expression in granulosa cells 
in response to FSH, LH, and EGF, insulin like growth factor-1 (IGF-1), insulin, and progesterone. 
We also examined effects of these ligands on expression of the glucose transporter type 4 
(GLUT4), a glucose transporter that is up-regulated by insulin, and on the levels of adenosine 
monophosphate-activated protein kinase (AMPK) which reflects the metabolic activity of 
granulosa cells.  
Polymerase chain reaction (PCR) following reverse transcription (RT) is a preferred 
technique to analyze mRNA expression using small numbers of cells.  High sensitivity RT–PCR 
makes possible quantification of changes in gene expression and evaluation of expression of 
comparatively rare transcripts. There are a number of advantages to this method which combines 
comparatively simple methodology with rapid and reliable outcomes. RT-PCR, as used in our 
studies, indirectly detects mRNA levels following mRNA conversion to cDNA using a fluorescent 
dye, SYBR Green I that binds to the minor groove in double-stranded DNA (62).   
The method used to quantify mRNA levels depends on the target sequence, the amount of 
mRNA in the sample, the level of accuracy desired and whether absolute or relative quantification 
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is needed (61).  There are two primary methods for quantification of mRNA in RT-PCR studies. 
One method achieves relative quantification based expression of the target gene as compared to a 
reference gene.  This technique is used to assess physiological changes in gene expression.  There 
is also a second approach that provides absolute levels of a gene product based on either an internal 
or an external calibration curve (62,63).  The use of a calibration curve helps validate the method 
and confirms whether there are reproducible levels of gene amplification for the mRNA standard 
and for the target cDNA (64-66).  
In our studies, the relative levels of gene expression were determined by comparing the 
level of gene expression of particular gene of interest in a “treated” sample with the level of gene 
expression in an “untreated” sample.  mRNA levels were examined using granulosa cells isolated 
from mature follicles following ovulation or aspiration.  mRNA was reverse transcribed into 
cDNA using the script cDNA Super Mix 5X reaction that contains reverse transcriptase used to 
obtain cDNA.  cDNA was placed in the LightCycle480 PCR system (Roche Applied Sciences) 
using a mixture of 1.0 μl cDNA and 9.0 μl of Master Mix in 384-well plates. Master Mix contains 
both the forward and reverse primers, SYBR Green I and water.  RT-PCR proceeds through 
multiple cycle until the gene of interest is detected at a preset threshold.  Abundant genes require 
fewer cycles for detection while less abundant genes require more cycles.  A limit to the number 
of cycles can also be preset.  In our studies, the PCR cycle conditions were as follows: 94 ºC for 5 
minutes, 40 cycles of 94 ºC for 15 seconds, 60 ºC for 30 seconds, and 72 ºC for 15 seconds, and 
72 ºC for 3 minutes flowed by a melt curve analysis to confirm amplification of single cDNA 
products. Raw Ct values, the number of cycles required for reaching threshold levels of detection, 
were normalized to internal control, and statistic differences were assessed at p < 0.05. 
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RT-PCR standards use reference or housekeeping genes such as glyceraldehyde-3-
phosphate dehydrogenase (G3PDH or GAPDH), albumin, actins, tubulins, cyclophilin, 18S rRNA 
or 28S rRNA (67).  These genes are present in nucleated cells, being necessary for cell survival. 
Although the constitutive synthesis of these genes is generally believed to remain stable under 
experimental treatments (67-69), some studies have shown that these levels of housekeeping genes 
may vary under experimental conditions (70-72).  Nonetheless, for most applications, normalizing 
expression of target transcripts to an endogenous housekeeping gene transcript provides a reliable 
and accurate method for evaluating expression levels of the target gene.  
To compensate for inter-PCR variations, normalization of target gene expression relative 
to an endogenous standard is the first step in assessing target gene expression.  In addition, control 
levels of the standard are included in mathematical modeling of RT-PCR results to standardize 
each reaction.  This allows the user to validate results with respect to the integrity of RNA, the 
efficiency of the reaction and/or variations in loading of the cDNA sample. In addition variation 
in the reproducibility of RT-PCR is almost impossible to eliminate due to the method used to 
isolate mRNA and the enzymes used in RT-PCR reactions.   Nevertheless, the Light Cycler real-
time PCR system using SYBR Green I fluorescence dye provides a reliable method to detect small 
amounts of mRNA and assess the level of mRNA expression. 
2.2:  Granulosa cell culture 
All procedures were done in accordance with the Colorado State University Institutional 
Animal Care and Use Committee. Mares were housed on dry lots with water and hay ad libitum. 
Reproductive tracts of the mares were examined using trans-rectal ultrasound.  Dominant follicles 
were determined based on follicle growth and diameter, relaxed cervical tone and endometrial 
19 
edema. For pre-ovulatory follicle collections, follicular maturation was induced by administration 
of hCG and/or deslorelin (2500 IU and 1.5 mg, respectively, IV), and follicular contents were 
collected by transvaginal, ultrasound-guided follicular aspirations (73).  Generally, equine 
granulosa cells were aspirated in mid-estrus from dominant follicles that were ~35 mm in diameter 
before induction of follicular maturation.  The oocyte in this dominant follicle, together with 
granulosa cells from the follicle, was collected 30-34 h after induction of follicular maturation and 
prior to ovulation from young (4-9 years old), middle age (10-16 years old) and old age (≥ 16 years 
old) estrous mares.  
Granulosa cells were separated from tissue debris and red blood cells using Fico/Lite-
LymphoH (Atlanta Biologicals, GA, Catalog # I40110) gradients and Manufacturer’s instructions.  
Granulosa cells were maintained in plastic tissue flasks in Dulbecco’s Modification of Eagle’s 
Minimum Medium (DMEM; Mediatech, Inc., Manassas, VA), supplemented with 10% fetal 
bovine serum (FBS) (Gemini Bio Products, Woodland, CA), and 200 mM L-glutamine, 10.000 
U/mL penicillin G,10 μg/mL streptomycin, and 25 μg/mL fungizone streptomycin/mL (Gemini 
Bio-Products, Woodland, CA).  
2.3: Cell treatments 
After cells were obtained from mares, cells were divided into two groups. One group of 
cells was serum starved (incubated without fetal bovine serum) and another group of cells was 
incubated with fetal bovine serum and 30mM glucose overnight. At the end of this incubation cell 
culture media was replaced by serum-free media before treating cells with either human epidermal 
growth factor (EGF; Sigma-Aldrich, E9644 SIGMA; 1 μM), Recombinant human IGF-1 (Life 
Technologies, 10 nM), progesterone (PR, Sigma-Aldrich P0130-25G, 100 nM), insulin (Sigma-
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Aldrich I-9278, 100 nM), or hCG (Fitzgerald, 100 nM) for 1 hour.  We then harvested cells by 
soaking dishes in 5 mM EDTA for 5 minutes, removing the EDTA and washing cells using 1x 
PBS.  Cells were washed using 15 ml centrifuge tubes and centrifugation at 300 x g for 3 min.  
This wash was repeated to eliminate any remaining supernatant.  Isolated cells were then used 
immediately or were snap frozen in liquid nitrogen and stored at -80ºC (74). 
2.4: Total RNA isolation 
RNA isolated from samples frozen at -80ºC were treated with insulin, insulin like growth 
factor-1, EGF, human chorionic gonadotropin (hCG), epidermal growth factor (EGF), or 
progesterone (P4).  RNA from these samples was then prepared using the RNeasy Mini kit (Qiagen 
Inc., Valencia, CA, Catalog #74104) according to the manufacturer’s instructions followed by 
DNase digestion with RNase-Free DNase (Qiagen Inc., Valencia, CA, Catalog #79254) to remove 
any residual genomic DNA.   The concentration of purified total RNA was determined by using a 
spectrophotometer at 260nm and 280nm (Nano Drop ND-1000, Nano Drop Technologies Inc., 
Rockland, DE). A ratio of readings at 260 nm and 280 nm (A260/A280) provides an estimate of 
the purity of RNA.  Pure RNA has an A260/A280 ratio of 1.7 or greater.  An A260/A230 ratio of 
2.0 or greater was used to select samples for analysis (75), and samples were then stored at -80ºC. 
2. 5:    Reverse transcription of mRNA
Messenger RNA was reverse transcribed into cDNA using the qScript cDNA Super Mix 
(Quanta Biosciences, Inc., Gaithersburg, MD) 5X reaction.  Reverse transcriptase was used to 
obtain cDNA (complementary DNA) from RNA that was extracted from our samples.  We used 
600ng of RNA per sample to obtain cDNA. Briefly, 5µl of RNA was combined with nuclease free 
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water and qScript Super Mix.  RNA was reserve transcribed by incubating the samples at 25ºC for 
5 minutes, 42 ºC for 30 minutes, and 28 ºC for 5 min, cDNA was used immediately for real time 
PCR analysis. 
2.6: Primer design, testing and sequencing 
Primers for ten equine genes, AMPKα1, AMPKα2, AMPKβ1, AMPKβ2, AMPKγ1, 
AMPKγ2, AMPKγ3, IGF-1, GLUT4, and IR, were designed using an online database at 
NCBI.nlm.nih.gov.  Oligonucleotide primers were purchased from (Euro Fins, Huntsville, AL).    
The primer sequences for the ten genes examined are shown in Table 2.1.  Also the primer 
sequences for the three housekeeping genes (HK), GAPDH, ACTB, and SADH, are shown in 
Table 2.2.  To ensure that only the target gene sequence was amplified, the primers were tested 
for efficiency by making a standard curve against pooled samples of equine granulosa cells that 
expressed the genes of interest, therefore serving as positive control.  In addition PCR products 
were run on a 2% agarose gel and visualized using ethidium bromide. A Qiaquick Gel Extraction 
Kit (Qiagen, Valencia, CA, Catalog # 28704) was used to extract and purify DNA of 70bp to 10 
kb from standard 2% agarose gel (Figure 2.1). These steps were performed to test for the 
accurate sequencing of specific primers and to verify that granulosa cells had the genes of 
interest to us. We also tested primers for their optimal temperature  56°C, 58°C, 60°C, and 62°C 
followed by use of gel separation to verify that the specific amplicon produced a single band of 
the correct size. The sample was washed with buffer PE to rinse away remaining gel and eluted 
in nuclease-free water. Samples were prepared to be sent for sequencing to the Colorado 
State University Proteomics Facility, Fort Collins, CO. 
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2. 7: Confirmation of primer specificity
Specificity of RT–PCR products was documented with high resolution gel electrophoresis 
(Figure 2.1) and resulted in a single product with the desired length. Light Cycler melting curve 
analysis was also performed which resulted in a single product-specific melting temperature, No 
primer “dimers” were generated during 40 RT-PCR amplification cycles. 
2. 8: Real-time PCR quantification of mRNA
The relative expression of ten genes involved in insulin signaling and AMPK activity 
(AMPKα1, AMPKα2, AMPKβ1, AMPKβ2, AMPKγ1, AMPKγ1, AMPKγ3, IGF-1, GLUT4, and IR) 
and three genes serving as internal control (GAPDH, ACTB, and SADH) were examined using RT-
PCR.  Amplification efficiencies were determined using a 10-fold serial dilution series. Analysis 
was performed in 10 µl reactions containing Sso Fast Eva Green Super mix (Bio-Rad, Hercules, 
CA), 0.5 µM gene specific forward and reverse primer, and cDNA using a Roche Light Cycler® 
480 Real-Time PCR System.  Eva Green dye is a fluorescent nucleic acid dye that is not toxic with 
safe handling and is easily disposed. It is far brighter than SYBR green 1 for detecting 
amplification due to novel DNA binding mechanisms. It is stable during storage and under PCR 
conditions, in addition, electrophoretically separated PCR products can be visualized directly via 
a UV box without the need for another gel stain. To ensure highly specific amplification, Eva green 
is used because it has the ability to bind and detect any dsDNA generated during amplification. 
The sequence of temperatures used in gene amplification were as follows: 94ºC for 5 minutes, 40 
cycles of 94ºC for 15 seconds, 60ºC for 30 seconds, 72ºC for 15 seconds, and 72 ºC for 3 minutes. 
As discussed above, a melt curve analysis was performed to confirm amplification of single PCR 
products.  
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2. 9: Data analysis of RT-PCR
 The principle of RT-PCR quantification read-out is to determine the number of PCR 
cycles, i.e. the cycle threshold, Ct, as described by Schmittgen and Livak (76) and calculating the 
geometric mean of housekeeping genes expression values for use as a normalization factor.  Ct is 
proportional to the logarithm of the initial amount of target in a sample.  The relative concentration 
of one target with respect to another is reflected in the difference in cycle number, ΔCt, necessary 
to achieve the same level of fluorescence (76). We use the formula 2-ΔCT to calculate ΔCt and to 
normalize our data. Prior to beginning these experiments, we confirmed our primer efficiency and 
specificity via PCR and sequencing (Go-Tag, Promega). We compared the level of gene expression 
of particular gene of interest in treated sample relative to the level of gene expression in untreated 
samples. Fold-change between treated and untreated samples was calculated as 2 ‾∆∆Ct. 
2.10: Statistical analysis 
SAS mixed procedure for repeated measures analysis was conducted for these data. 
Analysis was done using SAS Proc Mixed.  A total of n=18 horses were is included in this study 
(six young mares, four middle aged mares and eight older mares).   A repeated measure’s analysis 
was conducted for each gene (10 levels) and control +/- FBS and 30nM glucose separately. The 
response used log transformed expression to satisfy the assumption of normality. The “between 
subjects” factor was age (young, middle-aged and old mares) and the “within subjects” factor was 
treatment (12 levels).  Tukey adjusted pairwise comparisons of treatments were considered when 
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Tukey adjusted pairwise comparisons were used.  Dr. Hess also validated that the log transform of 
our data helped to satisfy model assumptions.  
Dr. Hess also performed the following tests.  TEST 1 gave the ANOVA F-tests for each 
variable.  TEST 2 provided pairwise comparisons on main effects (Age Category or Age) for each 
variable or gene.  The medium used for preincubation is indicated in her analyses as “m” for cells 
incubated in –FBS/-30nM glucose medium and “p” for cells incubated in +FBS/+30nM glucose.  
TEST 3 gave slice comparisons or interaction comparisons.  As a caution, Dr. Hess indicated that 
back transformed means might be substantially lower than the means in the original scale, 
particularly when the transformation is of ln y.  In addition, there were instances where adding a 
constant was required to calculate log values when there were zeros in the data.  A summary of 
Dr. Hess’ statistical analysis is included in Appendix I, II, and III. 
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Table 2.1: Sequences of the ten genes of interest used in this project including AMPKα1, 
AMPKα2, AMPKβ1, AMPKβ2, AMPKγ1, AMPKγ1, AMPKγ3, IGF-1, GLUT4, and IR. 
Equine Gene Sequence Amplicon size bp 
eIGF1-F CTCTTCTACCTGGCCCTGTG 225 
eIGF1-R CTCCAGCCTCCTCAGATCAC 
eIR-F CTACCTGGCCACCATTGACT 226 
eIR-R GCAGCCGTGTGACTTACAGA 
eGLUT4 F GGTCATCAATGCCCCACAGA 573 
eGLUT4 R CGGCTGATGTAGAGGTAGCG 
eAMPK alpha1-F GACAGCCGAGAAGCAGAAAC 223 
eAMPK alpha1-R AGGATGCCTGAAAAGCTTGA 
eAMPK alpha2-F GACGGGTTGAAGAGATGGAA 250 
eAMPK alpha2-R CCTGCATACAATCTGCCTGA 
eAMPK beta 1-F CGACCCTTCTGAGCCAATAG 239 
eAMPK beta 1-R GGATGACCTGGAGCAGATGT 
eAMPK beta2-F ACTTTGTTGCCATCCTGGAC 219 
eAMPK beta2-R AGCTGGAAAGGTCTCGACAA 
eAMPK gamma1-F GGGTGTCCTCAAGTGCTACC 506 
eAMPK gamma1-R GGTGAGGTGTGGGATCTCT 
eAMPK gamma2-F GTAGCCAATGGTGTTCGTGC 501 
eAMPK gamma2-R CACTACAGGCAAGGCTGACA 
eAMPK gamma3-F GCTGGTCATCTTCGACACCA 519 
eAMPK gamma3-R AAGATGTCCAGTGCGGTCAG 
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Table 2.2: Sequences of the three housekeeping genes used in this project. 
Equine Gene Sequence Amplicon size bp 
1. SDHA-F GCAGAAGAAGCCATTTGAGG 223 
SDHA-R CCTGTCGATTACGGGTCTGT 
2. ACTB-F CGACATCCGTAAGGACCTGT 250 
ACTB-R CAGGGCTGTGATCTCCTTCT 
3. GAPDH-F AGAAGGAGAAAGGCCCTCAG 239 
GAPDH-R GGAAACTGTGGAGGTCAGGA 
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Figure 2.1:  Images of gel electrophoresis using 2% agarose gel and visualization of primers 
using ethidium bromide staining of the primers and base pair molecular markers. Each panel 
shows a single band of the correct size for the gene being examined.     
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CHAPTER 3: RESULTS 
3. 1: Introduction
The data presented here were obtained from mares within the three age groups described in 
Materials and Methods.  For each animal, a complete data set was obtained which included ∆Ct 
values for cells pre-incubated in either -FBS/-30nM glucos or +FBS/+30nM glucose  medium and 
subsequently treated with insulin, IGF-1, EGF, P4 or hCG.  The complete results for each pre-
incubation condition and treatment are summarized in Tables 3.4 - 3.13 at the end of this chapter.    
3. 2: Comparison of the effects of medium containing -FBS/-30nM glucose  and medium
containing +/FBS/+30nM glucose glucose on ∆Ct values for IR, IGF-1R and GLUT4 
expression.   
With the exception of significantly lower IR expression in granulosa cells from older 
animals pre-incubated with +FBS/+30nM glucose  compared to cells pre-incubated in -
FBS/-30nM glucose (p<0.02), ∆Ct values for IGF-1R, IR or GLUT4 expression did not 
differ significantly for otherwise untreated granulosa cells from young, middle or older animals 
pre-incubated in medium containing either -FBS/-glucose or +FBS/+30nM glucose  (Figure 3.1).   
Figure 3.2 summarizes the values for IR gene expression in control granulosa cells and in 
hormone-treated cells preincubated with medium containing -FBS/-30nM glucose  or 
+FBS/+30nM glucose.  There was no significant effect of hormone treatment in cells pre-incubated
in medium containing +FBS/+30nM glucose.  There was, however, a significant increase in IR 
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expression following treatment with insulin in older animals compared to treatments with hCG, 
P4, EGF or IGF-1 (Figure 3.3) when FBS and glucose were absent from pre-incubation medium.  
The insert in Figure 3.3 shows values for mean ln y where y = 2-Ct which were used for statistical 
analysis of these results.  
Figure 3.4 summarizes the values for IGF-1R gene expression in control granulosa cells 
and with hormone treatment for cells preincubated with medium containing -FBS/-30nM glucose 
or +FBS/+30nM glucose.  As shown in Figure 3.5, there was a significant increase (p<0.03) in 
expression of IGF-1R in older animals (>16 years) relative to young aged mares (4-9 years) and 
middle-aged mares (10-16 years) in medium containing +FBS/+30nM glucose. The insert in 
Figure 3.5 shows the values for the mean ln y where y = 2-Ct for middle and older animals.  There 
were also significantly more IGF-1R expressed in EGF-treated cells compared to IGF-1-treated 
cells (p<0.03) in granulosa cells from older animals incubated in medium containing +FBS/+30nM 
glucose  (Table 3.).  There were no significant differences in effects of hormone treatments on 
IGF-1R expression for any age groups (Figure 3.4).   
3. 3: Effect of IR and IGF-1R expression on the predicted numbers of insulin receptors and
IGF-1 receptors assembled in individual animals.  
To examine the relationship between IR and IGF-1R expression in individual animals, Ct 
values were expressed as a ratio of the Ct for IR to the Ct for IGF-1R for each animal and then 
pooled by age (Table 3.1).  This was done for granulosa cells incubated without (-) or with (+) 
FBS/30nM glucose  and for untreated cells and cells treated with 100 nM insulin or 100 nM IGF-
1 100 nM hCG or 1 M EGF.   
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Assuming that assembly of IR homodimers, IGF-1R homodimers and IR·IGF-1R hybrid 
receptors is dependent on available IR and IGF-1R monomers, a ratio of Ct for IR relative to Ct 
for IGF-1R  of 1.0 could be expected to produce assembly of equal numbers of IR2 homodimers, 
IR.IGF-1R  hybrid receptors and IGF-1R2 homodimer in the endoplasmic reticulum (77).  When 
ratios of Ct for IR relative to Ct for IGF-1R are greater than 1.0, synthesis of IR monomers is 
expected to be lower than synthesis of IGF-1R monomers from these genes in the endoplasmic 
reticulum.  Thus there will be increased formation of IGF-1 receptor homodimers and IR.IGF-1R 
hybrid receptors compared to insulin receptor homodimer formation such that IGF-1R2 = IR·IGF-
1R hybrid receptors > IR2.  Similarly, when ratios of Ct for IR relative to IGF-1R are less than 
1.0, synthesis of the IR monomer expression is increased relative to IGF-1R monomer and there 
is a predominance of IR2 homodimers assembled in the endoplasmic reticulum.  Individual young 
animals thus differ significantly from middle-aged and older animals with respect to relative 
expression of IR and IGF1R genes.  In untreated granulosa cells from young animals, values for 
the ratio of Ct of IR to CT of IGF-1R ranged from 1.26-1.54 suggesting that there may be 
increased overall synthesis of IGF-1R monomers in the endoplasmic reticulum and, as a result, an 
increase in assembly of IGF-1R2 homodimers and hybrid receptors.  By contrast, in control 
granulosa cell populations of older animals (+FBS/+30nM glucose), the ratio is about 0.89 ± 0.19.  
We would expect that IR2 homodimers would be the predominant receptor assembled and 
expressed in the plasma membrane.   
3. 4:  Effects of the IR: IGF-1R on GLUT4 expression.
The question raised by the above results is whether granulosa cell function differs as a 
result of these age-dependent shifts in the ratio of Ct for IR relative to Ct for IGF-1R. Results 
31 
for GLUT4 expression in pre-incubation medium containing either -FBS/-30 nM glucose or 
+FBS/+30 nM glucose  are shown in Figure 3.6.   GLUT4 expression differed significantly between
young and older animals (p<0.05) in +FBS/+30 nM glucose -containing medium (Figure 3.7). 
Older animals demonstrated higher levels of GLUT4 expression for each of the treatments shown 
including insulin treatment. Whether this is due to higher levels of IR expression or other properties 
of granulosa cells is not known.  Middle-aged animals, predicted to express higher overall levels 
of IR related to IGF-1R, did not show a similar response.  It is also important to note that, in 
medium without FBS or glucose, there was no significant difference in the expression of IR or 
IGF-1R or the ratio of IR:IGF-1R for any age group. 
3. 5: Effects of aging or hormone treatment on AMPK subunit expression
We also examined expression of various subunits of AMP-activated protein kinase 
including 1 and 2, 1 and 2 and 1, 2 and 3 subunit isoforms.  AMPK is a heterotrimeric 
kinase formed from ,  and  subunits where the  subunit is the catalytic subunit and the  and 
 subunits serve regulatory functions (78).  AMPK functions as a metabolic regulator that can 
switch usage of ATP during metabolic stress away from ATP-dependent anabolic pathways (79).  
There were age-dependent effects on expression of AMPK 1 (Figure 3.8).  Young and older 
animals differed significantly in values for Ct AMPK 1 in the absence of FBS/30nM glucose 
(p<0.006) with higher expression of AMPK1 in older animals. Insulin treatment also affected 
AMPK1 expression following pre-incubation in either -FBS/-30nM glucose  compared to 
+FBS/+30nM glucose  (p<0.03) with higher expression in medium containing -FBS/-30nM glucose.
These data are indicated by a bar connecting the two Ct values. 
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 There were also significant age-related differences in expression of other AMPK subunits 
which are summarized in (Table 3.4).  Noteworthy were differences in responses to insulin 
treatment in young or middle-aged animals and older animals for AMPK β1 and AMPK3 subunits 
where insulin treatment consistently increased expression in cells from older animals when cells 
were-pre-incubated in -FBS/-30nM glucose  but not +FBS/+30nM glucose  medium.   
For middle aged and older animals but not young animals, differences in Ct values for 
expression of untreated cells or cells treated with insulin, hCG, EGF, IGF-1 or P4 were often 
significant within a given age group (Table 3.5).  In middle-aged animals, there was significant 
differences in expression of a specific AMPK subunit when cells were pre-incubated in 
+FBS/+glucose medium.  As examples, there were differences in the expression of AMPK1 gene
between insulin-treated and EGF-treated cells (p < 0.04), and insulin treatment and progesterone 
treatment (p < 0.03) with higher expression of AMPK1 in response to insulin in both examples.  
Also, in middle-aged mares, there was greater expression of AMPK2 in cells pre-incubated in 
+FBS/+30 nM glucose  medium in insulin-treated cells when compared to hCG treatments (p <
0.02), EGF treatment (p < 0.01), and progesterone treatment (p < 0.05). In middle-aged animals, 
there were significant effects on AMPK1 expression following preincubation with +FBS/+30 nM 
glucose  medium between control and EGF treatments (p < 0.004), and between insulin and EGF 
treatments (p < 0.05) insulin and progesterone treatments (p < 0.02), and hCG and EGF treatments 
(p < 0.02). 
 For expression of AMPK2 the only effect of treatment occurred in middle aged mares 
when cells were preincubated in +FBS/+30nM glucose  medium between insulin and progesterone 
treatments (p < 0.02). For AMPK1, there was no significant differences in expression for cells 
preincubated with or without FBS and 30nM glucose or for treated cells.  In expression of AMPK2 
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in middle age there was a significant effect following pre-incubation in +FBS/+30 nM glucose 
medium when comparing treatment with IGF-1 and progesterone (P4) (p < 0.04). 
In older animals, AMPK2 gene expression was significantly different between control 
samples obtained from medium containing +FBS/+30 nM glucose  and EGF-treated samples (p < 
0.04). AMPK3 expression was significantly affected in old aged animals pre-incubated in either 
in -FBS/-30 nM glucose or + FBS/+30 nM glucose media in old age.  In absence of glucose and FBS 
there was a significant effect between insulin and EGF treatments (p < 0.001), and between insulin 
and IGF-1 treatments (p < 0.03) as well as between hCG and EGF treatments (p < 0.04).   In 
presence of FBS and 30nM glucose, there were significant effects between hCG and control (p < 
0.02), hCG and EGF treatments (p < 0.04), and between hCG and IGF-1 treatments (p < 0.02).    
. 
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Figure 3.1: ΔCt values for IR, IGF-1R and GLUT 4 expression in granulosa cells incubated with 
(+) or without (-) FBS and 30 nM glucose.  As shown on the x-axis, lower values for ΔCt 
reflect  higher expression of a particular gene.  There was no significant difference between IR, 
IGF-1R or GLUT4 expression between young, middle or old mares with the exception of IR 
expression in older animals where older animals express less IR following pre-incubation in 
medium containing +FBS/+30 nM glucose  (p< 0.02).  This is indicated as a line between values 
for IR expression.
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Figure 3.2: Fold change in IR expression in granulosa cells from young, middle, and old 
mares following pre-incubation in either +FBS/+30 nM glucose  media or media without 





















































Figure 3.3:  Fold change (2-ΔΔCt) in expression of IR relative to control values (1.0) with 
insulin, hCG, EGF, IGF-1 and P4 treatments for granulosa cells incubated in medium 
containing -FBS/-30nM glucose  from young, middle and old animals.  The insert shows 
mean ln 2-ΔΔCt which, for statistical purposes, was calculated for each animal. Using ln 2-
ΔΔCt, old animals had statistically higher expression of IR with insulin treatment.
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Figure 3.4: Fold change in IGF-1R expression in granulosa cells from young, middle, and 
old mares pre-incubated in media containing either +FBS/+30 nM glucose  or -FBS/-30 nM 
glucose older animals had significantly higher expression of IGF-1R.. Also there was significant higher 
























































Figure 3.5:  Fold change (2-ΔΔCt) in expression of IGF-1R relative to control values (1.0) with 
insulin, hCG, EGF, IGF-1 and P4 treatments for granulosa cells from young, middle and old 
animals incubated in medium containing FBS and 30nM glucose .  The insert shows the mean ln 
2-ΔΔCt values for granulosa cells from individual middle aged and old aged animals with EGF
treatments which were used for statistical evaluation of these data.     
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Figure 3.6: Fold change in GLUT4 expression in granulosa cells from young, middle, and old 
mares pre-incubated in media containing either +FBS/+30nM glucose (lower panel) or -















































Figure 3.7: GLUT4 expression in granulosa cells from young and older mares incubated with 
+FBS/glucose medium.  After overnight incubation, cells were treated with insulin, hCG, EGF,
IGF-1 or progesterone (P4).  EGF and IGF-1 significantly increased GLUT4 expression in older 
animals compared to young animals (p<0.05). 
41 
Figure 3. 8:  Expression of AMPK β1 showing higher expression of AMPK β1 in older mares 
(p<0.006).  The red bar connecting ∆Ct values for insulin treatment (-FBS/-30nM glucose) and
insulin treatment (+FBS/+30nM glucose) indicates a significant difference in the effect of medium 
on AMPK β1 with higher expression in cells pre-incubated in -FBS/-30nM glucose  (p<0.03).  
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Table 3.1: The ratio ΔCt (IR) to ΔCt (IGF-1R) for individual animals and predicted effects of 
these ratios on expression of insulin receptor homodimers and IGF-1R homodimers. Note that, as 
ΔCt values increase, the amount of mRNA expressed decreases. Thus, ratios of ΔCt (IR) to ΔCt 
(IGF-1R) > 1, are predicted that IGF-1R monomers should be the predominant species expressed 
in granulosa cells and that these cells will contain increased numbers of IGF-1R and hybrid 
receptors formed from insulin and IGF-1R monomers.  When ratios are < 1, insulin receptors 
will be the predominant receptors found on granulosa cells. 
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Table 3.2:  Significant differences in expression of AMPK subunits with age. The AMPK subunit 
gene is shown in the left column. Treatments producing significant differences between young 
and old animals or middle-aged and old animals, values for 2-∆∆Ct comparing young or middle-
aged animals with older animals and p values are shown in the columns to the right. 
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Table 3. 3:  Significant differences in expression of AMPK subunits with various treatments. The 
AMPK subunit    gene is shown in the left column. Values for ∆CT for a specific treatment and values for
2-∆∆Ct between two treatments where there were significant differences are shown in the columns to the
right. 










Table 3. 4:  ∆Ct and fold change (2-∆∆Ct) in IR expression: 
Age Number Treatment Medium Δ Ct ± SE Mean Y ± SE 
Fold change 
Mean ln Y± SE 
Fold change 
Young 6 None - 10.85 ± 1.16 1.00 ± 0.00 1.00 ± 0.00 
6 Insulin - 10.21 ± 0.71 3.25 ± 0.41 0.41± 0.63 
6 hCG - 10.84 ± 0.66 1.84 ± 0.77 0.00 ± 0.57 
6 EGF - 11.40 ± 0.80 1.26 ± 0.54 - 0.38 ± 0.56
6 IGF-1 - 10.94 ± 1.14 1.53 ± 0.62 - 0.07 ± 0.47
6 P4 - 10.69 ± 0.94 2.38 ± 1.15 0.11 ± 0.58 
6 None + 11.40 ± 0.66 1.00 ± 0.00 1.00 ± 0.00 
6 Insulin + 11.12 ± 0.88 2.66 ± 1.82 - 0.28 ±0.81
6 hCG + 11.51 ± 0.93 0.72 ± 0.16 - 0.55 ± 0.36
6 EGF + 12.08 ± 0.83 0.55 ± 0.13 - 0.94 ± 0.48
6 IGF-1 + 12.06 ± 0.64 0.55 ± 0.11 - 0.93 ± 0.51
6 P4 + 12.37 ± 1.18 0.57 ± 0.21 - 1.15 ± 0.55
Middle 4 None - 8.34 ± 0.44 1.00 ± 0.00  1.00 ± 0.00 
4 Insulin - 9.20 ± 0.25 0.61 ± 0.14 - 0.59 ± 0.27
4 hCG - 9.16 ± 0.28 0.70 ± 0.25 - 0.57 ± 0.37
4 EGF - 9.20 ± 0.61 0.78 ± 0.43 - 0.72 ± 0.59
4 IGF-1 - 10.22 ± 0.83 0.42 ± 0.22 - 1.21 ± 0.46
4 P4 - 8.84 ± 0.37 0.95 ± 0.35 - 0.34 ± 0.49
4 None + 10.16 ± 0.74 1.00 ± 0.00 1.00 ± 0.00 
4 Insulin +  9.28 ± 0.59 1.95 ± 1.00 0.27 ± 0.49 
4 hCG +  9.38 ± 0.75 5.15 ± 4.15 0.58 ± 0.83 
4 EGF +   10.63 ± 1.12 1.10 ± 0.34 - 0.02 ± 0.27
4 IGF-1 + 8.83 ± 0.39 2.15 ± 0.78 0.55 ± 0.39 
4 P4 + 10.33 ± 0.67 0.89 ± 0.89 - 0.12 ± 0.81
Old 8 None -  9.10 ± 0.60 1.00 ± 0.00 1.00 ± 0.00 
8 Insulin -  8.19 ± 0.54 3.47 ± 1.73   0.63 ± 0.41 a 
8 hCG - 10.11 ± 1.19 1.91 ± 1.04 - 0.70 ± 0.97 b
8 EGF - 10.50 ± 1.29 2.89 ± 2.22 - 0.97 ± 1.08 b
8 IGF-1 - 10.22 ± 1.22 4.03 ± 3.23 - 0.78 ± 1.04 b
8 P4 - 11.08 ± 1.23 4.30 ± 3.57 - 0.68 ±  1.02 b
8 None + 11.07 ± 1.33 1.00 ± 0.00 1.00 ± 0.00 
7 Insulin +  9.69 ± 0.60 1.88 ± 0.66 0.15 ± 0.45 
8 hCG +  9.02 ± 1.77 12.99 ± 10.37 0.69 ± 0.69 
8 EGF + 10.38 ± 1.56 12.47 ± 10.77 0.48 ± 0.70 
8 IGF-1 + 11.33 ± 1.20 1.39 ± 0.53 - 0.18 ± 0.38
8 P4 + 10.29 ± 1.28 12.76 ± 7.87 0.54 ± 0.79 
a,b Values with different superscripts were (p < 0.001) significantly different 
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Table 3. 5: ∆Ct and fold change (2-∆∆Ct) in IGF-1R expression 
Age Number Treatment Medium Δ Ct ± SE Mean Y ± SE 
Fold change 
Mean ln Y± SE 
Fold change 
Young 6 None - 8.67 ± 0.98 1.00 ± 0.00 1.00 ± 0.00 
6 Insulin - 8.76 ± 1.45 2.41 ± 0.77 -0.09 ± 0.96
6 hCG - 9.61 ± 1.59 1.47 ± 0.53 -0.66 ± 0.94
6 EGF - 9.85 ± 1.50 1.19 ± 0.47 -0.82 ± 0.94
6 IGF-1 - 10.50 ± 1.52 0.75 ± 0.29 -1.27 ±0.89
6 P4 - 8.62 ± 1.56 2.66 ±1.29 0.03 ± 0.70 
6 None + 8.78 ± 1.15 1.00 ± 0.00 1.00 ± 0.00 
6 Insulin + 9.98 ± 1.56 1.83 ± 1.02 -0.83 ± 0.92 a
6 hCG + 10.93 ± 1.49 0.51 ± 0.17 -1.49 ± 0.79 a
6 EGF + 10.45 ± 1.44 0.58 ± 0.16 -1.15 ± 0.69 a
6 IGF-1 + 10.30 ± 1.72 1.11 ± 0.57 -1.05 ± 0.94 a
6 P4 + 10.24 ± 1.49 0.67 ± 0.22 -1.01 ± 0.62 a
Middle 4 None - 10.49 ± 0.30 1.00 ± 0.00 1.00 ± 0.00 
4 Insulin - 11.01 ± 0.93 1.05 ± 0.42 -0.36 ± 0.62
4 hCG - 9.59 ± 1.51 4.27 ± 1.67 0.62 ± 1.06 
4 EGF - 9.64 ± 1.56 4.67 ± 2.86 0.45 ± 1.15 
4 IGF-1 - 11.87 ± 1.13 1.00 ± 0.59 -0.87 ± 0.92
4 P4 - 11.23 ± 1.52 2.38 ± 1.82 -0.51 ± 1.16
4 None + 11.35 ± 0.66 1.00 ± 0.00 1.00 ± 0.00 
4 Insulin + 10.01 ± 1.39 2.43 ± 0.96 0.59 ± 0.48 
4 hCG + 10.32 ± 1.24 4.27 ± 3.01 0.76 ± 0.64 
4 EGF + 8.72 ± 0.93 10.44 ± 3.90 2.12 ± 0.40 
4 IGF-1 + 10.44 ± 1.13 1.74 ± 0.86 0.26 ± 0.42 
4 P4 + 11.24 ± 1.71 5.34 ± 4.81 0.08 ± 1.03 
Old 8 None - 10.45 ± 1.36 1.00 ± 0.00 1.00 ± 0.00 
8 Insulin - 10.29 ± 1.84 1.86 ± 0.71 0.18 ± 0.35 
8 hCG - 10.28 ± 1.58 3.65 ± 1.39 -0.51 ± 1.09
8 EGF - 11.72 ± 1.74 28.17 ± 25.73 -0.81 ± 1.61
8 IGF-1 - 10.28 ± 1.51 29.40 ± 27.10 0.18 ± 1.16 
8 P4 - 10.86 ± 1.34 14.57 ± 13.20 -0.22 ± 1.07
8 None + 12.42 ± 1.44 1.00 ± 0.00 1.00 ± 0.00 
8 Insulin + 11.40 ± 1.51 5.63 ± 2.90 0.71 ± 0.58 b 
8 hCG + 9.97 ± 1.74 41.58 ± 1.62 1.03 ± 0.75 b 
8 EGF + 9.65 ± 1.60 82.55 ± 1.82 1.29 ± 1.05 b 
8 IGF-1 + 11.51 ± 1.43 4.52 ± 2.35 0.63 ± 0.54 b 
8 P4 + 11.33 ± 1.51 32.0 ± 2.74 0.76 ± 0.83 b 
a, b Significant difference between young and old age (p < 0.025) in presence of +FBS/+glucose 
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Table 3. 6:  ∆Ct and fold change (2-∆∆Ct) in GLUT4 expression
Age Number Treatment Medium Δ Ct ± SE Mean Y ± SE 
Fold change 
Mean ln Y± SE 
Fold change 
Young 6 None - 16.55 ± 1.97 1.00 ± 0.00 1.00 ± 0.00 
6 Insulin - 17.03 ± 1.90 1.42 ± 0.69 -0.36 ± 0.64
6 hCG - 17.58 ± 2.21 1.70 ± 0.58 -0.71 ± 1.02
6 EGF - 17.94 ± 2.29 1.12 ± 0.47 -0.97 ± 0.86
6 IGF-1 - 16.65 ± 1.83 2.43 ± 1.76 -0.07 ± 0.55
6 P4 - 16.82 ± 1.95 3.33 ± 2.02 -0.18 ± 0.85
6 None + 16.50 ± 2.03 1.00 ± 0.00 1.00 ± 0.00 
6 Insulin + 18.87 ± 2.05 1.13 ± 0.97 -0.1.64 ± 0.82 a
6 hCG + 18.80 ± 2.17 0.49 ± 0.21 -1.59 ± 0.75 a
6 EGF + 18.48 ± 2.10 1.19 ± 0.94 -1.37 ± 0.86 a
6 IGF-1 + 19.45 ± 2.25 0.33 ± 0.14 -2.04 ± 0.78 a
6 P4 + 17.84 ±1.93 0.58 ± 0.16 -0.92 ± 0.49 a
Middle 4 None - 19.67 ± 0.47 1.00 ± 0.00 1.00 ± 0.00 
4 Insulin - 19.09 ± 1.07 3.39 ± 1.80 0.40 ± 0.90 
4 hCG - 18.43 ± 1.16 5.68 ± 3.28 0.77 ± 1.03 
4 EGF - 18.35 ± 1.39 5.91 ± 3.34 0.78 ± 1.10 
4 IGF-1 - 20.72 ± 0.57 0.86 ± 0.34 -0.64 ± 0.71
4 P4 - 17.75 ± 1.16 7.60 ± 2.84 1.24 ± 1.04 
4 None + 20.66 ± 0.29 1.00 ± 0.00 1.00 ± 0.00 
4 Insulin + 19.48 ± 1.35 2.67 ± 1.50 0.47 ± 0.59 
4 hCG + 19.51 ± 0.83 4.71 ± 2.88 0.84 ± 0.73 
4 EGF + 19.17 ± 0.82 5.59 ± 2.67 1.34 ± 0.52 
4 IGF-1 + 19.22 ± 0.87 4.11 ± 3.12 0.63 ± 0.67 
4 P4 + 20.45 ± 1.12 3.72 ± 2.93 0.14 ± 0.91 
Old 8 None - 17.04 ± 1.73 1.00 ± 0.00 1.00 ± 0.00 
8 Insulin - 16.84 ± 1.60 2.08 ± 0.71 0.14 ± 0.50 
8 hCG - 17.17 ± 1.42 4.11 ± 2.00 -0.08 ± 0.81
8 EGF - 17.33 ± 1.38 4.62 ± 3.60 -0.20 ± 0.73
8 IGF-1 - 17.70 ± 1.53 5.27 ± 4.40 -0.46 ± 0.83
8 P4 - 17.27 ± 1.43 1.96 ± 1.12 -0.16 ± 0.47
8 None + 17.82 ± 1.72 1.00 ± 0.00 1.00 ± 0.00 
8 Insulin + 16.87 ± 1.35 15.86 ± 7.66 0.66 ± 1.02 b 
8 hCG + 15.16 ± 1.68 90.75 ± 84.93 1.46 ± 0.95 b 
8 EGF + 16.46 ± 1.56 230.55± 227.13 0.94 ± 1.08 b 
8 IGF-1 + 17.34 ± 1.51 8.03 ± 4.79 0.33 ± 0.94 b 
8 P4 + 17.61 ± 1.81 25.80 ± 24.33 0.14 ± 0.89 b 
a, b Significant difference between young and old age (p < 0.05) in presence of +FBS/+glucose 
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 Table 3. 7: ∆Ct and fold change (2-∆∆Ct) in AMPKα1 expression
Age Number Treatment Medium Δ Ct ± SE Mean-Y ± SE 
(2-∆∆Ct) 
Mean ln Y± SE 
(2-∆∆Ct) 
Young 6 None - 8.95 ± 1.24 1.00 ± 0.00 1.00 ± 0.00 
6 Insulin - 8.86 ± 1.26 1.95 ± 1.19 0.03 ± 0.45 
6 hCG - 8.54 ± 1.07 1.57 ± 0.19 0.28 ± 0.25 
6 EGF - 9.25 ± 1.11 1.91 ± 0.16 -0.21 ± 0.23
6 IGF-1 - 8.11 ± 0.99 2.64 ± 1.07 0.58 ± 0.40 
6 P4 - 8.73 ± 0.97 1.86 ± 0.65 0.15 ± 0.53 
6 None + 9.53 ± 1.51 1.00 ± 0.00 1.00 ± 0.00 
6 Insulin + 8.29 ± 0.98 1.73 ± 0.67 0.18 ± 0.45 
6 hCG + 8.98 ± 0.90 4.45 ± 3.23 0.38 ± 0.62 
6 EGF + 8.65 ± 1.00 6.56 ± 5.60 0.55 ± 0.60 
6 IGF-1 + 8.25 ± 0.89 15.42 ± 14.08 0.70 ± 0.81 
6 P4 + 8.93 ± 0.92 18.18 ± 17.41 0.41 ± 0.88 
Middle 4 None - 8.62 ± 0.69 1.00 ± 0.00 1.00 ± 0.00 
4 Insulin - 8.62 ± 0.54 1.44 ± 0.65 0.00 ± 0.51 
4 hCG - 8.43 ± 0.19 1.66 ± 0.89 0.14 ± 0.47 
4 EGF - 8.69 ± 1.00 1.68 ± 0.73 -0.17 ± 0.88
4 IGF-1 - 9.33 ± 0.81 1.43 ± 0.97 -0.41 ± 0.74
4 P4 - 8.12 ± 0.45 1.74 ± 0.51 0.35 ± 0.42 
4 None + 8.41 ± 0.96 1.00 ± 0.00 1.00 ± 0.00 
4 Insulin + 7.30 ± 0.71 2.43 ± 0.65 0.42 ± 0.59 
4 hCG + 8.90 ± 1.25 0.96 ± 0.89 -0.29 ± 0.44
4 EGF + 9.75 ± 0.67 0.76 ± 0.73 -0.63 ± 0.54
4 IGF-1 + 8.22 ± 0.61 0.97 ± 0.97 -0.24 ± 0.39
4 P4 + 9.27 ± 0.42 1.00 ± 0.51 -0.59 ± 0.67
Old 8 None - 6.84 ± 0.45 1.00 ± 0.00 1.00 ± 0.00 
8 Insulin - 7.12 ± 0.40 1.56 ± 0.73 -0.20 ± 0.44
8 hCG - 7.34 ± 0.52 0.89 ± 0.23 -0.35 ± 0.26
8 EGF - 7.55 ± 0.52 0.83 ± 0.22 -0.50 ± 0.32
8 IGF-1 - 8.15 ± 0.64 0.64 ± 0.19 -0.91 ± 0.41
8 P4 - 7.02 ± 0.65 1.77 ± 0.89 -0.13 ± 0.44
8 None + 7.53 ± 0.50 1.00 ± 0.00 1.00 ± 0.00 
7 Insulin + 7.60 ± 0.50 3.50 ± 2.56 -0.05 ± 0.56
8 hCG + 7.83 ± 0.81 2.78 ± 2.07 -0.34 ± 0.59
8 EGF + 7.60 ± 0.46 1.62 ± 0.83 -0.05 ± 0.34
8 IGF-1 + 8.54 ± 0.74 0.92 ± 0.31 -0.70 ± 0.52
8 P4 + 7.87 ± 0.67 1.38 ± 0.47 -0.23 ± 0.48
49 
Table 3. 8: ∆Ct and fold change (2-∆∆Ct) in AMPKα2 expression 
Age Number Treatment Medium Δ Ct ± SE Mean-Y ± SE 
(2-∆∆Ct) 
Mean ln Y± SE 
(2-∆∆Ct) 
Young 6 None - 10.34 ± 1.21 1.00 ± 0.00 1.00 ± 0.00 
6 Insulin - 10.37 ± 1.06 2.99 ± 2.18 -0.05 ± 0.71 a
6 hCG - 8.97 ± 1.08 3.14 ± 0.88 0.95 ± 0.28 a 
6 EGF - 9.91 ± 0.92 1.77 ± 0.51 0.30 ± 0.37 a 
6 IGF-1 - 9.37 ± 0.92 2.71 ± 0.91 0.67 ± 0.38 a 
6 P4 - 9.36 ± 0.91 2.72 ± 0.79 0.68 ± 0.42 a 
6 None + 10.98 ± 1.32 1.00 ± 0.00 1.00 ± 0.00 
6 Insulin + 9.76 ± 0.64 9.42 ± 5.82 0.85 ± 0.78 
6 hCG + 9.91 ± 0.97 9.07 ± 6.49 0.75 ± 0.76 
6 EGF + 9.92 ± 0.87 3.93 ± 1.84 0.74 ± 0.50 
6 IGF-1 + 9.72 ± 0.76 7.11 ± 4.04 0.88 ± 0.68 
6 P4 + 10.19 ± 0.82 5.68 ± 3.23 0.55 ± 0.71 
Middle 4 None - 9.76 ± 1.04 1.00 ± 0.00 1.00 ± 0.00 
4 Insulin - 9.42 ± 0.19 2.24 ± 1.16 0.23 ± 0.68 
4 hCG - 9.02 ± 0.67 2.02 ± 0.78 0.51 ± 0.35 
4 EGF - 10.38 ± 1.47 0.83 ± 0.32 -0.56 ± 0.59
4 IGF-1 - 10.41 ± 1.13 0.92 ± 0.34 -0.37 ± 0.46
4 P4 - 9.58 ± 1.47 1.36 ± 0.45 0.12 ± 0.36 
4 None + 9.26 ± 0.79 1.00 ± 0.00 1.00 ± 0.00 
4 Insulin + 8.55 ± 0.84 1.78 ± 0.78 0.15 ± 0.58 
4 hCG + 10.78 ± 1.62 0.61 ± 0.25 -1.01 ± 0.74
4 EGF + 11.02 ± 1.01 0.89 ± 0.49 -0.92 ± 0.92
4 IGF-1 + 9.32 ± 1.33 0.88 ± 0.39 -0.41 ± 0.43
4 P4 + 10.45 ±0.93 0.78 ± 0.45 -0.83 ± 0.67
Old 8 None - 7.76 ± 0.52 1.00 ± 0.00 1.00 ± 0.00 
8 Insulin - 8.45 ± 0.60 1.10 ± 0.37 -0.47 ± 0.48 b
8 hCG - 8.22 ± 0.39 0.91 ± 0.24 -0.32 ± 0.26 b
8 EGF - 8.27 ± 0.46 0.93 ± 0.27 -0.35 ± 0.28 b
8 IGF-1 - 9.21 ± 0.49 0.41 ± 0.07 -1.00 ± 0.20 b
8 P4 - 7.90 ± 0.45 3.57 ± 2.92 -0.09 ± 0.50 b
8 None + 9.18 ± 0.51 1.00 ± 0.00 1.00 ± 0.00 
7 Insulin + 9.81 ± 0.62 5.43 ± 4.60 -0.44 ± 0.76
8 hCG + 8.95 ± 0.43 3.34 ± 2.44 0.14 ± 0.47 
8 EGF + 8.46 ± 0.39 4.03 ± 2.61 0.50 ± 0.46 
8 IGF-1 + 9.59 ± 0.56 1.49 ± 0.75 -0.29 ± 0.44
8 P4 + 9.05 ± 0.72 2.30 ± 0.82 0.09 ± 0.57 
a, b Significant difference between young and old age (p < 0.027) 
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Table 3. 9: ∆Ct and fold change (2-∆∆Ct) in AMPKβ1 expression 
Age Number Treatment Medium Δ Ct ± SE Mean-Y ± SE 
(2-∆∆Ct) 
Mean ln Y± SE 
(2-∆∆Ct) 
Young 6 None - 11.36 ± 1.03 a 1.00 ± 0.00 1.00 ± 0.00 
6 Insulin - 11.15 ± 0.83 a 5.38 ± 4.06 0.12 ± 0.86 
6 hCG - 11.08 ± 0.95 a 4.05 ± 2.03 0.89 ± 0.42 
6 EGF - 10.55 ± 0.47 a 2.52 ± 0.75 0.56 ± 0.45 
6 IGF-1 - 10.61 ± 0.43 a 2.77 ± 0.73 0.52 ± 0.61 
6 P4 - 10.26 ± 0.50 a 3.32 ± 1.23 0.76 ± 0.47 
6 None + 11.12 ± 1.16 1.00 ± 0.00 1.00 ± 0.00 
6 Insulin + 10.30 ± 0.72 7.65 ± 6.64 0.57 ± 0.65 
6 hCG + 10.01 ± 0.85 6.88 ± 4.92 0.77 ± 0.64 
6 EGF + 10.45 ± 0.64 5.44 ± 4.49 0.46 ± 0.59 
6 IGF-1 + 10.53 ± 0.50 5.14 ± 4.12 0.40 ± 0.62 
6 P4 + 11.09 ± 0.65 8.66 ± 8.09 0.02 ± 0.82 
Middle 4 None - 10.50 ± 0.84 1.00 ± 0.00 1.00 ± 0.00 
4 Insulin - 9.66 ± 0.85 2.69 ± 1.16 0.58 ± 0.56 
4 hCG - 9.69 ± 0.33 2.53 ± 1.33 0.56 ± 0.48 
4 EGF - 9.91 ± 1.01 3.25 ± 1.55 0.28 ± 1.07 
4 IGF-1 - 10.80 ± 0.74 1.41 ± 0.79 -0.13 ± 0.56
4 P4 - 9.46 ± 0.43 2.17 ± 1.25 0.28 ± 0.58 
4 None + 9.83 ± 1.06 1.00 ± 0.00 1.00 ± 0.00 
4 Insulin + 8.35 ± 0.47 2.55 ± 0.95 0.69 ± 0.42 
4 hCG + 9.56 ± 1.17 1.71 ± 0.79 0.24 ± 0.45 
4 EGF + 11.71 ± 1.07 0.78 ± 0.46 -1.00 ± 0.84
4 IGF-1 + 9.46 ± 0.42 1.80 ± 1.20 -0.11 ± 0.70
4 P4 + 10.44 ± 0.27 1.25 ± 0.70 -0.42 ± 0.71
Old 8 None - 7.90 ± 0.71 b 1.00 ± 0.00 1.00 ± 0.00 
8 Insulin - 7.77 ± 0.81 b 2.23 ± 1.00 0.09 ± 0.52 
8 hCG - 8.27 ± 0.69 b 1.15 ± 0.33 -0.26 ± 0.37
8 EGF - 8.55 ± 0.66 b 0.92 ± 0.22 -0.46 ± 0.38
8 IGF-1 - 8.77 ± 0.70 b 0.83 ± 0.23 -0.61 ± 0.40
8 P4 - 8.09 ± 0.74 b 2.94 ± 1.79 -0.13 ± 0.61
8 None + 9.07 ± 0.67 1.00 ± 0.00 1.00 ± 0.00 
7 Insulin + 9.18 ± 0.45 5.16 ± 4.01 -0.08 ± 0.65
8 hCG + 9.00 ± 0.76 2.92 ± 2.15 -0.06 ± 0.50
8 EGF + 8.39 ± 0.66 3.85 ± 2.37 0.47 ± 0.45 
8 IGF-1 + 9.54 ± 0.83 1.83 ± 1.13 -0.32 ± 0.49
8 P4 + 9.12 ± 0.75 1.95 ± 0.88 -0.03 ± 0.49
a, b Significant difference between young and age (p < 0.006) in -FBS/-glucose for all
treatments.  
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Table 3. 10: ∆Ct and fold change (2-∆∆Ct) in AMPKβ2 expression 
Age Number Treatment Medium Δ Ct ± SE Mean-Y ± SE 
(2-∆∆Ct) 
Mean ln Y± SE 
(2-∆∆Ct) 
Young 6 None - 8.50 ± 0.50 1.00 ± 0.00 1.00 ± 0.00 
6 Insulin - 8.31 ± 0.51 1.58 ± 0.66 0.11 ± 0.36 
6 hCG - 8.48 ± 0.47 1.36 ± 0.53 0.02 ± 0.32 
6 EGF - 8.64 ± 0.26 1.20 ± 0.39 -0.09 ± 0.34
6 IGF-1 - 8.97 ± 0.40 1.63 ± 0.32 0.37 ± 0..23 
6 P4 - 7.97 ± 0.39 1.97 ± 0.73 0.37 ± 0.35 
6 None + 9.15 ± 0.92 1.00 ± 0.00 1.00 ± 0.00 
6 Insulin + 8.56 ± 0.68 8.20 ± 0.41 0.41 ± 0.75 
6 hCG + 8.41 ± 0.37 5.00 ± 0.52 0.52 ± 0.67 
6 EGF + 8.45 ± 0.37 5.13 ± 0.49 0.49 ± 0.63 
6 IGF-1 + 8.32 ± 0.32 5.57 ± 0.58 0.58 ± 0.70 
6 P4 + 8.15 ± 0.39 9.54 ± 0.69 0.69 ± 0.83 
Middle 4 None - 8.09 ± 0.52 1.00 ± 0.00 1.00 ± 0.00 
4 Insulin - 8.39 ± 0.47 0.94 ± 0.28 0.21 ± 0.32 
4 hCG - 7.84 ± 0.36 1.27 ± 0.26 0.17 ± 0.22 
4 EGF - 7.82 ± 0.56 1.32 ± 0.46 0.06 ± 0.40 
4 IGF-1 - 9.13 ± 0.69 0.61 ± 0.16 0.64 ± 0.34 
4 P4 - 8.14 ± 0.46 1.06 ± 0.23 -0.03 ± 0.26
4 None + 8.07 ± 0.64 1.00 ± 0.00 1.00 ± 0.00 
4 Insulin + 7.20 ± 0.53 1.40 ± 0.32 0.26 ± 0.23 
4 hCG + 8.59 ± 1.02 0.93 ± 0.31 0.32 ± 0.44 
4 EGF + 9.03 ± 0.80 0.85 ± 0.26 0.37 ± 0.41 
4 IGF-1 + 7.98 ± 0.37 0.85 ± 0.27 0.31 ± 0.32 
4 P4 + 9.43 ± 0.74 0.47 ± 0.15 -0.95 ± 0.38
Old 8 None - 7.70 ± 0.64 1.00 ± 0.00 1.00 ± 0.00 
8 Insulin - 7.40 ± 0.76 2.79 ± 1.44 0.21 ± 0.49 
8 hCG - 8.44 ± 0.73 1.53 ± 0.91 -0.51 ± 0.53
8 EGF - 8.00 ± 0.62 1.18 ± 0.37 -0.21 ± 0.35
8 IGF-1 - 7.73 ± 0.69 2.42 ± 1.30 -0.02 ± 0.48
8 P4 - 7.54 ± 0.66 2.54 ± 1.49 0.12 ± 0.46 
8 None + 7.94 ± 0.66 1.00 ± 0.00 1.00 ± 0.00 
7 Insulin + 8.72 ± 1.11 3.59 ± 1.95 -0.54 ± 1.06
8 hCG + 8.41 ± 0.47 1.25 ± 0.54 -0.29 ± 0.39
8 EGF + 7.93 ± 0.54 1.36 ± 0.44 0.00 ± 0.28 
8 IGF-1 + 8.29 ± 0.70 0.98 ± 0.20 -0.24 ± 0.29
8 P4 + 7.85 ± 0.96 2.13 ± 1.01 0.06 ± 0.47 
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Table 3. 11: ∆Ct and fold change (2-∆∆Ct) in AMPKγ1 expression 
Age Number Treatment Medium Δ Ct ± SE Mean-Y ± SE 
(2-∆∆Ct) 
Mean ln Y± SE 
(2-∆∆Ct) 
Young 6 None - 8.10 ± 0.91 1.00 ± 0.00 1.00 ± 0.00 
6 Insulin - 8.36 ± 1.60 1.89 ± 0.64 -0.21 ± 0.88
6 hCG - 9.04 ± 1.94 1.32 ± 0.41 -0.66 ± 0.98
6 EGF - 9.08 ± 1.77 1.42 ± 0.58 -0.68 ± 0.95
6 IGF-1 - 8.29 ± 1.61 1.95 ± 0.62 -0.13 ± 0.85
6 P4 - 7.77 ± 1.83 2.67 ± 0.65 0.23 ± 0.89 
6 None + 8.05 ± 0.73 1.00 ± 0.00 1.00 ± 0.00 
6 Insulin + 8.50 ± 1.56 1.41 ± 0.42 -0.31 ± 0.74
6 hCG + 9.17 ± 1.60 0.87 ± 0.23 -0.78 ± 0.75
6 EGF + 8.88 ± 1.71 1.33 ± 0.51 -0.57 ± 0.86
6 IGF-1 + 9.34 ± 1.75 0.92 ± 0.29 -0.89 ± 0.89
6 P4 + 8.68 ± 1.29 1.28 ± 0.54 -0.43 ± 0.61
Middle 4 None - 10.00 ± 1.06 1.00 ± 0.00 1.00 ± 0.00 
4 Insulin - 8.52 ± 0.57 4.17 ± 3.39 0.63 ± 0.89 
4 hCG - 8.14 ± 0.22 3.77 ± 2.29 0.80 ± 0.80 
4 EGF - 8.36 ± 0.28 3.58 ± 2.18 0.56 ± 1.02 
4 IGF-1 - 8.79 ± 0.50 3.03 ± 2.12 0.56 ± 0.74 
4 P4 - 8.52 ± 0.16 3.19 ± 1.97 0.55 ± 0.89 
4 None + 8.90 ± 1.04 1.00 ± 0.00 1.00 ± 0.00 
4 Insulin + 7.78 ± 0.14 0.93 ± 0.31 0.22 ± 0.42 
4 hCG + 7.69 ± 0.40 2.08 ± 0.95 0.52 ± 0.46 
4 EGF + 8.94 ± 0.37 1.96 ± 1.52 -0.03 ± 0.83
4 IGF-1 + 7.76 ± 0.03 0.98 ± 0.31 -0.18 ± 0.43
4 P4 + 9.26 ± 0.56 0.50 ± 0.18 -0.81 ± 0.33
Old 8 None - 10.62 ± 1.61 1.00 ± 0.00 1.00 ± 0.00 
8 Insulin - 9.33 ± 1.75 4.21 ± 2.33 0.58 ± 0.61 
8 hCG - 9.56 ± 1.51 6.01 ± 3.59 0.67 ± 0.72 
8 EGF - 9.95 ± 1.34 2.63 ± 1.03 0.51 ± 0.46 
8 IGF-1 - 10.09 ± 1.14 3.54 ± 1.42 0.38 ± 0.74 
8 P4 - 9.62 ± 1.05 10.79 ± 6.25 0.72 ± 1.00 
8 None + 10.56 ± 1.67 1.00 ± 0.00 1.00 ± 0.00 
7 Insulin + 10.53 ± 1.65 3.11 ± 1.59 0.13 ± 0.78 
8 hCG + 9.34 ± 0.95 12.70 ± 9.88 1.17 ± 0.69 
8 EGF + 9.81 ± 1.11 22.52 ± 17.86 1.10 ± 0.98 
8 IGF-1 + 10.56 ± 1.46 2.50 ± 0.71 0.73 ± 0.26 
8 P4 + 10.13 ± 1.11 17.25 ± 15.89 0.68 ± 0.87 
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Table 3. 12: ∆Ct and fold change (2-∆∆Ct) in AMPKγ2 expression 
Age Number Treatment Medium Δ Ct ± SE Mean-Y ± SE 
(2-∆∆Ct) 
Mean ln Y± SE 
(2-∆∆Ct) 
Young 6 None - 13.93 ± 1.87 1.00 ± 0.00 1.00 ± 0.00 
6 Insulin - 12.41 ± 1.42 4.70 ± 1.78 1.03 ± 0.52 
6 hCG - 11.60 ± 1.92 6.59 ± 2.37 1.62 ± 0.32 
6 EGF - 13.19 ± 1.45 4.43 ± 1.99 0.52 ± 0.77 
6 IGF-1 - 11.80 ± 1.76 14.31 ± 10.91 1.48 ± 0.64 
6 P4 - 13.26 ± 1.75 16.34 ± 14.06 0.47 ± 1.02 
6 None + 12.94 ± 1.59 1.00 ± 0.00 1.00 ± 0.00 
6 Insulin + 12.77 ± 1.78 5.00 ± 4.37 0.12 ± 0.65 
6 hCG + 11.35 ± 1.65 6.50 ± 3.00 1.06 ± 0.75 
6 EGF + 12.61 ± 1.73 5.28 ± 4.12 0.23 ± 0.74 
6 IGF-1 + 12.40 ± 1.52 4.96 ± 3.42 0.37 ± 0.68 
6 P4 + 12.80 ± 1.63 4.12 ± 3.13 0.10 ± 0.74 
Middle 4 None - 14.62 ± 1.69 1.00 ± 0.00 1.00 ± 0.00 
4 Insulin - 15.04 ± 2.17 1.23 ± 0.69 -0.29 ± 0.59 a
4 hCG - 14.39 ± 2.19 1.93 ± 0.22  0.65 ± 0.12 
4 EGF - 12.24 ± 2.15 3.48 ± 1.55    0.76 ± 0.85 b 
4 IGF-1 - 13.83 ± 0.65 1.01 ± 0.42 -0.25 ± 0.57
4 P4 - 12.09 ± 1.43 2.90 ± 1.01   0.95 ± 0.32 b 
4 None + 15.61 ± 2.32 1.00 ± 0.00 1.00 ± 0.00 
4 Insulin + 13.55 ± 2.51 6.70 ± 4.57 1.42 ± 0.67 
4 hCG + 14.80 ± 2.40 1.96 ± 0.66 0.55 ± 0.36 
4 EGF + 14.56 ± 1.32 2.45 ± 2.04 -0.08 ± 1.04
4 IGF-1 + 12.83 ± 1.51 2.01 ± 0.97 -0.07 ± 1.15
4 P4 + 15.03 ± 2.62 1.52 ± 1.48 -1.67 ± 1.59
Old 8 None - 13.22 ± 1.85 1.00 ± 0.00 1.00 ± 0.00 
8 Insulin - 12.71 ± 1.79 1.68 ± 0.71 0.01 ± 0.42 
8 hCG - 12.30 ± 1.23 13.64 ± 11.40 0.63 ± 0.87 
8 EGF - 12.59 ± 1.12 11.28 ± 9.88 0.25 ± 0.93 
8 IGF-1 - 13.40 ± 0.70 25.75 ± 24.60 -0.22 ± 1.25
8 P4 - 12.35 ± 0.92 33.84 ± 22.99 0.70 ± 1.68 
8 None + 14.32 ± 1.36 1.00 ± 0.00 1.00 ± 0.00 
7 Insulin + 13.98 ± 1.09 2.56 ± 1.06   0.04 ± 0.66 a 
8 hCG + 12.98 ± 0.76 16.39 ± 12.15 1.19 ± 0.75 
8 EGF + 12.12 ± 1.18 54.48 ± 37.08   1.46 ± 1.08 b 
8 IGF-1 + 13.38 ± 0.96 60.48 ± 56.79 0.64 ± 1.17 
8 P4 + 12.55 ± 1.43 21.95 ± 19.06   1.84 ± 1.19 b 
a, b Significant difference between treatments (p < 0.05) 
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Table 3. 13: ∆Ct and fold change (2-∆∆Ct) in AMPKγ3 expression 
Age Number Treatment Medium Δ Ct ± SE Mean-Y ± SE 
(2-∆∆Ct) 
Mean ln Y± SE 
(2-∆∆Ct) 
Young 6 None - 14.34 ± 0.88 1.00 ± 0.00 1.00 ± 0.00 
6 Insulin - 12.28 ± 0.75 10.43 ± 6.48 1.40 ± 0.71 
6 hCG - 12.94 ± 1.18 6.37 ± 2.80 0.97 ± 0.72 
6 EGF - 13.82 ± 0.93 2.87 ± 1.21 0.36 ± 0.62 
6 IGF-1 - 14.23 ± 0.76 1.74 ± 0.62 0.07 ± 0.54 
6 P4 - 12.48 ± 1.04 12.92 ± 8.52 1.29 ± 0.90 
6 None + 13.54 ± 0.51 1.00 ± 0.00 1.00 ± 0.00 
6 Insulin + 13.74 ± 0.65 2.27 ± 1.69 -0.14 ± 0.54
6 hCG + 12.72 ± 1.12 8.43 ± 7.02 0.57 ± 0.73 
6 EGF + 14.06 ± 0.76 0.86 ± 0.20 -0.36 ± 0.32
6 IGF-1 + 13.89 ± 0.73 0.91 ± 0.20 -0.24 ± 0.24
6 P4 + 13.45 ± 1.03 3.75 ± 2.86 0.07 ± 0.72 
Middle 4 None - 14.01 ± 1.06 1.00 ± 0.00 1.00 ± 0.00 
4 Insulin - 13.77 ± 1.48 1.37 ± 0.47 0.17 ± 0.30 
4 hCG - 13.09 ± 1.84 3.38 ± 2.42 0.83 ± 0.92 
4 EGF - 13.11 ± 2.00 3.82 ± 1.99 0.49 ± 0.87 
4 IGF-1 - 13.99 ± 1.56 2.01 ± 1.02 0.10 ± 0.70 
4 P4 - 12.83 ± 1.44 3.40 ± 1.47 0.82 ± 0.57 
4 None + 13.88 ± 1.57 1.00 ± 0.00 1.00 ± 0.00 
4 Insulin + 12.71 ± 1.63 2.30 ± 1.11 0.46 ± 0.50 
4 hCG + 14.43 ± 2.28 1.39 ± 0.84 -0.34 ± 0.73
4 EGF + 12.73 ± 1.23 3.68 ± 1.37 1.09 ± 0.38 
4 IGF-1 + 12.46 ± 1.72 2.53 ± 1.30 0.61 ± 0.43 
4 P4 + 13.27 ± 0.81 2.39 ± 1.26 0.42 ± 0.58 
Old 8 None - 11.31 ± 0.81 1.00 ± 0.00 1.00 ± 0.00 
8 Insulin - *10.21 ± 1.12 4.51 ± 2.48 0.59 ± 0.54 a 
8 hCG - 11.27 ± 0.66 2.47 ± 0.88 -0.14 ± 0.78
8 EGF - *13.31 ± 1.28 1.70 ± 0.94 -1.55 ± 1.22 b
8 IGF-1 - *12.32 ± 0.77 1.98 ± 0.89 -0.86 ± 0.95 b
8 P4 - 10.67 ± 0.99 23.28 ± 21.07 0.28 ± 1.05 
8 None + 12.27 ± 1.03 1.00 ± 0.00 1.00 ± 0.00 
7 Insulin + 11.82 ± 0.91 8.63 ± 5.63 0.32 ± 0.93 
8 hCG + 10.03 ± 0.63 49.59 ± 44.59 1.39 ± 0.83 a 
8 EGF + 12.00 ± 0.67 5.78 ± 3.92 0.19 ± 0.81 
8 IGF-1 + 12.62 ± 0.86 2.09 ± 1.05 -0.24 ± 0.59 b
8 P4 + 11.40 ± 1.30 114.39 ± 99.31 0.61 ± 1.25 
a, b Significant difference between treatments in old age (p < 0.01). 
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Table 3. 14: Significant differences in expression of AMPK subunit genes.  The specific 
gene shown in the left column treatments produced significant differences between young 
and old animals or middle aged and old animals together with (p values) are shown in the 
column to the right 
Gene Medium Treatment 




ΔCt  ± SE 
Middle 
ΔCt  ± SE 
Old 
ΔCt  ± SE 
AMPK α1 - None 8.95±1.24 - 6.95±0.45 4.35 < 0.05 
AMPK α2 - None 10.34 ± 1.21 - 7.76 ± 0.52 6.0 < 0.02 
AMPK α2 + EGF - 11.02 ± 1.01 8.46 ± 0.39 5.9 < 0.04 
AMPK β1 - None - 10.50 ± 0.84 7.90 ± 0.71 6.1 < 0.03 
AMPK β1 - None 11.36 ± 1.03 - 7.90 ± 0.71 11.0 < 0.001 
AMPK β1 - Insulin 11.15 ± 0.83 - 7.77 ± 0.81 10.4 < 0.002 
AMPK β1 + EGF - 11.71 ± 1.07 8.39 ± 0.66 10.0 < 0.005 
AMPK β1 + EGF 10.45 ± 0.64 - 8.39 ± 0.66 4.2 < 0.05 
AMPK β1 - P4 10.26 ± 0.50 - 8.09 ± 0.74 4.5 < 0.04 
AMPK β1 + P4 11.09±0.65 - 9.23±0.75 3.63 < 0.05 
AMPK γ3 - None 14.34 ± 0.88 - 11.31 ± 0.81 8.2 < 0.04 
AMPK γ3 - Insulin - 13.77 ± 1.48 10.21 ± 1.12 11.8 < 0.03 
AMPK γ3 + hCG - 14.43 ± 2.28 10.03 ± 0.63 21.1 < 0.01 
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Table 3. 15:  Significant differences in expression of IR, IGF-1R, and GLUT4 with various treatments. 
The gene is shown in the left column. Values for ∆CT for a specific treatment and values for 2-∆∆Ct
between two treatments where there were significant differences are shown in the columns to the right.  






ΔCt  ± SE 
Insulin 
ΔCt  ± SE 
hCG 
ΔCt  ± SE 
EGF 
ΔCt  ± SE 
IGF-1 
ΔCt  ± SE 
P4 
ΔCt  ± SE 
IR - Old 8.19±0.54 10.11±1.19 3.78 < 0.03 
IR - Old 8.19±0.54 10.50±1.29 4.96 < 0.007 
IR - Old 8.19±0.54 10.22±1.21 4.08 < 0.02 
IR - Old 
e
8.19±0.54 10.08±1.23 3.71 < 0.03 
IR + Old 11.07±1.32 9.02±1.77 0.24 < 0.02 
IR + Old 9.02±1.77 11.32±1.20 4.92 < 0.008 
IGF-1R + Old 12.42±1.43 9.97±1.74 0.18 < 0.03 
IGF-1R + Old 
ΔCt ± 
12.42±1.43 9.65±1.60 0.15 < 0.01 
GLUT4 -  Middle 
ΔCt ± 
20.17±0.57 17.75±1.16 0.19 < 0.04 
GLUT4 + Old 
 
ΔCt ± 
17.82±1.27 15.16±1.68 0.16 < 0.007 
GLUT4 + Old 
ΔCt  ± 
15.16±1.68 17.34±1.51 4.53 < 0.03 
GLUT4 + Old 15.16±1.68 17.61±1.80 5.46 < 0.01 
GLUT4 + Young 16.50±2.03 18.87±2.04 5.17 < 0.04 
GLUT4 + Young 
ΔCt  ± 
16.50±2.03 18.80±2.17 4.92 < 0.04 
GLUT4 + Young 16.50±2.03 19.45±2.25 7.73 < 0.01 
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CHAPTER 4: DISCUSSION
Results presented here suggest that assembly of insulin receptor homodimers is reduced 
in older animals, a result that would affect insulin responsiveness.  Moreover, EGF increased 
GLUT4 expression over 200-fold in older animals while insulin and IGF-1 had more 
modest, albeit significant effects.  Thus, in older animals, even in the presence of high 
circulating levels of glucose, insulin may have modest effects on glucose uptake into granulosa 
cells and availability of GLUT4 transporters in the membrane.  Insulin resistance in older 
animals could therefore be a combination of several factors that include reductions in insulin 
receptor homodimers, insulin or decreased available GLUT4 transporters, any one of which 
would be sufficient to negatively impact insulin utilization by granulosa cells.   
Our results are consistent with observations that insulin-resistance in mares is associated 
with aging and characterized by the impaired ability of insulin to stimulate glucose uptake 
into insulin sensitive tissues, particularly muscle and adipose tissue, in all species.  Obesity 
may exacerbate insulin resistance associated with aging by placing additional stress on 
energy homeostatic mechanisms (80).  Unger et al. (29) have suggested that fat accumulation as 
well as changes in the distribution of lipids may predispose an individual to insulin resistance.  In 
horses, obesity, even over a duration of a few months, promotes insulin-resistance in healthy 
horses (81-83).  
In addition to maintain insulin responsiveness, granulosa cells need to maintain 
IGF-1 responsiveness.  The lack of IGF-1 receptor signaling in granulosa cells can increase 
apoptosis at all stages of follicle development and reduce responsiveness of secondary stage 
follicles to FSH 
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(16). Reduced FSH responsiveness prevents initiation of follicle development and subsequent 
estradiol production.  Together, arrest of folliculogenesis can result with a loss of fertility.   
Insulin-resistance alone is a serious metabolic disorder.  However, other diseases 
associated with insulin resistance can affect overall animal health.  As an example, laminitis in 
horses is a devastating clinical syndrome that may affect 15% of horses (84,85). Equine 
practitioners identify endocrine/metabolic issues as the most common causes of laminitis 
diagnosed in practice (86). In general, middle-aged horses are more susceptible to the development 
of endocrinopathic laminitis. Horses presented for laminitis at a veterinary hospital and diagnosed 
with endocrinopathic laminitis averaged 15 years of age, with two-thirds of the cases presenting 
with hyperinsulinemia and associated obesity (87).  Vasoconstriction in the feet is ultimately 
believed to be a major contributor (86). As insulin has vasoregulatory properties, IRS could 
predispose horses to vasoconstriction through a series of events that reduce production of nitric 
oxide (NO) and the ability of blood vessels to handle vascular challenges  (86). Administration of 
insulin to healthy horses will induce laminitis, indicating that there is a direct link to the hormone 
(88,89).  
In humans, menopause may contribute to insulin resistance in women.  Menopause is 
accompanied by the loss of ovarian estrogen production which, in turn, affects intra-abdominal fat 
deposition.  Ovariectomy in rats causes weight gain and accumulation of adipose tissue in the 
abdomen (90), a result similar to that seen in estrogen receptor α knockout mice (91,92).  Insulin-
resistance is also linked to polycystic ovary syndrome (PCOS) which is characterized by reduced 
insulin secretion and glucose intolerance.  Because PCOS is quite common, a subset of women 
with PCOS also have Type II diabetes as well.  Interestingly, insulin resistance in women with 
PCOS may be related to a genetic condition affecting insulin receptor signaling as well as an 
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enzyme involved in androgen biosynthesis, thus linking both insulin resistance and excess 
androgen biosynthesis seen in the syndrome.   
A significant result of our studies is that GLUT4 expression in these studies is decreased in 
middle aged and older animals compared to young animals following pre-incubation with or 
without FBS/glucose between middle and young mares (p < 0.09) and between old and young 
mares(p < 0.05).     Glucose uptake, primarily by skeletal and cardiac muscle and adipose tissue, is 
a rate limiting step in glucose utilization by these tissues and is dependent on availability in the 
cell membrane of an insulin-responsive glucose transporter.  In horses, as is the case of the other 
10 ISRN Veterinary Science species, the insulin-responsive glucose transporter GLUT4 is 
impaired in skeletal muscle and adipose tissue during naturally occurring insulin resistance in 
horses.  There is also evidence that decreased GLUT4 expression in aging animals is linked to 
insulin resistance (93,94).    
In cells pre-incubated with +FBS/+glucose, treatment with insulin, IGF-1, progesterone, 
hCG and EGF significantly increased expression of GLUT4 with the largest effect seen in EGF-
treated cells.  This increased GLUT4 expression presumably increased the likelihood of hormone-
dependent glucose uptake by these cells if sufficient hormone-responsive insulin receptors were 
available.  This may be problematic for granulosa cells from older animals exposed to high glucose 
if, as suggested in Figure 3.2, these cells are expressing fewer insulin receptor homodimers.  
Although there have been comparatively few studies evaluating effects of insulin-
resistance in granulose cells, GLUT4 transporter function and subsequent nutrient deficiency in 
cells has been suggested as a contributor to reduced fertility in horses (95).  Aging effects on 
gastrocnemius muscle glucose uptake, both under basal conditions and following insulin treatment, 
have been shown in rats where basal levels decreased about 37% and insulin-induced glucose 
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uptake was reduced 69% in older animals compared to young rats (53).  These decreases in glucose 
uptake appeared to result from reduced expression of GLUT4 transporter mRNA and GLUT4 
protein.    Whether effects on GLUT4 expression are direct response to aging is not clear.  The 
appearance of insulin-resistance linked to GLUT4, may also reflect long-standing the nutritional 
status of the animal.  In pigs with mildly inadequate nutrition, (96) revealed that GLUT4 was 
upregulated in their skeletal muscles with concurrent decrease in insulin sensitivity when 
compared with pig receiving twice daily nutrition intake.  Negative energy balance selectively up-
regulates muscle GLUT4 gene expression, but conversely reduces insulin-dependent glucose 
uptake during postnatal development.  
 Age-related differences in the expression of AMPK genes suggests that there are 
significant differences in the metabolic activity of younger and older animals.  This heterotrimeric 
enzyme is comprising of an α catalytic subunit (α1 or α2), and β and γ regulatory subunit (β1, β2; 
γ1, γ2 or γ3) (reviewed in (97,98).  In skeletal muscle, activation of AMPK serves as an ATP and 
AMP sensor through the regulatory subunit.  Active AMPK is important in pathways leading to 
ATP production via glucose metabolism, fatty acid oxidation and mitochondrial biosynthesis 
(34,99,100) while inhibiting anabolic pathways that use ATP (101,102).  While effects of AMPK 
on metabolic function are reasonably well understood, there are, in contrast to results presented 
here, no clear effects of aging on AMPK gene expression.  Qiang and coworkers examined 
expression of AMPK1  and AMPK2 mRNA and protein in the gastrocnemius muscle and found 
no effect of age in rats (53).  
Finally, hCG treatment significantly increased expression of IGF-1R and GLUT4, but not 
IR, in granulosa cells from older animals pre-incubated in +FBS/+glucose medium.  This result 
was somewhat surprising given reports of decreasing luteinizing hormone receptor number in older 
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mares.  Sessions-Bresnahan and Carnevale (103) suggest that LHR levels are significantly reduced 
in older mares while FSHR levels are reduced but not significantly so.  Incidentally, results for 
LHR differ from those reported for bovine granulosa cells where LHR levels were elevated (104).  
There are several experimental factors that may affect this result including the presence of growth 
factors in FBS or, less likely given the lack of hCG response in cells pre-incubated without 
FBS/glucose, the use of hCG to induce ovulation in these animals.  
One difficulty with these data are the variable effects of aging on our results. At the 
beginning of this project, we made a decision to separate animals into three groups that were 
comprised of young, middle-aged and older animals.  As discussed in Chapter 1, it is difficult to 
determine whether there is a single, specific age at which mares transition from being young to 
middle-aged and from middle-aged to old.  Aging in mares, as in humans, is influenced by the 
genetic make-up of an individual and environmental conditions.  In mares, metabolic disease 
which is often difficult to identify without extensive laboratory work, can occur at any age and 
becomes more prevalent as animals age.  To both simplify data analysis and also to make 
differences between young and older animals more apparent, it would be appropriate to eliminate 
the separate group of middle-aged animals from our analysis or, alternatively, to reassign animals 
into two groups made up of young animals ( <15 years old) and old animals (>15 years old).   
Reanalyzing all of our data is beyond the scope of this dissertation.  However, when we 
examine the ratio of IR:IGF1R expression as originally presented in Table 3.1, the following 
results shown in Table 4.1 were obtained.  Younger animals are predicted to express more IGF-1 
receptor under control conditions, either -FBS/-glucose or +FBS/+glucose, and following 
treatment of cells with EGF, insulin, IGF-1 or hCG.  Older animals, on the other hand, are predicted 
to express approximately equal numbers of insulin receptors, IGF-1 receptors and hybrid receptors 
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in the absence of FBS/30 nM glucose but demonstrate a marked increase in insulin receptor 
expression when exposed to high glucose.  Thus, in the presence of FBS/glucose, older animals 
are likely to have more insulin receptors and, assuming that other components of the insulin 
signaling pathway remain available, more responsive to insulin.    
The other effect of age is seen in EGF-treated cells where, in the absense of FBS/30 nM 
glucose , cells are predicted to express approximately equal numbers of insulin receptors, IGF-1 
receptors and hybrid receptors.  Interestingly, when FBS/30 nM glucose  are present, 
the expression of IGF-1R increases markedly and this would be predicted to assembly of 
IGF-1 receptors and hybrid receptors at the expense of insulin receptor formation leading to 
decreased insulin responsiveness. 
This reanalysis of available data point out another important result of this project.  Insulin 
insensitivity is likely to be due to a number of factors including many factors that we have not 
identified in this project.  As discussed in the next chapter, there are a number of approaches that 
would be appropriate at this point.  Probably the most straight forward approach would be to 
analyze samples that we obtained and preserved when collecting the data presented in this 
dissertation.  We made a decision to use only “complete” data sets from a given animal and to 
combine these data with “complete data sets” obtained from other animals of similar age.  There 
are, however, incomplete data sets where some effects of treatments, as an example, are missing. 
Nonetheless, with appropriate statistical analysis, this data is usable.  This additional data might 
clarify effects of aging with specific treatments.   
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Table 4.1: The ratio ΔCt (IR) to ΔCt (IGF-1R) for individual young mares less than 15 years old 
(n = 10 animals) and older animals greater than 15 years old (n = 8 animals).  Shown are 
predicted effects of these ratios on expression of insulin receptor homodimers and IGF-1R 
homodimers. Note that, as ΔCt values increase, the amount of mRNA expressed decreases. 
Thus, ratios of ΔCt (IR) to ΔCt (IGF-1R) > 1, are predicted that IGF-1R monomers should be the 
predominant species expressed in granulosa cells and that these cells will contain increased 
numbers of IGF-1R and hybrid receptors formed from insulin and IGF-1R monomers.  When 
ratios are < 1, insulin receptors will be the predominant receptors found on granulosa cells.  
Young Mares 




ΔCt (IR) /  
ΔCt (IGF-1R) interpretation 
ΔCt (IR) / 
ΔCt (IGF-1R) interpretation 
Control (-) 1.16 ± 0.19 (10) ↑ IGF-1R 0.99 ± 0.19 (8) IR ≈ IGF-1R 
Control (+) 1.28 ± 0.24 (10) ↑ IGF-1R 0.89 ± 0.19 (8) ↑ IR 
Insulin (-) 1.27 ± 0.32 (10) ↑ IGF-1R 1.22 ± 0.42 (8) ↑ IGF-1R 
Insulin (+) 1.16 ± 0.17 (10) ↑ IGF-1R 1.29 ± 0.51 (8) ↑ IGF-1R 
hCG (-) 1.31 ± 0.30 (10) ↑ IGF-1R 1.51 ± 0.68 (8) ↑ IGF-1R 
hCG (+) 1.14 ± 0.20 (10) ↑ IGF-1R 1.34 ± 0.55 (8) ↑ IGF-1R 
EGF (-) 1.29 ± 0.27 (10) ↑ IGF-1R 1.04 ± 0.24 (8) IR ≈ IGF-1R 
EGF (+) 1.35 ± 0.21 (10) ↑ IGF-1R 1.22 ± 0.25 (8) ↑ IGF-1R 
IGF-1 (-) 1.13 ± 0.23 (10) ↑ IGF-1R 1.49 ± 0.21 (8) ↑ IGF-1R 
IGF-1 (+) 1.25 ± 0.26 (10) ↑ IGF-1R 1.33 ± 0.16 (8) ↑ IGF-1R 
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CHAPTER 5: CONCLUSIONS AND FUTURE DIRECTIONS 
5. 1: Conclusions
There are significant differences between young and old mares with respect to insulin 
responses, predicted expression of insulin and IGF-1 receptors and metabolic activity.  These 
differences are summarized in Tables 5.1 – 5.5.  As shown in Table 5.1, expression of IGF-1R is 
signficiantly reduced in older animals as indicated by an increase in ∆Ct values from 8.8 in 
young animals to 12.4 in older animals.  Such a decrease in IGF-1R expression without a 
significant change in IR expression would be likely to increase the availability of IR 
monomers in the endoplasmic reticulum and thus increase numbers of insulin receptors and 
hybrid receptors formed from insulin monomers.  This predicted result is shown in Table 3.1 
for otherwise untreated granulosa cells preincubated with medium containing +FBS/+30 nM 
glucose.   
Two things are notable here.  First, this predicted increase in insulin receptor assembly 
occurs in the presence of +FBS/+30 nM glucose  and is not seen when cells are incubated in 
-FBS/-glucose medium.  Second, a similar response to the presence of +FBS/+30 nM glucose  is 
not seen in younger animals where receptors formed from IGF-1R monomers are believed to be 
the predominant receptor species.  To test whether predicted changes in receptor populartons are 
significant, it would be necessary to measure the absolte numbers of insulin receptors, IGF-1 
receptors and hybrid receptors present on the cell membrane of granulosa cells.  This is discussed 
below in future studies.   
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Also shown in Table 5.1 are changes in AMPK subunit expression in medium lacking 
FBS and glucose.  For each of the subunits shown, there is a 4.2 - 11.0 fold increase in AMPK 
subunit expression in older animals compared to younger animals that is significant.  These 
subunits are both regulatory and catalytic subunits.  This suggests that these granulosa cells from 
older animals are more metabolically active in the absence of FBS/30 nM glucose.  Insulin 
treatment similarly increases AMPKβ1 expression.
Tables 5.2 and 5.3 provide details for significant differences between AMPKα2 and 
AMPK 1β expression in young and older animals when granulosa cells are pre-incubated in 
medium lacking FBS/30 nM glucose.   These data, as discussed in Chapter 3 were evaluated 
collectively and showed that there was a significant difference in age for both untreated and 
treated cells, regardless of treatment.  In the presence of FBS/30 nM glucose, IGF-1R and 
GLUT4 exhibited increased expression in granulosa cells from older animals pre-incubated in 
+FBS/+30 nM glucose  and then treated with various hormones (Tables 5.4 and 5.5).  Together
these results support the idea that older mares are more labile with respect to changes in cell 
environment compared to younger animals.   This affects both the metabolic activity of the cells 
as well as availability of intracellular glucose for catabolic metabolism.  Whether these changes in 
gene expression reflect the development of insulin-resistance with aging would need to be 
assessed in individual animals using glucose tolerance tests and body scoring together with gene 
expression studies.   
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5. 2: Future directions
Reduced fertility in obese mares (105) suggests that long-term metabolic status may 
affect IR in sub-fertile animals.  Our preliminary results suggest that increased expression of 
IGF-1R relative to IR may reduce the numbers of IR2 homodimers and increase both IGF1R2 
homodimers and formation of IR·IGF-1R hybrid receptors in young animals while older 
animals are more environmentally- or hormone- sensitive with respect to IR2 and IGF-1R2 
expression.  The goal of future studies would be to clarify whether the environmental sensitivity 
of granulosa cells in older mares is due to the presence of growth factors as found, for example in 
FBS, extracellular glucose or to hormonal effects such as effects of follicle stimulating hormone 
(FSH) (106).   
To study the effects of pre-incubation media, we would be interested in times 
immediately following isolation of granulosa cells from mares.  At that time, the effects of 
media, i.e. low or high glucose, the presence of FBS providing a growth factor-rich medium or 
a combination of high glucose and FBS, could be assessed.  The responsiveness of these 
granulosa cells to hormone exposure for 24 or 48 hr treatment on gene expression by these 
cells would then be examined.  These experiments are shown schematically in Figure 5.1.   
After isolating granulosa cells, we would then evaluate levels of genes for IR, IGF-1R, 
AMP kinase subunits as described above and GLUT4.  In addition, we would examine levels 
of genes for FSH receptor (FSHR) and LH receptors (LHR) as described by Sessions-Bresnahan 
and Carnevale (103).  Their results suggest that LHR levels are significantly reduced in older 
mares while FSHR levels are reduced but not significantly so.  Incidentally, results for LHR 
differ from those reported for bovine granulosa cells where LHR levels were elevated (104).  At 
the same time, we would begin an incubation of these cells in medium containing either +FBS or 
+30 nM glucose alone or +FBS/+30 nM glucose.
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Cells would be harvested at 1 hr and at 24 hrs and gene expression will be evaluated for the genes
described above.  Finally, we would look in more detail at effects of 24 to 48 hr treatments with 
insulin, P4, IGF-1, FSH, hCG, IGF-1 and EGF.     
In conjunction with these experiments, cell aliquots would be tested for cell proliferation 
using a commercial MTT assay (107).  Baranao and Hammond (108) report that porcine 
granulosa cells are differentially sensitive to IGF-1 > insulin with respect to cell proliferation 
although animal age was not considered as a factor in these studies.  IGF-1 is also reported to 
increase numbers of granulosa cells in bovine granulosa cells (109).   Dupont and Scaramuzzi 
(106) suggest that FSH- and LH-mediated signaling may interact with insulin signaling although
the consequences of such interactions on granulosa cells are not known.    
To better understand the role of insulin receptors and IGF-1R in granulosa cell signaling, 
it is also important to understand what receptor species are involved in signaling, where they are 
located laterally in the membrane and how the magnitude of hormone-induced signals relates to 
receptor expression and actual receptor surface densities. Fluorescence correlation spectroscopy 
(FCS) makes possible direct measurements of molecular density for molecular species on 
individual living cells and has been applied to studies ennumerating insulin receptors and IGF-1R 
on single cells (110).  In FCS a low-power laser beam is focused on a cell surface and 
fluorescence from the molecule(s) of interest are measured over time using single-photon 
counting.  As fluorescent molecules diffuse in and out of the laser spot, the fluorescence signal 
fluctuates.  The time-scale of these fluctuations reflects the diffusion constant of the molecules.  
The number of molecules in the illuminated spot is contained in the time-zero amplitude of an 
appropriate auto- or cross-correlation function g (τ) of signal(s) from detector(s) measuring a 





where brackets denote time-averages of data. The receptor surface density σ is then calculated 
as σ=2/ (π r02g(0)). The only required calibration parameter is the laser spot size r0 which is 
known from optical system parameters and verified from measured fluorescent dye diffusion
rates.  
A related method, photon counting histogram (PCH) analysis, provides complementary 
information on molecular sizes and speciation (111). PCH analysis is performed on fluorescence 
intensities measured by individual photon counting as in FCS experiments.  When a laser beam 
is focused on a cell surface, the number of photons n detected within a measurement interval Δt 
from an annulus i around the beam having area dAi and intensity Bi fluctuates not only because 
of diffusion-caused fluctuations in the number of particles in the laser beam, but also because of 
Poisson fluctuations in the number of photons emitted and detected from each particle. The 
photon counting histogram (PCH) curve shape P, a double Poisson distribution, reflects the 
surface densities σ of molecular aggregates of various sizes m and the rate of detected photon 
emission per molecule, the so-called molecular brightness q.  Besides providing an alternative 
measurement of molecular surface densities, PCH analysis provides a direct measure of the 
aggregate size of a diffusing species since its molecular brightness can be compared to that of a 
known monomer. For example, we have used PCH analysis to examine possible multivalent 
binding of insulin to insulin receptors (110) and hormone-induced clustering of LHR (112). 
Together these studies will establish in small numbers of cells or, in the case of 
fluorescence correlation spectroscopy and related methods, individual cells, the effect of 
cell environment on cell proliferation and numbers of receptors for insulin and IGF-1.  These 
studies would represent an important methodlogical advance to understanding follicle function in 
the mare and, by extension, in humans.  Moreover, single cell methods provide an opportunity to 
examine another critical cell in the pre-ovulatory follicle, the oocyte.  
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Information on the oocyte, together with information on granulosa cells that support 
oocyte development and function, would be invaluable to our understanding of
similarities and differences in these cell types and suggest possible synergistic functions for 
these cells within the follicle.  These studies, if conducted in younger animals and older 
animals would also be important in determining a time-course for follicular changes during 
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24-48 hrs post treatment
Aim 2: Fluorescence Correlation Spectroscopy 
or photon counting histogram analysis
Measure IR2, IGF-1R2 and IR·IGF-1R2 hybrid 
receptor numbers
Aim 3:  Evaluate models of 
receptor dimer assembly  and 
speciation (IR and IGF-1R)
0 hours 1 hours 2 hours
Figure 5.1: Schematic representation of an experimental plan to evaluate the effects of 
granulosa cell medium on gene expression of insulin and IGF-1 receptor populations.  
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Table 5. 1: Comparison of young and older animals showing genes exhibiting significant 




ΔCt  ± SE 
Old 




AMPK 1 - None 8.95±1.24 6.95±0.45 4.35   < 0.05 
AMPK 2 - None 10.34 ± 1.21 7.76 ± 0.52 6.0   < 0.02 
AMPK 1 - None 11.36 ± 1.03 7.90 ± 0.71 11.0   < 0.001 
AMPK 1 - Insulin 11.15 ± 0.83 7.77 ± 0.81 10.4   < 0.002 
AMPK 1 + EGF 10.45 ± 0.64 8.39 ± 0.66 4.2   < 0.05 
AMPK 3 - None 14.34 ± 0.88 11.31 ± 0.81 8.2   < 0.04 
IGF1R + None 8.78±1.15 12.42±1.44 12.47    < 0.05 
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Table 5.2: Fold-change in expression of AMPK α2 in older mares compared to younger mares 
Gene Medium Treatment 
Age 
Young 
ΔCt  ± SE 
Old 




AMPK α2 - None 10.34 ± 1.21 7.76 ± 0.52 3.98   < 0.027 
AMPK α2 - Insulin 10.37 ± 1.06 8.45 ± 0.60 3.78   < 0.027 
AMPK α2 - hCG 8.97 ± 1.08 8.22 ± 0.39 1.68   < 0.027 
AMPK α2 - EGF 9.91 ± 0.92 8.27 ± 0.46 3.12   < 0.027 
AMPK α2 - IGF-1 9.37 ± 0.92 9.21 ± 0.49 1.12   < 0.027 
AMPK α2 - P4 9.36 ± 0.91 7.90 ± 0.45 2.75    < 0.027 
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Table 5.3: Fold-change in expression of AMPK β1 in older mares compared to younger mares 
Gene Medium Treatment 
Age 
Young 
ΔCt  ± SE 
Old 




AMPK β1 - None 11.36 ± 1.03 7.90 ± 0.71 11   < 0.006 
AMPK β1 - Insulin 11.15 ± 0.83 7.77 ± 0.81 10.41   < 0.006 
AMPK β1 - hCG 11.08 ± 0.95 8.27 ± 0.69 7.01   < 0.006 
AMPK β1 - EGF 10.55 ± 0.47 8.55 ± 0.66 4.00   < 0.006 
AMPK β1 - IGF-1 10.61 ± 0.43 8.77 ± 0.70 3.58   < 0.006 
AMPK β1 - P4 10.26 ± 0.50 8.09 ± 0.74 4.50    < 0.006 
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Table 5.4: Fold-change in expression of IGF-1R in older mares compared to younger mares 
Gene Medium Treatment 
Age 
Young 
ΔCt  ± SE 
Old 




IGF1R + None 8.78 ± 1.15 12.42 ± 1.44 12.47   < 0.025 
IGF1R + Insulin 9.98 ± 1.56 11.40 ± 1.51 2.68   < 0.025 
IGF1R + hCG 10.93 ± 1.49 9.97 ± 1.74 0.51   < 0.025 
IGF1R + EGF 10.45 ± 1.44 9.65 ± 1.60 0.57   < 0.025 
IGF1R + IGF-1 10.30 ± 1.72 11.51 ± 1.43 2.31   < 0.025 
IGF1R + P4 10.24 ± 1.49 11.33 ± 1.51 2.13    < 0.025 
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Table 5.5: Fold-change in expression of GLUT4 in older mares compared to younger mares 
Gene Medium Treatment 
Age 
Young 
ΔCt  ± SE 
Old 
ΔCt  ± SE 
(2-Ct) for Fold-
change   
P 
GLUT4 + None 16.50 ± 2.03 17.82 ± 1.72 0.40   < 0.05 
GLUT4 + Insulin 18.87 ± 2.05 16.87 ± 1.35 4.00   < 0.05 
GLUT4 + hCG 18.80 ± 2.17 15.16 ± 1.68 12.47   < 0.05 
GLUT4 + EGF 18.48 ± 2.10 16.46 ± 1.56 4.06   < 0.05 
GLUT4 + IGF-1 19.45 ± 2.25 17.34 ± 1.51 4.32   < 0.05 
GLUT4 + P4 17.84 ±1.93 17.61 ± 1.81 1.17    < 0.05 
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LIST OF ABBREVIATIONS 
ACTB Beta-actin 
AICAR         Aminoimidazole-4-carboxamide ribonucleotide 
AKT           protein kinase B, also known as Akt 
AMP             Activated protein kinase 
AMPK          Adenosine monophosphate-activated protein kinase 
α:   alpha subunit 
β:   beta subunit 




BMP-15   
BTC 






Germinal vesicle breakdown 
CaMKKβ     Calamedulin-dependent protein kinase kinase 
cAMP         Cyclic Activated protein kinase 
CBS    Cystathione β -Synthase  
CBS1            Cystathione β -Synthase repeats 1 
CBS2 Cystathione β -Synthase repeats 2 
CBS3 Cystathione β -Synthase repeats 3 
CBS4 Cystathione β -Synthase repeats 4 
cDNA          Complementary DNA 
CMB Carbohydrate-binding molecule 
CRTC – 1    Cyclic AMP-regulated transcriptional Co-activator-1 
CTD C-terminal Domine
DAF – 16     Abnormal dauer formation protein – 16 
DHEA-S      Dehydroepiandrosterone - sulfate 
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DMEM         Dulbecco’s modified minimum essential medium 
DNA  Deoxynucleic acid 
dsDNA         Double stranded DNA 
e IGF-1         Equine Insulin like growth factor 
E2   17β-estradiol  
EDTA Ethylenediamine tetraacetic Acid 
EGF   Epidermal growth factor 
EPI Epiregulin 
ErbBs            Epidermal growth factor receptor (EGFR) family, also known as ErbB receptors 
FBS   Fetal Bovine serum 
FCS Fluorescence correlation spectroscopy 
FoxO Forkhead box protein O 
FSH     Follicle stimulating hormone 
GADPH        Glyceraldehyde-3 phosphate dehydrogenase 
GDF-9          Growth and differentiation factor-9 
GLUT4         Glucose transporter 4 
GTP   Guanosine Triphosphate 
hCG  Human chorionic gonadotropin 
HKG  Housekeeping gene 
IGF-1R         Insulin like growth factor receptor 
IL-1 Interleukin-1  
InsL3 Insulin-like peptide 3 
IR Insulin Receptor 
IRS Insulin Receptor substrate 
IU Internatioal Unit 
IV  Intra Veins 
LH   Luteinizing hormone 
m minus 
m RNA         Messenger RNA 
mTOR,     mammalian target of rapamycin 


















Phosphate buffer saline 
Photon counting histogram  
Polycystic ovarian fibrosis 
Prostaglandin E2 
Post Injection
phosphatidyl inositol 3-OH-kinase 
Protein phosphatase
phosphatase and tensin homolog
qRT-PCR    
Rab  
RNA
quantititative Real-time reverse transcription polymerase chain reaction 
Rab family of proteins is a member of the Ras superfamily of 




SIRT1          
SKN-1          
T4





Δ ΔCT          
ΔCT      
PTEN
PI3K 
Ribosomal ribonucleic acid 
Reverse transcription 
Succinate dehydrogenase complex 
Silent information regular 1 
Skinhead -1 
Thyroxine 
Transforming growth factor-β-activated kinase 1 
Tuberous sclerosis complex1/2 
Thyrotropin Stimulating Hormone 
UltraViolet 
Vascular endothelial growth factor 
Double Delta Ct  
Delta cycle threshold 
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APPENDIX I: ∆Ct RAW DATA








T8; IGF-1,  
T9; GLUT4 
T10; IR  
KEY:  Treatments (G) 
G0: Control  
G1: Insulin 





m: minus (without FBS and glucose) 
p: plus (without FBS and glucose). 
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TEST 1: ANOVA F-tests for each variable 
Gene Effect NumDF DenDF FValue Rawp 
T1 Age Cat 2 15 1.124087 0.350841 
T1 Treatment 5 165 0.898507 0.483568 
T1 Age Cat* Treatment 10 165 1.172924 0.312533 
T1 Glucose 1 165 1.132597 0.288777 
T1 Age Cat*Glucose 2 165 0.816783 0.443629 
T1 Treatment *Glucose 5 165 0.940962 0.456049 
T1 Age Cat* Treatment *Glucose 10 165 0.699855 0.723669 
T10 Age Cat 2 15 1.001194 0.390715 
T10 Treatment 5 165 1.879314 0.100562 
T10 Age Cat* Treatment 10 165 0.305349 0.979013 
T10 Glucose 1 165 8.648967 0.003743 
T10 Age Cat*Glucose 2 165 0.229958 0.794821 
T10 Treatment *Glucose 5 165 0.861692 0.508239 
T10 Age Cat* Treatment *Glucose 10 165 0.966766 0.474407 
T2 Age Cat 2 15 1.299408 0.301688 
T2 Treatment 5 165 0.331476 0.893399 
T2 Age Cat* Treatment 10 165 1.929902 0.044422 
T2 Glucose 1 165 5.629937 0.018808 
T2 Age Cat*Glucose 2 165 1.425449 0.243345 
T2 Treatment *Glucose 5 165 1.200511 0.311193 
T2 Age Cat* Treatment *Glucose 10 165 0.809315 0.61999 
T3 Age Cat 2 15 3.599971 0.05285 
T3 Treatment 5 165 1.316345 0.259524 
T3 Age Cat* Treatment 10 165 1.200987 0.293807 
T3 Glucose 1 165 1.271024 0.261212 
T3 Age Cat*Glucose 2 165 3.323709 0.038446 
T3 Treatment *Glucose 5 165 1.023454 0.405588 
T3 Age Cat* Treatment *Glucose 10 165 1.261707 0.256122 
T4 Age Cat 2 15 0.305942 0.740917 
T4 Treatment 5 165 0.155681 0.978067 
T4 Age Cat* Treatment 10 165 0.651057 0.76815 
T4 Glucose 1 165 1.548906 0.215062 
T4 Age Cat*Glucose 2 165 0.15869 0.853391 
T4 Treatment *Glucose 5 165 0.221513 0.95287 
T4 Age Cat* Treatment *Glucose 10 165 0.959542 0.480775 
T5 Age Cat 2 15 0.434834 0.655278 
T5 Treatment 5 165 0.694961 0.627959 
T5 Age Cat* Treatment 10 165 1.322583 0.22216 
T5 Glucose 1 165 0.2144 0.643951 
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Gene Effect NumDF DenDF FValue Rawp 
T5 Age Cat*Glucose 2 165 0.896129 0.410123 
T5 Treatment *Glucose 5 165 0.560466 0.730182 
T5 Age Cat* Treatment *Glucose 10 165 0.470051 0.907473 
T6 Age Cat 2 15 0.265599 0.770278 
T6 Treatment 5 165 1.483529 0.197825 
T6 Age Cat* Treatment 10 165 0.735698 0.690065 
T6 Glucose 1 165 0.943493 0.332803 
T6 Age Cat*Glucose 2 165 0.703632 0.496264 
T6 Treatment *Glucose 5 165 0.202632 0.961002 
T6 Age Cat* Treatment *Glucose 10 165 0.839367 0.591419 
T7 Age Cat 2 15 2.086496 0.158676 
T7 Treatment 5 165 1.804357 0.114655 
T7 Age Cat* Treatment t 10 165 0.79511 0.633539 
T7 Glucose 1 165 0.046047 0.830355 
T7 Age Cat*Glucose 2 165 0.215193 0.806612 
T7 Treatment *Glucose 5 165 0.644138 0.66634 
T7 Age Cat*Trt*Glucose 10 165 0.867583 0.564808 
T8 Age Cat 2 15 0.2476 0.783801 
T8 Treatment 5 165 0.559481 0.730933 
T8 Age Cat* Treatment 10 165 1.057547 0.398096 
T8 Glucose 1 165 0.579256 0.44769 
T8 Age Cat*Glucose 2 165 0.886828 0.413915 
T8 Treatment *Glucose 5 165 0.689378 0.632146 
T8 Age Cat* Treatment *Glucose 10 165 0.907424 0.527798 
T9 Age Cat 2 15 0.500882 0.61578 
T9 Treatment 5 165 0.527274 0.755401 
T9 Age Cat* Treatment 10 165 1.269034 0.251834 
T9 Glucose 1 165 3.738331 0.054889 
T9 Age Cat*Glucose 2 165 3.474421 0.033265 
T9 Treatment *Glucose 5 165 0.468675 0.7992 
T9 Age Cat* Treatment *Glucose 10 165 1.076989 0.382736 
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SUMSTATS TEST: Values needed to plot mean and standard error 
Gene Glucose AgeCat Treatment n mean sd SE 
T1 m Middle G0 4 8.6231 1.3721 0.6861 
T1 m Middle G1 4 8.6194 1.0755 0.5377 
T1 m Middle G2 4 8.4269 0.3734 0.1867 
T1 m Middle G3 4 8.685 1.9941 0.997 
T1 m Middle G4 4 9.3338 1.625 0.8125 
T1 m Middle G5 4 8.1244 0.9081 0.454 
T1 m Old G0 8 6.835 1.2735 0.4502 
T1 m Old G1 8 7.1216 1.1378 0.4023 
T1 m Old G2 8 7.3397 1.4748 0.5214 
T1 m Old G3 8 7.5547 1.4794 0.5231 
T1 m Old G4 8 8.1544 1.8116 0.6405 
T1 m Old G5 8 7.0178 1.844 0.652 
T1 m Young G0 6 8.9479 3.0279 1.2362 
T1 m Young G1 6 8.86 3.0948 1.2635 
T1 m Young G2 6 8.5446 2.629 1.0733 
T1 m Young G3 6 9.2467 2.7191 1.11 
T1 m Young G4 6 8.1104 2.4204 0.9881 
T1 m Young G5 6 8.7279 2.3787 0.9711 
T1 p Middle G0 4 8.4125 1.9201 0.96 
T1 p Middle G1 4 7.3046 1.4128 0.7064 
T1 p Middle G2 4 8.8969 2.4963 1.2481 
T1 p Middle G3 4 9.7519 1.3363 0.6682 
T1 p Middle G4 4 8.221 1.2115 0.6057 
T1 p Middle G5 4 9.2669 0.8458 0.4229 
T1 p Old G0 8 7.5347 1.4177 0.5012 
T1 p Old G1 8 7.6006 1.422 0.5028 
T1 p Old G2 8 7.8275 2.2908 0.8099 
T1 p Old G3 8 7.6025 1.3047 0.4613 
T1 p Old G4 8 8.5397 2.0902 0.739 
T1 p Old G5 8 7.865 1.89 0.6682 
T1 p Young G0 6 9.5271 3.6938 1.508 
T1 p Young G1 6 8.2908 2.4002 0.9799 
T1 p Young G2 6 8.9817 2.2149 0.9042 
T1 p Young G3 6 8.6504 2.4404 0.9963 
T1 p Young G4 6 8.5213 2.1774 0.8889 
T1 p Young G5 6 8.9288 2.2441 0.9162 
T10 m Middle G0 4 8.3417 0.8715 0.4357 
T10 m Middle G1 4 9.1969 0.4942 0.2471 
T10 m Middle G2 4 9.1594 0.5594 0.2797 
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T10 m Middle G3 4 9.1975 1.2234 0.6117 
T10 m Middle G4 4 10.216 1.6546 0.8273 
T10 m Middle G5 4 8.8394 0.7353 0.3677 
T10 m Old G0 8 9.0988 1.6869 0.5964 
T10 m Old G1 8 8.1891 1.5196 0.5373 
T10 m Old G2 8 10.11 3.3605 1.1881 
T10 m Old G3 8 10.501 3.6567 1.2928 
T10 m Old G4 8 10.218 3.437 1.2152 
T10 m Old G5 8 10.082 3.492 1.2346 
T10 m Young G0 6 10.848 2.8521 1.1644 
T10 m Young G1 6 10.21 1.7285 0.7057 
T10 m Young G2 6 10.845 1.6156 0.6596 
T10 m Young G3 6 11.396 1.9474 0.795 
T10 m Young G4 6 10.944 2.7919 1.1398 
T10 m Young G5 6 10.686 2.2969 0.9377 
T10 p Middle G0 4 10.16 1.4806 0.7403 
T10 p Middle G1 4 9.2783 1.1789 0.5895 
T10 p Middle G2 4 9.3844 1.4971 0.7486 
T10 p Middle G3 4 10.627 2.2408 1.1204 
T10 p Middle G4 4 8.8294 0.7791 0.3895 
T10 p Middle G5 4 10.327 1.3321 0.6661 
T10 p Old G0 8 11.065 3.7503 1.3259 
T10 p Old G1 8 9.6863 1.7089 0.6042 
T10 p Old G2 8 9.0238 5.0144 1.7729 
T10 p Old G3 8 10.378 4.4093 1.5589 
T10 p Old G4 8 11.326 3.4029 1.2031 
T10 p Old G5 8 10.288 3.6097 1.2762 
T10 p Young G0 6 11.403 1.6198 0.6613 
T10 p Young G1 6 11.121 2.1503 0.8779 
T10 p Young G2 6 11.508 2.266 0.9251 
T10 p Young G3 6 12.075 2.0331 0.83 
T10 p Young G4 6 12.061 1.5783 0.6444 
T10 p Young G5 6 12.366 2.8955 1.1821 
T2 m Middle G0 4 9.76 2.08 1.04 
T2 m Middle G1 4 9.42 0.37 0.19 
T2 m Middle G2 4 9.02 1.34 0.67 
T2 m Middle G3 4 10.38 2.93 1.47 
T2 m Middle G4 4 10.41 2.26 1.13 
T2 m Middle G5 4 9.58 2.93 1.47 
T2 m Old G0 8 7.76 1.47 0.52 
T2 m Old G1 8 8.45 1.70 0.60 
T2 m Old G2 8 8.22 1.11 0.39 
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Gene Glucose AgeCat Treatment n mean sd SE 
T2 m Old G3 8 8.27 1.30 0.46 
T2 m Old G4 8 9.21 1.38 0.49 
T2 m Old G5 8 7.90 1.28 0.45 
T2 m Young G0 6 10.34 2.97 1.21 
T2 m Young G1 6 10.37 2.61 1.06 
T2 m Young G2 6 8.97 2.65 1.08 
T2 m Young G3 6 9.91 2.25 0.92 
T2 m Young G4 6 9.37 2.26 0.92 
T2 m Young G5 6 9.36 2.24 0.91 
T2 p Middle G0 4 9.26 1.58 0.79 
T2 p Middle G1 4 8.55 1.68 0.84 
T2 p Middle G2 4 10.78 3.25 1.62 
T2 p Middle G3 4 11.02 2.02 1.01 
T2 p Middle G4 4 9.32 2.65 1.33 
T2 p Middle G5 4 10.45 1.86 0.93 
T2 p Old G0 8 9.18 1.43 0.51 
T2 p Old G1 8 9.81 1.76 0.62 
T2 p Old G2 8 8.95 1.21 0.43 
T2 p Old G3 8 8.46 1.09 0.39 
T2 p Old G4 8 9.59 1.58 0.56 
T2 p Old G5 8 9.05 2.03 0.72 
T2 p Young G0 6 10.98 3.24 1.32 
T2 p Young G1 6 9.76 1.58 0.64 
T2 p Young G2 6 9.91 2.37 0.97 
T2 p Young G3 6 9.92 2.13 0.87 
T2 p Young G4 6 9.72 1.86 0.76 
T2 p Young G5 6 10.19 2.00 0.82 
T3 m Middle G0 4 10.498 1.6726 0.8363 
T3 m Middle G1 4 9.6644 1.7046 0.8523 
T3 m Middle G2 4 9.6906 0.6595 0.3297 
T3 m Middle G3 4 9.9113 2.0264 1.0132 
T3 m Middle G4 4 10.804 1.4744 0.7372 
T3 m Middle G5 4 9.4556 0.8516 0.4258 
T3 m Old G0 8 7.8963 2.0214 0.7147 
T3 m Old G1 8 7.7728 2.2947 0.8113 
T3 m Old G2 8 8.2697 1.9582 0.6923 
T3 m Old G3 8 8.5541 1.8547 0.6557 
T3 m Old G4 8 8.7738 1.9932 0.7047 
T3 m Old G5 8 8.0903 2.1051 0.7443 
T3 m Young G0 6 11.359 2.5303 1.033 
T3 m Young G1 6 11.15 2.0247 0.8266 
T3 m Young G2 6 10.081 2.334 0.9529 
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T3 m Young G3 6 10.55 1.1403 0.4655 
T3 m Young G4 6 10.614 1.0561 0.4312 
T3 m Young G5 6 10.263 1.2363 0.5047 
T3 p Middle G0 4 9.8338 2.1299 1.0649 
T3 p Middle G1 4 8.3458 0.9454 0.4727 
T3 p Middle G2 4 9.5594 2.3388 1.1694 
T3 p Middle G3 4 11.712 2.1486 1.0743 
T3 p Middle G4 4 9.4573 0.8326 0.4163 
T3 p Middle G5 4 10.437 0.5331 0.2665 
T3 p Old G0 8 9.0741 1.8977 0.671 
T3 p Old G1 8 9.1844 1.2816 0.4531 
T3 p Old G2 8 8.9963 2.1496 0.76 
T3 p Old G3 8 8.39 1.8621 0.6583 
T3 p Old G4 8 9.5378 2.3349 0.8255 
T3 p Old G5 8 9.1219 2.1147 0.7477 
T3 p Young G0 6 11.118 2.8366 1.158 
T3 p Young G1 6 10.298 1.763 0.7197 
T3 p Young G2 6 10.012 2.0812 0.8497 
T3 p Young G3 6 10.448 1.5772 0.6439 
T3 p Young G4 6 10.534 1.2145 0.4958 
T3 p Young G5 6 11.091 1.5827 0.6461 
T4 m Middle G0 4 8.0931 1.0411 0.5205 
T4 m Middle G1 4 8.3931 0.9336 0.4668 
T4 m Middle G2 4 7.8431 0.7298 0.3649 
T4 m Middle G3 4 7.8188 1.124 0.562 
T4 m Middle G4 4 9.1325 1.3838 0.6919 
T4 m Middle G5 4 8.1356 0.9294 0.4647 
T4 m Old G0 8 7.7019 1.8055 0.6383 
T4 m Old G1 8 7.3997 2.1394 0.7564 
T4 m Old G2 8 8.4434 2.0517 0.7254 
T4 m Old G3 8 8.0028 1.7461 0.6173 
T4 m Old G4 8 7.7294 1.9531 0.6905 
T4 m Old G5 8 7.5359 1.8666 0.6599 
T4 m Young G0 6 8.5046 1.2257 0.5004 
T4 m Young G1 6 8.3108 1.2531 0.5116 
T4 m Young G2 6 8.4771 1.1548 0.4714 
T4 m Young G3 6 8.6408 0.6446 0.2632 
T4 m Young G4 6 7.9679 0.9899 0.4041 
T4 m Young G5 6 7.9654 0.9606 0.3922 
T4 p Middle G0 4 8.0675 1.2882 0.6441 
T4 p Middle G1 4 7.1983 1.0657 0.5329 
T4 p Middle G2 4 8.5906 2.0402 1.0201 
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T4 p Middle G3 4 9.0331 1.5966 0.7983 
T4 p Middle G4 4 7.9798 0.732 0.366 
T4 p Middle G5 4 9.4344 1.4888 0.7444 
T4 p Old G0 8 7.9366 1.8706 0.6614 
T4 p Old G1 8 8.7181 3.1425 1.111 
T4 p Old G2 8 8.4081 1.3192 0.4664 
T4 p Old G3 8 7.9306 1.5293 0.5407 
T4 p Old G4 8 8.2891 1.985 0.7018 
T4 p Old G5 8 7.8456 2.707 0.9571 
T4 p Young G0 6 9.1521 2.2612 0.9231 
T4 p Young G1 6 8.5558 1.6692 0.6814 
T4 p Young G2 6 8.405 0.9024 0.3684 
T4 p Young G3 6 8.4479 0.9042 0.3692 
T4 p Young G4 6 8.3221 0.7795 0.3182 
T4 p Young G5 6 8.1529 0.9464 0.3864 
T5 m Middle G0 4 10.001 2.1125 1.0562 
T5 m Middle G1 4 8.5181 1.1397 0.5698 
T5 m Middle G2 4 8.1419 0.4384 0.2192 
T5 m Middle G3 4 8.3588 0.5527 0.2763 
T5 m Middle G4 4 8.7925 1.0081 0.504 
T5 m Middle G5 4 8.5181 0.3261 0.163 
T5 m Old G0 8 10.622 4.5599 1.6122 
T5 m Old G1 8 9.3284 4.9472 1.7491 
T5 m Old G2 8 9.5622 4.2836 1.5145 
T5 m Old G3 8 9.9491 3.7813 1.3369 
T5 m Old G4 8 10.089 3.2288 1.1416 
T5 m Old G5 8 9.6172 2.977 1.0525 
T5 m Young G0 6 8.0971 2.2185 0.9057 
T5 m Young G1 6 8.36 3.9158 1.5986 
T5 m Young G2 6 9.0421 4.7446 1.937 
T5 m Young G3 6 9.0792 4.345 1.7738 
T5 m Young G4 6 8.2879 3.9333 1.6058 
T5 m Young G5 6 7.7721 4.4779 1.8281 
T5 p Middle G0 4 8.9025 2.0765 1.0383 
T5 p Middle G1 4 7.7771 0.2898 0.1449 
T5 p Middle G2 4 7.6856 0.7904 0.3952 
T5 p Middle G3 4 8.9406 0.7326 0.3663 
T5 p Middle G4 4 7.7623 0.0598 0.0299 
T5 p Middle G5 4 9.2581 1.126 0.563 
T5 p Old G0 8 10.555 4.7139 1.6666 
T5 p Old G1 8 10.528 4.6669 1.65 
T5 p Old G2 8 9.3419 2.6798 0.9475 
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T5 p Old G3 8 9.8069 3.1495 1.1135 
T5 p Old G4 8 10.563 4.1247 1.4583 
T5 p Old G5 8 10.127 3.1281 1.106 
T5 p Young G0 6 8.0546 1.7969 0.7336 
T5 p Young G1 6 8.4958 3.8242 1.5612 
T5 p Young G2 6 9.1742 3.9212 1.6008 
T5 p Young G3 6 8.8763 4.1883 1.7099 
T5 p Young G4 6 9.3446 4.2763 1.7458 
T5 p Young G5 6 8.6779 3.1528 1.2871 
T6 m Middle G0 4 14.618 3.3743 1.6871 
T6 m Middle G1 4 15.042 4.3349 2.1674 
T6 m Middle G2 4 14.387 4.3871 2.1935 
T6 m Middle G3 4 12.235 4.3057 2.1529 
T6 m Middle G4 4 13.83 1.309 0.6545 
T6 m Middle G5 4 12.094 2.8656 1.4328 
T6 m Old G0 8 13.215 5.2312 1.8495 
T6 m Old G1 8 12.707 5.0629 1.79 
T6 m Old G2 8 12.301 3.4839 1.2317 
T6 m Old G3 8 12.589 3.1707 1.121 
T6 m Old G4 8 13.404 1.9897 0.7035 
T6 m Old G5 8 12.348 2.6024 0.9201 
T6 m Young G0 6 13.933 4.577 1.8686 
T6 m Young G1 6 12.408 3.4669 1.4153 
T6 m Young G2 6 11.599 4.7094 1.9226 
T6 m Young G3 6 13.185 3.5515 1.4499 
T6 m Young G4 6 11.798 4.3069 1.7583 
T6 m Young G5 6 13.256 4.2928 1.7525 
T6 p Middle G0 4 15.605 4.6301 2.315 
T6 p Middle G1 4 13.551 5.0233 2.5117 
T6 p Middle G2 4 14.802 4.808 2.404 
T6 p Middle G3 4 14.559 2.6467 1.3233 
T6 p Middle G4 4 12.829 3.029 1.5145 
T6 p Middle G5 4 15.032 5.2463 2.6231 
T6 p Old G0 8 14.324 3.8533 1.3624 
T6 p Old G1 8 13.978 3.0796 1.0888 
T6 p Old G2 8 12.976 2.1368 0.7555 
T6 p Old G3 8 12.117 3.3447 1.1825 
T6 p Old G4 8 13.38 2.7187 0.9612 
T6 p Old G5 8 12.553 4.0554 1.4338 
T6 p Young G0 6 12.941 3.8987 1.5916 
T6 p Young G1 6 12.773 4.3533 1.7772 
T6 p Young G2 6 11.35 4.0463 1.6519 
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T6 p Young G3 6 12.612 4.2326 1.7279 
T6 p Young G4 6 12.404 3.7152 1.5167 
T6 p Young G5 6 12.8 4.0037 1.6345 
T7 m Middle G0 4 14.009 2.1231 1.0616 
T7 m Middle G1 4 13.767 2.9659 1.4829 
T7 m Middle G2 4 13.089 3.6893 1.8446 
T7 m Middle G3 4 13.113 3.9953 1.9977 
T7 m Middle G4 4 13.985 3.111 1.5555 
T7 m Middle G5 4 12.832 2.8802 1.4401 
T7 m Old G0 8 11.309 2.2894 0.8094 
T7 m Old G1 8 10.213 3.1775 1.1234 
T7 m Old G2 8 11.273 1.8599 0.6576 
T7 m Old G3 8 13.313 3.6294 1.2832 
T7 m Old G4 8 12.319 2.1754 0.7691 
T7 m Old G5 8 10.669 2.7947 0.9881 
T7 m Young G0 6 14.336 2.156 0.8802 
T7 m Young G1 6 12.278 1.825 0.745 
T7 m Young G2 6 12.935 2.9013 1.1845 
T7 m Young G3 6 13.818 2.2789 0.9304 
T7 m Young G4 6 14.23 1.8522 0.7561 
T7 m Young G5 6 12.476 2.5419 1.0377 
T7 p Middle G0 4 13.875 3.1363 1.5681 
T7 p Middle G1 4 12.711 3.2681 1.634 
T7 p Middle G2 4 14.432 4.5631 2.2815 
T7 p Middle G3 4 12.734 2.4616 1.2308 
T7 p Middle G4 4 12.459 3.4356 1.7178 
T7 p Middle G5 4 13.273 1.6104 0.8052 
T7 p Old G0 8 12.274 2.9202 1.0324 
T7 p Old G1 8 11.819 2.5718 0.9093 
T7 p Old G2 8 10.028 1.768 0.6251 
T7 p Old G3 8 12.001 1.8846 0.6663 
T7 p Old G4 8 12.617 2.4218 0.8562 
T7 p Old G5 8 11.401 3.6636 1.2953 
T7 p Young G0 6 13.541 1.259 0.514 
T7 p Young G1 6 13.743 1.6043 0.6549 
T7 p Young G2 6 12.724 2.7516 1.1233 
T7 p Young G3 6 14.059 1.8573 0.7583 
T7 p Young G4 6 13.885 1.7975 0.7338 
T7 p Young G5 6 13.446 2.5231 1.03 
T8 m Middle G0 4 10.487 0.5921 0.296 
T8 m Middle G1 4 11.008 1.8627 0.9313 
T8 m Middle G2 4 9.5906 3.0298 1.5149 
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T8 m Middle G3 4 9.6425 3.1221 1.561 
T8 m Middle G4 4 11.869 2.2698 1.1349 
T8 m Middle G5 4 11.226 3.0311 1.5156 
T8 m Old G0 8 10.543 3.8521 1.3619 
T8 m Old G1 8 10.29 5.2171 1.8445 
T8 m Old G2 8 11.284 4.4824 1.5848 
T8 m Old G3 8 11.718 4.9287 1.7425 
T8 m Old G4 8 10.278 4.2799 1.5132 
T8 m Old G5 8 10.858 3.79 1.34 
T8 m Young G0 6 8.6654 2.3957 0.9781 
T8 m Young G1 6 8.7558 3.5435 1.4466 
T8 m Young G2 6 9.6146 3.9047 1.5941 
T8 m Young G3 6 9.8525 3.6707 1.4986 
T8 m Young G4 6 10.498 3.7266 1.5214 
T8 m Young G5 6 8.6229 3.8242 1.5612 
T8 p Middle G0 4 11.35 1.3149 0.6575 
T8 p Middle G1 4 10.008 2.7716 1.3858 
T8 p Middle G2 4 10.324 2.4736 1.2368 
T8 p Middle G3 4 8.7219 1.8692 0.9346 
T8 p Middle G4 4 10.442 2.2573 1.1287 
T8 p Middle G5 4 11.237 3.4236 1.7118 
T8 p Old G0 8 12.421 4.0621 1.4362 
T8 p Old G1 8 11.398 4.278 1.5125 
T8 p Old G2 8 9.9725 4.9151 1.7378 
T8 p Old G3 8 9.6531 4.5341 1.603 
T8 p Old G4 8 11.507 4.0536 1.4332 
T8 p Old G5 8 11.326 4.2759 1.5118 
T8 p Young G0 6 8.7821 2.8279 1.1545 
T8 p Young G1 6 9.975 3.8288 1.5631 
T8 p Young G2 6 10.925 3.6508 1.4905 
T8 p Young G3 6 10.448 3.5175 1.436 
T8 p Young G4 6 10.299 4.2124 1.7197 
T8 p Young G5 6 10.245 3.65 1.4901 
T9 m Middle G0 4 19.668 0.9402 0.4701 
T9 m Middle G1 4 19.093 2.1498 1.0749 
T9 m Middle G2 4 18.432 2.3289 1.1645 
T9 m Middle G3 4 18.349 2.7876 1.3938 
T9 m Middle G4 4 20.72 1.1379 0.569 
T9 m Middle G5 4 17.749 2.3174 1.1587 
T9 m Old G0 8 17.044 4.8862 1.7275 
T9 m Old G1 8 16.837 4.5265 1.6004 
T9 m Old G2 8 17.166 4.0135 1.419 
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T9 m Old G3 8 17.332 3.9155 1.3843 
T9 m Old G4 8 17.704 4.3239 1.5287 
T9 m Old G5 8 17.272 4.0402 1.4284 
T9 m Young G0 6 16.551 4.8276 1.9709 
T9 m Young G1 6 17.03 4.6457 1.8966 
T9 m Young G2 6 17.578 5.4092 2.2083 
T9 m Young G3 6 17.944 5.615 2.2923 
T9 m Young G4 6 16.652 4.4929 1.8342 
T9 m Young G5 6 16.816 4.7764 1.9499 
T9 p Middle G0 4 20.662 0.5713 0.2856 
T9 p Middle G1 4 19.481 2.6958 1.3479 
T9 p Middle G2 4 19.509 1.6653 0.8327 
T9 p Middle G3 4 19.169 1.6362 0.8181 
T9 p Middle G4 4 19.219 1.736 0.868 
T9 p Middle G5 4 20.453 2.2498 1.1249 
T9 p Old G0 8 17.818 3.6 1.2728 
T9 p Old G1 8 16.873 3.8154 1.349 
T9 p Old G2 8 15.161 4.7613 1.6834 
T9 p Old G3 8 16.456 4.4122 1.5599 
T9 p Old G4 8 17.342 4.2805 1.5134 
T9 p Old G5 8 17.611 5.1135 1.8079 
T9 p Young G0 6 16.504 4.9788 2.0326 
T9 p Young G1 6 18.865 5.0122 2.0462 
T9 p Young G2 6 18.796 5.3152 2.1699 
T9 p Young G3 6 18.478 5.151 2.1029 
T9 p Young G4 6 19.45 5.5009 2.2458 
T9 p Young G5 6 17.838 4.7201 1.927 
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T1 1 Trt*Glucose Glucose m G0 G1 -0.06 0.4412 165 -0.1 0.883 Tukey-K 1 
T1 1 Trt*Glucose Glucose m G0 G2 0.032 0.4412 165 0.07 0.943 Tukey-K 1 
T1 1 Trt*Glucose Glucose m G0 G3 -0.36 0.4412 165 -0.8 0.416 Tukey-K 0.964 
T1 1 Trt*Glucose Glucose m G0 G4 -0.4 0.4412 165 -0.9 0.369 Tukey-K 0.946 
T1 1 Trt*Glucose Glucose m G0 G5 0.179 0.4412 165 0.4 0.686 Tukey-K 0.999 
T1 1 Trt*Glucose Glucose m G1 G2 0.097 0.4412 165 0.22 0.827 Tukey-K 1 
T1 1 Trt*Glucose Glucose m G1 G3 -0.3 0.4412 165 -0.7 0.504 Tukey-K 0.985 
T1 1 Trt*Glucose Glucose m G1 G4 -0.33 0.4412 165 -0.8 0.452 Tukey-K 0.975 
T1 1 Trt*Glucose Glucose m G1 G5 0.244 0.4412 165 0.55 0.582 Tukey-K 0.994 
T1 1 Trt*Glucose Glucose m G2 G3 -0.39 0.4412 165 -0.9 0.376 Tukey-K 0.949 
T1 1 Trt*Glucose Glucose m G2 G4 -0.43 0.4412 165 -1 0.332 Tukey-K 0.926 
T1 1 Trt*Glucose Glucose m G2 G5 0.147 0.4412 165 0.33 0.739 Tukey-K 0.999 
T1 1 Trt*Glucose Glucose m G3 G4 -0.04 0.4412 165 -0.1 0.933 Tukey-K 1 
T1 1 Trt*Glucose Glucose m G3 G5 0.539 0.4412 165 1.22 0.224 Tukey-K 0.826 
T1 1 Trt*Glucose Glucose m G4 G5 0.576 0.4412 165 1.31 0.193 Tukey-K 0.782 
T1 1 Trt*Glucose Glucose p G0 G1 0.759 0.4412 165 1.72 0.087 Tukey-K 0.52 
T1 1 Trt*Glucose Glucose p G0 G2 -0.08 0.4412 165 -0.2 0.861 Tukey-K 1 
T1 1 Trt*Glucose Glucose p G0 G3 -0.18 0.4412 165 -0.4 0.689 Tukey-K 0.999 
T1 1 Trt*Glucose Glucose p G0 G4 0.064 0.4412 165 0.15 0.885 Tukey-K 1 
T1 1 Trt*Glucose Glucose p G0 G5 -0.2 0.4412 165 -0.4 0.658 Tukey-K 0.998 
T1 1 Trt*Glucose Glucose p G1 G2 -0.84 0.4412 165 -1.9 0.06 Tukey-K 0.408 
T1 1 Trt*Glucose Glucose p G1 G3 -0.94 0.4412 165 -2.1 0.035 Tukey-K 0.281 
T1 1 Trt*Glucose Glucose p G1 G4 -0.7 0.4412 165 -1.6 0.117 Tukey-K 0.616 
T1 1 Trt*Glucose Glucose p G1 G5 -0.95 0.4412 165 -2.2 0.032 Tukey-K 0.26 
T1 1 Trt*Glucose Glucose p G2 G3 -0.1 0.4412 165 -0.2 0.822 Tukey-K 1 
T1 1 Trt*Glucose Glucose p G2 G4 0.141 0.4412 165 0.32 0.749 Tukey-K 1 
T1 1 Trt*Glucose Glucose p G2 G5 -0.12 0.4412 165 -0.3 0.789 Tukey-K 1 
T1 1 Trt*Glucose Glucose p G3 G4 0.241 0.4412 165 0.55 0.586 Tukey-K 0.994 
T1 1 Trt*Glucose Glucose p G3 G5 -0.02 0.4412 165 -0 0.966 Tukey-K 1 
T1 1 Trt*Glucose Glucose p G4 G5 -0.26 0.4412 165 -0.6 0.557 Tukey-K 0.992 
T10 1 Trt*Glucose Glucose m G0 G1 0.231 0.5937 165 0.39 0.698 Tukey-K 0.999 
T10 1 Trt*Glucose Glucose m G0 G2 -0.61 0.5937 165 -1 0.307 Tukey-K 0.909 
T10 1 Trt*Glucose Glucose m G0 G3 -0.94 0.5937 165 -1.6 0.117 Tukey-K 0.616 
T10 1 Trt*Glucose Glucose m G0 G4 -1.03 0.5937 165 -1.7 0.085 Tukey-K 0.511 
T10 1 Trt*Glucose Glucose m G0 G5 -0.44 0.5937 165 -0.7 0.46 Tukey-K 0.977 
T10 1 Trt*Glucose Glucose m G1 G2 -0.84 0.5937 165 -1.4 0.159 Tukey-K 0.719 
T10 1 Trt*Glucose Glucose m G1 G3 -1.17 0.5937 165 -2 0.051 Tukey-K 0.367 
T10 1 Trt*Glucose Glucose m G1 G4 -1.26 0.5937 165 -2.1 0.035 Tukey-K 0.28 
T10 1 Trt*Glucose Glucose m G1 G5 -0.67 0.5937 165 -1.1 0.26 Tukey-K 0.869 
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T10 1 Trt*Glucose Glucose m G2 G3 -0.33 0.5937 165 -0.6 0.583 Tukey-K 0.994 
T10 1 Trt*Glucose Glucose m G2 G4 -0.42 0.5937 165 -0.7 0.479 Tukey-K 0.981 
T10 1 Trt*Glucose Glucose m G2 G5 0.169 0.5937 165 0.28 0.776 Tukey-K 1 
T10 1 Trt*Glucose Glucose m G3 G4 -0.09 0.5937 165 -0.2 0.874 Tukey-K 1 
T10 1 Trt*Glucose Glucose m G3 G5 0.496 0.5937 165 0.83 0.405 Tukey-K 0.961 
T10 1 Trt*Glucose Glucose m G4 G5 0.59 0.5937 165 0.99 0.322 Tukey-K 0.919 
T10 1 Trt*Glucose Glucose p G0 G1 0.848 0.5937 165 1.43 0.155 Tukey-K 0.71 
T10 1 Trt*Glucose Glucose p G0 G2 0.904 0.5937 165 1.52 0.13 Tukey-K 0.65 
T10 1 Trt*Glucose Glucose p G0 G3 -0.15 0.5937 165 -0.3 0.8 Tukey-K 1 
T10 1 Trt*Glucose Glucose p G0 G4 0.137 0.5937 165 0.23 0.817 Tukey-K 1 
T10 1 Trt*Glucose Glucose p G0 G5 -0.12 0.5937 165 -0.2 0.843 Tukey-K 1 
T10 1 Trt*Glucose Glucose p G1 G2 0.056 0.5937 165 0.1 0.924 Tukey-K 1 
T10 1 Trt*Glucose Glucose p G1 G3 -1 0.5937 165 -1.7 0.095 Tukey-K 0.546 
T10 1 Trt*Glucose Glucose p G1 G4 -0.71 0.5937 165 -1.2 0.233 Tukey-K 0.838 
T10 1 Trt*Glucose Glucose p G1 G5 -0.97 0.5937 165 -1.6 0.106 Tukey-K 0.583 
T10 1 Trt*Glucose Glucose p G2 G3 -1.05 0.5937 165 -1.8 0.077 Tukey-K 0.484 
T10 1 Trt*Glucose Glucose p G2 G4 -0.77 0.5937 165 -1.3 0.198 Tukey-K 0.789 
T10 1 Trt*Glucose Glucose p G2 G5 -1.02 0.5937 165 -1.7 0.087 Tukey-K 0.52 
T10 1 Trt*Glucose Glucose p G3 G4 0.288 0.5937 165 0.49 0.628 Tukey-K 0.997 
T10 1 Trt*Glucose Glucose p G3 G5 0.033 0.5937 165 0.06 0.955 Tukey-K 1 
T10 1 Trt*Glucose Glucose p G4 G5 -0.25 0.5937 165 -0.4 0.668 Tukey-K 0.998 
T2 1 Trt*Glucose Glucose m G0 G1 -0.13 0.4703 165 -0.3 0.786 Tukey-K 1 
T2 1 Trt*Glucose Glucose m G0 G2 0.546 0.4703 165 1.16 0.248 Tukey-K 0.855 
T2 1 Trt*Glucose Glucose m G0 G3 -0.23 0.4703 165 -0.5 0.622 Tukey-K 0.996 
T2 1 Trt*Glucose Glucose m G0 G4 -0.38 0.4703 165 -0.8 0.421 Tukey-K 0.966 
T2 1 Trt*Glucose Glucose m G0 G5 0.339 0.4703 165 0.72 0.472 Tukey-K 0.979 
T2 1 Trt*Glucose Glucose m G1 G2 0.673 0.4703 165 1.43 0.154 Tukey-K 0.708 
T2 1 Trt*Glucose Glucose m G1 G3 -0.1 0.4703 165 -0.2 0.824 Tukey-K 1 
T2 1 Trt*Glucose Glucose m G1 G4 -0.25 0.4703 165 -0.5 0.594 Tukey-K 0.995 
T2 1 Trt*Glucose Glucose m G1 G5 0.467 0.4703 165 0.99 0.322 Tukey-K 0.92 
T2 1 Trt*Glucose Glucose m G2 G3 -0.78 0.4703 165 -1.7 0.1 Tukey-K 0.564 
T2 1 Trt*Glucose Glucose m G2 G4 -0.92 0.4703 165 -2 0.051 Tukey-K 0.366 
T2 1 Trt*Glucose Glucose m G2 G5 -0.21 0.4703 165 -0.4 0.661 Tukey-K 0.998 
T2 1 Trt*Glucose Glucose m G3 G4 -0.15 0.4703 165 -0.3 0.755 Tukey-K 1 
T2 1 Trt*Glucose Glucose m G3 G5 0.572 0.4703 165 1.22 0.226 Tukey-K 0.829 
T2 1 Trt*Glucose Glucose m G4 G5 0.718 0.4703 165 1.53 0.129 Tukey-K 0.647 
T2 1 Trt*Glucose Glucose p G0 G1 0.436 0.4703 165 0.93 0.356 Tukey-K 0.939 
T2 1 Trt*Glucose Glucose p G0 G2 -0.07 0.4703 165 -0.2 0.88 Tukey-K 1 
T2 1 Trt*Glucose Glucose p G0 G3 0.006 0.4703 165 0.01 0.99 Tukey-K 1 
T2 1 Trt*Glucose Glucose p G0 G4 0.266 0.4703 165 0.57 0.572 Tukey-K 0.993 
T2 1 Trt*Glucose Glucose p G0 G5 -0.09 0.4703 165 -0.2 0.85 Tukey-K 1 
T2 1 Trt*Glucose Glucose p G1 G2 -0.51 0.4703 165 -1.1 0.283 Tukey-K 0.89 
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T2 1 Trt*Glucose Glucose p G1 G3 -0.43 0.4703 165 -0.9 0.362 Tukey-K 0.943 
T2 1 Trt*Glucose Glucose p G1 G4 -0.17 0.4703 165 -0.4 0.719 Tukey-K 0.999 
T2 1 Trt*Glucose Glucose p G1 G5 -0.52 0.4703 165 -1.1 0.266 Tukey-K 0.874 
T2 1 Trt*Glucose Glucose p G2 G3 0.077 0.4703 165 0.16 0.87 Tukey-K 1 
T2 1 Trt*Glucose Glucose p G2 G4 0.337 0.4703 165 0.72 0.474 Tukey-K 0.98 
T2 1 Trt*Glucose Glucose p G2 G5 -0.02 0.4703 165 -0 0.969 Tukey-K 1 
T2 1 Trt*Glucose Glucose p G3 G4 0.26 0.4703 165 0.55 0.581 Tukey-K 0.994 
T2 1 Trt*Glucose Glucose p G3 G5 -0.1 0.4703 165 -0.2 0.84 Tukey-K 1 
T2 1 Trt*Glucose Glucose p G4 G5 -0.36 0.4703 165 -0.8 0.451 Tukey-K 0.974 
T3 1 Trt*Glucose Glucose m G0 G1 0.389 0.4529 165 0.86 0.392 Tukey-K 0.956 
T3 1 Trt*Glucose Glucose m G0 G2 0.571 0.4529 165 1.26 0.21 Tukey-K 0.806 
T3 1 Trt*Glucose Glucose m G0 G3 0.246 0.4529 165 0.54 0.588 Tukey-K 0.994 
T3 1 Trt*Glucose Glucose m G0 G4 -0.15 0.4529 165 -0.3 0.748 Tukey-K 1 
T3 1 Trt*Glucose Glucose m G0 G5 0.648 0.4529 165 1.43 0.154 Tukey-K 0.708 
T3 1 Trt*Glucose Glucose m G1 G2 0.182 0.4529 165 0.4 0.689 Tukey-K 0.999 
T3 1 Trt*Glucose Glucose m G1 G3 -0.14 0.4529 165 -0.3 0.753 Tukey-K 1 
T3 1 Trt*Glucose Glucose m G1 G4 -0.53 0.4529 165 -1.2 0.239 Tukey-K 0.846 
T3 1 Trt*Glucose Glucose m G1 G5 0.259 0.4529 165 0.57 0.568 Tukey-K 0.993 
T3 1 Trt*Glucose Glucose m G2 G3 -0.32 0.4529 165 -0.7 0.475 Tukey-K 0.98 
T3 1 Trt*Glucose Glucose m G2 G4 -0.72 0.4529 165 -1.6 0.116 Tukey-K 0.611 
T3 1 Trt*Glucose Glucose m G2 G5 0.078 0.4529 165 0.17 0.864 Tukey-K 1 
T3 1 Trt*Glucose Glucose m G3 G4 -0.39 0.4529 165 -0.9 0.388 Tukey-K 0.954 
T3 1 Trt*Glucose Glucose m G3 G5 0.402 0.4529 165 0.89 0.376 Tukey-K 0.949 
T3 1 Trt*Glucose Glucose m G4 G5 0.794 0.4529 165 1.75 0.081 Tukey-K 0.499 
T3 1 Trt*Glucose Glucose p G0 G1 0.733 0.4529 165 1.62 0.108 Tukey-K 0.588 
T3 1 Trt*Glucose Glucose p G0 G2 0.486 0.4529 165 1.07 0.285 Tukey-K 0.891 
T3 1 Trt*Glucose Glucose p G0 G3 -0.17 0.4529 165 -0.4 0.7 Tukey-K 0.999 
T3 1 Trt*Glucose Glucose p G0 G4 0.166 0.4529 165 0.37 0.715 Tukey-K 0.999 
T3 1 Trt*Glucose Glucose p G0 G5 -0.21 0.4529 165 -0.5 0.647 Tukey-K 0.997 
T3 1 Trt*Glucose Glucose p G1 G2 -0.25 0.4529 165 -0.5 0.587 Tukey-K 0.994 
T3 1 Trt*Glucose Glucose p G1 G3 -0.91 0.4529 165 -2 0.047 Tukey-K 0.345 
T3 1 Trt*Glucose Glucose p G1 G4 -0.57 0.4529 165 -1.3 0.212 Tukey-K 0.81 
T3 1 Trt*Glucose Glucose p G1 G5 -0.94 0.4529 165 -2.1 0.039 Tukey-K 0.304 
T3 1 Trt*Glucose Glucose p G2 G3 -0.66 0.4529 165 -1.5 0.146 Tukey-K 0.691 
T3 1 Trt*Glucose Glucose p G2 G4 -0.32 0.4529 165 -0.7 0.48 Tukey-K 0.981 
T3 1 Trt*Glucose Glucose p G2 G5 -0.69 0.4529 165 -1.5 0.127 Tukey-K 0.644 
T3 1 Trt*Glucose Glucose p G3 G4 0.34 0.4529 165 0.75 0.453 Tukey-K 0.975 
T3 1 Trt*Glucose Glucose p G3 G5 -0.03 0.4529 165 -0.1 0.941 Tukey-K 1 
T3 1 Trt*Glucose Glucose p G4 G5 -0.37 0.4529 165 -0.8 0.41 Tukey-K 0.963 
T4 1 Trt*Glucose Glucose m G0 G1 0.065 0.478 165 0.14 0.891 Tukey-K 1 
T4 1 Trt*Glucose Glucose m G0 G2 -0.15 0.478 165 -0.3 0.747 Tukey-K 1 
T4 1 Trt*Glucose Glucose m G0 G3 -0.05 0.478 165 -0.1 0.91 Tukey-K 1 
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T4 1 Trt*Glucose Glucose m G0 G4 -0.18 0.478 165 -0.4 0.712 Tukey-K 0.999 
T4 1 Trt*Glucose Glucose m G0 G5 0.221 0.478 165 0.46 0.645 Tukey-K 0.997 
T4 1 Trt*Glucose Glucose m G1 G2 -0.22 0.478 165 -0.5 0.646 Tukey-K 0.997 
T4 1 Trt*Glucose Glucose m G1 G3 -0.12 0.478 165 -0.3 0.803 Tukey-K 1 
T4 1 Trt*Glucose Glucose m G1 G4 -0.24 0.478 165 -0.5 0.613 Tukey-K 0.996 
T4 1 Trt*Glucose Glucose m G1 G5 0.156 0.478 165 0.33 0.745 Tukey-K 1 
T4 1 Trt*Glucose Glucose m G2 G3 0.1 0.478 165 0.21 0.834 Tukey-K 1 
T4 1 Trt*Glucose Glucose m G2 G4 -0.02 0.478 165 -0 0.963 Tukey-K 1 
T4 1 Trt*Glucose Glucose m G2 G5 0.376 0.478 165 0.79 0.433 Tukey-K 0.97 
T4 1 Trt*Glucose Glucose m G3 G4 -0.12 0.478 165 -0.3 0.798 Tukey-K 1 
T4 1 Trt*Glucose Glucose m G3 G5 0.275 0.478 165 0.58 0.566 Tukey-K 0.992 
T4 1 Trt*Glucose Glucose m G4 G5 0.398 0.478 165 0.83 0.407 Tukey-K 0.961 
T4 1 Trt*Glucose Glucose p G0 G1 0.228 0.478 165 0.48 0.634 Tukey-K 0.997 
T4 1 Trt*Glucose Glucose p G0 G2 -0.08 0.478 165 -0.2 0.863 Tukey-K 1 
T4 1 Trt*Glucose Glucose p G0 G3 -0.09 0.478 165 -0.2 0.859 Tukey-K 1 
T4 1 Trt*Glucose Glucose p G0 G4 0.188 0.478 165 0.39 0.694 Tukey-K 0.999 
T4 1 Trt*Glucose Glucose p G0 G5 -0.09 0.478 165 -0.2 0.847 Tukey-K 1 
T4 1 Trt*Glucose Glucose p G1 G2 -0.31 0.478 165 -0.6 0.517 Tukey-K 0.987 
T4 1 Trt*Glucose Glucose p G1 G3 -0.31 0.478 165 -0.7 0.513 Tukey-K 0.986 
T4 1 Trt*Glucose Glucose p G1 G4 -0.04 0.478 165 -0.1 0.934 Tukey-K 1 
T4 1 Trt*Glucose Glucose p G1 G5 -0.32 0.478 165 -0.7 0.504 Tukey-K 0.985 
T4 1 Trt*Glucose Glucose p G2 G3 -0 0.478 165 -0 0.996 Tukey-K 1 
T4 1 Trt*Glucose Glucose p G2 G4 0.271 0.478 165 0.57 0.572 Tukey-K 0.993 
T4 1 Trt*Glucose Glucose p G2 G5 -0.01 0.478 165 -0 0.984 Tukey-K 1 
T4 1 Trt*Glucose Glucose p G3 G4 0.274 0.478 165 0.57 0.568 Tukey-K 0.993 
T4 1 Trt*Glucose Glucose p G3 G5 -0.01 0.478 165 -0 0.988 Tukey-K 1 
T4 1 Trt*Glucose Glucose p G4 G5 -0.28 0.478 165 -0.6 0.558 Tukey-K 0.992 
T5 1 Trt*Glucose Glucose m G0 G1 0.838 0.5099 165 1.64 0.102 Tukey-K 0.572 
T5 1 Trt*Glucose Glucose m G0 G2 0.658 0.5099 165 1.29 0.199 Tukey-K 0.79 
T5 1 Trt*Glucose Glucose m G0 G3 0.444 0.5099 165 0.87 0.385 Tukey-K 0.953 
T5 1 Trt*Glucose Glucose m G0 G4 0.517 0.5099 165 1.01 0.312 Tukey-K 0.913 
T5 1 Trt*Glucose Glucose m G0 G5 0.937 0.5099 165 1.84 0.068 Tukey-K 0.444 
T5 1 Trt*Glucose Glucose m G1 G2 -0.18 0.5099 165 -0.4 0.725 Tukey-K 0.999 
T5 1 Trt*Glucose Glucose m G1 G3 -0.39 0.5099 165 -0.8 0.441 Tukey-K 0.972 
T5 1 Trt*Glucose Glucose m G1 G4 -0.32 0.5099 165 -0.6 0.53 Tukey-K 0.989 
T5 1 Trt*Glucose Glucose m G1 G5 0.1 0.5099 165 0.2 0.845 Tukey-K 1 
T5 1 Trt*Glucose Glucose m G2 G3 -0.21 0.5099 165 -0.4 0.676 Tukey-K 0.998 
T5 1 Trt*Glucose Glucose m G2 G4 -0.14 0.5099 165 -0.3 0.782 Tukey-K 1 
T5 1 Trt*Glucose Glucose m G2 G5 0.28 0.5099 165 0.55 0.584 Tukey-K 0.994 
T5 1 Trt*Glucose Glucose m G3 G4 0.072 0.5099 165 0.14 0.887 Tukey-K 1 
T5 1 Trt*Glucose Glucose m G3 G5 0.493 0.5099 165 0.97 0.335 Tukey-K 0.928 
T5 1 Trt*Glucose Glucose m G4 G5 0.421 0.5099 165 0.83 0.41 Tukey-K 0.962 
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T5 1 Trt*Glucose Glucose p G0 G1 0.237 0.5099 165 0.47 0.642 Tukey-K 0.997 
T5 1 Trt*Glucose Glucose p G0 G2 0.437 0.5099 165 0.86 0.393 Tukey-K 0.956 
T5 1 Trt*Glucose Glucose p G0 G3 -0.04 0.5099 165 -0.1 0.942 Tukey-K 1 
T5 1 Trt*Glucose Glucose p G0 G4 -0.05 0.5099 165 -0.1 0.918 Tukey-K 1 
T5 1 Trt*Glucose Glucose p G0 G5 -0.18 0.5099 165 -0.4 0.719 Tukey-K 0.999 
T5 1 Trt*Glucose Glucose p G1 G2 0.2 0.5099 165 0.39 0.696 Tukey-K 0.999 
T5 1 Trt*Glucose Glucose p G1 G3 -0.27 0.5099 165 -0.5 0.591 Tukey-K 0.995 
T5 1 Trt*Glucose Glucose p G1 G4 -0.29 0.5099 165 -0.6 0.57 Tukey-K 0.993 
T5 1 Trt*Glucose Glucose p G1 G5 -0.42 0.5099 165 -0.8 0.41 Tukey-K 0.962 
T5 1 Trt*Glucose Glucose p G2 G3 -0.47 0.5099 165 -0.9 0.354 Tukey-K 0.938 
T5 1 Trt*Glucose Glucose p G2 G4 -0.49 0.5099 165 -1 0.338 Tukey-K 0.93 
T5 1 Trt*Glucose Glucose p G2 G5 -0.62 0.5099 165 -1.2 0.225 Tukey-K 0.828 
T5 1 Trt*Glucose Glucose p G3 G4 -0.02 0.5099 165 -0 0.976 Tukey-K 1 
T5 1 Trt*Glucose Glucose p G3 G5 -0.15 0.5099 165 -0.3 0.774 Tukey-K 1 
T5 1 Trt*Glucose Glucose p G4 G5 -0.13 0.5099 165 -0.3 0.798 Tukey-K 1 
T6 1 Trt*Glucose Glucose m G0 G1 0.536 0.7894 165 0.68 0.498 Tukey-K 0.984 
T6 1 Trt*Glucose Glucose m G0 G2 1.16 0.7894 165 1.47 0.144 Tukey-K 0.684 
T6 1 Trt*Glucose Glucose m G0 G3 1.252 0.7894 165 1.59 0.115 Tukey-K 0.609 
T6 1 Trt*Glucose Glucose m G0 G4 0.911 0.7894 165 1.15 0.25 Tukey-K 0.858 
T6 1 Trt*Glucose Glucose m G0 G5 1.356 0.7894 165 1.72 0.088 Tukey-K 0.522 
T6 1 Trt*Glucose Glucose m G1 G2 0.624 0.7894 165 0.79 0.431 Tukey-K 0.969 
T6 1 Trt*Glucose Glucose m G1 G3 0.716 0.7894 165 0.91 0.366 Tukey-K 0.944 
T6 1 Trt*Glucose Glucose m G1 G4 0.375 0.7894 165 0.48 0.635 Tukey-K 0.997 
T6 1 Trt*Glucose Glucose m G1 G5 0.819 0.7894 165 1.04 0.301 Tukey-K 0.904 
T6 1 Trt*Glucose Glucose m G2 G3 0.093 0.7894 165 0.12 0.907 Tukey-K 1 
T6 1 Trt*Glucose Glucose m G2 G4 -0.25 0.7894 165 -0.3 0.753 Tukey-K 1 
T6 1 Trt*Glucose Glucose m G2 G5 0.196 0.7894 165 0.25 0.804 Tukey-K 1 
T6 1 Trt*Glucose Glucose m G3 G4 -0.34 0.7894 165 -0.4 0.666 Tukey-K 0.998 
T6 1 Trt*Glucose Glucose m G3 G5 0.103 0.7894 165 0.13 0.896 Tukey-K 1 
T6 1 Trt*Glucose Glucose m G4 G5 0.444 0.7894 165 0.56 0.574 Tukey-K 0.993 
T6 1 Trt*Glucose Glucose p G0 G1 0.856 0.7894 165 1.08 0.28 Tukey-K 0.887 
T6 1 Trt*Glucose Glucose p G0 G2 1.248 0.7894 165 1.58 0.116 Tukey-K 0.613 
T6 1 Trt*Glucose Glucose p G0 G3 1.194 0.7894 165 1.51 0.132 Tukey-K 0.657 
T6 1 Trt*Glucose Glucose p G0 G4 1.419 0.7894 165 1.8 0.074 Tukey-K 0.47 
T6 1 Trt*Glucose Glucose p G0 G5 0.829 0.7894 165 1.05 0.295 Tukey-K 0.9 
T6 1 Trt*Glucose Glucose p G1 G2 0.392 0.7894 165 0.5 0.621 Tukey-K 0.996 
T6 1 Trt*Glucose Glucose p G1 G3 0.338 0.7894 165 0.43 0.669 Tukey-K 0.998 
T6 1 Trt*Glucose Glucose p G1 G4 0.563 0.7894 165 0.71 0.476 Tukey-K 0.98 
T6 1 Trt*Glucose Glucose p G1 G5 -0.03 0.7894 165 -0 0.972 Tukey-K 1 
T6 1 Trt*Glucose Glucose p G2 G3 -0.05 0.7894 165 -0.1 0.946 Tukey-K 1 
T6 1 Trt*Glucose Glucose p G2 G4 0.172 0.7894 165 0.22 0.828 Tukey-K 1 
T6 1 Trt*Glucose Glucose p G2 G5 -0.42 0.7894 165 -0.5 0.596 Tukey-K 0.995 
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T6 1 Trt*Glucose Glucose p G3 G4 0.225 0.7894 165 0.29 0.776 Tukey-K 1 
T6 1 Trt*Glucose Glucose p G3 G5 -0.37 0.7894 165 -0.5 0.644 Tukey-K 0.997 
T6 1 Trt*Glucose Glucose p G4 G5 -0.59 0.7894 165 -0.7 0.455 Tukey-K 0.975 
T7 1 Trt*Glucose Glucose m G0 G1 1.132 0.671 165 1.69 0.093 Tukey-K 0.542 
T7 1 Trt*Glucose Glucose m G0 G2 0.786 0.671 165 1.17 0.243 Tukey-K 0.85 
T7 1 Trt*Glucose Glucose m G0 G3 -0.2 0.671 165 -0.3 0.77 Tukey-K 1 
T7 1 Trt*Glucose Glucose m G0 G4 -0.29 0.671 165 -0.4 0.663 Tukey-K 0.998 
T7 1 Trt*Glucose Glucose m G0 G5 1.226 0.671 165 1.83 0.07 Tukey-K 0.451 
T7 1 Trt*Glucose Glucose m G1 G2 -0.35 0.671 165 -0.5 0.606 Tukey-K 0.995 
T7 1 Trt*Glucose Glucose m G1 G3 -1.33 0.671 165 -2 0.049 Tukey-K 0.359 
T7 1 Trt*Glucose Glucose m G1 G4 -1.42 0.671 165 -2.1 0.035 Tukey-K 0.28 
T7 1 Trt*Glucose Glucose m G1 G5 0.094 0.671 165 0.14 0.889 Tukey-K 1 
T7 1 Trt*Glucose Glucose m G2 G3 -0.98 0.671 165 -1.5 0.145 Tukey-K 0.688 
T7 1 Trt*Glucose Glucose m G2 G4 -1.08 0.671 165 -1.6 0.11 Tukey-K 0.595 
T7 1 Trt*Glucose Glucose m G2 G5 0.44 0.671 165 0.66 0.513 Tukey-K 0.986 
T7 1 Trt*Glucose Glucose m G3 G4 -0.1 0.671 165 -0.1 0.886 Tukey-K 1 
T7 1 Trt*Glucose Glucose m G3 G5 1.422 0.671 165 2.12 0.036 Tukey-K 0.283 
T7 1 Trt*Glucose Glucose m G4 G5 1.519 0.671 165 2.26 0.025 Tukey-K 0.215 
T7 1 Trt*Glucose Glucose p G0 G1 0.472 0.671 165 0.7 0.483 Tukey-K 0.981 
T7 1 Trt*Glucose Glucose p G0 G2 0.835 0.671 165 1.24 0.215 Tukey-K 0.814 
T7 1 Trt*Glucose Glucose p G0 G3 0.299 0.671 165 0.45 0.657 Tukey-K 0.998 
T7 1 Trt*Glucose Glucose p G0 G4 0.243 0.671 165 0.36 0.718 Tukey-K 0.999 
T7 1 Trt*Glucose Glucose p G0 G5 0.523 0.671 165 0.78 0.436 Tukey-K 0.971 
T7 1 Trt*Glucose Glucose p G1 G2 0.363 0.671 165 0.54 0.589 Tukey-K 0.994 
T7 1 Trt*Glucose Glucose p G1 G3 -0.17 0.671 165 -0.3 0.796 Tukey-K 1 
T7 1 Trt*Glucose Glucose p G1 G4 -0.23 0.671 165 -0.3 0.733 Tukey-K 0.999 
T7 1 Trt*Glucose Glucose p G1 G5 0.051 0.671 165 0.08 0.939 Tukey-K 1 
T7 1 Trt*Glucose Glucose p G2 G3 -0.54 0.671 165 -0.8 0.425 Tukey-K 0.967 
T7 1 Trt*Glucose Glucose p G2 G4 -0.59 0.671 165 -0.9 0.379 Tukey-K 0.95 
T7 1 Trt*Glucose Glucose p G2 G5 -0.31 0.671 165 -0.5 0.643 Tukey-K 0.997 
T7 1 Trt*Glucose Glucose p G3 G4 -0.06 0.671 165 -0.1 0.934 Tukey-K 1 
T7 1 Trt*Glucose Glucose p G3 G5 0.225 0.671 165 0.33 0.738 Tukey-K 0.999 
T7 1 Trt*Glucose Glucose p G4 G5 0.28 0.671 165 0.42 0.677 Tukey-K 0.998 
T8 1 Trt*Glucose Glucose m G0 G1 -0.12 0.7567 165 -0.2 0.875 Tukey-K 1 
T8 1 Trt*Glucose Glucose m G0 G2 -0.26 0.7567 165 -0.3 0.727 Tukey-K 0.999 
T8 1 Trt*Glucose Glucose m G0 G3 -0.51 0.7567 165 -0.7 0.505 Tukey-K 0.985 
T8 1 Trt*Glucose Glucose m G0 G4 -0.98 0.7567 165 -1.3 0.196 Tukey-K 0.785 
T8 1 Trt*Glucose Glucose m G0 G5 -0.34 0.7567 165 -0.4 0.657 Tukey-K 0.998 
T8 1 Trt*Glucose Glucose m G1 G2 -0.15 0.7567 165 -0.2 0.848 Tukey-K 1 
T8 1 Trt*Glucose Glucose m G1 G3 -0.39 0.7567 165 -0.5 0.61 Tukey-K 0.996 
T8 1 Trt*Glucose Glucose m G1 G4 -0.86 0.7567 165 -1.1 0.256 Tukey-K 0.864 
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T8 1 Trt*Glucose Glucose m G1 G5 -0.22 0.7567 165 -0.3 0.774 Tukey-K 1 
T8 1 Trt*Glucose Glucose m G2 G3 -0.24 0.7567 165 -0.3 0.75 Tukey-K 1 
T8 1 Trt*Glucose Glucose m G2 G4 -0.72 0.7567 165 -0.9 0.344 Tukey-K 0.933 
T8 1 Trt*Glucose Glucose m G2 G5 -0.07 0.7567 165 -0.1 0.924 Tukey-K 1 
T8 1 Trt*Glucose Glucose m G3 G4 -0.48 0.7567 165 -0.6 0.529 Tukey-K 0.989 
T8 1 Trt*Glucose Glucose m G3 G5 0.169 0.7567 165 0.22 0.824 Tukey-K 1 
T8 1 Trt*Glucose Glucose m G4 G5 0.646 0.7567 165 0.85 0.395 Tukey-K 0.957 
T8 1 Trt*Glucose Glucose p G0 G1 0.391 0.7567 165 0.52 0.606 Tukey-K 0.995 
T8 1 Trt*Glucose Glucose p G0 G2 0.444 0.7567 165 0.59 0.559 Tukey-K 0.992 
T8 1 Trt*Glucose Glucose p G0 G3 1.243 0.7567 165 1.64 0.102 Tukey-K 0.571 
T8 1 Trt*Glucose Glucose p G0 G4 0.102 0.7567 165 0.13 0.893 Tukey-K 1 
T8 1 Trt*Glucose Glucose p G0 G5 -0.08 0.7567 165 -0.1 0.911 Tukey-K 1 
T8 1 Trt*Glucose Glucose p G1 G2 0.053 0.7567 165 0.07 0.944 Tukey-K 1 
T8 1 Trt*Glucose Glucose p G1 G3 0.853 0.7567 165 1.13 0.261 Tukey-K 0.87 
T8 1 Trt*Glucose Glucose p G1 G4 -0.29 0.7567 165 -0.4 0.703 Tukey-K 0.999 
T8 1 Trt*Glucose Glucose p G1 G5 -0.48 0.7567 165 -0.6 0.531 Tukey-K 0.989 
T8 1 Trt*Glucose Glucose p G2 G3 0.8 0.7567 165 1.06 0.292 Tukey-K 0.897 
T8 1 Trt*Glucose Glucose p G2 G4 -0.34 0.7567 165 -0.5 0.652 Tukey-K 0.998 
T8 1 Trt*Glucose Glucose p G2 G5 -0.53 0.7567 165 -0.7 0.486 Tukey-K 0.982 
T8 1 Trt*Glucose Glucose p G3 G4 -1.14 0.7567 165 -1.5 0.133 Tukey-K 0.659 
T8 1 Trt*Glucose Glucose p G3 G5 -1.33 0.7567 165 -1.8 0.081 Tukey-K 0.498 
T8 1 Trt*Glucose Glucose p G4 G5 -0.19 0.7567 165 -0.2 0.806 Tukey-K 1 
T9 1 Trt*Glucose Glucose m G0 G1 0.101 0.6863 165 0.15 0.883 Tukey-K 1 
T9 1 Trt*Glucose Glucose m G0 G2 0.029 0.6863 165 0.04 0.966 Tukey-K 1 
T9 1 Trt*Glucose Glucose m G0 G3 -0.12 0.6863 165 -0.2 0.861 Tukey-K 1 
T9 1 Trt*Glucose Glucose m G0 G4 -0.6 0.6863 165 -0.9 0.38 Tukey-K 0.951 
T9 1 Trt*Glucose Glucose m G0 G5 0.475 0.6863 165 0.69 0.49 Tukey-K 0.983 
T9 1 Trt*Glucose Glucose m G1 G2 -0.07 0.6863 165 -0.1 0.917 Tukey-K 1 
T9 1 Trt*Glucose Glucose m G1 G3 -0.22 0.6863 165 -0.3 0.747 Tukey-K 1 
T9 1 Trt*Glucose Glucose m G1 G4 -0.71 0.6863 165 -1 0.306 Tukey-K 0.908 
T9 1 Trt*Glucose Glucose m G1 G5 0.374 0.6863 165 0.55 0.586 Tukey-K 0.994 
T9 1 Trt*Glucose Glucose m G2 G3 -0.15 0.6863 165 -0.2 0.827 Tukey-K 1 
T9 1 Trt*Glucose Glucose m G2 G4 -0.63 0.6863 165 -0.9 0.357 Tukey-K 0.94 
T9 1 Trt*Glucose Glucose m G2 G5 0.446 0.6863 165 0.65 0.516 Tukey-K 0.987 
T9 1 Trt*Glucose Glucose m G3 G4 -0.48 0.6863 165 -0.7 0.482 Tukey-K 0.981 
T9 1 Trt*Glucose Glucose m G3 G5 0.596 0.6863 165 0.87 0.386 Tukey-K 0.953 
T9 1 Trt*Glucose Glucose m G4 G5 1.08 0.6863 165 1.57 0.118 Tukey-K 0.617 
T9 1 Trt*Glucose Glucose p G0 G1 -0.08 0.6863 165 -0.1 0.909 Tukey-K 1 
T9 1 Trt*Glucose Glucose p G0 G2 0.506 0.6863 165 0.74 0.462 Tukey-K 0.977 
T9 1 Trt*Glucose Glucose p G0 G3 0.294 0.6863 165 0.43 0.669 Tukey-K 0.998 
T9 1 Trt*Glucose Glucose p G0 G4 -0.34 0.6863 165 -0.5 0.618 Tukey-K 0.996 
T9 1 Trt*Glucose Glucose p G0 G5 -0.31 0.6863 165 -0.4 0.657 Tukey-K 0.998 
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T9 1 Trt*Glucose Glucose p G1 G2 0.584 0.6863 165 0.85 0.396 Tukey-K 0.957 
T9 1 Trt*Glucose Glucose p G1 G3 0.372 0.6863 165 0.54 0.589 Tukey-K 0.994 
T9 1 Trt*Glucose Glucose p G1 G4 -0.26 0.6863 165 -0.4 0.701 Tukey-K 0.999 
T9 1 Trt*Glucose Glucose p G1 G5 -0.23 0.6863 165 -0.3 0.741 Tukey-K 0.999 
T9 1 Trt*Glucose Glucose p G2 G3 -0.21 0.6863 165 -0.3 0.757 Tukey-K 1 
T9 1 Trt*Glucose Glucose p G2 G4 -0.85 0.6863 165 -1.2 0.218 Tukey-K 0.818 
T9 1 Trt*Glucose Glucose p G2 G5 -0.81 0.6863 165 -1.2 0.239 Tukey-K 0.844 
T9 1 Trt*Glucose Glucose p G3 G4 -0.64 0.6863 165 -0.9 0.355 Tukey-K 0.939 
T9 1 Trt*Glucose Glucose p G3 G5 -0.6 0.6863 165 -0.9 0.384 Tukey-K 0.952 
T9 1 Trt*Glucose Glucose p G4 G5 0.037 0.6863 165 0.05 0.957 Tukey-K 1 
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Gene StmtNo Effect Slice AgeCat _AgeCat Estimate StdErr DF tValue Rawp Adjustment Adjp 
T1 2 AgeCat*Gluc Glu m Middle Old 1.3 1.01 16.6 1.285 0.217 Tukey-K 0.41 
T1 2 AgeCat*Gluc Glu m Middle Young -0.1 1.07 16.6 -0.1 0.923 Tukey-K 0.99 
T1 2 AgeCat*Gluc Glu m Old Young -1.4 0.89 16.6 -1.57 0.134 Tukey-K 0.26 
T1 2 AgeCat*Glucose Glu p Middle Old 0.81 1.01 16.6 0.805 0.432 Tukey-K 0.7 
T1 2 AgeCat*Glucose Glu p Middle Young -0.17 1.07 16.6 -0.16 0.872 Tukey-K 0.99 
T1 2 AgeCat*Glucose Glu p Old Young -0.99 0.89 16.6 -1.11 0.283 Tukey-K 0.51 
T10 2 AgeCat*Glucose Glu m Middle Old -0.54 1.36 16.6 -0.4 0.696 Tukey-K 0.92 
T10 2 AgeCat*Glucose Glu m Middle Young -1.66 1.43 16.6 -1.16 0.263 Tukey-K 0.48 
T10 2 AgeCat*Glucose Glu m Old Young -1.12 1.2 16.6 -0.93 0.363 Tukey-K 0.62 
T10 2 AgeCat*Glucose Glu p Middle Old -0.53 1.36 16.6 -0.39 0.704 Tukey-K 0.92 
T10 2 AgeCat*Glucose Glu p Middle Young -1.99 1.43 16.6 -1.39 0.184 Tukey-K 0.35 
T10 2 AgeCat*Glucose Glu p Old Young -1.46 1.2 16.6 -1.22 0.24 Tukey-K 0.44 
T2 2 AgeCat*Glucose Glu m Middle Old 1.46 0.94 17.1 1.554 0.139 Tukey-K 0.27 
T2 2 AgeCat*Glucose Glu m Middle Young 0.04 0.99 17.1 0.041 0.968 Tukey-K 1 
T2 2 AgeCat*Glucose Glu m Old Young -1.42 0.83 17.1 -1.71 0.105 Tukey-K 0.2
T2 2 AgeCat*Glucose Glu p Middle Old 0.72 0.94 17.1 0.77 0.452 Tukey-K 0.72 
T2 2 AgeCat*Glucose Glu p Middle Young -0.18 0.99 17.1 -0.18 0.858 Tukey-K 0.98 
T2 2 AgeCat*Glucose Glu p Old Young -0.91 0.83 17.1 -1.09 0.291 Tukey-K 0.52 
T3 2 AgeCat*Glucose Glu m Middle Old 1.78 0.89 17.2 1.997 0.062 Tukey-K 0.12 
T3 2 AgeCat*Glucose Glu m Middle Young -0.67 0.94 17.2 -0.71 0.488 Tukey-K 0.76 
T3 2 AgeCat*Glucose Glu m Old Young -2.44 0.79 17.2 -3.11 0.006 Tukey-K 0.01 
T3 2 AgeCat*Glucose Glu p Middle Old 0.84 0.89 17.2 0.944 0.358 Tukey-K 0.61 
T3 2 AgeCat*Glucose Glu p Middle Young -0.69 0.94 17.2 -0.74 0.471 Tukey-K 0.74 
T3 2 AgeCat*Glucose Glu p Old Young -1.53 0.79 17.2 -1.95 0.067 Tukey-K 0.13 
T4 2 AgeCat*Glucose Glu m Middle Old 0.43 0.67 19.8 0.643 0.527 Tukey-K 0.8 
T4 2 AgeCat*Glucose Glu m Middle Young -0.08 0.71 19.8 -0.11 0.917 Tukey-K 0.99 
T4 2 AgeCat*Glucose Glu m Old Young -0.51 0.59 19.8 -0.86 0.402 Tukey-K 0.67 
T4 2 AgeCat*Glucose Glu p Middle Old 0.2 0.67 19.8 0.291 0.774 Tukey-K 0.95 
T4 2 AgeCat*Glucose Glu p Middle Young -0.12 0.71 19.8 -0.17 0.865 Tukey-K 0.98 
T4 2 AgeCat*Glucose Glu p Old Young -0.32 0.59 19.8 -0.53 0.599 Tukey-K 0.85 
T5 2 AgeCat*Glucose Glu m Middle Old -1.14 1.99 15.5 -0.57 0.574 Tukey-K 0.83 
T5 2 AgeCat*Glucose Glu m Middle Young 0.28 2.09 15.5 0.135 0.895 Tukey-K 0.99 
T5 2 AgeCat*Glucose Glu m Old Young 1.42 1.75 15.5 0.811 0.429 Tukey-K 0.7
T5 2 AgeCat*Glucose Glu p Middle Old -1.77 1.99 15.5 -0.89 0.388 Tukey-K 0.65 
T5 2 AgeCat*Glucose Glu p Middle Young -0.38 2.09 15.5 -0.18 0.857 Tukey-K 0.98 
T5 2 AgeCat*Glucose Glu p Old Young 1.38 1.75 15.5 0.789 0.442 Tukey-K 0.71 
T6 2 AgeCat*Glucose Glu m Middle Old 0.94 1.97 16.3 0.477 0.639 Tukey-K 0.88 
T6 2 AgeCat*Glucose Glu m Middle Young 1 2.08 16.3 0.484 0.635 Tukey-K 0.88 
T6 2 AgeCat*Glucose Glu m Old Young 0.06 1.74 16.3 0.037 0.971 Tukey-K 1 
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T6 2 AgeCat*Glucose Glu p Middle Old 1.17 1.97 16.3 0.597 0.559 Tukey-K 0.82 
T6 2 AgeCat*Glucose Glu p Middle Young 1.92 2.08 16.3 0.923 0.369 Tukey-K 0.63 
T6 2 AgeCat*Glucose Glu p Old Young 0.74 1.74 16.3 0.427 0.675 Tukey-K 0.9 
T7 2 AgeCat*Glucose Glu m Middle Old 1.95 1.2 17.8 1.629 0.121 Tukey-K 0.24 
T7 2 AgeCat*Glucose Glu m Middle Young 0.12 1.26 17.8 0.095 0.925 Tukey-K 1 
T7 2 AgeCat*Glucose Glu m Old Young -1.83 1.06 17.8 -1.73 0.1 Tukey-K 0.2
T7 2 AgeCat*Glucose Glu p Middle Old 1.56 1.2 17.8 1.301 0.21 Tukey-K 0.4 
T7 2 AgeCat*Glucose Glu p Middle Young -0.32 1.26 17.8 -0.25 0.803 Tukey-K 0.97 
T7 2 AgeCat*Glucose Glu p Old Young -1.88 1.06 17.8 -1.78 0.093 Tukey-K 0.18 
T8 2 AgeCat*Glucose Glu m Middle Old -0.19 2 16.2 -0.1 0.925 Tukey-K 0.99 
T8 2 AgeCat*Glucose Glu m Middle Young 1.3 2.1 16.2 0.619 0.545 Tukey-K 0.81 
T8 2 AgeCat*Glucose Glu m Old Young 1.49 1.76 16.2 0.848 0.409 Tukey-K 0.67 
T8 2 AgeCat*Glucose Glu p Middle Old -0.7 2 16.2 -0.35 0.731 Tukey-K 0.93 
T8 2 AgeCat*Glucose Glu p Middle Young 0.23 2.1 16.2 0.112 0.912 Tukey-K 0.99 
T8 2 AgeCat*Glucose Glu p Old Young 0.93 1.76 16.2 0.53 0.603 Tukey-K 0.86 
T9 2 AgeCat*Glucose Glu m Middle Old 1.78 2.35 15.7 0.755 0.461 Tukey-K 0.73 
T9 2 AgeCat*Glucose Glu m Middle Young 1.91 2.48 15.7 0.769 0.453 Tukey-K 0.72 
T9 2 AgeCat*Glucose Glu m Old Young 0.13 2.07 15.7 0.063 0.951 Tukey-K 1 
T9 2 AgeCat*Glucose Glu p Middle Old 2.87 2.35 15.7 1.221 0.24 Tukey-K 0.44 
T9 2 AgeCat*Glucose Glu p Middle Young 1.43 2.48 15.7 0.575 0.573 Tukey-K 0.83 
T9 2 AgeCat*Glucose Glu p Old Young -1.45 2.07 15.7 -0.7 0.496 Tukey-K 0.77 
116 
TEST 4: Gave the differences between Age, Treatmen, and -/+ FBS, 30 nM glucose in specific age and 
treatment: 
No Effect AgeCat Trt Trt Estimate Std Er DF tValue Rawp Adjustment Adjp 
T1 3 AgeCat*Trt*Gluco Middle Gluco m G0 G1 0.004 0.9 165 0 0.997 Tukey-K 1 
T1 3 AgeCat*Trt*Gluco Middle Gluco m G0 G2 0.196 0.9 165 0.22 0.828 Tukey-K 1 
T1 3 AgeCat*Trt*Gluco Middle Gluco m G0 G3 -0.06 0.9 165 -0.1 0.945 Tukey-K 1 
T1 3 AgeCat*Trt*Gluco Middle Gluco m G0 G4 -0.71 0.9 165 -0.8 0.431 Tukey-K 0.969 
T1 3 AgeCat*Trt*Gluco Middle Gluco m G0 G5 0.499 0.9 165 0.55 0.58 Tukey-K 0.994 
T1 3 AgeCat*Trt*Gluco Middle Gluco m G1 G2 0.193 0.9 165 0.21 0.831 Tukey-K 1 
T1 3 AgeCat*Trt*Gluco Middle Gluco m G1 G3 -0.07 0.9 165 -0.1 0.942 Tukey-K 1 
T1 3 AgeCat*Trt*Gluco Middle Gluco m G1 G4 -0.71 0.9 165 -0.8 0.428 Tukey-K 0.968 
T1 3 AgeCat*Trt*Gluco Middle Gluco m G1 G5 0.495 0.9 165 0.55 0.583 Tukey-K 0.994 
T1 3 AgeCat*Trt*Gluco Middle Gluco m G2 G3 -0.26 0.9 165 -0.3 0.774 Tukey-K 1 
T1 3 AgeCat*Trt*Gluco Middle Gluco m G2 G4 -0.91 0.9 165 -1 0.315 Tukey-K 0.915 
T1 3 AgeCat*Trt*Gluco Middle Gluco m G2 G5 0.303 0.9 165 0.34 0.737 Tukey-K 0.999 
T1 3 AgeCat*Trt*Gluco Middle Gluco m G3 G4 -0.65 0.9 165 -0.7 0.472 Tukey-K 0.979 
T1 3 AgeCat*Trt*Gluco Middle Gluco m G3 G5 0.561 0.9 165 0.62 0.534 Tukey-K 0.989 
T1 3 AgeCat*Trt*Glucose Middle Gluco m G4 G5 1.209 0.9 165 1.34 0.181 Tukey-K 0.759 
T1 3 AgeCat*Trt*Glucose Middle Gluco p G0 G1 1.108 0.9 165 1.23 0.22 Tukey-K 0.821 
T1 3 AgeCat*Trt*Glucose Middle Gluco p G0 G2 -0.48 0.9 165 -0.5 0.591 Tukey-K 0.994 
T1 3 AgeCat*Trt*Glucose Middle Gluco p G0 G3 -1.34 0.9 165 -1.5 0.138 Tukey-K 0.672 
T1 3 AgeCat*Trt*Glucose Middle Gluco p G0 G4 0.191 0.9 165 0.21 0.832 Tukey-K 1 
T1 3 AgeCat*Trt*Glucose Middle Gluco p G0 G5 -0.85 0.9 165 -1 0.343 Tukey-K 0.933 
T1 3 AgeCat*Trt*Glucose Middle Gluco p G1 G2 -1.59 0.9 165 -1.8 0.078 Tukey-K 0.488 
T1 3 AgeCat*Trt*Glucose Middle Gluco p G1 G3 -2.45 0.9 165 -2.7 0.007 Tukey-K 0.076 
T1 3 AgeCat*Trt*Glucose Middle Gluco p G1 G4 -0.92 0.9 165 -1 0.31 Tukey-K 0.911 
T1 3 AgeCat*Trt*Glucose Middle Gluco p G1 G5 -1.96 0.9 165 -2.2 0.031 Tukey-K 0.252 
T1 3 AgeCat*Trt*Glucose Middle Gluco p G2 G3 -0.85 0.9 165 -1 0.343 Tukey-K 0.932 
T1 3 AgeCat*Trt*Glucose Middle Gluco p G2 G4 0.676 0.9 165 0.75 0.453 Tukey-K 0.975 
T1 3 AgeCat*Trt*Glucose Middle Glu p G2 G5 -0.37 0.9 165 -0.4 0.681 Tukey-K 0.998 
T1 3 AgeCat*Trt*Glucose Middle Gluco p G3 G4 1.531 0.9 165 1.7 0.091 Tukey-K 0.532 
T1 3 AgeCat*Trt*Glucose Middle Gluco p G3 G5 0.485 0.9 165 0.54 0.59 Tukey-K 0.994 
T1 3 AgeCat*Trt*Glucose Middle Gluco p G4 G5 -1.05 0.9 165 -1.2 0.247 Tukey-K 0.854 
T1 3 AgeCat*Trt*Glucose Old    Gluc m G0 G1 -0.29 0.6 165 -0.5 0.653 Tukey-K 0.998 
T1 3 AgeCat*Trt*Glucose Old  Gluc m G0 G2 -0.5 0.6 165 -0.8 0.429 Tukey-K 0.968 
T1 3 AgeCat*Trt*Glucose Old  Gluc m G0 G3 -0.72 0.6 165 -1.1 0.259 Tukey-K 0.867 
T1 3 AgeCat*Trt*Glucose Old       Gluc m G0 G4 -1.32 0.6 165 -2.1 0.04 Tukey-K 0.306 
T1 3 AgeCat*Trt*Glucose Old  Gluc m G0 G5 -0.18 0.6 165 -0.3 0.774 Tukey-K 1 
T1 3 AgeCat*Trt*Glucose Old  Gluc m G1 G2 -0.22 0.6 165 -0.3 0.732 Tukey-K 0.999 
T1 3 AgeCat*Trt*Glucose Old       Gluc m G1 G3 -0.43 0.6 165 -0.7 0.497 Tukey-K 0.984 
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T1 3 AgeCat*Trt*Glucose Old  Gluc m G1 G4 -1.03 0.6 165 -1.6 0.106 Tukey-K 0.584 
T1 3 AgeCat*Trt*Glucose Old  Gluc m G1 G5 0.104 0.6 165 0.16 0.871 Tukey-K 1 
T1 3 AgeCat*Trt*Glucose Old  Gluc m G2 G3 -0.22 0.6 165 -0.3 0.736 Tukey-K 0.999 
T1 3 AgeCat*Trt*Glucose Old  Gluc m G2 G4 -0.81 0.6 165 -1.3 0.202 Tukey-K 0.795 
T1 3 AgeCat*Trt*Glucose Old  Gluc m G2 G5 0.322 0.6 165 0.51 0.613 Tukey-K 0.996 
T1 3 AgeCat*Trt*Glucose Old  Gluc m G3 G4 -0.6 0.6 165 -0.9 0.347 Tukey-K 0.935 
T1 3 AgeCat*Trt*Glucose Old  Gluc m G3 G5 0.537 0.6 165 0.84 0.4 Tukey-K 0.959 
T1 3 AgeCat*Trt*Glucose Old   Glu m G4 G5 1.137 0.6 165 1.79 0.076 Tukey-K 0.477 
T1 3 AgeCat*Trt*Glucose Old  Glu m G0 G1 -0.07 0.6 165 -0.1 0.918 Tukey-K 1 
T1 3 AgeCat*Trt*Glucose Old  Glu p G0 G2 -0.29 0.6 165 -0.5 0.646 Tukey-K 0.997 
T1 3 AgeCat*Trt*Glucose Old  Glu p G0 G3 -0.07 0.6 165 -0.1 0.915 Tukey-K 1 
T1 3 AgeCat*Trt*Glucose Old  Glu p G0 G4 -1.01 0.6 165 -1.6 0.116 Tukey-K 0.613 
T1 3 AgeCat*Trt*Glucose Old  Glu p G0 G5 -0.33 0.6 165 -0.5 0.604 Tukey-K 0.995 
T1 3 AgeCat*Trt*Glucose Old  Glu p G1 G2 -0.23 0.6 165 -0.4 0.722 Tukey-K 0.999 
T1 3 AgeCat*Trt*Glucose Old  Glu p G1 G3 -0 0.6 165 -0 0.998 Tukey-K 1 
T1 3 AgeCat*Trt*Glucose Old  Glu p G1 G4 -0.94 0.6 165 -1.5 0.142 Tukey-K 0.68 
T1 3 AgeCat*Trt*Glucose Old  Glu p G1 G5 -0.26 0.6 165 -0.4 0.678 Tukey-K 0.998 
T1 3 AgeCat*Trt*Glucose Old  Glu p G2 G3 0.225 0.6 165 0.35 0.724 Tukey-K 0.999 
T1 3 AgeCat*Trt*Glucose Old  Glu p G2 G4 -0.71 0.6 165 -1.1 0.264 Tukey-K 0.873 
T1 3 AgeCat*Trt*Glucose Old  Glu p G2 G5 -0.04 0.6 165 -0.1 0.953 Tukey-K 1 
T1 3 AgeCat*Trt*Glucose Old  Glu p G3 G4 -0.94 0.6 165 -1.5 0.142 Tukey-K 0.681 
T1 3 AgeCat*Trt*Glucose Old  Glu p G3 G5 -0.26 0.6 165 -0.4 0.68 Tukey-K 0.998 
T1 3 AgeCat*Trt*Glucose Old  Glu p G4 G5 0.675 0.6 165 1.06 0.29 Tukey-K 0.896 
T1 3 AgeCat*Trt*Glucose Young Glu m G0 G1 0.088 0.7 165 0.12 0.905 Tukey-K 1 
T1 3 AgeCat*Trt*Glucose Young Glu m G0 G2 0.403 0.7 165 0.55 0.584 Tukey-K 0.994 
T1 3 AgeCat*Trt*Glucose Young Glu m G0 G3 -0.3 0.7 165 -0.4 0.685 Tukey-K 0.999 
T1 3 AgeCat*Trt*Glucose Young Glu m G0 G4 0.838 0.7 165 1.14 0.256 Tukey-K 0.864 
T1 3 AgeCat*Trt*Glucose Young Glu m G0 G5 0.22 0.7 165 0.3 0.765 Tukey-K 1 
T1 3 AgeCat*Trt*Glucose Young Glu m G1 G2 0.315 0.7 165 0.43 0.668 Tukey-K 0.998 
T1 3 AgeCat*Trt*Glucose Young Glu m G1 G3 -0.39 0.7 165 -0.5 0.599 Tukey-K 0.995 
T1 3 AgeCat*Trt*Glucose Young Glu m G1 G4 0.75 0.7 165 1.02 0.309 Tukey-K 0.91 
T1 3 AgeCat*Trt*Glucose Young Glu m G1 G5 0.132 0.7 165 0.18 0.857 Tukey-K 1 
T1 3 AgeCat*Trt*Glucose Young Glu m G2 G3 -0.7 0.7 165 -1 0.34 Tukey-K 0.931 
T1 3 AgeCat*Trt*Glucose Young Glu m G2 G4 0.434 0.7 165 0.59 0.555 Tukey-K 0.992 
T1 3 AgeCat*Trt*Glucose Young Glu m G2 G5 -0.18 0.7 165 -0.2 0.803 Tukey-K 1 
T1 3 AgeCat*Trt*Glucose Young Glu m G3 G4 1.136 0.7 165 1.55 0.124 Tukey-K 0.634 
T1 3 AgeCat*Trt*Glucose Young Glu m G3 G5 0.519 0.7 165 0.71 0.481 Tukey-K 0.981 
T1 3 AgeCat*Trt*Glucose Young Glu m G4 G5 -0.62 0.7 165 -0.8 0.402 Tukey-K 0.959 
T1 3 AgeCat*Trt*Glucose Young Glu p G0 G1 1.236 0.7 165 1.68 0.094 Tukey-K 0.545 
T1 3 AgeCat*Trt*Glucose Young Glu p G0 G2 0.545 0.7 165 0.74 0.459 Tukey-K 0.976 
T1 3 AgeCat*Trt*Glucose Young Glu p G0 G3 0.877 0.7 165 1.19 0.234 Tukey-K 0.839 
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T1 3 AgeCat*Trt*Glucose Young Glu p G0 G4 1.006 0.7 165 1.37 0.173 Tukey-K 0.745 
T1 3 AgeCat*Trt*Glucose Young Glu p G0 G5 0.598 0.7 165 0.81 0.416 Tukey-K 0.964 
T1 3 AgeCat*Trt*Glucose Young Glu p G1 G2 -0.69 0.7 165 -0.9 0.348 Tukey-K 0.935 
T1 3 AgeCat*Trt*Glucose Young Glu p G1 G3 -0.36 0.7 165 -0.5 0.625 Tukey-K 0.996 
T1 3 AgeCat*Trt*Glucose Young Glu p G1 G4 -0.23 0.7 165 -0.3 0.754 Tukey-K 1 
T1 3 AgeCat*Trt*Glucose Young Glu p G1 G5 -0.64 0.7 165 -0.9 0.386 Tukey-K 0.953 
T1 3 AgeCat*Trt*Glucose Young Glu p G2 G3 0.331 0.7 165 0.45 0.652 Tukey-K 0.998 
T1 3 AgeCat*Trt*Glucose Young Glu p G2 G4 0.46 0.7 165 0.63 0.531 Tukey-K 0.989 
T1 3 AgeCat*Trt*Glucose Young Glu p G2 G5 0.053 0.7 165 0.07 0.943 Tukey-K 1 
T1 3 AgeCat*Trt*Glucose Young Glu p G3 G4 0.129 0.7 165 0.18 0.861 Tukey-K 1 
T1 3 AgeCat*Trt*Glucose Young Glu p G3 G5 -0.28 0.7 165 -0.4 0.705 Tukey-K 0.999 
T1 3 AgeCat*Trt*Glucose Young Glu p G4 G5 -0.41 0.7 165 -0.6 0.58 Tukey-K 0.994 
T10 3 AgeCat*Trt*Glucose Middle Glu m G0 G1 -0.86 1.2 165 -0.7 0.481 Tukey-K 0.981 
T10 3 AgeCat*Trt*Glucose Middle Glu m G0 G2 -0.82 1.2 165 -0.7 0.5 Tukey-K 0.984 
T10 3 AgeCat*Trt*Glucose Middle Glu m G0 G3 -0.86 1.2 165 -0.7 0.48 Tukey-K 0.981 
T10 3 AgeCat*Trt*Glucose Middle Glu m G0 G4 -1.87 1.2 165 -1.5 0.123 Tukey-K 0.633 
T10 3 AgeCat*Trt*Glucose Middle Glu m G0 G5 -0.5 1.2 165 -0.4 0.681 Tukey-K 0.998 
T10 3 AgeCat*Trt*Glucose Middle Glu m G1 G2 0.037 1.2 165 0.03 0.975 Tukey-K 1 
T10 3 AgeCat*Trt*Glucose Middle Glu m G1 G3 -0 1.2 165 -0 1 Tukey-K 1 
T10 3 AgeCat*Trt*Glucose Middle Glu m G1 G4 -1.02 1.2 165 -0.8 0.401 Tukey-K 0.959 
T10 3 AgeCat*Trt*Glucose Middle Glu m G1 G5 0.357 1.2 165 0.3 0.768 Tukey-K 1 
T10 3 AgeCat*Trt*Glucose Middle Glu m G2 G3 -0.04 1.2 165 -0 0.975 Tukey-K 1 
T10 3 AgeCat*Trt*Glucose Middle Glu m G2 G4 -1.06 1.2 165 -0.9 0.384 Tukey-K 0.952 
T10 3 AgeCat*Trt*Glucose Middle Glu m G2 G5 0.32 1.2 165 0.26 0.792 Tukey-K 1 
T10 3 AgeCat*Trt*Glucose Middle Glu m G3 G4 -1.02 1.2 165 -0.8 0.401 Tukey-K 0.959 
T10 3 AgeCat*Trt*Glucose Middle Glu m G3 G5 0.358 1.2 165 0.3 0.768 Tukey-K 1 
T10 3 AgeCat*Trt*Glucose Middle Glu m G4 G5 1.377 1.2 165 1.14 0.257 Tukey-K 0.865 
T10 3 AgeCat*Trt*Glucose Middle Glu p G0 G1 0.882 1.2 165 0.73 0.467 Tukey-K 0.978 
T10 3 AgeCat*Trt*Glucose Middle Glu p G0 G2 0.776 1.2 165 0.64 0.522 Tukey-K 0.988 
T10 3 AgeCat*Trt*Glucose Middle Glu p G0 G3 -0.47 1.2 165 -0.4 0.7 Tukey-K 0.999 
T10 3 AgeCat*Trt*Glucose Middle Glu p G0 G4 1.331 1.2 165 1.1 0.273 Tukey-K 0.881 
T10 3 AgeCat*Trt*Glucose Middle Glu p G0 G5 -0.17 1.2 165 -0.1 0.89 Tukey-K 1 
T10 3 AgeCat*Trt*Glucose Middle Glu p G1 G2 -0.11 1.2 165 -0.1 0.93 Tukey-K 1 
T10 3 AgeCat*Trt*Glucose Middle Glu p G1 G3 -1.35 1.2 165 -1.1 0.267 Tukey-K 0.875 
T10 3 AgeCat*Trt*Glucose Middle Glu p G1 G4 0.449 1.2 165 0.37 0.711 Tukey-K 0.999 
T10 3 AgeCat*Trt*Glucose Middle Glu p G1 G5 -1.05 1.2 165 -0.9 0.387 Tukey-K 0.954 
T10 3 AgeCat*Trt*Glucose Middle Glu p G2 G3 -1.24 1.2 165 -1 0.306 Tukey-K 0.908 
T10 3 AgeCat*Trt*Glucose Middle Glu p G2 G4 0.555 1.2 165 0.46 0.647 Tukey-K 0.997 
T10 3 AgeCat*Trt*Glucose Middle Glu p G2 G5 -0.94 1.2 165 -0.8 0.437 Tukey-K 0.971 
T10 3 AgeCat*Trt*Glucose Middle Glu p G3 G4 1.798 1.2 165 1.49 0.139 Tukey-K 0.674 
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T10 3 AgeCat*Trt*Glucose Middle Glu p G3 G5 0.3 1.2 165 0.25 0.804 Tukey-K 1 
T10 3 AgeCat*Trt*Glucose Middle Glu p G4 G5 -1.5 1.2 165 -1.2 0.218 Tukey-K 0.818 
T10 3 AgeCat*Trt*Glucose Old Glu m G0 G1 0.91 0.9 165 1.06 0.289 Tukey-K 0.895 
T10 3 AgeCat*Trt*Glucose Old Glu m G0 G2 -1.01 0.9 165 -1.2 0.239 Tukey-K 0.845 
T10 3 AgeCat*Trt*Glucose Old Glu m G0 G3 -1.4 0.9 165 -1.6 0.103 Tukey-K 0.574 
T10 3 AgeCat*Trt*Glucose Old Glu m G0 G4 -1.12 0.9 165 -1.3 0.193 Tukey-K 0.78 
T10 3 AgeCat*Trt*Glucose Old Glu m G0 G5 -0.98 0.9 165 -1.1 0.252 Tukey-K 0.86 
T10 3 AgeCat*Trt*Glucose Old Glu m G1 G2 -1.92 0.9 165 -2.2 0.026 Tukey-K 0.223 
T10 3 AgeCat*Trt*Glucose Old Glu m G1 G3 -2.31 0.9 165 -2.7 0.008 Tukey-K 0.08 
T10 3 AgeCat*Trt*Glucose Old Glu m G1 G4 -2.03 0.9 165 -2.4 0.019 Tukey-K 0.173 
T10 3 AgeCat*Trt*Glucose Old Glu m G1 G5 -1.89 0.9 165 -2.2 0.028 Tukey-K 0.238 
T10 3 AgeCat*Trt*Glucose Old Glu m G2 G3 -0.39 0.9 165 -0.5 0.649 Tukey-K 0.997 
T10 3 AgeCat*Trt*Glucose Old Glu m G2 G4 -0.11 0.9 165 -0.1 0.9 Tukey-K 1 
T10 3 AgeCat*Trt*Glucose Old Glu m G2 G5 0.029 0.9 165 0.03 0.973 Tukey-K 1 
T10 3 AgeCat*Trt*Glucose Old Glu m G3 G4 0.283 0.9 165 0.33 0.741 Tukey-K 0.999 
T10 3 AgeCat*Trt*Glucose Old Glu m G3 G5 0.419 0.9 165 0.49 0.625 Tukey-K 0.996 
T10 3 AgeCat*Trt*Glucose Old Glu m G4 G5 0.136 0.9 165 0.16 0.874 Tukey-K 1 
T10 3 AgeCat*Trt*Glucose Old Glu p G0 G1 1.379 0.9 165 1.61 0.109 Tukey-K 0.592 
T10 3 AgeCat*Trt*Glucose Old Glu p G0 G2 2.042 0.9 165 2.39 0.018 Tukey-K 0.167 
T10 3 AgeCat*Trt*Glucose Old Glu p G0 G3 0.687 0.9 165 0.8 0.423 Tukey-K 0.967 
T10 3 AgeCat*Trt*Glucose Old Glu p G0 G4 -0.26 0.9 165 -0.3 0.761 Tukey-K 1 
T10 3 AgeCat*Trt*Glucose Old Glu p G0 G5 0.778 0.9 165 0.91 0.365 Tukey-K 0.944 
T10 3 AgeCat*Trt*Glucose Old Glu p G1 G2 0.663 0.9 165 0.77 0.44 Tukey-K 0.971 
T10 3 AgeCat*Trt*Glucose Old Glu p G1 G3 -0.69 0.9 165 -0.8 0.42 Tukey-K 0.966 
T10 3 AgeCat*Trt*Glucose Old Glu p G1 G4 -1.64 0.9 165 -1.9 0.057 Tukey-K 0.396 
T10 3 AgeCat*Trt*Glucose Old Glu p G1 G5 -0.6 0.9 165 -0.7 0.483 Tukey-K 0.981 
T10 3 AgeCat*Trt*Glucose Old Glu p G2 G3 -1.35 0.9 165 -1.6 0.115 Tukey-K 0.611 
T10 3 AgeCat*Trt*Glucose Old Glu p G2 G4 -2.3 0.9 165 -2.7 0.008 Tukey-K 0.083 
T10 3 AgeCat*Trt*Glucose Old Glu p G2 G5 -1.26 0.9 165 -1.5 0.142 Tukey-K 0.679 
T10 3 AgeCat*Trt*Glucose Old Glu p G3 G4 -0.95 0.9 165 -1.1 0.27 Tukey-K 0.878 
T10 3 AgeCat*Trt*Glucose Old Glu p G3 G5 0.091 0.9 165 0.11 0.916 Tukey-K 1 
T10 3 AgeCat*Trt*Glucose Old Glu p G4 G5 1.038 0.9 165 1.21 0.227 Tukey-K 0.83 
T10 3 AgeCat*Trt*Glucose Young Glu m G0 G1 0.638 1 165 0.65 0.519 Tukey-K 0.987 
T10 3 AgeCat*Trt*Glucose Young Glu m G0 G2 0.003 1 165 0 0.997 Tukey-K 1 
T10 3 AgeCat*Trt*Glucose Young Glu m G0 G3 -0.55 1 165 -0.6 0.58 Tukey-K 0.994 
T10 3 AgeCat*Trt*Glucose Young Glu m G0 G4 -0.1 1 165 -0.1 0.923 Tukey-K 1 
T10 3 AgeCat*Trt*Glucose Young Glu m G0 G5 0.162 1 165 0.16 0.87 Tukey-K 1 
T10 3 AgeCat*Trt*Glucose Young Glu m G1 G2 -0.63 1 165 -0.6 0.522 Tukey-K 0.988 
T10 3 AgeCat*Trt*Glucose Young Glu m G1 G3 -1.19 1 165 -1.2 0.232 Tukey-K 0.836 
T10 3 AgeCat*Trt*Glucose Young Glu m G1 G4 -0.73 1 165 -0.7 0.459 Tukey-K 0.976 
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T10 3 AgeCat*Trt*Glucose Young Glu m G1 G5 -0.48 1 165 -0.5 0.63 Tukey-K 0.997 
T10 3 AgeCat*Trt*Glucose Young Glu m G2 G3 -0.55 1 165 -0.6 0.578 Tukey-K 0.994 
T10 3 AgeCat*Trt*Glucose Young Glu m G2 G4 -0.1 1 165 -0.1 0.92 Tukey-K 1 
T10 3 AgeCat*Trt*Glucose Young Glu m G2 G5 0.158 1 165 0.16 0.873 Tukey-K 1 
T10 3 AgeCat*Trt*Glucose Young Glu m G3 G4 0.452 1 165 0.46 0.648 Tukey-K 0.997 
T10 3 AgeCat*Trt*Glucose Young Glu m G3 G5 0.71 1 165 0.72 0.474 Tukey-K 0.979 
T10 3 AgeCat*Trt*Glucose Young Glu m G4 G5 0.258 1 165 0.26 0.795 Tukey-K 1 
T10 3 AgeCat*Trt*Glucose Young Glu p G0 G1 0.282 1 165 0.29 0.776 Tukey-K 1 
T10 3 AgeCat*Trt*Glucose Young Glu p G0 G2 -0.1 1 165 -0.1 0.915 Tukey-K 1 
T10 3 AgeCat*Trt*Glucose Young Glu p G0 G3 -0.67 1 165 -0.7 0.497 Tukey-K 0.984 
T10 3 AgeCat*Trt*Glucose Young Glu p G0 G4 -0.66 1 165 -0.7 0.506 Tukey-K 0.985 
T10 3 AgeCat*Trt*Glucose Young Glu p G0 G5 -0.96 1 165 -1 0.331 Tukey-K 0.925 
T10 3 AgeCat*Trt*Glucose Young Glu p G1 G2 -0.39 1 165 -0.4 0.696 Tukey-K 0.999 
T10 3 AgeCat*Trt*Glucose Young Glu p G1 G3 -0.95 1 165 -1 0.335 Tukey-K 0.928 
T10 3 AgeCat*Trt*Glucose Young Glu p G1 G4 -0.94 1 165 -1 0.343 Tukey-K 0.932 
T10 3 AgeCat*Trt*Glucose Young Glu p G1 G5 -1.25 1 165 -1.3 0.209 Tukey-K 0.806 
T10 3 AgeCat*Trt*Glucose Young Glu p G2 G3 -0.57 1 165 -0.6 0.566 Tukey-K 0.993 
T10 3 AgeCat*Trt*Glucose Young Glu p G2 G4 -0.55 1 165 -0.6 0.576 Tukey-K 0.993 
T10 3 AgeCat*Trt*Glucose Young Glu p G2 G5 -0.86 1 165 -0.9 0.386 Tukey-K 0.953 
T10 3 AgeCat*Trt*Glucose Young Glu p G3 G4 0.014 1 165 0.01 0.989 Tukey-K 1 
T10 3 AgeCat*Trt*Glucose Young Glu p G3 G5 -0.29 1 165 -0.3 0.769 Tukey-K 1 
T10 3 AgeCat*Trt*Glucose Young Glu p G4 G5 -0.3 1 165 -0.3 0.758 Tukey-K 1 
T2 3 AgeCat*Trt*Glucose Middle Glu m G0 G1 0.339 1 165 0.35 0.724 Tukey-K 0.999 
T2 3 AgeCat*Trt*Glucose Middle Glu m G0 G2 0.736 1 165 0.77 0.443 Tukey-K 0.972 
T2 3 AgeCat*Trt*Glucose Middle Glu m G0 G3 -0.62 1 165 -0.7 0.516 Tukey-K 0.987 
T2 3 AgeCat*Trt*Glucose Middle Glu m G0 G4 -0.65 1 165 -0.7 0.497 Tukey-K 0.984 
T2 3 AgeCat*Trt*Glucose Middle Glu m G0 G5 0.176 1 165 0.18 0.854 Tukey-K 1 
T2 3 AgeCat*Trt*Glucose Middle Glu m G1 G2 0.397 1 165 0.41 0.679 Tukey-K 0.998 
T2 3 AgeCat*Trt*Glucose Middle Glu m G1 G3 -0.96 1 165 -1 0.316 Tukey-K 0.916 
T2 3 AgeCat*Trt*Glucose Middle Glu m G1 G4 -0.99 1 165 -1 0.302 Tukey-K 0.906 
T2 3 AgeCat*Trt*Glucose Middle Glu m G1 G5 -0.16 1 165 -0.2 0.866 Tukey-K 1 
T2 3 AgeCat*Trt*Glucose Middle Glu m G2 G3 -1.36 1 165 -1.4 0.158 Tukey-K 0.715 
T2 3 AgeCat*Trt*Glucose Middle Glu m G2 G4 -1.39 1 165 -1.4 0.149 Tukey-K 0.697 
T2 3 AgeCat*Trt*Glucose Middle Glu m G2 G5 -0.56 1 165 -0.6 0.56 Tukey-K 0.992 
T2 3 AgeCat*Trt*Glucose Middle Glu m G3 G4 -0.03 1 165 -0 0.976 Tukey-K 1 
T2 3 AgeCat*Trt*Glucose Middle Glu m G3 G5 0.801 1 165 0.84 0.405 Tukey-K 0.961 
T2 3 AgeCat*Trt*Glucose Middle Glu m G4 G5 0.829 1 165 0.87 0.388 Tukey-K 0.954 
T2 3 AgeCat*Trt*Glucose Middle Glu p G0 G1 0.712 1 165 0.74 0.459 Tukey-K 0.976 
T2 3 AgeCat*Trt*Glucose Middle Glu p G0 G2 -1.52 1 165 -1.6 0.115 Tukey-K 0.609 
T2 3 AgeCat*Trt*Glucose Middle Glu p G0 G3 -1.76 1 165 -1.8 0.068 Tukey-K 0.444 
T2 3 AgeCat*Trt*Glucose Middle Glu p G0 G4 -0.05 1 165 -0.1 0.956 Tukey-K 1 
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T2 3 AgeCat*Trt*Glucose Middle Glu p G0 G5 -1.19 1 165 -1.2 0.216 Tukey-K 0.815 
T2 3 AgeCat*Trt*Glucose Middle Glu p G1 G2 -2.23 1 165 -2.3 0.021 Tukey-K 0.188 
T2 3 AgeCat*Trt*Glucose Middle Glu p G1 G3 -2.47 1 165 -2.6 0.011 Tukey-K 0.108 
T2 3 AgeCat*Trt*Glucose Middle Glu p G1 G4 -0.77 1 165 -0.8 0.426 Tukey-K 0.967 
T2 3 AgeCat*Trt*Glucose Middle Glu p G1 G5 -1.9 1 165 -2 0.049 Tukey-K 0.356 
T2 3 AgeCat*Trt*Glucose Middle Glu p G2 G3 -0.24 1 165 -0.3 0.802 Tukey-K 1 
T2 3 AgeCat*Trt*Glucose Middle Glu p G2 G4 1.467 1 165 1.53 0.128 Tukey-K 0.645 
T2 3 AgeCat*Trt*Glucose Middle Glu p G2 G5 0.33 1 165 0.34 0.731 Tukey-K 0.999 
T2 3 AgeCat*Trt*Glucose Middle Glu p G3 G4 1.708 1 165 1.78 0.077 Tukey-K 0.48 
T2 3 AgeCat*Trt*Glucose Middle Glu p G3 G5 0.571 1 165 0.6 0.552 Tukey-K 0.991 
T2 3 AgeCat*Trt*Glucose Middle Glu p G4 G5 -1.14 1 165 -1.2 0.237 Tukey-K 0.843 
T2 3 AgeCat*Trt*Glucose Old  Glu m G0 G1 -0.69 0.7 165 -1 0.309 Tukey-K 0.911 
T2 3 AgeCat*Trt*Glucose Old  Glu m G0 G2 -0.47 0.7 165 -0.7 0.49 Tukey-K 0.983 
T2 3 AgeCat*Trt*Glucose Old  Glu m G0 G3 -0.51 0.7 165 -0.8 0.453 Tukey-K 0.975 
T2 3 AgeCat*Trt*Glucose Old  Glu m G0 G4 -1.46 0.7 165 -2.1 0.033 Tukey-K 0.268 
T2 3 AgeCat*Trt*Glucose Old  Glu m G0 G5 -0.14 0.7 165 -0.2 0.836 Tukey-K 1 
T2 3 AgeCat*Trt*Glucose Old  Glu m G1 G2 0.223 0.7 165 0.33 0.742 Tukey-K 0.999 
T2 3 AgeCat*Trt*Glucose Old  Glu m G1 G3 0.182 0.7 165 0.27 0.789 Tukey-K 1 
T2 3 AgeCat*Trt*Glucose Old  Glu m G1 G4 -0.76 0.7 165 -1.1 0.261 Tukey-K 0.869 
T2 3 AgeCat*Trt*Glucose Old  Glu m G1 G5 0.551 0.7 165 0.81 0.417 Tukey-K 0.965 
T2 3 AgeCat*Trt*Glucose Old  Glu m G2 G3 -0.04 0.7 165 -0.1 0.952 Tukey-K 1 
T2 3 AgeCat*Trt*Glucose Old  Glu m G2 G4 -0.99 0.7 165 -1.5 0.147 Tukey-K 0.692 
T2 3 AgeCat*Trt*Glucose Old  Glu m G2 G5 0.328 0.7 165 0.48 0.629 Tukey-K 0.997 
T2 3 AgeCat*Trt*Glucose Old  Glu m G3 G4 -0.95 0.7 165 -1.4 0.164 Tukey-K 0.729 
T2 3 AgeCat*Trt*Glucose Old  Glu m G3 G5 0.369 0.7 165 0.55 0.586 Tukey-K 0.994 
T2 3 AgeCat*Trt*Glucose Old  Glu m G4 G5 1.316 0.7 165 1.94 0.054 Tukey-K 0.381 
T2 3 AgeCat*Trt*Glucose Old  Glu p G0 G1 -0.63 0.7 165 -0.9 0.355 Tukey-K 0.939 
T2 3 AgeCat*Trt*Glucose Old  Glu p G0 G2 0.231 0.7 165 0.34 0.734 Tukey-K 0.999 
T2 3 AgeCat*Trt*Glucose Old  Glu p G0 G3 0.715 0.7 165 1.06 0.293 Tukey-K 0.898 
T2 3 AgeCat*Trt*Glucose Old  Glu p G0 G4 -0.42 0.7 165 -0.6 0.541 Tukey-K 0.99 
T2 3 AgeCat*Trt*Glucose Old  Glu p G0 G5 0.125 0.7 165 0.18 0.854 Tukey-K 1 
T2 3 AgeCat*Trt*Glucose Old  Glu p G1 G2 0.86 0.7 165 1.27 0.206 Tukey-K 0.801 
T2 3 AgeCat*Trt*Glucose Old  Glu p G1 G3 1.344 0.7 165 1.98 0.049 Tukey-K 0.356 
T2 3 AgeCat*Trt*Glucose Old  Glu p G1 G4 0.214 0.7 165 0.32 0.753 Tukey-K 1 
T2 3 AgeCat*Trt*Glucose Old  Glu p G1 G5 0.754 0.7 165 1.11 0.267 Tukey-K 0.875 
T2 3 AgeCat*Trt*Glucose Old  Glu p G2 G3 0.484 0.7 165 0.71 0.476 Tukey-K 0.98 
T2 3 AgeCat*Trt*Glucose Old  Glu p G2 G4 -0.65 0.7 165 -1 0.342 Tukey-K 0.932 
T2 3 AgeCat*Trt*Glucose Old  Glu p G2 G5 -0.11 0.7 165 -0.2 0.876 Tukey-K 1 
T2 3 AgeCat*Trt*Glucose Old  Glu p G3 G4 -1.13 0.7 165 -1.7 0.097 Tukey-K 0.555 
T2 3 AgeCat*Trt*Glucose Old  Glu p G3 G5 -0.59 0.7 165 -0.9 0.385 Tukey-K 0.953 
T2 3 AgeCat*Trt*Glucose Old  Glu p G4 G5 0.54 0.7 165 0.8 0.426 Tukey-K 0.968 
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T2 3 AgeCat*Trt*Glucose Old  Glu p G0 G1 -0.03 0.8 165 -0 0.969 Tukey-K 1 
T2 3 AgeCat*Trt*Glucose Old  Glu p G0 G2 1.369 0.8 165 1.75 0.082 Tukey-K 0.501 
T2 3 AgeCat*Trt*Glucose Young Glu m G0 G3 0.437 0.8 165 0.56 0.577 Tukey-K 0.993 
T2 3 AgeCat*Trt*Glucose Young Glu m G0 G4 0.972 0.8 165 1.24 0.216 Tukey-K 0.816 
T2 3 AgeCat*Trt*Glucose Young Glu m G0 G5 0.982 0.8 165 1.25 0.211 Tukey-K 0.809 
T2 3 AgeCat*Trt*Glucose Young Glu m G1 G2 1.4 0.8 165 1.79 0.076 Tukey-K 0.476 
T2 3 AgeCat*Trt*Glucose Young Glu m G1 G3 0.467 0.8 165 0.6 0.551 Tukey-K 0.991 
T2 3 AgeCat*Trt*Glucose Young Glu m G1 G4 1.002 0.8 165 1.28 0.202 Tukey-K 0.795 
T2 3 AgeCat*Trt*Glucose Young Glu m G1 G5 1.012 0.8 165 1.29 0.198 Tukey-K 0.788 
T2 3 AgeCat*Trt*Glucose Young Glu m G2 G3 -0.93 0.8 165 -1.2 0.235 Tukey-K 0.841 
T2 3 AgeCat*Trt*Glucose Young Glu m G2 G4 -0.4 0.8 165 -0.5 0.612 Tukey-K 0.996 
T2 3 AgeCat*Trt*Glucose Young Glu m G2 G5 -0.39 0.8 165 -0.5 0.621 Tukey-K 0.996 
T2 3 AgeCat*Trt*Glucose Young Glu m G3 G4 0.535 0.8 165 0.68 0.496 Tukey-K 0.984 
T2 3 AgeCat*Trt*Glucose Young Glu m G3 G5 0.545 0.8 165 0.7 0.487 Tukey-K 0.982 
T2 3 AgeCat*Trt*Glucose Young Glu m G4 G5 0.01 0.8 165 0.01 0.99 Tukey-K 1 
T2 3 AgeCat*Trt*Glucose Young Glu p G0 G1 1.225 0.8 165 1.56 0.12 Tukey-K 0.623 
T2 3 AgeCat*Trt*Glucose Young Glu p G0 G2 1.077 0.8 165 1.38 0.171 Tukey-K 0.741 
T2 3 AgeCat*Trt*Glucose Young Glu p G0 G3 1.065 0.8 165 1.36 0.175 Tukey-K 0.75 
T2 3 AgeCat*Trt*Glucose Young Glu p G0 G4 1.267 0.8 165 1.62 0.107 Tukey-K 0.587 
T2 3 AgeCat*Trt*Glucose Young Glu p G0 G5 0.798 0.8 165 1.02 0.309 Tukey-K 0.911 
T2 3 AgeCat*Trt*Glucose Young Glu p G1 G2 -0.15 0.8 165 -0.2 0.851 Tukey-K 1 
T2 3 AgeCat*Trt*Glucose Young Glu p G1 G3 -0.16 0.8 165 -0.2 0.839 Tukey-K 1 
T2 3 AgeCat*Trt*Glucose Young Glu p G1 G4 0.043 0.8 165 0.05 0.956 Tukey-K 1 
T2 3 AgeCat*Trt*Glucose Young Glu p G1 G5 -0.43 0.8 165 -0.5 0.587 Tukey-K 0.994 
T2 3 AgeCat*Trt*Glucose Young Glu p G2 G3 -0.01 0.8 165 -0 0.988 Tukey-K 1 
T2 3 AgeCat*Trt*Glucose Young Glu p G2 G4 0.19 0.8 165 0.24 0.808 Tukey-K 1 
T2 3 AgeCat*Trt*Glucose Young Glu p G2 G5 -0.28 0.8 165 -0.4 0.722 Tukey-K 0.999 
T2 3 AgeCat*Trt*Glucose Young Glu p G3 G4 0.202 0.8 165 0.26 0.796 Tukey-K 1 
T2 3 AgeCat*Trt*Glucose Young Glu p G3 G5 -0.27 0.8 165 -0.3 0.734 Tukey-K 0.999 
T2 3 AgeCat*Trt*Glucose Young Glu p G4 G5 -0.47 0.8 165 -0.6 0.55 Tukey-K 0.991 
T3 3 AgeCat*Trt*Glucose Middle Glu m G0 G1 0.834 0.9 165 0.9 0.368 Tukey-K 0.945 
T3 3 AgeCat*Trt*Glucose Middle Glu m G0 G2 0.807 0.9 165 0.87 0.383 Tukey-K 0.952 
T3 3 AgeCat*Trt*Glucose Middle Glu m G0 G3 0.587 0.9 165 0.64 0.526 Tukey-K 0.988 
T3 3 AgeCat*Trt*Glucose Middle Glu m G0 G4 -0.31 0.9 165 -0.3 0.741 Tukey-K 0.999 
T3 3 AgeCat*Trt*Glucose Middle Glu m G0 G5 1.043 0.9 165 1.13 0.26 Tukey-K 0.869 
T3 3 AgeCat*Trt*Glucose Middle Glu m G1 G2 -0.03 0.9 165 -0 0.977 Tukey-K 1 
T3 3 AgeCat*Trt*Glucose Middle Glu m G1 G3 -0.25 0.9 165 -0.3 0.789 Tukey-K 1 
T3 3 AgeCat*Trt*Glucose Middle Glu m G1 G4 -1.14 0.9 165 -1.2 0.219 Tukey-K 0.819 
T3 3 AgeCat*Trt*Glucose Middle Glu m G1 G5 0.209 0.9 165 0.23 0.821 Tukey-K 1 
T3 3 AgeCat*Trt*Glucose Middle Glu m G2 G3 -0.22 0.9 165 -0.2 0.811 Tukey-K 1 
T3 3 AgeCat*Trt*Glucose Middle Glu m G2 G4 -1.11 0.9 165 -1.2 0.23 Tukey-K 0.833 
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T3 3 AgeCat*Trt*Glucose Middle Glu m G2 G5 0.235 0.9 165 0.25 0.799 Tukey-K 1 
T3 3 AgeCat*Trt*Glucose Middle Glu m G3 G4 -0.89 0.9 165 -1 0.335 Tukey-K 0.928 
T3 3 AgeCat*Trt*Glucose Middle Glu m G3 G5 0.456 0.9 165 0.49 0.622 Tukey-K 0.996 
T3 3 AgeCat*Trt*Glucose Middle Glu m G4 G5 1.348 0.9 165 1.46 0.146 Tukey-K 0.69 
T3 3 AgeCat*Trt*Glucose Middle Glu p G0 G1 1.488 0.9 165 1.61 0.109 Tukey-K 0.592 
T3 3 AgeCat*Trt*Glucose Middle Glu p G0 G2 0.274 0.9 165 0.3 0.767 Tukey-K 1 
T3 3 AgeCat*Trt*Glucose Middle Glu p G0 G3 -1.88 0.9 165 -2 0.043 Tukey-K 0.327 
T3 3 AgeCat*Trt*Glucose Middle Glu p G0 G4 0.376 0.9 165 0.41 0.684 Tukey-K 0.999 
T3 3 AgeCat*Trt*Glucose Middle Glu p G0 G5 -0.6 0.9 165 -0.7 0.514 Tukey-K 0.987 
T3 3 AgeCat*Trt*Glucose Middle Glu p G1 G2 -1.21 0.9 165 -1.3 0.19 Tukey-K 0.777 
T3 3 AgeCat*Trt*Glucose Middle Glu p G1 G3 -3.37 0.9 165 -3.6 4E-04 Tukey-K 0.005 
T3 3 AgeCat*Trt*Glucose Middle Glu p G1 G4 -1.11 0.9 165 -1.2 0.23 Tukey-K 0.834 
T3 3 AgeCat*Trt*Glucose Middle Glu p G1 G5 -2.09 0.9 165 -2.3 0.025 Tukey-K 0.214 
T3 3 AgeCat*Trt*Glucose Middle Glu p G2 G3 -2.15 0.9 165 -2.3 0.021 Tukey-K 0.187 
T3 3 AgeCat*Trt*Glucose Middle Glu p G2 G4 0.102 0.9 165 0.11 0.912 Tukey-K 1 
T3 3 AgeCat*Trt*Glucose Middle Glu p G2 G5 -0.88 0.9 165 -1 0.343 Tukey-K 0.932 
T3 3 AgeCat*Trt*Glucose Middle Glu p G3 G4 2.255 0.9 165 2.44 0.016 Tukey-K 0.148 
T3 3 AgeCat*Trt*Glucose Middle Glu p G3 G5 1.275 0.9 165 1.38 0.169 Tukey-K 0.738 
T3 3 AgeCat*Trt*Glucose Middle Glu p G4 G5 -0.98 0.9 165 -1.1 0.29 Tukey-K 0.896 
T3 3 AgeCat*Trt*Glucose Old Glu m G0 G1 0.123 0.7 165 0.19 0.85 Tukey-K 1 
T3 3 AgeCat*Trt*Glucose Old Glu m G0 G2 -0.37 0.7 165 -0.6 0.568 Tukey-K 0.993 
T3 3 AgeCat*Trt*Glucose Old Glu m G0 G3 -0.66 0.7 165 -1 0.315 Tukey-K 0.915 
T3 3 AgeCat*Trt*Glucose Old Glu m G0 G4 -0.88 0.7 165 -1.3 0.181 Tukey-K 0.76 
T3 3 AgeCat*Trt*Glucose Old Glu m G0 G5 -0.19 0.7 165 -0.3 0.767 Tukey-K 1 
T3 3 AgeCat*Trt*Glucose Old Glu m G1 G2 -0.5 0.7 165 -0.8 0.448 Tukey-K 0.974 
T3 3 AgeCat*Trt*Glucose Old Glu m G1 G3 -0.78 0.7 165 -1.2 0.233 Tukey-K 0.838 
T3 3 AgeCat*Trt*Glucose Old Glu m G1 G4 -1 0.7 165 -1.5 0.127 Tukey-K 0.643 
T3 3 AgeCat*Trt*Glucose Old Glu m G1 G5 -0.32 0.7 165 -0.5 0.627 Tukey-K 0.997 
T3 3 AgeCat*Trt*Glucose Old Glu m G2 G3 -0.28 0.7 165 -0.4 0.664 Tukey-K 0.998 
T3 3 AgeCat*Trt*Glucose Old Glu m G2 G4 -0.5 0.7 165 -0.8 0.441 Tukey-K 0.972 
T3 3 AgeCat*Trt*Glucose Old Glu m G2 G5 0.179 0.7 165 0.27 0.784 Tukey-K 1 
T3 3 AgeCat*Trt*Glucose Old Glu m G3 G4 -0.22 0.7 165 -0.3 0.737 Tukey-K 0.999 
T3 3 AgeCat*Trt*Glucose Old Glu m G3 G5 0.464 0.7 165 0.71 0.478 Tukey-K 0.98 
T3 3 AgeCat*Trt*Glucose Old Glu m G4 G5 0.683 0.7 165 1.05 0.297 Tukey-K 0.901 
T3 3 AgeCat*Trt*Glucose Old Glu  p G0 G1 -0.11 0.7 165 -0.2 0.866 Tukey-K 1 
T3 3 AgeCat*Trt*Glucose Old Glu  p G0 G2 0.078 0.7 165 0.12 0.905 Tukey-K 1 
T3 3 AgeCat*Trt*Glucose Old Glu  p G0 G3 0.684 0.7 165 1.05 0.296 Tukey-K 0.901 
T3 3 AgeCat*Trt*Glucose Old Glu  p G0 G4 -0.46 0.7 165 -0.7 0.478 Tukey-K 0.98 
T3 3 AgeCat*Trt*Glucose Old Glu  p G0 G5 -0.05 0.7 165 -0.1 0.942 Tukey-K 1 
T3 3 AgeCat*Trt*Glucose Old Glu  p G1 G2 0.188 0.7 165 0.29 0.774 Tukey-K 1 
T3 3 AgeCat*Trt*Glucose Old Glu  p G1 G3 0.794 0.7 165 1.22 0.225 Tukey-K 0.828 
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T3 3 AgeCat*Trt*Glucose Old Glu  p G1 G4 -0.35 0.7 165 -0.5 0.589 Tukey-K 0.994 
T3 3 AgeCat*Trt*Glucose Old Glu  p G1 G5 0.062 0.7 165 0.1 0.924 Tukey-K 1 
T3 3 AgeCat*Trt*Glucose Old Glu  p G2 G3 0.606 0.7 165 0.93 0.354 Tukey-K 0.939 
T3 3 AgeCat*Trt*Glucose Old Glu  p G2 G4 -0.54 0.7 165 -0.8 0.408 Tukey-K 0.962 
T3 3 AgeCat*Trt*Glucose Old Glu  p G2 G5 -0.13 0.7 165 -0.2 0.848 Tukey-K 1 
T3 3 AgeCat*Trt*Glucose Old Glu  p G3 G4 -1.15 0.7 165 -1.8 0.081 Tukey-K 0.495 
T3 3 AgeCat*Trt*Glucose Old Glu  p G3 G5 -0.73 0.7 165 -1.1 0.264 Tukey-K 0.872 
T3 3 AgeCat*Trt*Glucose Old Glu  p G4 G5 0.416 0.7 165 0.64 0.525 Tukey-K 0.988 
T3 3 AgeCat*Trt*Glucose Young Glu m G0 G1 0.209 0.8 165 0.28 0.782 Tukey-K 1 
T3 3 AgeCat*Trt*Glucose Young Glu m G0 G2 1.278 0.8 165 1.7 0.092 Tukey-K 0.537 
T3 3 AgeCat*Trt*Glucose Young Glu m G0 G3 0.809 0.8 165 1.07 0.285 Tukey-K 0.891 
T3 3 AgeCat*Trt*Glucose Young Glu m G0 G4 0.745 0.8 165 0.99 0.324 Tukey-K 0.921 
T3 3 AgeCat*Trt*Glucose Young Glu m G0 G5 1.096 0.8 165 1.45 0.148 Tukey-K 0.694 
T3 3 AgeCat*Trt*Glucose Young Glu m G1 G2 1.069 0.8 165 1.42 0.158 Tukey-K 0.716 
T3 3 AgeCat*Trt*Glucose Young Glu m G1 G3 0.6 0.8 165 0.8 0.427 Tukey-K 0.968 
T3 3 AgeCat*Trt*Glucose Young Glu m G1 G4 0.536 0.8 165 0.71 0.478 Tukey-K 0.98 
T3 3 AgeCat*Trt*Glucose Young Glu m G1 G5 0.887 0.8 165 1.18 0.241 Tukey-K 0.847 
T3 3 AgeCat*Trt*Glucose Young Glu m G2 G3 -0.47 0.8 165 -0.6 0.535 Tukey-K 0.989 
T3 3 AgeCat*Trt*Glucose Young Glu m G2 G4 -0.53 0.8 165 -0.7 0.481 Tukey-K 0.981 
T3 3 AgeCat*Trt*Glucose Young Glu m G2 G5 -0.18 0.8 165 -0.2 0.81 Tukey-K 1 
T3 3 AgeCat*Trt*Glucose Young Glu m G3 G4 -0.06 0.8 165 -0.1 0.933 Tukey-K 1 
T3 3 AgeCat*Trt*Glucose Young Glu m G3 G5 0.287 0.8 165 0.38 0.704 Tukey-K 0.999 
T3 3 AgeCat*Trt*Glucose Young Glu m G4 G5 0.351 0.8 165 0.47 0.642 Tukey-K 0.997 
T3 3 AgeCat*Trt*Glucose Young Glu p G0 G1 0.82 0.8 165 1.09 0.278 Tukey-K 0.885 
T3 3 AgeCat*Trt*Glucose Young Glu p G0 G2 1.106 0.8 165 1.47 0.144 Tukey-K 0.685 
T3 3 AgeCat*Trt*Glucose Young Glu p G0 G3 0.67 0.8 165 0.89 0.375 Tukey-K 0.949 
T3 3 AgeCat*Trt*Glucose Young Glu p G0 G4 0.584 0.8 165 0.78 0.439 Tukey-K 0.971 
T3 3 AgeCat*Trt*Glucose Young Glu p G0 G5 0.027 0.8 165 0.04 0.972 Tukey-K 1 
T3 3 AgeCat*Trt*Glucose Young Glu p G1 G2 0.286 0.8 165 0.38 0.705 Tukey-K 0.999 
T3 3 AgeCat*Trt*Glucose Young Glu p G1 G3 -0.15 0.8 165 -0.2 0.842 Tukey-K 1 
T3 3 AgeCat*Trt*Glucose Young Glu p G1 G4 -0.24 0.8 165 -0.3 0.754 Tukey-K 1 
T3 3 AgeCat*Trt*Glucose Young Glu p G1 G5 -0.79 0.8 165 -1.1 0.294 Tukey-K 0.899 
T3 3 AgeCat*Trt*Glucose Young Glu p G2 G3 -0.44 0.8 165 -0.6 0.563 Tukey-K 0.992 
T3 3 AgeCat*Trt*Glucose Young Glu p G2 G4 -0.52 0.8 165 -0.7 0.489 Tukey-K 0.983 
T3 3 AgeCat*Trt*Glucose Young Glu p G2 G5 -1.08 0.8 165 -1.4 0.154 Tukey-K 0.707 
T3 3 AgeCat*Trt*Glucose Young Glu p G3 G4 -0.09 0.8 165 -0.1 0.909 Tukey-K 1 
T3 3 AgeCat*Trt*Glucose Young Glu p G3 G5 -0.64 0.8 165 -0.9 0.395 Tukey-K 0.957 
T3 3 AgeCat*Trt*Glucose Young Glu p G4 G5 -0.56 0.8 165 -0.7 0.461 Tukey-K 0.977 
T4 3 AgeCat*Trt*Glucose Middle Glu m G0 G1 -0.3 1 165 -0.3 0.759 Tukey-K 1 
T4 3 AgeCat*Trt*Glucose Middle Glu m G0 G2 0.25 1 165 0.26 0.798 Tukey-K 1 
T4 3 AgeCat*Trt*Glucose Middle Glu m G0 G3 0.274 1 165 0.28 0.779 Tukey-K 1 
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T4 3 AgeCat*Trt*Glucose Middle Glu m G0 G4 -1.04 1 165 -1.1 0.288 Tukey-K 0.894 
T4 3 AgeCat*Trt*Glucose Middle Glu m G0 G5 -0.04 1 165 -0 0.965 Tukey-K 1 
T4 3 AgeCat*Trt*Glucose Middle Glu m G1 G2 0.55 1 165 0.56 0.573 Tukey-K 0.993 
T4 3 AgeCat*Trt*Glucose Middle Glu m G1 G3 0.574 1 165 0.59 0.556 Tukey-K 0.992 
T4 3 AgeCat*Trt*Glucose Middle Glu m G1 G4 -0.74 1 165 -0.8 0.449 Tukey-K 0.974 
T4 3 AgeCat*Trt*Glucose Middle Glu m G1 G5 0.258 1 165 0.26 0.792 Tukey-K 1 
T4 3 AgeCat*Trt*Glucose Middle Glu m G2 G3 0.024 1 165 0.03 0.98 Tukey-K 1 
T4 3 AgeCat*Trt*Glucose Middle Glu m G2 G4 -1.29 1 165 -1.3 0.188 Tukey-K 0.772 
T4 3 AgeCat*Trt*Glucose Middle Glu m G2 G5 -0.29 1 165 -0.3 0.764 Tukey-K 1 
T4 3 AgeCat*Trt*Glucose Middle Glu m G3 G4 -1.31 1 165 -1.3 0.179 Tukey-K 0.757 
T4 3 AgeCat*Trt*Glucose Middle Glu m G3 G5 -0.32 1 165 -0.3 0.745 Tukey-K 1 
T4 3 AgeCat*Trt*Glucose Middle Glu m G4 G5 0.997 1 165 1.02 0.308 Tukey-K 0.91 
T4 3 AgeCat*Trt*Glucose Middle Glu m G0 G1 0.869 1 165 0.89 0.374 Tukey-K 0.948 
T4 3 AgeCat*Trt*Glucose Middle Glu m G0 G2 -0.52 1 165 -0.5 0.592 Tukey-K 0.995 
T4 3 AgeCat*Trt*Glucose Middle Glu m G0 G3 -0.97 1 165 -1 0.323 Tukey-K 0.92 
T4 3 AgeCat*Trt*Glucose Middle Glu p G0 G4 0.088 1 165 0.09 0.928 Tukey-K 1 
T4 3 AgeCat*Trt*Glucose Middle Glu p G0 G5 -1.37 1 165 -1.4 0.162 Tukey-K 0.725 
T4 3 AgeCat*Trt*Glucose Middle Glu p G1 G2 -1.39 1 165 -1.4 0.155 Tukey-K 0.709 
T4 3 AgeCat*Trt*Glucose Middle Glu p G1 G3 -1.83 1 165 -1.9 0.061 Tukey-K 0.416 
T4 3 AgeCat*Trt*Glucose Middle Glu p G1 G4 -0.78 1 165 -0.8 0.424 Tukey-K 0.967 
T4 3 AgeCat*Trt*Glucose Middle Glu p G1 G5 -2.24 1 165 -2.3 0.023 Tukey-K 0.202 
T4 3 AgeCat*Trt*Glucose Middle Glu p G2 G3 -0.44 1 165 -0.5 0.65 Tukey-K 0.998 
T4 3 AgeCat*Trt*Glucose Middle Glu p G2 G4 0.611 1 165 0.63 0.532 Tukey-K 0.989 
T4 3 AgeCat*Trt*Glucose Middle Glu p G2 G5 -0.84 1 165 -0.9 0.388 Tukey-K 0.954 
T4 3 AgeCat*Trt*Glucose Middle Glu p G3 G4 1.053 1 165 1.08 0.281 Tukey-K 0.888 
T4 3 AgeCat*Trt*Glucose Middle Glu p G3 G5 -0.4 1 165 -0.4 0.681 Tukey-K 0.998 
T4 3 AgeCat*Trt*Glucose Middle Glu p G4 G5 -1.45 1 165 -1.5 0.137 Tukey-K 0.669 
T4 3 AgeCat*Trt*Glucose Old Glu m G0 G1 0.302 0.7 165 0.44 0.661 Tukey-K 0.998 
T4 3 AgeCat*Trt*Glucose Old Glu m G0 G2 -0.74 0.7 165 -1.1 0.283 Tukey-K 0.89 
T4 3 AgeCat*Trt*Glucose Old Glu m G0 G3 -0.3 0.7 165 -0.4 0.663 Tukey-K 0.998 
T4 3 AgeCat*Trt*Glucose Old Glu m G0 G4 -0.03 0.7 165 -0 0.968 Tukey-K 1 
T4 3 AgeCat*Trt*Glucose Old Glu m G0 G5 0.166 0.7 165 0.24 0.81 Tukey-K 1 
T4 3 AgeCat*Trt*Glucose Old Glu m G1 G2 -1.04 0.7 165 -1.5 0.132 Tukey-K 0.655 
T4 3 AgeCat*Trt*Glucose Old Glu m G1 G3 -0.6 0.7 165 -0.9 0.383 Tukey-K 0.952 
T4 3 AgeCat*Trt*Glucose Old Glu m G1 G4 -0.33 0.7 165 -0.5 0.633 Tukey-K 0.997 
T4 3 AgeCat*Trt*Glucose Old Glu m G1 G5 -0.14 0.7 165 -0.2 0.843 Tukey-K 1 
T4 3 AgeCat*Trt*Glucose Old Glu m G2 G3 0.441 0.7 165 0.64 0.523 Tukey-K 0.988 
T4 3 AgeCat*Trt*Glucose Old Glu m G2 G4 0.714 0.7 165 1.04 0.301 Tukey-K 0.905 
T4 3 AgeCat*Trt*Glucose Old Glu m G2 G5 0.908 0.7 165 1.32 0.19 Tukey-K 0.775 
T4 3 AgeCat*Trt*Glucose Old Glu m G3 G4 0.273 0.7 165 0.4 0.692 Tukey-K 0.999 
T4 3 AgeCat*Trt*Glucose Old Glu m G3 G5 0.467 0.7 165 0.68 0.499 Tukey-K 0.984 
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T4 3 AgeCat*Trt*Glucose Old Glu m G4 G5 0.193 0.7 165 0.28 0.779 Tukey-K 1 
T4 3 AgeCat*Trt*Glucose Old Glu p G0 G1 -0.78 0.7 165 -1.1 0.258 Tukey-K 0.866 
T4 3 AgeCat*Trt*Glucose Old Glu p G0 G2 -0.47 0.7 165 -0.7 0.495 Tukey-K 0.983 
T4 3 AgeCat*Trt*Glucose Old Glu p G0 G3 0.006 0.7 165 0.01 0.993 Tukey-K 1 
T4 3 AgeCat*Trt*Glucose Old Glu p G0 G4 -0.35 0.7 165 -0.5 0.61 Tukey-K 0.996 
T4 3 AgeCat*Trt*Glucose Old Glu p G0 G5 0.091 0.7 165 0.13 0.895 Tukey-K 1 
T4 3 AgeCat*Trt*Glucose Old Glu p G1 G2 0.31 0.7 165 0.45 0.653 Tukey-K 0.998 
T4 3 AgeCat*Trt*Glucose Old Glu p G1 G3 0.788 0.7 165 1.14 0.255 Tukey-K 0.863 
T4 3 AgeCat*Trt*Glucose Old Glu p G1 G4 0.429 0.7 165 0.62 0.534 Tukey-K 0.989 
T4 3 AgeCat*Trt*Glucose Old Glu p G1 G5 0.873 0.7 165 1.27 0.207 Tukey-K 0.803 
T4 3 AgeCat*Trt*Glucose Old Glu p G2 G3 0.478 0.7 165 0.69 0.489 Tukey-K 0.983 
T4 3 AgeCat*Trt*Glucose Old Glu p G2 G4 0.119 0.7 165 0.17 0.863 Tukey-K 1 
T4 3 AgeCat*Trt*Glucose Old Glu p G2 G5 0.563 0.7 165 0.82 0.415 Tukey-K r 0.964 
T4 3 AgeCat*Trt*Glucose Old Glu p G3 G4 -0.36 0.7 165 -0.5 0.604 Tukey-K 0.995 
T4 3 AgeCat*Trt*Glucose Old Glu p G3 G5 0.085 0.7 165 0.12 0.902 Tukey-K 1 
T4 3 AgeCat*Trt*Glucose Old Glu p G4 G5 0.443 0.7 165 0.64 0.521 Tukey-K 0.987 
T4 3 AgeCat*Trt*Glucose Young Glu m G0 G1 0.194 0.8 165 0.24 0.808 Tukey-K 1 
T4 3 AgeCat*Trt*Glucose Young Glu m G0 G2 0.028 0.8 165 0.03 0.972 Tukey-K 1 
T4 3 AgeCat*Trt*Glucose Young Glu m G0 G3 -0.14 0.8 165 -0.2 0.864 Tukey-K 1 
T4 3 AgeCat*Trt*Glucose Young Glu m G0 G4 0.537 0.8 165 0.67 0.501 Tukey-K 0.985 
T4 3 AgeCat*Trt*Glucose Young Glu m G0 G5 0.539 0.8 165 0.68 0.499 Tukey-K 0.984 
T4 3 AgeCat*Trt*Glucose Young Glu m G1 G2 -0.17 0.8 165 -0.2 0.835 Tukey-K 1 
T4 3 AgeCat*Trt*Glucose Young Glu m G1 G3 -0.33 0.8 165 -0.4 0.679 Tukey-K 0.998 
T4 3 AgeCat*Trt*Glucose Young Glu m G1 G4 0.343 0.8 165 0.43 0.667 Tukey-K 0.998 
T4 3 AgeCat*Trt*Glucose Young Glu m G1 G5 0.345 0.8 165 0.43 0.665 Tukey-K 0.998 
T4 3 AgeCat*Trt*Glucose Young Glu m G2 G3 -0.16 0.8 165 -0.2 0.837 Tukey-K 1 
T4 3 AgeCat*Trt*Glucose Young Glu m G2 G4 0.509 0.8 165 0.64 0.523 Tukey-K 0.988 
T4 3 AgeCat*Trt*Glucose Young Glu m G2 G5 0.512 0.8 165 0.64 0.521 Tukey-K 0.988 
T4 3 AgeCat*Trt*Glucose Young Glu m G3 G4 0.673 0.8 165 0.85 0.399 Tukey-K 0.958 
T4 3 AgeCat*Trt*Glucose Young Glu m G3 G5 0.675 0.8 165 0.85 0.397 Tukey-K 0.958 
T4 3 AgeCat*Trt*Glucose Young Glu m G4 G5 0.003 0.8 165 0 0.997 Tukey-K 1 
T4 3 AgeCat*Trt*Glucose Young Glu p G0 G1 0.596 0.8 165 0.75 0.455 Tukey-K 0.975 
T4 3 AgeCat*Trt*Glucose Young Glu p G0 G2 0.747 0.8 165 0.94 0.349 Tukey-K 0.936 
T4 3 AgeCat*Trt*Glucose Young Glu p G0 G3 0.704 0.8 165 0.89 0.377 Tukey-K 0.95 
T4 3 AgeCat*Trt*Glucose Young Glu p G0 G4 0.83 0.8 165 1.04 0.298 Tukey-K 0.902 
T4 3 AgeCat*Trt*Glucose Young Glu p G0 G5 0.999 0.8 165 1.26 0.211 Tukey-K 0.808 
T4 3 AgeCat*Trt*Glucose Young Glu p G1 G2 0.151 0.8 165 0.19 0.85 Tukey-K 1 
T4 3 AgeCat*Trt*Glucose Young Glu p G1 G3 0.108 0.8 165 0.14 0.892 Tukey-K 1 
T4 3 AgeCat*Trt*Glucose Young Glu p G1 G4 0.234 0.8 165 0.29 0.769 Tukey-K 1 
T4 3 AgeCat*Trt*Glucose Young Glu p G1 G5 0.403 0.8 165 0.51 0.613 Tukey-K 0.996 
T4 3 AgeCat*Trt*Glucose Young Glu p G2 G3 -0.04 0.8 165 -0.1 0.957 Tukey-K 1 
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T4 3 AgeCat*Trt*Glucose Young Glu p G2 G4 0.083 0.8 165 0.1 0.917 Tukey-K 1 
T4 3 AgeCat*Trt*Glucose Young Glu p G2 G5 0.252 0.8 165 0.32 0.752 Tukey-K 1 
T4 3 AgeCat*Trt*Glucose Young Glu p G3 G4 0.126 0.8 165 0.16 0.875 Tukey-K 1 
T4 3 AgeCat*Trt*Glucose Young Glu p G3 G5 0.295 0.8 165 0.37 0.711 Tukey-K 0.999 
T4 3 AgeCat*Trt*Glucose Young Glu p G4 G5 0.169 0.8 165 0.21 0.832 Tukey-K 1 
T5 3 AgeCat*Trt*Glucose Middle Glu m G0 G1 1.483 1 165 1.43 0.156 Tukey-K 0.711 
T5 3 AgeCat*Trt*Glucose Middle Glu m G0 G2 1.859 1 165 1.79 0.076 Tukey-K 0.476 
T5 3 AgeCat*Trt*Glucose Middle Glu m G0 G3 1.642 1 165 1.58 0.116 Tukey-K 0.613 
T5 3 AgeCat*Trt*Glucose Middle Glu m G0 G4 1.208 1 165 1.16 0.247 Tukey-K 0.854 
T5 3 AgeCat*Trt*Glucose Middle Glu m G0 G5 1.482 1 165 1.43 0.156 Tukey-K 0.711 
T5 3 AgeCat*Trt*Glucose Middle Glu m G1 G2 0.376 1 165 0.36 0.718 Tukey-K 0.999 
T5 3 AgeCat*Trt*Glucose Middle Glu m G1 G3 0.159 1 165 0.15 0.878 Tukey-K 1 
T5 3 AgeCat*Trt*Glucose Middle Glu m G1 G4 -0.27 1 165 -0.3 0.792 Tukey-K 1 
T5 3 AgeCat*Trt*Glucose Middle Glu m G1 G5 -0 1 165 -0 1 Tukey-K 1 
T5 3 AgeCat*Trt*Glucose Middle Glu m G2 G3 -0.22 1 165 -0.2 0.835 Tukey-K 1 
T5 3 AgeCat*Trt*Glucose Middle Glu m G2 G4 -0.65 1 165 -0.6 0.532 Tukey-K 0.989 
T5 3 AgeCat*Trt*Glucose Middle Glu m G2 G5 -0.38 1 165 -0.4 0.718 Tukey-K 0.999 
T5 3 AgeCat*Trt*Glucose Middle Glu m G3 G4 -0.43 1 165 -0.4 0.677 Tukey-K 0.998 
T5 3 AgeCat*Trt*Glucose Middle Glu m G3 G5 -0.16 1 165 -0.2 0.878 Tukey-K 1 
T5 3 AgeCat*Trt*Glucose Middle Glu m G4 G5 0.274 1 165 0.26 0.792 Tukey-K 1 
T5 3 AgeCat*Trt*Glucose Middle Glu p G0 G1 1.125 1 165 1.08 0.28 Tukey-K 0.888 
T5 3 AgeCat*Trt*Glucose Middle Glu p G0 G2 1.217 1 165 1.17 0.243 Tukey-K 0.85 
T5 3 AgeCat*Trt*Glucose Middle Glu p G0 G3 -0.04 1 165 -0 0.971 Tukey-K 1 
T5 3 AgeCat*Trt*Glucose Middle Glu p G0 G4 1.14 1 165 1.1 0.274 Tukey-K 0.882 
T5 3 AgeCat*Trt*Glucose Middle Glu p G0 G5 -0.36 1 165 -0.3 0.733 Tukey-K 0.999 
T5 3 AgeCat*Trt*Glucose Middle Glu p G1 G2 0.091 1 165 0.09 0.93 Tukey-K 1 
T5 3 AgeCat*Trt*Glucose Middle Glu p G1 G3 -1.16 1 165 -1.1 0.265 Tukey-K 0.873 
T5 3 AgeCat*Trt*Glucose Middle Glu p G1 G4 0.015 1 165 0.01 0.989 Tukey-K 1 
T5 3 AgeCat*Trt*Glucose Middle Glu p G1 G5 -1.48 1 165 -1.4 0.156 Tukey-K 0.712 
T5 3 AgeCat*Trt*Glucose Middle Glu p G2 G3 -1.26 1 165 -1.2 0.229 Tukey-K 0.833 
T5 3 AgeCat*Trt*Glucose Middle Glu p G2 G4 -0.08 1 165 -0.1 0.941 Tukey-K 1 
T5 3 AgeCat*Trt*Glucose Middle Glu p G2 G5 -1.57 1 165 -1.5 0.132 Tukey-K 0.656 
T5 3 AgeCat*Trt*Glucose Middle Glu p G3 G4 1.178 1 165 1.13 0.259 Tukey-K 0.867 
T5 3 AgeCat*Trt*Glucose Middle Glu p G3 G5 -0.32 1 165 -0.3 0.76 Tukey-K 1 
T5 3 AgeCat*Trt*Glucose Middle Glu p G4 G5 -1.5 1 165 -1.4 0.152 Tukey-K 0.703 
T5 3 AgeCat*Trt*Glucose Middle Glu p G0 G1 1.293 0.7 165 1.76 0.08 Tukey-K 0.494 
T5 3 AgeCat*Trt*Glucose Old Glu m G0 G2 1.06 0.7 165 1.44 0.151 Tukey-K 0.701 
T5 3 AgeCat*Trt*Glucose Old Glu m G0 G3 0.673 0.7 165 0.92 0.361 Tukey-K 0.942 
T5 3 AgeCat*Trt*Glucose Old Glu m G0 G4 0.532 0.7 165 0.72 0.47 Tukey-K 0.979 
T5 3 AgeCat*Trt*Glucose Old Glu m G0 G5 1.005 0.7 165 1.37 0.173 Tukey-K 0.747 
T5 3 AgeCat*Trt*Glucose Old Glu m G1 G2 -0.23 0.7 165 -0.3 0.751 Tukey-K 1 
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T5 3 AgeCat*Trt*Glucose Old Glu m G1 G3 -0.62 0.7 165 -0.8 0.4 Tukey-K 0.959 
T5 3 AgeCat*Trt*Glucose Old Glu m G1 G4 -0.76 0.7 165 -1 0.302 Tukey-K 0.905 
T5 3 AgeCat*Trt*Glucose Old Glu m G1 G5 -0.29 0.7 165 -0.4 0.695 Tukey-K 0.999 
T5 3 AgeCat*Trt*Glucose Old Glu m G2 G3 -0.39 0.7 165 -0.5 0.599 Tukey-K 0.995 
T5 3 AgeCat*Trt*Glucose Old Glu m G2 G4 -0.53 0.7 165 -0.7 0.474 Tukey-K 0.98 
T5 3 AgeCat*Trt*Glucose Old Glu m G2 G5 -0.06 0.7 165 -0.1 0.94 Tukey-K 1 
T5 3 AgeCat*Trt*Glucose Old Glu m G3 G4 -0.14 0.7 165 -0.2 0.849 Tukey-K 1 
T5 3 AgeCat*Trt*Glucose Old Glu m G3 G5 0.332 0.7 165 0.45 0.652 Tukey-K 0.998 
T5 3 AgeCat*Trt*Glucose Old Glu m G4 G5 0.472 0.7 165 0.64 0.521 Tukey-K 0.988 
T5 3 AgeCat*Trt*Glucose Old Glu p G0 G1 0.028 0.7 165 0.04 0.97 Tukey-K 1 
T5 3 AgeCat*Trt*Glucose Old Glu p G0 G2 1.213 0.7 165 1.65 0.101 Tukey-K 0.566 
T5 3 AgeCat*Trt*Glucose Old Glu p G0 G3 0.748 0.7 165 1.02 0.31 Tukey-K 0.911 
T5 3 AgeCat*Trt*Glucose Old Glu p G0 G4 -0.01 0.7 165 -0 0.991 Tukey-K 1 
T5 3 AgeCat*Trt*Glucose Old Glu p G0 G5 0.428 0.7 165 0.58 0.561 Tukey-K 0.992 
T5 3 AgeCat*Trt*Glucose Old Glu p G1 G2 1.186 0.7 165 1.61 0.109 Tukey-K 0.591 
T5 3 AgeCat*Trt*Glucose Old Glu p G1 G3 0.721 0.7 165 0.98 0.328 Tukey-K 0.924 
T5 3 AgeCat*Trt*Glucose Old Glu p G1 G4 -0.04 0.7 165 -0 0.961 Tukey-K 1 
T5 3 AgeCat*Trt*Glucose Old Glu p G1 G5 0.401 0.7 165 0.55 0.586 Tukey-K 0.994 
T5 3 AgeCat*Trt*Glucose Old Glu p G2 G3 -0.46 0.7 165 -0.6 0.528 Tukey-K 0.988 
T5 3 AgeCat*Trt*Glucose Old Glu p G2 G4 -1.22 0.7 165 -1.7 0.098 Tukey-K 0.559 
T5 3 AgeCat*Trt*Glucose Old Glu p G2 G5 -0.79 0.7 165 -1.1 0.287 Tukey-K 0.893 
T5 3 AgeCat*Trt*Glucose Old Glu p G3 G4 -0.76 0.7 165 -1 0.305 Tukey-K 0.907 
T5 3 AgeCat*Trt*Glucose Old Glu p G3 G5 -0.32 0.7 165 -0.4 0.664 Tukey-K 0.998 
T5 3 AgeCat*Trt*Glucose Old Glu p G4 G5 0.437 0.7 165 0.59 0.553 Tukey-K 0.991 
T5 3 AgeCat*Trt*Glucose Young Glu m G0 G1 -0.26 0.8 165 -0.3 0.757 Tukey-K 1 
T5 3 AgeCat*Trt*Glucose Young Glu m G0 G2 -0.95 0.8 165 -1.1 0.267 Tukey-K 0.875 
T5 3 AgeCat*Trt*Glucose Young Glu m G0 G3 -0.98 0.8 165 -1.2 0.249 Tukey-K 0.856 
T5 3 AgeCat*Trt*Glucose Young Glu m G0 G4 -0.19 0.8 165 -0.2 0.822 Tukey-K 1 
T5 3 AgeCat*Trt*Glucose Young Glu m G0 G5 0.325 0.8 165 0.38 0.702 Tukey-K 0.999 
T5 3 AgeCat*Trt*Glucose Young Glu m G1 G2 -0.68 0.8 165 -0.8 0.423 Tukey-K 0.966 
T5 3 AgeCat*Trt*Glucose Young Glu m G1 G3 -0.72 0.8 165 -0.8 0.398 Tukey-K 0.958 
T5 3 AgeCat*Trt*Glucose Young Glu m G1 G4 0.072 0.8 165 0.08 0.932 Tukey-K 1 
T5 3 AgeCat*Trt*Glucose Young Glu m G1 G5 0.588 0.8 165 0.69 0.489 Tukey-K 0.983 
T5 3 AgeCat*Trt*Glucose Young Glu m G2 G3 -0.04 0.8 165 -0 0.965 Tukey-K 1 
T5 3 AgeCat*Trt*Glucose Young Glu m G2 G4 0.754 0.8 165 0.89 0.375 Tukey-K 0.949 
T5 3 AgeCat*Trt*Glucose Young Glu m G2 G5 1.27 0.8 165 1.5 0.136 Tukey-K 0.667 
T5 3 AgeCat*Trt*Glucose Young Glu m G3 G4 0.791 0.8 165 0.93 0.352 Tukey-K 0.938 
T5 3 AgeCat*Trt*Glucose Young Glu m G3 G5 1.307 0.8 165 1.54 0.125 Tukey-K 0.639 
T5 3 AgeCat*Trt*Glucose Young Glu m G4 G5 0.516 0.8 165 0.61 0.544 Tukey-K 0.99 
T5 3 AgeCat*Trt*Glucose Young Glu p G0 G1 -0.44 0.8 165 -0.5 0.604 Tukey-K 0.995 
T5 3 AgeCat*Trt*Glucose Young Glu p G0 G2 -1.12 0.8 165 -1.3 0.189 Tukey-K 0.774 
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T5 3 AgeCat*Trt*Glucose Young Glu p G0 G3 -0.82 0.8 165 -1 0.334 Tukey-K 0.927 
T5 3 AgeCat*Trt*Glucose Young Glu p G0 G4 -1.29 0.8 165 -1.5 0.13 Tukey-K 0.652 
T5 3 AgeCat*Trt*Glucose Young Glu p G0 G5 -0.62 0.8 165 -0.7 0.464 Tukey-K 0.977 
T5 3 AgeCat*Trt*Glucose Young Glu p G1 G2 -0.68 0.8 165 -0.8 0.425 Tukey-K 0.967 
T5 3 AgeCat*Trt*Glucose Young Glu p G1 G3 -0.38 0.8 165 -0.4 0.655 Tukey-K 0.998 
T5 3 AgeCat*Trt*Glucose Young Glu p G1 G4 -0.85 0.8 165 -1 0.319 Tukey-K 0.917 
T5 3 AgeCat*Trt*Glucose Young Glu p G1 G5 -0.18 0.8 165 -0.2 0.83 Tukey-K 1 
T5 3 AgeCat*Trt*Glucose Young Glu p G2 G3 0.298 0.8 165 0.35 0.726 Tukey-K 0.999 
T5 3 AgeCat*Trt*Glucose Young Glu p G2 G4 -0.17 0.8 165 -0.2 0.841 Tukey-K 1 
T5 3 AgeCat*Trt*Glucose Young Glu p G2 G5 0.496 0.8 165 0.58 0.559 Tukey-K 0.992 
T5 3 AgeCat*Trt*Glucose Young Glu p G3 G4 -0.47 0.8 165 -0.6 0.582 Tukey-K 0.994 
T5 3 AgeCat*Trt*Glucose Young Glu p G3 G5 0.198 0.8 165 0.23 0.815 Tukey-K 1 
T5 3 AgeCat*Trt*Glucose Young Glu p G4 G5 0.667 0.8 165 0.79 0.433 Tukey-K 0.97 
T6 3 AgeCat*Trt*Glucose Middle Glu m G0 G1 -0.42 1.6 165 -0.3 0.793 Tukey-K 1 
T6 3 AgeCat*Trt*Glucose Middle Glu m G0 G2 0.231 1.6 165 0.14 0.886 Tukey-K 1 
T6 3 AgeCat*Trt*Glucose Middle Glu m G0 G3 2.383 1.6 165 1.48 0.14 Tukey-K 0.677 
T6 3 AgeCat*Trt*Glucose Middle Glu m G0 G4 0.788 1.6 165 0.49 0.625 Tukey-K 0.996 
T6 3 AgeCat*Trt*Glucose Middle Glu m G0 G5 2.524 1.6 165 1.57 0.119 Tukey-K 0.62 
T6 3 AgeCat*Trt*Glucose Middle Glu m G1 G2 0.655 1.6 165 0.41 0.684 Tukey-K 0.999 
T6 3 AgeCat*Trt*Glucose Middle Glu m G1 G3 2.807 1.6 165 1.74 0.083 Tukey-K 0.504 
T6 3 AgeCat*Trt*Glucose Middle Glu m G1 G4 1.212 1.6 165 0.75 0.452 Tukey-K 0.975 
T6 3 AgeCat*Trt*Glucose Middle Glu m G1 G5 2.947 1.6 165 1.83 0.069 Tukey-K 0.448 
T6 3 AgeCat*Trt*Glucose Middle Glu m G2 G3 2.152 1.6 165 1.34 0.183 Tukey-K 0.764 
T6 3 AgeCat*Trt*Glucose Middle Glu m G2 G4 0.557 1.6 165 0.35 0.73 Tukey-K 0.999 
T6 3 AgeCat*Trt*Glucose Middle Glu m G2 G5 2.292 1.6 165 1.42 0.156 Tukey-K 0.712 
T6 3 AgeCat*Trt*Glucose Middle Glu m G3 G4 -1.6 1.6 165 -1 0.323 Tukey-K 0.92 
T6 3 AgeCat*Trt*Glucose Middle Glu m G3 G5 0.141 1.6 165 0.09 0.93 Tukey-K 1 
T6 3 AgeCat*Trt*Glucose Middle Glu m G4 G5 1.736 1.6 165 1.08 0.282 Tukey-K 0.889 
T6 3 AgeCat*Trt*Glucose Middle Glu p G0 G1 2.054 1.6 165 1.28 0.203 Tukey-K 0.797 
T6 3 AgeCat*Trt*Glucose Middle Glu p G0 G2 0.803 1.6 165 0.5 0.618 Tukey-K 0.996 
T6 3 AgeCat*Trt*Glucose Middle Glu p G0 G3 1.046 1.6 165 0.65 0.517 Tukey-K 0.987 
T6 3 AgeCat*Trt*Glucose Middle Glu p G0 G4 2.776 1.6 165 1.73 0.086 Tukey-K 0.517 
T6 3 AgeCat*Trt*Glucose Middle Glu p G0 G5 0.573 1.6 165 0.36 0.722 Tukey-K 0.999 
T6 3 AgeCat*Trt*Glucose Middle Glu p G1 G2 -1.25 1.6 165 -0.8 0.438 Tukey-K 0.971 
T6 3 AgeCat*Trt*Glucose Middle Glu p G1 G3 -1.01 1.6 165 -0.6 0.532 Tukey-K 0.989 
T6 3 AgeCat*Trt*Glucose Middle Glu p G1 G4 0.722 1.6 165 0.45 0.654 Tukey-K 0.998 
T6 3 AgeCat*Trt*Glucose Middle Glu p G1 G5 -1.48 1.6 165 -0.9 0.359 Tukey-K 0.941 
T6 3 AgeCat*Trt*Glucose Middle Glu p G2 G3 0.242 1.6 165 0.15 0.88 Tukey-K 1 
T6 3 AgeCat*Trt*Glucose Middle Glu p G2 G4 1.973 1.6 165 1.23 0.222 Tukey-K 0.823 
T6 3 AgeCat*Trt*Glucose Middle Glu p G2 G5 -0.23 1.6 165 -0.1 0.886 Tukey-K 1 
T6 3 AgeCat*Trt*Glucose Middle Glu p G3 G4 1.731 1.6 165 1.08 0.284 Tukey-K 0.89 
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T6 3 AgeCat*Trt*Glucose Middle Glu p G3 G5 -0.47 1.6 165 -0.3 0.769 Tukey-K 1 
T6 3 AgeCat*Trt*Glucose Middle Glu p G4 G5 -2.2 1.6 165 -1.4 0.173 Tukey-K 0.745 
T6 3 AgeCat*Trt*Glucose Old Glu m G0 G1 0.508 1.1 165 0.45 0.656 Tukey-K 0.998 
T6 3 AgeCat*Trt*Glucose Old Glu m G0 G2 0.914 1.1 165 0.8 0.423 Tukey-K 0.967 
T6 3 AgeCat*Trt*Glucose OldGlu m G0 G3 0.626 1.1 165 0.55 0.583 Tukey-K 0.994 
T6 3 AgeCat*Trt*Glucose Old Glu m G0 G4 -0.19 1.1 165 -0.2 0.868 Tukey-K 1 
T6 3 AgeCat*Trt*Glucose Old Glu m G0 G5 0.867 1.1 165 0.76 0.447 Tukey-K 0.973 
T6 3 AgeCat*Trt*Glucose Old Glu m G1 G2 0.406 1.1 165 0.36 0.721 Tukey-K 0.999 
T6 3 AgeCat*Trt*Glucose Old Glu m G1 G3 0.118 1.1 165 0.1 0.917 Tukey-K 1 
T6 3 AgeCat*Trt*Glucose Old Glu m G1 G4 -0.7 1.1 165 -0.6 0.541 Tukey-K 0.99 
T6 3 AgeCat*Trt*Glucose Old Glu m G1 G5 0.359 1.1 165 0.32 0.753 Tukey-K 1 
T6 3 AgeCat*Trt*Glucose Old Glu m G2 G3 -0.29 1.1 165 -0.3 0.8 Tukey-K 1 
T6 3 AgeCat*Trt*Glucose Old Glu m G2 G4 -1.1 1.1 165 -1 0.333 Tukey-K 0.927 
T6 3 AgeCat*Trt*Glucose Old Glu m G2 G5 -0.05 1.1 165 -0 0.967 Tukey-K 1 
T6 3 AgeCat*Trt*Glucose Old Glu m G3 G4 -0.82 1.1 165 -0.7 0.475 Tukey-K 0.98 
T6 3 AgeCat*Trt*Glucose Old Glu m G3 G5 0.241 1.1 165 0.21 0.833 Tukey-K 1 
T6 3 AgeCat*Trt*Glucose Old Glu m G4 G5 1.056 1.1 165 0.93 0.355 Tukey-K 0.939 
T6 3 AgeCat*Trt*Glucose Old Glu p G0 G1 0.346 1.1 165 0.3 0.761 Tukey-K 1 
T6 3 AgeCat*Trt*Glucose Old Glu p G0 G2 1.348 1.1 165 1.19 0.238 Tukey-K 0.843 
T6 3 AgeCat*Trt*Glucose Old Glu p G0 G3 2.207 1.1 165 1.94 0.054 Tukey-K 0.382 
T6 3 AgeCat*Trt*Glucose Old Glu p G0 G4 0.944 1.1 165 0.83 0.408 Tukey-K 0.962 
T6 3 AgeCat*Trt*Glucose Old Glu p G0 G5 1.771 1.1 165 1.56 0.121 Tukey-K 0.628 
T6 3 AgeCat*Trt*Glucose Old Glu p G1 G2 1.003 1.1 165 0.88 0.379 Tukey-K 0.951 
T6 3 AgeCat*Trt*Glucose Old Glu p G1 G3 1.861 1.1 165 1.64 0.104 Tukey-K 0.576 
T6 3 AgeCat*Trt*Glucose Old Glu p G1 G4 0.598 1.1 165 0.53 0.6 Tukey-K 0.995 
T6 3 AgeCat*Trt*Glucose Old Glu p G1 G5 1.425 1.1 165 1.25 0.212 Tukey-K 0.81 
T6 3 AgeCat*Trt*Glucose Old Glu p G2 G3 0.859 1.1 165 0.75 0.451 Tukey-K 0.974 
T6 3 AgeCat*Trt*Glucose Old Glu p G2 G4 -0.4 1.1 165 -0.4 0.723 Tukey-K 0.999 
T6 3 AgeCat*Trt*Glucose Old Glu p G2 G5 0.422 1.1 165 0.37 0.711 Tukey-K 0.999 
T6 3 AgeCat*Trt*Glucose Old Glu p G3 G4 -1.26 1.1 165 -1.1 0.269 Tukey-K 0.877 
T6 3 AgeCat*Trt*Glucose Old Glu p G3 G5 -0.44 1.1 165 -0.4 0.702 Tukey-K 0.999 
T6 3 AgeCat*Trt*Glucose Old Glu p G4 G5 0.827 1.1 165 0.73 0.469 Tukey-K 0.978 
T6 3 AgeCat*Trt*Glucose Young Glu m G0 G1 1.525 1.3 165 1.16 0.247 Tukey-K 0.855 
T6 3 AgeCat*Trt*Glucose Young Glu m G0 G2 2.334 1.3 165 1.78 0.077 Tukey-K 0.483 
T6 3 AgeCat*Trt*Glucose Young Glu m G0 G3 0.748 1.3 165 0.57 0.57 Tukey-K 0.993 
T6 3 AgeCat*Trt*Glucose Young Glu m G0 G4 2.135 1.3 165 1.63 0.106 Tukey-K 0.583 
T6 3 AgeCat*Trt*Glucose Young Glu m G0 G5 0.677 1.3 165 0.52 0.607 Tukey-K 0.996 
T6 3 AgeCat*Trt*Glucose Young Glu m G1 G2 0.81 1.3 165 0.62 0.539 Tukey-K 0.99 
T6 3 AgeCat*Trt*Glucose Young Glu m G1 G3 -0.78 1.3 165 -0.6 0.555 Tukey-K 0.992 
T6 3 AgeCat*Trt*Glucose Young Glu m G1 G4 0.61 1.3 165 0.46 0.643 Tukey-K 0.997 
T6 3 AgeCat*Trt*Glucose Young Glu m G1 G5 -0.85 1.3 165 -0.6 0.52 Tukey-K 0.987 
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T6 3 AgeCat*Trt*Glucose Young Glu m G2 G3 -1.59 1.3 165 -1.2 0.229 Tukey-K 0.833 
T6 3 AgeCat*Trt*Glucose Young Glu m G2 G4 -0.2 1.3 165 -0.2 0.88 Tukey-K 1 
T6 3 AgeCat*Trt*Glucose Young Glu m G2 G5 -1.66 1.3 165 -1.3 0.209 Tukey-K 0.805 
T6 3 AgeCat*Trt*Glucose Young Glu m G3 G4 1.387 1.3 165 1.06 0.293 Tukey-K 0.898 
T6 3 AgeCat*Trt*Glucose Young Glu m G3 G5 -0.07 1.3 165 -0.1 0.957 Tukey-K 1 
T6 3 AgeCat*Trt*Glucose Young Glu m G4 G5 -1.46 1.3 165 -1.1 0.269 Tukey-K 0.877 
T6 3 AgeCat*Trt*Glucose Young Glu p G0 G1 0.168 1.3 165 0.13 0.898 Tukey-K 1 
T6 3 AgeCat*Trt*Glucose Young Glu p G0 G2 1.591 1.3 165 1.21 0.227 Tukey-K 0.831 
T6 3 AgeCat*Trt*Glucose Young Glu p G0 G3 0.329 1.3 165 0.25 0.802 Tukey-K 1 
T6 3 AgeCat*Trt*Glucose Young Glu p G0 G4 0.538 1.3 165 0.41 0.683 Tukey-K 0.999 
T6 3 AgeCat*Trt*Glucose Young Glu p G0 G5 0.142 1.3 165 0.11 0.914 Tukey-K 1 
T6 3 AgeCat*Trt*Glucose Young Glu p G1 G2 1.423 1.3 165 1.08 0.28 Tukey-K 0.887 
T6 3 AgeCat*Trt*Glucose Young Glu p G1 G3 0.161 1.3 165 0.12 0.902 Tukey-K 1 
T6 3 AgeCat*Trt*Glucose Young Glu p G1 G4 0.37 1.3 165 0.28 0.779 Tukey-K 1 
T6 3 AgeCat*Trt*Glucose Young Glu p G1 G5 -0.03 1.3 165 -0 0.984 Tukey-K 1 
T6 3 AgeCat*Trt*Glucose Young Glu p G2 G3 -1.26 1.3 165 -1 0.338 Tukey-K 0.93 
T6 3 AgeCat*Trt*Glucose Young Glu p G2 G4 -1.05 1.3 165 -0.8 0.424 Tukey-K 0.967 
T6 3 AgeCat*Trt*Glucose Young Glu p G2 G5 -1.45 1.3 165 -1.1 0.271 Tukey-K 0.879 
T6 3 AgeCat*Trt*Glucose Young Glu p G3 G4 0.208 1.3 165 0.16 0.874 Tukey-K 1 
T6 3 AgeCat*Trt*Glucose Young Glu p G3 G5 -0.19 1.3 165 -0.1 0.887 Tukey-K 1 
T6 3 AgeCat*Trt*Glucose Young Glu p G4 G5 -0.4 1.3 165 -0.3 0.764 Tukey-K 1 
T7 3 AgeCat*Trt*Glucose Middle Glu m G0 G1 0.242 1.4 165 0.18 0.86 Tukey-K 1 
T7 3 AgeCat*Trt*Glucose Middle Glu m G0 G2 0.92 1.4 165 0.67 0.502 Tukey-K 0.985 
T7 3 AgeCat*Trt*Glucose Middle Glu m G0 G3 0.897 1.4 165 0.66 0.513 Tukey-Kramer 0.986 
T7 3 AgeCat*Trt*Glucose Middle Glu m G0 G4 0.024 1.4 165 0.02 0.986 Tukey-K 1 
T7 3 AgeCat*Trt*Glucose Middle Glu m G0 G5 1.177 1.4 165 0.86 0.391 Tukey-K 0.955 
T7 3 AgeCat*Trt*Glucose Middle Glu m G1 G2 0.678 1.4 165 0.5 0.621 Tukey-K 0.996 
T7 3 AgeCat*Trt*Glucose Middle Glu m G1 G3 0.654 1.4 165 0.48 0.633 Tukey-K 0.997 
T7 3 AgeCat*Trt*Glucose Middle Glu m G1 G4 -0.22 1.4 165 -0.2 0.873 Tukey-K 1 
T7 3 AgeCat*Trt*Glucose Middle Glu m G1 G5 0.935 1.4 165 0.68 0.495 Tukey-K 0.984 
T7 3 AgeCat*Trt*Glucose Middle Glu m G2 G3 -0.02 1.4 165 -0 0.987 Tukey-K 1 
T7 3 AgeCat*Trt*Glucose Middle Glu m G2 G4 -0.9 1.4 165 -0.7 0.513 Tukey-K 0.986 
T7 3 AgeCat*Trt*Glucose Middle Glu m G2 G5 0.257 1.4 165 0.19 0.851 Tukey-K 1 
T7 3 AgeCat*Trt*Glucose Middle Glu m G3 G4 -0.87 1.4 165 -0.6 0.524 Tukey-K 0.988 
T7 3 AgeCat*Trt*Glucose Middle Glu m G3 G5 0.281 1.4 165 0.21 0.838 Tukey-K 1 
T7 3 AgeCat*Trt*Glucose Middle Glu m G4 G5 1.153 1.4 165 0.84 0.4 Tukey-K 0.959 
T7 3 AgeCat*Trt*Glucose Middle Glu p G0 G1 1.164 1.4 165 0.85 0.396 Tukey-K 0.957 
T7 3 AgeCat*Trt*Glucose Middle Glu p G0 G2 -0.56 1.4 165 -0.4 0.684 Tukey-K 0.999 
T7 3 AgeCat*Trt*Glucose Middle Glu p G0 G3 1.141 1.4 165 0.83 0.405 Tukey-K 0.961 
T7 3 AgeCat*Trt*Glucose Middle Glu p G0 G4 1.416 1.4 165 1.04 0.302 Tukey-K 0.905 
T7 3 AgeCat*Trt*Glucose Middle Glu p G0 G5 0.602 1.4 165 0.44 0.66 Tukey-K 0.998 
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T7 3 AgeCat*Trt*Glucose Middle Glu p G1 G2 -1.72 1.4 165 -1.3 0.21 Tukey-K 0.807 
T7 3 AgeCat*Trt*Glucose Middle Glu p G1 G3 -0.02 1.4 165 -0 0.986 Tukey-K 1 
T7 3 AgeCat*Trt*Glucose Middle Glu p G1 G4 0.251 1.4 165 0.18 0.854 Tukey-K 1 
T7 3 AgeCat*Trt*Glucose Middle Glu p G1 G5 -0.56 1.4 165 -0.4 0.681 Tukey-K 0.998 
T7 3 AgeCat*Trt*Glucose Middle Glu p G2 G3 1.698 1.4 165 1.24 0.216 Tukey-K 0.816 
T7 3 AgeCat*Trt*Glucose Middle Glu p G2 G4 1.972 1.4 165 1.44 0.151 Tukey-K 0.701 
T7 3 AgeCat*Trt*Glucose Middle Glu p G2 G5 1.159 1.4 165 0.85 0.398 Tukey-K 0.958 
T7 3 AgeCat*Trt*Glucose Middle Glu p G3 G4 0.275 1.4 165 0.2 0.841 Tukey-K 1 
T7 3 AgeCat*Trt*Glucose Middle Glu p G3 G5 -0.54 1.4 165 -0.4 0.694 Tukey-K 0.999 
T7 3 AgeCat*Trt*Glucose Middle Glu p G4 G5 -0.81 1.4 165 -0.6 0.553 Tukey-K 0.991 
T7 3 AgeCat*Trt*Glucose Old Glu m G0 G1 1.096 1 165 1.13 0.259 Tukey-K 0.867 
T7 3 AgeCat*Trt*Glucose Old Glu m G0 G2 0.037 1 165 0.04 0.97 Tukey-K 1 
T7 3 AgeCat*Trt*Glucose Old Glu m G0 G3 -2 1 165 -2.1 0.04 Tukey-K 0.307 
T7 3 AgeCat*Trt*Glucose Old Glu m G0 G4 -1.01 1 165 -1 0.298 Tukey-K 0.902 
T7 3 AgeCat*Trt*Glucose Old Glu m G0 G5 0.64 1 165 0.66 0.509 Tukey-K 0.986 
T7 3 AgeCat*Trt*Glucose Old Glu m G1 G2 -1.06 1 165 -1.1 0.275 Tukey-K 0.883 
T7 3 AgeCat*Trt*Glucose Old Glu m G1 G3 -3.1 1 165 -3.2 0.002 Tukey-K 0.02 
T7 3 AgeCat*Trt*Glucose Old Glu m G1 G4 -2.11 1 165 -2.2 0.031 Tukey-K 0.254 
T7 3 AgeCat*Trt*Glucose Old Glu m G1 G5 -0.46 1 165 -0.5 0.638 Tukey-K 0.997 
T7 3 AgeCat*Trt*Glucose Old Glu m G2 G3 -2.04 1 165 -2.1 0.036 Tukey-K 0.287 
T7 3 AgeCat*Trt*Glucose Old Glu m G2 G4 -1.05 1 165 -1.1 0.281 Tukey-K 0.888 
T7 3 AgeCat*Trt*Glucose Old Glu m G2 G5 0.604 1 165 0.62 0.533 Tukey-K 0.989 
T7 3 AgeCat*Trt*Glucose Old Glu m G3 G4 0.995 1 165 1.03 0.305 Tukey-K 0.908 
T7 3 AgeCat*Trt*Glucose Old Glu m G3 G5 2.644 1 165 2.73 0.007 Tukey-K 0.074 
T7 3 AgeCat*Trt*Glucose Old Glu m G4 G5 1.65 1 165 1.71 0.09 Tukey-K 0.53 
T7 3 AgeCat*Trt*Glucose Old Glu p G0 G1 0.455 1 165 0.47 0.639 Tukey-K 0.997 
T7 3 AgeCat*Trt*Glucose Old Glu p G0 G2 2.246 1 165 2.32 0.021 Tukey-K 0.191 
T7 3 AgeCat*Trt*Glucose Old Glu p G0 G3 0.273 1 165 0.28 0.778 Tukey-K 1 
T7 3 AgeCat*Trt*Glucose Old Glu p G0 G4 -0.34 1 165 -0.4 0.724 Tukey-K 0.999 
T7 3 AgeCat*Trt*Glucose Old Glu p G0 G5 0.873 1 165 0.9 0.368 Tukey-K 0.945 
T7 3 AgeCat*Trt*Glucose Old Glu p G1 G2 1.791 1 165 1.85 0.066 Tukey-K 0.435 
T7 3 AgeCat*Trt*Glucose Old Glu p G1 G3 -0.18 1 165 -0.2 0.852 Tukey-K 1 
T7 3 AgeCat*Trt*Glucose Old Glu p G1 G4 -0.8 1 165 -0.8 0.411 Tukey-K 0.963 
T7 3 AgeCat*Trt*Glucose Old Glu p G1 G5 0.419 1 165 0.43 0.666 Tukey-K 0.998 
T7 3 AgeCat*Trt*Glucose Old Glu p G2 G3 -1.97 1 165 -2 0.043 Tukey-K 0.325 
T7 3 AgeCat*Trt*Glucose Old Glu p G2 G4 -2.59 1 165 -2.7 0.008 Tukey-K 0.086 
T7 3 AgeCat*Trt*Glucose Old Glu p G2 G5 -1.37 1 165 -1.4 0.158 Tukey-K 0.715 
T7 3 AgeCat*Trt*Glucose Old Glu p G3 G4 -0.62 1 165 -0.6 0.525 Tukey-K 0.988 
T7 3 AgeCat*Trt*Glucose Old Glu p G3 G5 0.6 1 165 0.62 0.536 Tukey-K 0.989 
T7 3 AgeCat*Trt*Glucose Old Glu p G4 G5 1.216 1 165 1.26 0.21 Tukey-K 0.808 
T7 3 AgeCat*Trt*Glucose Young Glu m G0 G1 2.058 1.1 165 1.84 0.067 Tukey-K 0.441 
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T7 3 AgeCat*Trt*Glucose Young Glu m G0 G2 1.401 1.1 165 1.25 0.211 Tukey-K 0.809 
T7 3 AgeCat*Trt*Glucose Young Glu m G0 G3 0.519 1.1 165 0.46 0.643 Tukey-K 0.997 
T7 3 AgeCat*Trt*Glucose Young Glu m G0 G4 0.107 1.1 165 0.1 0.924 Tukey-K 1 
T7 3 AgeCat*Trt*Glucose Young Glu m G0 G5 1.86 1.1 165 1.67 0.098 Tukey-K 0.556 
T7 3 AgeCat*Trt*Glucose Young Glu m G1 G2 -0.66 1.1 165 -0.6 0.557 Tukey-K 0.992 
T7 3 AgeCat*Trt*Glucose Young Glu m G1 G3 -1.54 1.1 165 -1.4 0.17 Tukey-K 0.74 
T7 3 AgeCat*Trt*Glucose Young Glu m G1 G4 -1.95 1.1 165 -1.7 0.082 Tukey-K 0.503 
T7 3 AgeCat*Trt*Glucose Young Glu m G1 G5 -0.2 1.1 165 -0.2 0.86 Tukey-K 1 
T7 3 AgeCat*Trt*Glucose Young Glu m G2 G3 -0.88 1.1 165 -0.8 0.431 Tukey-K 0.969 
T7 3 AgeCat*Trt*Glucose Young Glu m G2 G4 -1.29 1.1 165 -1.2 0.248 Tukey-K 0.856 
T7 3 AgeCat*Trt*Glucose Young Glu m G2 G5 0.459 1.1 165 0.41 0.681 Tukey-K 0.998 
T7 3 AgeCat*Trt*Glucose Young Glu m G3 G4 -0.41 1.1 165 -0.4 0.713 Tukey-K 0.999 
T7 3 AgeCat*Trt*Glucose Young Glu m G3 G5 1.341 1.1 165 1.2 0.231 Tukey-K 0.836 
T7 3 AgeCat*Trt*Glucose Young Glu m G4 G5 1.753 1.1 165 1.57 0.118 Tukey-K 0.619 
T7 3 AgeCat*Trt*Glucose Young Glu p G0 G1 -0.2 1.1 165 -0.2 0.857 Tukey-K 1 
T7 3 AgeCat*Trt*Glucose Young Glu p G0 G2 0.817 1.1 165 0.73 0.465 Tukey-K 0.978 
T7 3 AgeCat*Trt*Glucose Young Glu p G0 G3 -0.52 1.1 165 -0.5 0.644 Tukey-K 0.997 
T7 3 AgeCat*Trt*Glucose Young Glu p G0 G4 -0.34 1.1 165 -0.3 0.758 Tukey-K 1 
T7 3 AgeCat*Trt*Glucose Young Glu p G0 G5 0.095 1.1 165 0.09 0.932 Tukey-K 1 
T7 3 AgeCat*Trt*Glucose Young Glu p G1 G2 1.019 1.1 165 0.91 0.363 Tukey-K 0.943 
T7 3 AgeCat*Trt*Glucose Young Glu p G1 G3 -0.32 1.1 165 -0.3 0.778 Tukey-K 1 
T7 3 AgeCat*Trt*Glucose Young Glu p G1 G4 -0.14 1.1 165 -0.1 0.899 Tukey-K 1 
T7 3 AgeCat*Trt*Glucose Young Glu p G1 G5 0.297 1.1 165 0.27 0.791 Tukey-K 1 
T7 3 AgeCat*Trt*Glucose Young Glu p G2 G3 -1.33 1.1 165 -1.2 0.234 Tukey-K 0.839 
T7 3 AgeCat*Trt*Glucose Young Glu p G2 G4 -1.16 1.1 165 -1 0.3 Tukey-K 0.904 
T7 3 AgeCat*Trt*Glucose Young Glu p G2 G5 -0.72 1.1 165 -0.6 0.519 Tukey-K 0.987 
T7 3 AgeCat*Trt*Glucose Young Glu p G3 G4 0.173 1.1 165 0.16 0.877 Tukey-K 1 
T7 3 AgeCat*Trt*Glucose Young Glu p G3 G5 0.613 1.1 165 0.55 0.584 Tukey-K 0.994 
T7 3 AgeCat*Trt*Glucose Young Glu p G4 G5 0.439 1.1 165 0.39 0.695 Tukey-K 0.999 
T8 3 AgeCat*Trt*Glucose Middle Glu m G0 G1 -0.52 1.5 165 -0.3 0.736 Tukey-K 0.999 
T8 3 AgeCat*Trt*Glucose Middle Glu m G0 G2 0.896 1.5 165 0.58 0.562 Tukey-K 0.992 
T8 3 AgeCat*Trt*Glucose Middle Glu m G0 G3 0.844 1.5 165 0.55 0.585 Tukey-K 0.994 
T8 3 AgeCat*Trt*Glucose Middle Glu m G0 G4 -1.38 1.5 165 -0.9 0.371 Tukey-K 0.947 
T8 3 AgeCat*Trt*Glucose Middle Glu m G0 G5 -0.74 1.5 165 -0.5 0.632 Tukey-K 0.997 
T8 3 AgeCat*Trt*Glucose Middle Glu m G1 G2 1.418 1.5 165 0.92 0.359 Tukey-K 0.941 
T8 3 AgeCat*Trt*Glucose Middle Glu m G1 G3 1.366 1.5 165 0.89 0.377 Tukey-K 0.95 
T8 3 AgeCat*Trt*Glucose Middle Glu m G1 G4 -0.86 1.5 165 -0.6 0.578 Tukey-K 0.993 
T8 3 AgeCat*Trt*Glucose Middle Glu m G1 G5 -0.22 1.5 165 -0.1 0.888 Tukey-K 1 
T8 3 AgeCat*Trt*Glucose Middle Glu m G2 G3 -0.05 1.5 165 -0 0.973 Tukey-K 1 
T8 3 AgeCat*Trt*Glucose Middle Glu m G2 G4 -2.28 1.5 165 -1.5 0.142 Tukey-K 0.679 
T8 3 AgeCat*Trt*Glucose Middle Glu m G2 G5 -1.64 1.5 165 -1.1 0.291 Tukey-K 0.896 
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T8 3 AgeCat*Trt*Glucose Middle Glu m G3 G4 -2.23 1.5 165 -1.4 0.151 Tukey-K 0.7 
T8 3 AgeCat*Trt*Glucose Middle Glu m G3 G5 -1.58 1.5 165 -1 0.306 Tukey-K 0.908 
T8 3 AgeCat*Trt*Glucose Middle Glu m G4 G5 0.643 1.5 165 0.42 0.677 Tukey-K 0.998 
T8 3 AgeCat*Trt*Glucose Middle Glu p G0 G1 1.342 1.5 165 0.87 0.386 Tukey-K 0.953 
T8 3 AgeCat*Trt*Glucose Middle Glu p G0 G2 1.026 1.5 165 0.67 0.507 Tukey-K 0.985 
T8 3 AgeCat*Trt*Glucose Middle Glu p G0 G3 2.628 1.5 165 1.7 0.09 Tukey-K 0.531 
T8 3 AgeCat*Trt*Glucose Middle Glu p G0 G4 0.908 1.5 165 0.59 0.557 Tukey-K 0.992 
T8 3 AgeCat*Trt*Glucose Middle Glu p G0 G5 0.113 1.5 165 0.07 0.942 Tukey-K 1 
T8 3 AgeCat*Trt*Glucose Middle Glu p G1 G2 -0.32 1.5 165 -0.2 0.838 Tukey-K 1 
T8 3 AgeCat*Trt*Glucose Middle Glu p G1 G3 1.286 1.5 165 0.83 0.405 Tukey-K 0.961 
T8 3 AgeCat*Trt*Glucose Middle Glu p G1 G4 -0.43 1.5 165 -0.3 0.779 Tukey-K 1 
T8 3 AgeCat*Trt*Glucose Middle Glu p G1 G5 -1.23 1.5 165 -0.8 0.427 Tukey-K 0.968 
T8 3 AgeCat*Trt*Glucose Middle Glu p G2 G3 1.603 1.5 165 1.04 0.3 Tukey-K 0.904 
T8 3 AgeCat*Trt*Glucose Middle Glu p G2 G4 -0.12 1.5 165 -0.1 0.939 Tukey-K 1 
T8 3 AgeCat*Trt*Glucose Middle Glu p G2 G5 -0.91 1.5 165 -0.6 0.555 Tukey-K 0.991 
T8 3 AgeCat*Trt*Glucose Middle Glu p G3 G4 -1.72 1.5 165 -1.1 0.266 Tukey-K 0.874 
T8 3 AgeCat*Trt*Glucose Middle Glu p G3 G5 -2.52 1.5 165 -1.6 0.105 Tukey-K 0.579 
T8 3 AgeCat*Trt*Glucose Middle Glu p G4 G5 -0.8 1.5 165 -0.5 0.607 Tukey-K 0.996 
T8 3 AgeCat*Trt*Glucose Old  Glu m G0 G1 0.253 1.1 165 0.23 0.817 Tukey-K 1 
T8 3 AgeCat*Trt*Glucose Old  Glu m G0 G2 -0.74 1.1 165 -0.7 0.498 Tukey-K 0.984 
T8 3 AgeCat*Trt*Glucose Old  Glu m G0 G3 -1.17 1.1 165 -1.1 0.283 Tukey-K 0.89 
T8 3 AgeCat*Trt*Glucose Old  Glu m G0 G4 0.266 1.1 165 0.24 0.808 Tukey-K 1 
T8 3 AgeCat*Trt*Glucose Old  Glu m G0 G5 -0.31 1.1 165 -0.3 0.773 Tukey-K 1 
T8 3 AgeCat*Trt*Glucose Old  Glu m G1 G2 -0.99 1.1 165 -0.9 0.363 Tukey-K 0.943 
T8 3 AgeCat*Trt*Glucose Old  Glu m G1 G3 -1.43 1.1 165 -1.3 0.192 Tukey-K 0.78 
T8 3 AgeCat*Trt*Glucose Old  Glu m G1 G4 0.013 1.1 165 0.01 0.991 Tukey-K 1 
T8 3 AgeCat*Trt*Glucose Old  Glu m G1 G5 -0.57 1.1 165 -0.5 0.603 Tukey-K 0.995 
T8 3 AgeCat*Trt*Glucose Old  Glu m G2 G3 -0.43 1.1 165 -0.4 0.691 Tukey-K 0.999 
T8 3 AgeCat*Trt*Glucose Old  Glu m G2 G4 1.007 1.1 165 0.92 0.357 Tukey-K 0.94 
T8 3 AgeCat*Trt*Glucose Old  Glu m G2 G5 0.426 1.1 165 0.39 0.696 Tukey-K 0.999 
T8 3 AgeCat*Trt*Glucose Old  Glu m G3 G4 1.44 1.1 165 1.32 0.188 Tukey-K 0.773 
T8 3 AgeCat*Trt*Glucose Old  Glu m G3 G5 0.86 1.1 165 0.79 0.431 Tukey-K 0.969 
T8 3 AgeCat*Trt*Glucose Old  Glu m G4 G5 -0.58 1.1 165 -0.5 0.595 Tukey-K 0.995 
T8 3 AgeCat*Trt*Glucose Old  Glu p G0 G1 1.023 1.1 165 0.94 0.349 Tukey-K 0.936 
T8 3 AgeCat*Trt*Glucose Old  Glu p G0 G2 2.448 1.1 165 2.25 0.026 Tukey-K 0.223 
T8 3 AgeCat*Trt*Glucose Old  Glu p G0 G3 2.768 1.1 165 2.54 0.012 Tukey-K 0.119 
T8 3 AgeCat*Trt*Glucose Old  Glu p G0 G4 0.914 1.1 165 0.84 0.403 Tukey-K 0.96 
T8 3 AgeCat*Trt*Glucose Old  Glu p G0 G5 1.095 1.1 165 1 0.317 Tukey-K 0.916 
T8 3 AgeCat*Trt*Glucose Old  Glu p G1 G2 1.425 1.1 165 1.31 0.193 Tukey-K 0.781 
T8 3 AgeCat*Trt*Glucose Old  Glu p G1 G3 1.744 1.1 165 1.6 0.112 Tukey-K 0.6 
T8 3 AgeCat*Trt*Glucose Old  Glu p G1 G4 -0.11 1.1 165 -0.1 0.92 Tukey-K 1 
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T8 3 AgeCat*Trt*Glucose Old  Glu p G1 G5 0.072 1.1 165 0.07 0.948 Tukey-K 1 
T8 3 AgeCat*Trt*Glucose Old  Glu p G2 G3 0.319 1.1 165 0.29 0.77 Tukey-K 1 
T8 3 AgeCat*Trt*Glucose Old  Glu p G2 G4 -1.53 1.1 165 -1.4 0.161 Tukey-K 0.723 
T8 3 AgeCat*Trt*Glucose Old  Glu p G2 G5 -1.35 1.1 165 -1.2 0.216 Tukey-K 0.816 
T8 3 AgeCat*Trt*Glucose Old  Glu p G3 G4 -1.85 1.1 165 -1.7 0.091 Tukey-K 0.534 
T8 3 AgeCat*Trt*Glucose Old  Glu p G3 G5 -1.67 1.1 165 -1.5 0.127 Tukey-K 0.643 
T8 3 AgeCat*Trt*Glucose Old  Glu p G4 G5 0.182 1.1 165 0.17 0.868 Tukey-K 1 
T8 3 AgeCat*Trt*Glucose Young Glu m G0 G1 -0.09 1.3 165 -0.1 0.943 Tukey-K 1 
T8 3 AgeCat*Trt*Glucose Young Glu m G0 G2 -0.95 1.3 165 -0.8 0.452 Tukey-K 0.975 
T8 3 AgeCat*Trt*Glucose Young Glu m G0 G3 -1.19 1.3 165 -0.9 0.347 Tukey-K 0.935 
T8 3 AgeCat*Trt*Glucose Young Glu m G0 G4 -1.83 1.3 165 -1.5 0.147 Tukey-K 0.693 
T8 3 AgeCat*Trt*Glucose Young Glu m G0 G5 0.043 1.3 165 0.03 0.973 Tukey-K 1 
T8 3 AgeCat*Trt*Glucose Young Glu m G1 G2 -0.86 1.3 165 -0.7 0.496 Tukey-K 0.984 
T8 3 AgeCat*Trt*Glucose Young Glu m G1 G3 -1.1 1.3 165 -0.9 0.385 Tukey-K 0.953 
T8 3 AgeCat*Trt*Glucose Young Glu m G1 G4 -1.74 1.3 165 -1.4 0.168 Tukey-K 0.737 
T8 3 AgeCat*Trt*Glucose Young Glu m G1 G5 0.133 1.3 165 0.11 0.916 Tukey-K 1 
T8 3 AgeCat*Trt*Glucose Young Glu m G2 G3 -0.24 1.3 165 -0.2 0.85 Tukey-K 1 
T8 3 AgeCat*Trt*Glucose Young Glu m G2 G4 -0.88 1.3 165 -0.7 0.484 Tukey-K 0.982 
T8 3 AgeCat*Trt*Glucose Young Glu m G2 G5 0.992 1.3 165 0.79 0.432 Tukey-K 0.969 
T8 3 AgeCat*Trt*Glucose Young Glu m G3 G4 -0.65 1.3 165 -0.5 0.609 Tukey-K 0.996 
T8 3 AgeCat*Trt*Glucose Young Glu m G3 G5 1.23 1.3 165 0.98 0.33 Tukey-K 0.925 
T8 3 AgeCat*Trt*Glucose Young Glu m G4 G5 1.875 1.3 165 1.49 0.138 Tukey-K 0.672 
T8 3 AgeCat*Trt*Glucose Young Glu p G0 G1 -1.19 1.3 165 -0.9 0.345 Tukey-K 0.933 
T8 3 AgeCat*Trt*Glucose Young Glu p G0 G2 -2.14 1.3 165 -1.7 0.091 Tukey-K 0.532 
T8 3 AgeCat*Trt*Glucose Young Glu p G0 G3 -1.67 1.3 165 -1.3 0.188 Tukey-K 0.772 
T8 3 AgeCat*Trt*Glucose Young Glu p G0 G4 -1.52 1.3 165 -1.2 0.23 Tukey-K 0.834 
T8 3 AgeCat*Trt*Glucose Young Glu p G0 G5 -1.46 1.3 165 -1.2 0.247 Tukey-K 0.854 
T8 3 AgeCat*Trt*Glucose Young Glu p G1 G2 -0.95 1.3 165 -0.8 0.451 Tukey-K 0.974 
T8 3 AgeCat*Trt*Glucose Young Glu p G1 G3 -0.47 1.3 165 -0.4 0.708 Tukey-K 0.999 
T8 3 AgeCat*Trt*Glucose Young Glu p G1 G4 -0.32 1.3 165 -0.3 0.797 Tukey-K 1 
T8 3 AgeCat*Trt*Glucose Young Glu p G1 G5 -0.27 1.3 165 -0.2 0.831 Tukey-K 1 
T8 3 AgeCat*Trt*Glucose Young Glu p G2 G3 0.477 1.3 165 0.38 0.705 Tukey-K 0.999 
T8 3 AgeCat*Trt*Glucose Young Glu p G2 G4 0.627 1.3 165 0.5 0.619 Tukey-K 0.996 
T8 3 AgeCat*Trt*Glucose Young Glu p G2 G5 0.681 1.3 165 0.54 0.589 Tukey-K 0.994 
T8 3 AgeCat*Trt*Glucose Young Glu p G3 G4 0.149 1.3 165 0.12 0.906 Tukey-K 1 
T8 3 AgeCat*Trt*Glucose Young Glu p G3 G5 0.203 1.3 165 0.16 0.872 Tukey-K 1 
T8 3 AgeCat*Trt*Glucose Young Glu p G4 G5 0.054 1.3 165 0.04 0.966 Tukey-K 1 
T9 3 AgeCat*Trt*Glucose Middle Glu m G0 G1 0.575 1.4 165 0.41 0.682 Tukey-K 0.998 
T9 3 AgeCat*Trt*Glucose Middle Glu m G0 G2 1.236 1.4 165 0.88 0.378 Tukey-K 0.95 
T9 3 AgeCat*Trt*Glucose Middle Glu m G0 G3 1.319 1.4 165 0.94 0.347 Tukey-K 0.935 
T9 3 AgeCat*Trt*Glucose Middle Glu m G0 G4 -1.05 1.4 165 -0.8 0.453 Tukey-K 0.975 
136 
T9 3 AgeCat*Trt*Glucose Middle Glu m G0 G5 1.919 1.4 165 1.37 0.172 Tukey-K 0.744 
T9 3 AgeCat*Trt*Glucose Middle Glu m G1 G2 0.661 1.4 165 0.47 0.637 Tukey-K 0.997 
T9 3 AgeCat*Trt*Glucose Middle Glu m G1 G3 0.744 1.4 165 0.53 0.595 Tukey-K 0.995 
T9 3 AgeCat*Trt*Glucose Middle Glu m G1 G4 -1.63 1.4 165 -1.2 0.246 Tukey-K 0.854 
T9 3 AgeCat*Trt*Glucose Middle Glu m G1 G5 1.344 1.4 165 0.96 0.338 Tukey-K 0.93 
T9 3 AgeCat*Trt*Glucose Middle Glu m G2 G3 0.083 1.4 165 0.06 0.953 Tukey-K 1 
T9 3 AgeCat*Trt*Glucose Middle Glu m G2 G4 -2.29 1.4 165 -1.6 0.104 Tukey-K 0.576 
T9 3 AgeCat*Trt*Glucose Middle Glu m G2 G5 0.683 1.4 165 0.49 0.626 Tukey-K 0.997 
T9 3 AgeCat*Trt*Glucose Middle Glu m G3 G4 -2.37 1.4 165 -1.7 0.092 Tukey-K 0.537 
T9 3 AgeCat*Trt*Glucose Middle Glu m G3 G5 0.599 1.4 165 0.43 0.669 Tukey-K 0.998 
T9 3 AgeCat*Trt*Glucose Middle Glu m G4 G5 2.971 1.4 165 2.12 0.035 Tukey-K 0.28 
T9 3 AgeCat*Trt*Glucose Middle Glu p G0 G1 1.181 1.4 165 0.84 0.4 Tukey-K 0.959 
T9 3 AgeCat*Trt*Glucose Middle Glu p G0 G2 1.153 1.4 165 0.82 0.411 Tukey-K 0.963 
T9 3 AgeCat*Trt*Glucose Middle Glu p G0 G3 1.493 1.4 165 1.07 0.287 Tukey-K 0.894 
T9 3 AgeCat*Trt*Glucose Middle Glu p G0 G4 1.443 1.4 165 1.03 0.304 Tukey-K 0.907 
T9 3 AgeCat*Trt*Glucose Middle Glu p G0 G5 0.209 1.4 165 0.15 0.882 Tukey-K 1 
T9 3 AgeCat*Trt*Glucose Middle Glu p G1 G2 -0.03 1.4 165 -0 0.984 Tukey-K 1 
T9 3 AgeCat*Trt*Glucose Middle Glu p G1 G3 0.311 1.4 165 0.22 0.824 Tukey-K 1 
T9 3 AgeCat*Trt*Glucose Middle Glu p G1 G4 0.261 1.4 165 0.19 0.852 Tukey-K 1 
T9 3 AgeCat*Trt*Glucose Middle Glu p G1 G5 -0.97 1.4 165 -0.7 0.488 Tukey-K 0.982 
T9 3 AgeCat*Trt*Glucose Middle Glu p G2 G3 0.34 1.4 165 0.24 0.808 Tukey-K 1 
T9 3 AgeCat*Trt*Glucose Middle Glu p G2 G4 0.29 1.4 165 0.21 0.836 Tukey-K 1 
T9 3 AgeCat*Trt*Glucose Middle Glu p G2 G5 -0.94 1.4 165 -0.7 0.501 Tukey-K 0.984 
T9 3 AgeCat*Trt*Glucose Middle Glu p G3 G4 -0.05 1.4 165 -0 0.972 Tukey-K 1 
T9 3 AgeCat*Trt*Glucose Middle Glu p G3 G5 -1.28 1.4 165 -0.9 0.36 Tukey-K 0.941 
T9 3 AgeCat*Trt*Glucose Middle Glu p G4 G5 -1.23 1.4 165 -0.9 0.379 Tukey-K 0.95 
T9 3 AgeCat*Trt*Glucose Old Glu m G0 G1 0.208 1 165 0.21 0.834 Tukey-K 1 
T9 3 AgeCat*Trt*Glucose Old Glu m G0 G2 -0.12 1 165 -0.1 0.902 Tukey-K 1 
T9 3 AgeCat*Trt*Glucose Old Glu m G0 G3 -0.29 1 165 -0.3 0.771 Tukey-K 1 
T9 3 AgeCat*Trt*Glucose Old Glu m G0 G4 -0.66 1 165 -0.7 0.506 Tukey-K 0.985 
T9 3 AgeCat*Trt*Glucose Old Glu m G0 G5 -0.23 1 165 -0.2 0.819 Tukey-K 1 
T9 3 AgeCat*Trt*Glucose Old Glu m G1 G2 -0.33 1 165 -0.3 0.74 Tukey-K 0.999 
T9 3 AgeCat*Trt*Glucose Old Glu m G1 G3 -0.5 1 165 -0.5 0.617 Tukey-K 0.996 
T9 3 AgeCat*Trt*Glucose Old Glu m G1 G4 -0.87 1 165 -0.9 0.382 Tukey-K 0.952 
T9 3 AgeCat*Trt*Glucose Old Glu m G1 G5 -0.43 1 165 -0.4 0.661 Tukey-K 0.998 
T9 3 AgeCat*Trt*Glucose Old Glu m G2 G3 -0.17 1 165 -0.2 0.867 Tukey-K 1 
T9 3 AgeCat*Trt*Glucose Old Glu m G2 G4 -0.54 1 165 -0.5 0.587 Tukey-K 0.994 
T9 3 AgeCat*Trt*Glucose Old Glu m G2 G5 -0.11 1 165 -0.1 0.915 Tukey-K 1 
T9 3 AgeCat*Trt*Glucose Old Glu m G3 G4 -0.37 1 165 -0.4 0.708 Tukey-K 0.999 
T9 3 AgeCat*Trt*Glucose Old Glu m G3 G5 0.061 1 165 0.06 0.951 Tukey-K 1 
T9 3 AgeCat*Trt*Glucose Old Glu m G4 G5 0.432 1 165 0.44 0.663 Tukey-K 0.998 
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T9 3 AgeCat*Trt*Glucose Old Glu p G0 G1 0.945 1 165 0.96 0.341 Tukey-K 0.931 
T9 3 AgeCat*Trt*Glucose Old Glu p G0 G2 2.658 1 165 2.69 0.008 Tukey-K 0.083 
T9 3 AgeCat*Trt*Glucose Old Glu p G0 G3 1.362 1 165 1.38 0.17 Tukey-K 0.741 
T9 3 AgeCat*Trt*Glucose Old Glu p G0 G4 0.476 1 165 0.48 0.631 Tukey-K 0.997 
T9 3 AgeCat*Trt*Glucose Old Glu p G0 G5 0.208 1 165 0.21 0.834 Tukey-K 1 
T9 3 AgeCat*Trt*Glucose Old Glu p G1 G2 1.713 1 165 1.73 0.085 Tukey-K 0.513 
T9 3 AgeCat*Trt*Glucose Old Glu p G1 G3 0.417 1 165 0.42 0.674 Tukey-K 0.998 
T9 3 AgeCat*Trt*Glucose Old Glu p G1 G4 -0.47 1 165 -0.5 0.636 Tukey-K 0.997 
T9 3 AgeCat*Trt*Glucose Old Glu p G1 G5 -0.74 1 165 -0.7 0.457 Tukey-K 0.976 
T9 3 AgeCat*Trt*Glucose Old Glu p G2 G3 -1.3 1 165 -1.3 0.192 Tukey-K 0.779 
T9 3 AgeCat*Trt*Glucose Old Glu p G2 G4 -2.18 1 165 -2.2 0.029 Tukey-K 0.241 
T9 3 AgeCat*Trt*Glucose Old Glu p G2 G5 -2.45 1 165 -2.5 0.014 Tukey-K 0.137 
T9 3 AgeCat*Trt*Glucose Old Glu p G3 G4 -0.89 1 165 -0.9 0.372 Tukey-K 0.947 
T9 3 AgeCat*Trt*Glucose Old Glu p G3 G5 -1.15 1 165 -1.2 0.245 Tukey-K 0.852 
T9 3 AgeCat*Trt*Glucose Old Glu p G4 G5 -0.27 1 165 -0.3 0.786 Tukey-K 1 
T9 3 AgeCat*Trt*Glucose Young Glu m G0 G1 -0.48 1.1 165 -0.4 0.675 Tukey-K 0.998 
T9 3 AgeCat*Trt*Glucose Young Glu m G0 G2 -1.03 1.1 165 -0.9 0.37 Tukey-K 0.946 
T9 3 AgeCat*Trt*Glucose Young Glu m G0 G3 -1.39 1.1 165 -1.2 0.224 Tukey-K 0.826 
T9 3 AgeCat*Trt*Glucose Young Glu m G0 G4 -0.1 1.1 165 -0.1 0.929 Tukey-K 1 
T9 3 AgeCat*Trt*Glucose Young Glu m G0 G5 -0.27 1.1 165 -0.2 0.816 Tukey-K 1 
T9 3 AgeCat*Trt*Glucose Young Glu m G1 G2 -0.55 1.1 165 -0.5 0.632 Tukey-K 0.997 
T9 3 AgeCat*Trt*Glucose Young Glu m G1 G3 -0.91 1.1 165 -0.8 0.425 Tukey-K 0.967 
T9 3 AgeCat*Trt*Glucose Young Glu m G1 G4 0.378 1.1 165 0.33 0.741 Tukey-K 0.999 
T9 3 AgeCat*Trt*Glucose Young Glu m G1 G5 0.214 1.1 165 0.19 0.852 Tukey-K 1 
T9 3 AgeCat*Trt*Glucose Young Glu m G2 G3 -0.37 1.1 165 -0.3 0.749 Tukey-K 1 
T9 3 AgeCat*Trt*Glucose Young Glu m G2 G4 0.926 1.1 165 0.81 0.419 Tukey-K 0.965 
T9 3 AgeCat*Trt*Glucose Young Glu m G2 G5 0.762 1.1 165 0.67 0.506 Tukey-K 0.985 
T9 3 AgeCat*Trt*Glucose Young Glu m G3 G4 1.292 1.1 165 1.13 0.26 Tukey-K 0.868 
T9 3 AgeCat*Trt*Glucose Young Glu m G3 G5 1.128 1.1 165 0.99 0.325 Tukey-K 0.921 
T9 3 AgeCat*Trt*Glucose Young Glu m G4 G5 -0.16 1.1 165 -0.1 0.886 Tukey-K 1 
T9 3 AgeCat*Trt*Glucose Young Glu p G0 G1 -2.36 1.1 165 -2.1 0.04 Tukey-K 0.31 
T9 3 AgeCat*Trt*Glucose Young Glu p G0 G2 -2.29 1.1 165 -2 0.046 Tukey-K 0.343 
T9 3 AgeCat*Trt*Glucose Young Glu p G0 G3 -1.97 1.1 165 -1.7 0.086 Tukey-K 0.515 
T9 3 AgeCat*Trt*Glucose Young Glu p G0 G4 -2.95 1.1 165 -2.6 0.011 Tukey-K 0.108 
T9 3 AgeCat*Trt*Glucose Young Glu p G0 G5 -1.33 1.1 165 -1.2 0.245 Tukey-K 0.851 
T9 3 AgeCat*Trt*Glucose Young Glu p G1 G2 0.069 1.1 165 0.06 0.952 Tukey-K 1 
T9 3 AgeCat*Trt*Glucose Young Glu p G1 G3 0.387 1.1 165 0.34 0.735 Tukey-K 0.999 
T9 3 AgeCat*Trt*Glucose Young Glu p G1 G4 -0.59 1.1 165 -0.5 0.609 Tukey-K 0.996 
T9 3 AgeCat*Trt*Glucose Young Glu p G1 G5 1.027 1.1 165 0.9 0.37 Tukey-K 0.946 
T9 3 AgeCat*Trt*Glucose Young Glu p G2 G3 0.318 1.1 165 0.28 0.781 Tukey-K 1 
T9 3 AgeCat*Trt*Glucose Young Glu p G2 G4 -0.65 1.1 165 -0.6 0.568 Tukey-K 0.993 
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T9 3 AgeCat*Trt*Glucose Young Glu p G2 G5 0.958 1.1 165 0.84 0.403 Tukey-K 0.96 
T9 3 AgeCat*Trt*Glucose Young Glu p G3 G4 -0.97 1.1 165 -0.9 0.396 Tukey-K 0.957 
T9 3 AgeCat*Trt*Glucose Young Glu p G3 G5 0.64 1.1 165 0.56 0.576 Tukey-K 0.993 
T9 3 AgeCat*Trt*Glucose Young Glu p G4 G5 1.613 1.1 165 1.41 0.16 Tukey-K 0.72 
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TEST 5: Gave the differences between –FBS/- 30nM glucose and +FBS/+ 30 nM glucose in specific age 
and specific treatment: 
Gene Slice Glu _Glu Estimate StdErr DF tValue Raw_p fdr_p 
T1 AgeCat Middle Trt G0 m p 0.2106 0.8993 165 0.2342 0.8151 0.8631 
T1 AgeCat Middle Trt G1 m p 1.3148 0.8993 165 1.4621 0.1456 0.7223 
T1 AgeCat Middle Trt G2 m p -0.47 0.8993 165 -0.523 0.6019 0.7223
T1 AgeCat Middle Trt G3 m p -1.067 0.8993 165 -1.186 0.2372 0.7223
T1 AgeCat Middle Trt G4 m p 1.1127 0.8993 165 1.2374 0.2177 0.7223 
T1 AgeCat Middle Trt G5 m p -1.143 0.8993 165 -1.27 0.2057 0.7223 
T1 AgeCat Old Trt G0 m p -0.7 0.6359 165 -1.1 0.2728 0.7223 
T1 AgeCat Old Trt G1 m p -0.479 0.6359 165 -0.753 0.4523 0.7223
T1 AgeCat Old Trt G2 m p -0.488 0.6359 165 -0.767 0.4441 0.7223
T1 AgeCat Old Trt G3 m p -0.048 0.6359 165 -0.075 0.9402 0.9402
T1 AgeCat Old Trt G4 m p -0.385 0.6359 165 -0.606 0.5454 0.7223
T1 AgeCat Old Trt G5 m p -0.847 0.6359 165 -1.332 0.1846 0.7223
T1 AgeCat Young Trt G0 m p -0.579 0.7342 165 -0.789 0.4314 0.7223
T1 AgeCat Young Trt G1 m p 0.5692 0.7342 165 0.7752 0.4393 0.7223 
T1 AgeCat Young Trt G2 m p -0.437 0.7342 165 -0.595 0.5525 0.7223
T1 AgeCat Young Trt G3 m p 0.5963 0.7342 165 0.8121 0.4179 0.7223 
T1 AgeCat Young Trt G4 m p -0.411 0.7342 165 -0.56 0.5766 0.7223 
T1 AgeCat Young Trt G5 m p -0.201 0.7342 165 -0.274 0.7848 0.8631
T10 AgeCat Middle Trt G0 m p -1.818 1.2099 165 -1.503 0.1348 0.4673
T10 AgeCat Middle Trt G1 m p -0.081 1.2099 165 -0.067 0.9464 0.9464
T10 AgeCat Middle Trt G2 m p -0.225 1.2099 165 -0.186 0.8527 0.9382
T10 AgeCat Middle Trt G3 m p -1.429 1.2099 165 -1.181 0.2392 0.4673
T10 AgeCat Middle Trt G4 m p 1.3869 1.2099 165 1.1462 0.2534 0.4673 
T10 AgeCat Middle Trt G5 m p -1.488 1.2099 165 -1.229 0.2207 0.4673
T10 AgeCat Old Trt G0 m p -1.967 0.8556 165 -2.299 0.0228 0.4101
T10 AgeCat Old Trt G1 m p -1.497 0.8556 165 -1.75 0.082 0.4673 
T10 AgeCat Old Trt G2 m p 1.0866 0.8556 165 1.27 0.2059 0.4673 
T10 AgeCat Old Trt G3 m p 0.1228 0.8556 165 0.1435 0.886 0.9382 
T10 AgeCat Old Trt G4 m p -1.108 0.8556 165 -1.296 0.1969 0.4673
T10 AgeCat Old Trt G5 m p -0.206 0.8556 165 -0.241 0.8101 0.9382
T10 AgeCat Young Trt G0 m p -0.555 0.9879 165 -0.562 0.5751 0.7394
T10 AgeCat Young Trt G1 m p -0.911 0.9879 165 -0.922 0.3579 0.5856
T10 AgeCat Young Trt G2 m p -0.663 0.9879 165 -0.671 0.5029 0.6963
T10 AgeCat Young Trt G3 m p -0.68 0.9879 165 -0.688 0.4925 0.6963
T10 AgeCat Young Trt G4 m p -1.118 0.9879 165 -1.131 0.2596 0.4673
T10 AgeCat Young Trt G5 m p -1.68 0.9879 165 -1.701 0.0909 0.4673
T2 AgeCat Middle Trt G0 m p 0.4956 0.9585 165 0.5171 0.6058 0.7269 
T2 AgeCat Middle Trt G1 m p 0.8685 0.9585 165 0.9062 0.3662 0.6506 
T2 AgeCat Middle Trt G2 m p -1.761 0.9585 165 -1.838 0.0679 0.4033
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T2 AgeCat Middle Trt G3 m p -0.642 0.9585 165 -0.67 0.504 0.6978 
T2 AgeCat Middle Trt G4 m p 1.0952 0.9585 165 1.1427 0.2548 0.6506 
T2 AgeCat Middle Trt G5 m p -0.871 0.9585 165 -0.909 0.3647 0.6506
T2 AgeCat Old Trt G0 m p -1.423 0.6777 165 -2.099 0.0373 0.4033
T2 AgeCat Old Trt G1 m p -1.36 0.6777 165 -2.007 0.0464 0.4033
T2 AgeCat Old Trt G2 m p -0.723 0.6777 165 -1.067 0.2873 0.6506
T2 AgeCat Old Trt G3 m p -0.198 0.6777 165 -0.292 0.7708 0.8161
T2 AgeCat Old Trt G4 m p -0.382 0.6777 165 -0.563 0.5742 0.7269
T2 AgeCat Old Trt G5 m p -1.157 0.6777 165 -1.707 0.0896 0.4033
T2 AgeCat Young Trt G0 m p -0.641 0.7826 165 -0.819 0.414 0.6506 
T2 AgeCat Young Trt G1 m p 0.6142 0.7826 165 0.7848 0.4337 0.6506 
T2 AgeCat Young Trt G2 m p -0.933 0.7826 165 -1.192 0.2349 0.6506
T2 AgeCat Young Trt G3 m p -0.013 0.7826 165 -0.017 0.9869 0.9869
T2 AgeCat Young Trt G4 m p -0.345 0.7826 165 -0.441 0.6599 0.7424
T2 AgeCat Young Trt G5 m p -0.824 0.7826 165 -1.053 0.2938 0.6506
T3 AgeCat Middle Trt G0 m p 0.6644 0.923 165 0.7198 0.4727 0.709 
T3 AgeCat Middle Trt G1 m p 1.3185 0.923 165 1.4285 0.155 0.4651 
T3 AgeCat Middle Trt G2 m p 0.1313 0.923 165 0.1422 0.8871 0.9266 
T3 AgeCat Middle Trt G3 m p -1.801 0.923 165 -1.951 0.0528 0.4378
T3 AgeCat Middle Trt G4 m p 1.3465 0.923 165 1.4587 0.1465 0.4651 
T3 AgeCat Middle Trt G5 m p -0.981 0.923 165 -1.063 0.2893 0.4734
T3 AgeCat Old Trt G0 m p -1.178 0.6527 165 -1.805 0.073 0.4378 
T3 AgeCat Old Trt G1 m p -1.412 0.6527 165 -2.163 0.032 0.4378 
T3 AgeCat Old Trt G2 m p -0.727 0.6527 165 -1.113 0.2673 0.4734
T3 AgeCat Old Trt G3 m p 0.1641 0.6527 165 0.2514 0.8018 0.9266 
T3 AgeCat Old Trt G4 m p -0.764 0.6527 165 -1.171 0.2434 0.4734
T3 AgeCat Old Trt G5 m p -1.032 0.6527 165 -1.58 0.1159 0.4651 
T3 AgeCat Young Trt G0 m p 0.2408 0.7537 165 0.3195 0.7497 0.9266 
T3 AgeCat Young Trt G1 m p 0.8525 0.7537 165 1.1311 0.2596 0.4734 
T3 AgeCat Young Trt G2 m p 0.0696 0.7537 165 0.0923 0.9266 0.9266 
T3 AgeCat Young Trt G3 m p 0.1021 0.7537 165 0.1354 0.8924 0.9266 
T3 AgeCat Young Trt G4 m p 0.08 0.7537 165 0.1061 0.9156 0.9266 
T3 AgeCat Young Trt G5 m p -0.828 0.7537 165 -1.099 0.2733 0.4734
T4 AgeCat Middle Trt G0 m p 0.0256 0.9742 165 0.0263 0.979 0.979 
T4 AgeCat Middle Trt G1 m p 1.1948 0.9742 165 1.2264 0.2218 0.8584 
T4 AgeCat Middle Trt G2 m p -0.747 0.9742 165 -0.767 0.444 0.979 
T4 AgeCat Middle Trt G3 m p -1.214 0.9742 165 -1.246 0.2144 0.8584
T4 AgeCat Middle Trt G4 m p 1.1527 0.9742 165 1.1832 0.2384 0.8584 
T4 AgeCat Middle Trt G5 m p -1.299 0.9742 165 -1.333 0.1843 0.8584
T4 AgeCat Old Trt G0 m p -0.235 0.6889 165 -0.341 0.7338 0.979 
T4 AgeCat Old Trt G1 m p -1.318 0.6889 165 -1.914 0.0574 0.8584
T4 AgeCat Old Trt G2 m p 0.0353 0.6889 165 0.0513 0.9592 0.979 
T4 AgeCat Old Trt G3 m p 0.0722 0.6889 165 0.1048 0.9167 0.979 
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T4 AgeCat Old Trt G4 m p -0.56 0.6889 165 -0.812 0.4177 0.979 
T4 AgeCat Old Trt G5 m p -0.31 0.6889 165 -0.45 0.6536 0.979 
T4 AgeCat Young Trt G0 m p -0.648 0.7955 165 -0.814 0.4168 0.979 
T4 AgeCat Young Trt G1 m p -0.245 0.7955 165 -0.308 0.7585 0.979 
T4 AgeCat Young Trt G2 m p 0.0721 0.7955 165 0.0906 0.9279 0.979 
T4 AgeCat Young Trt G3 m p 0.1929 0.7955 165 0.2425 0.8087 0.979 
T4 AgeCat Young Trt G4 m p -0.354 0.7955 165 -0.445 0.6567 0.979 
T4 AgeCat Young Trt G5 m p -0.187 0.7955 165 -0.236 0.8139 0.979 
T5 AgeCat Middle Trt G0 m p 1.0981 1.0392 165 1.0567 0.2922 0.9601 
T5 AgeCat Middle Trt G1 m p 0.741 1.0392 165 0.7131 0.4768 0.9601 
T5 AgeCat Middle Trt G2 m p 0.4562 1.0392 165 0.439 0.6612 0.9601 
T5 AgeCat Middle Trt G3 m p -0.582 1.0392 165 -0.56 0.5763 0.9601 
T5 AgeCat Middle Trt G4 m p 1.0302 1.0392 165 0.9913 0.323 0.9601 
T5 AgeCat Middle Trt G5 m p -0.74 1.0392 165 -0.712 0.4774 0.9601
T5 AgeCat Old Trt G0 m p 0.0666 0.7349 165 0.0906 0.9279 0.9601 
T5 AgeCat Old Trt G1 m p -1.199 0.7349 165 -1.632 0.1046 0.9601
T5 AgeCat Old Trt G2 m p 0.2203 0.7349 165 0.2998 0.7647 0.9601 
T5 AgeCat Old Trt G3 m p 0.1422 0.7349 165 0.1935 0.8468 0.9601 
T5 AgeCat Old Trt G4 m p -0.474 0.7349 165 -0.645 0.5198 0.9601
T5 AgeCat Old Trt G5 m p -0.51 0.7349 165 -0.694 0.4889 0.9601
T5 AgeCat Young Trt G0 m p 0.0425 0.8485 165 0.0501 0.9601 0.9601 
T5 AgeCat Young Trt G1 m p -0.136 0.8485 165 -0.16 0.873 0.9601 
T5 AgeCat Young Trt G2 m p -0.132 0.8485 165 -0.156 0.8765 0.9601
T5 AgeCat Young Trt G3 m p 0.2029 0.8485 165 0.2391 0.8113 0.9601 
T5 AgeCat Young Trt G4 m p -1.057 0.8485 165 -1.245 0.2148 0.9601
T5 AgeCat Young Trt G5 m p -0.906 0.8485 165 -1.068 0.2873 0.9601
T6 AgeCat Middle Trt G0 m p -0.987 1.6088 165 -0.613 0.5404 0.9079
T6 AgeCat Middle Trt G1 m p 1.4913 1.6088 165 0.9269 0.3553 0.9079 
T6 AgeCat Middle Trt G2 m p -0.415 1.6088 165 -0.258 0.7968 0.9079
T6 AgeCat Middle Trt G3 m p -2.324 1.6088 165 -1.445 0.1504 0.9079
T6 AgeCat Middle Trt G4 m p 1.0015 1.6088 165 0.6225 0.5345 0.9079 
T6 AgeCat Middle Trt G5 m p -2.937 1.6088 165 -1.826 0.0697 0.9079
T6 AgeCat Old Trt G0 m p -1.109 1.1376 165 -0.975 0.331 0.9079 
T6 AgeCat Old Trt G1 m p -1.271 1.1376 165 -1.117 0.2655 0.9079
T6 AgeCat Old Trt G2 m p -0.675 1.1376 165 -0.593 0.5539 0.9079
T6 AgeCat Old Trt G3 m p 0.4722 1.1376 165 0.4151 0.6786 0.9079 
T6 AgeCat Old Trt G4 m p 0.0247 1.1376 165 0.0217 0.9827 0.9827 
T6 AgeCat Old Trt G5 m p -0.205 1.1376 165 -0.18 0.8574 0.9079 
T6 AgeCat Young Trt G0 m p 0.9917 1.3136 165 0.7549 0.4514 0.9079 
T6 AgeCat Young Trt G1 m p -0.365 1.3136 165 -0.278 0.7815 0.9079
T6 AgeCat Young Trt G2 m p 0.2488 1.3136 165 0.1894 0.85 0.9079 
T6 AgeCat Young Trt G3 m p 0.5729 1.3136 165 0.4361 0.6633 0.9079 
T6 AgeCat Young Trt G4 m p -0.606 1.3136 165 -0.461 0.6453 0.9079
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T6 AgeCat Young Trt G5 m p 0.4567 1.3136 165 0.3476 0.7285 0.9079 
T7 AgeCat Middle Trt G0 m p 0.1342 1.3676 165 0.0981 0.922 0.922 
T7 AgeCat Middle Trt G1 m p 1.056 1.3676 165 0.7722 0.4411 0.7814 
T7 AgeCat Middle Trt G2 m p -1.342 1.3676 165 -0.982 0.3277 0.7814
T7 AgeCat Middle Trt G3 m p 0.3781 1.3676 165 0.2765 0.7825 0.9002 
T7 AgeCat Middle Trt G4 m p 1.5256 1.3676 165 1.1155 0.2662 0.7814 
T7 AgeCat Middle Trt G5 m p -0.441 1.3676 165 -0.323 0.7474 0.9002
T7 AgeCat Old Trt G0 m p -0.965 0.967 165 -0.998 0.32 0.7814 
T7 AgeCat Old Trt G1 m p -1.606 0.967 165 -1.661 0.0987 0.7814
T7 AgeCat Old Trt G2 m p 1.2447 0.967 165 1.2871 0.1999 0.7814 
T7 AgeCat Old Trt G3 m p 1.3128 0.967 165 1.3575 0.1765 0.7814 
T7 AgeCat Old Trt G4 m p -0.298 0.967 165 -0.308 0.7585 0.9002
T7 AgeCat Old Trt G5 m p -0.732 0.967 165 -0.756 0.4504 0.7814
T7 AgeCat Young Trt G0 m p 0.795 1.1167 165 0.712 0.4775 0.7814 
T7 AgeCat Young Trt G1 m p -1.465 1.1167 165 -1.312 0.1914 0.7814
T7 AgeCat Young Trt G2 m p 0.2112 1.1167 165 0.1892 0.8502 0.9002 
T7 AgeCat Young Trt G3 m p -0.241 1.1167 165 -0.216 0.8292 0.9002
T7 AgeCat Young Trt G4 m p 0.3442 1.1167 165 0.3082 0.7583 0.9002 
T7 AgeCat Young Trt G5 m p -0.97 1.1167 165 -0.869 0.3863 0.7814
T8 AgeCat Middle Trt G0 m p -0.863 1.5421 165 -0.56 0.5764 0.8022 
T8 AgeCat Middle Trt G1 m p 0.9998 1.5421 165 0.6483 0.5177 0.8022 
T8 AgeCat Middle Trt G2 m p -0.734 1.5421 165 -0.476 0.6348 0.8022
T8 AgeCat Middle Trt G3 m p 0.9206 1.5421 165 0.597 0.5513 0.8022 
T8 AgeCat Middle Trt G4 m p 1.4269 1.5421 165 0.9253 0.3562 0.7124 
T8 AgeCat Middle Trt G5 m p -0.011 1.5421 165 -0.007 0.9942 0.9942
T8 AgeCat Old Trt G0 m p -1.878 1.0905 165 -1.722 0.0869 0.7124
T8 AgeCat Old Trt G1 m p -1.107 1.0905 165 -1.015 0.3114 0.7124
T8 AgeCat Old Trt G2 m p 1.3116 1.0905 165 1.2028 0.2308 0.7124 
T8 AgeCat Old Trt G3 m p 2.0647 1.0905 165 1.8934 0.0601 0.7124 
T8 AgeCat Old Trt G4 m p -1.23 1.0905 165 -1.128 0.2611 0.7124
T8 AgeCat Old Trt G5 m p -0.468 1.0905 165 -0.429 0.6685 0.8022
T8 AgeCat Young Trt G0 m p -0.117 1.2592 165 -0.093 0.9263 0.9808
T8 AgeCat Young Trt G1 m p -1.219 1.2592 165 -0.968 0.3343 0.7124
T8 AgeCat Young Trt G2 m p -1.311 1.2592 165 -1.041 0.2994 0.7124
T8 AgeCat Young Trt G3 m p -0.595 1.2592 165 -0.473 0.6369 0.8022
T8 AgeCat Young Trt G4 m p 0.1992 1.2592 165 0.1582 0.8745 0.9808 
T8 AgeCat Young Trt G5 m p -1.622 1.2592 165 -1.288 0.1996 0.7124
T9 AgeCat Middle Trt G0 m p -0.994 1.3987 165 -0.711 0.4783 0.7827
T9 AgeCat Middle Trt G1 m p -0.388 1.3987 165 -0.277 0.782 0.8797 
T9 AgeCat Middle Trt G2 m p -1.078 1.3987 165 -0.77 0.4422 0.7827 
T9 AgeCat Middle Trt G3 m p -0.821 1.3987 165 -0.587 0.5582 0.8373
T9 AgeCat Middle Trt G4 m p 1.5006 1.3987 165 1.0729 0.2849 0.7827 
T9 AgeCat Middle Trt G5 m p -2.704 1.3987 165 -1.933 0.0549 0.3296
143 
T9 AgeCat Old Trt G0 m p -0.774 0.989 165 -0.783 0.4349 0.7827
T9 AgeCat Old Trt G1 m p -0.037 0.989 165 -0.037 0.9706 0.9706
T9 AgeCat Old Trt G2 m p 2.0053 0.989 165 2.0276 0.0442 0.3296 
T9 AgeCat Old Trt G3 m p 0.8759 0.989 165 0.8857 0.3771 0.7827 
T9 AgeCat Old Trt G4 m p 0.3616 0.989 165 0.3656 0.7151 0.8786 
T9 AgeCat Old Trt G5 m p -0.339 0.989 165 -0.343 0.7322 0.8786
T9 AgeCat Young Trt G0 m p 0.0464 1.142 165 0.0406 0.9676 0.9706 
T9 AgeCat Young Trt G1 m p -1.835 1.142 165 -1.607 0.11 0.495 
T9 AgeCat Young Trt G2 m p -1.218 1.142 165 -1.067 0.2876 0.7827
T9 AgeCat Young Trt G3 m p -0.534 1.142 165 -0.467 0.6408 0.8786
T9 AgeCat Young Trt G4 m p -2.798 1.142 165 -2.45 0.0153 0.2757 
T9 AgeCat Young Trt G5 m p -1.022 1.142 165 -0.895 0.3723 0.7827
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APPENDIX II: FOLD CHANGE 








T8; IGF-1,  
T9; GLUT4 
T10; IR  
KEY:  Treatments (G) 
G0: Control  
G1: Insulin 





m: minus (without FBS and glucose) 
p: plus (without FBS and glucose). 
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TEST 1: Gave the ANOVA F-tests for each variable 
Var Effect NumDF DenDF FValue p-value
T10m AgeCat 2 15 0.211429 0.81180 
T10m Trt 4 60 2.303104 0.06877 
T10m AgeCat* Treatment 8 60 0.802178 0.60306 
T10p AgeCat 2 14.86441 1.693066 0.21756 
T10p Treatment 4 58.93003 0.649981 0.62915 
T10p AgeCat* Treatment 8 58.9353 0.509224 0.84466 
T1m AgeCat 2 15 0.932055 0.41539 
T1m Treatment 4 60 0.830884 0.51084 
T1m AgeCat* Treatment 8 60 0.856651 0.55764 
T1p AgeCat 2 14.69823 0.82667 0.45685 
T1p Treatment 4 58.73118 0.975984 0.42765 
T1p AgeCat* Treatment 8 58.73173 0.55009 0.81380 
T2m AgeCat 2 15 3.026008 0.07870 
T2m Treatment 4 60 1.704006 0.16095 
T2m AgeCat* Treatment 8 60 0.921565 0.50535 
T2p AgeCat 2 15 1.261717 0.31156 
T2p Treatment 4 60 0.217748 0.92755 
T2p AgeCat* Treatment 8 60 1.216081 0.30536 
T3m AgeCat 2 15 1.057016 0.37200 
T3m Treatment 4 60 0.690918 0.60112 
T3m AgeCat* Treatment 8 60 0.549264 0.81455 
T3p AgeCat 2 15 0.287714 0.75402 
T3p Treatment 4 60 1.386159 0.24955 
T3p AgeCat* Treatment 8 60 1.665696 0.12570 
T4m AgeCat 2 15 0.210882 0.81223 
T4m Treatment 4 60 0.349397 0.84344 
T4m AgeCat* Treatment 8 60 0.811633 0.59510 
T4p AgeCat 2 15 0.929923 0.41618 
T4p Treatment 4 60 0.02788 0.99846 
T4p AgeCat* Treatment 8 60 0.475467 0.86874 
T5m AgeCat 2 12 0.424224 0.66372 
T5m Treatment 4 48 0.38278 0.81985 
T5m AgeCat* Treatment 8 48 0.479915 0.86435 
T5p AgeCat 2 12 1.184092 0.33937 
T5p Treatment 4 48 0.725806 0.57868 
T5p AgeCat* Treatment 8 48 0.910947 0.51556 
T6m AgeCat 2 14.4291 0.338082 0.71864 
T6m Treatment 4 53.04814 0.526133 0.71695 
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Var Effect NumDF DenDF FValue p-value
T6m AgeCat* Treatment 8 52.89547 0.659503 0.72422 
T6p AgeCat 2 13.02258 0.376947 0.69320 
T6p Treatment 4 51.05843 0.72371 0.57979 
T6p AgeCat* Treatment 8 51.06189 2.162163 0.04630 
T7m AgeCat 2 15.07685 0.71634 0.50443 
T7m Treatment 4 59.12579 2.559807 0.04774 
T7m AgeCat* Treatment 8 59.1049 0.700554 0.68966 
T7p AgeCat 2 15 0.1842 0.83362 
T7p Treatment 4 60 0.300503 0.87649 
T7p AgeCat* Treatment 8 60 0.885634 0.53401 
T8m AgeCat 2 15 0.050949 0.95049 
T8m Treatment 4 60 0.358771 0.83694 
T8m AgeCat* Treatment 8 60 0.900744 0.52187 
T8p AgeCat 2 15 3.340991 0.06309 
T8p Treatment 4 60 1.792275 0.14220 
T8p AgeCat* Treatment 8 60 0.722909 0.67057 
T9m AgeCat 2 15 0.377183 0.69211 
T9m Treatment 4 60 1.112481 0.35908 
T9m AgeCat* Treatment 8 60 1.289302 0.26634 
T9p AgeCat 2 15 2.671699 0.10174 
T9p Treatment 4 60 0.793092 0.53431 
T9p AgeCat* Treatment 8 60 0.623415 0.75483 
- The log transform the data to help satisfy model assumptions
- The trans
- TEST 1: gives the ANOVA F-tests for each variable.
- TEST2: gives pairwise comparisons on main effects (Age Category or Age) for each var.
or gene m, p combination.
- TESTS3: gives slice comparisons or interaction comparisons.
- Back trans formed means can be substantially lower than the means in the original scale,
particularly when transformation is log
Transformation: adding a constant is required to take logs when there are zero’s in the data 
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TEST 3: gave slice comparisons or interaction comparisons. 
Var StmtNo Effect Slice Trt _Trt Estimate StdErr DF tValue Raw p Adjustment Adj p 
T10m 1 AgeCat*Trt Middle G1 G2 -0 0.657 60 -0.04 0.96857 Tukey-K 1 
T10m 1 AgeCat*Trt Middle G1 G3 0.13 0.657 60 0.199 0.84284 Tukey-K 0.9996 
T10m 1 AgeCat*Trt Middle G1 G4 0.62 0.657 60 0.947 0.34752 Tukey-K 0.8773 
T10m 1 AgeCat*Trt Middle G1 G5 -0.2 0.657 60 -0.38 0.70739 Tukey-K 0.9956
T10m 1 AgeCat*Trt Middle G2 G3 0.16 0.657 60 0.239 0.81216 Tukey-K 0.9993 
T10m 1 AgeCat*Trt Middle G2 G4 0.65 0.657 60 0.986 0.3279 Tukey-K 0.8604 
T10m 1 AgeCat*Trt Middle G2 G5 -0.2 0.657 60 -0.34 0.73685 Tukey-K 0.9971
T10m 1 AgeCat*Trt Middle G3 G4 0.49 0.657 60 0.748 0.45756 Tukey-K 0.9442 
T10m 1 AgeCat*Trt Middle G3 G5 -0.4 0.657 60 -0.58 0.56659 Tukey-K 0.9781
T10m 1 AgeCat*Trt Middle G4 G5 -0.9 0.657 60 -1.32 0.19053 Tukey-K 0.6775
T10m 1 AgeCat*Trt Old G1 G2 1.33 0.465 60 2.866 0.00572 Tukey-K 0.04368 
T10m 1 AgeCat*Trt Old G1 G3 1.6 0.465 60 3.449 0.00103 Tukey-K 0.00883 
T10m 1 AgeCat*Trt Old G1 G4 1.41 0.465 60 3.026 0.00364 Tukey-K 0.02886 
T10m 1 AgeCat*Trt Old G1 G5 1.31 0.465 60 2.824 0.00644 Tukey-K 0.04864 
T10m 1 AgeCat*Trt Old G2 G3 0.27 0.465 60 0.583 0.562218 Tukey-K 0.9771 
T10m 1 AgeCat*Trt Old G2 G4 0.07 0.465 60 0.16 0.873483 Tukey-K 0.9998 
T10m 1 AgeCat*Trt Old G2 G5 -0 0.465 60 -0.04 0.965929 Tukey-K 1 
T10m 1 AgeCat*Trt Old G3 G4 -0.2 0.465 60 -0.42 0.673900 Tukey-K 0.9931
T10m 1 AgeCat*Trt Old G3 G5 -0.3 0.465 60 -0.63 0.533895 Tukey-K 0.9704
T10m 1 AgeCat*Trt Old G4 G5 -0.1 0.465 60 -0.2 0.839969 Tukey-K 0.9996
T10m 1 AgeCat*Trt Young G1 G2 0.41 0.536 60 0.766 0.446630 Tukey-K 0.9393 
T10m 1 AgeCat*Trt Young G1 G3 0.79 0.536 60 1.478 0.144550 Tukey-K 0.5803 
T10m 1 AgeCat*Trt Young G1 G4 0.48 0.536 60 0.894 0.374781 Tukey-K 0.8979 
T10m 1 AgeCat*Trt Young G1 G5 0.3 0.536 60 0.562 0.576543 Tukey-K 0.9801 
T10m 1 AgeCat*Trt Young G2 G3 0.38 0.536 60 0.712 0.479072 Tukey-K 0.9529 
T10m 1 AgeCat*Trt Young G2 G4 0.07 0.536 60 0.128 0.898475 Tukey-K 0.9999 
T10m 1 AgeCat*Trt Young G2 G5 -0.1 0.536 60 -0.2 0.838596 Tukey-K 0.9996
T10m 1 AgeCat*Trt Young G3 G4 -0.3 0.536 60 -0.58 0.561330 Tukey-K 0.9769
T10m 1 AgeCat*Trt Young G3 G5 -0.5 0.536 60 -0.92 0.362905 Tukey-K 0.8893
T10m 1 AgeCat*Trt Young G4 G5 -0.2 0.536 60 -0.33 0.740516 Tukey-K 0.9973
T10p 1 AgeCat*Trt Middle G1 G2 -0.3 0.759 59 -0.42 0.678960 Tukey-Kr 0.9936
T10p 1 AgeCat*Trt Middle G1 G3 0.29 0.759 59 0.382 0.704047 Tukey-K 0.9954 
T10p 1 AgeCat*Trt Middle G1 G4 -0.3 0.759 59 -0.37 0.713049 Tukey-K 0.9959
T10p 1 AgeCat*Trt Middle G1 G5 0.38 0.759 59 0.504 0.615871 Tukey-K 0.9866 
T10p 1 AgeCat*Trt Middle G2 G3 0.61 0.759 59 0.798 0.428271 Tukey-K 0.9303 
T10p 1 AgeCat*Trt Middle G2 G4 0.04 0.759 59 0.046 0.963143 Tukey-K 1 
T10p 1 AgeCat*Trt Middle G2 G5 0.7 0.759 59 0.92 0.36115 Tukey-K 0.8879 
T10p 1 AgeCat*Trt Middle G3 G4 -0.6 0.759 59 -0.75 0.45549 Tukey-K 0.9433
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T10p 1 AgeCat*Trt Middle G3 G5 0.09 0.759 59 0.123 0.90278 Tukey-K 0.9999 
T10p 1 AgeCat*Trt Middle G4 G5 0.66 0.759 59 0.874 0.38571 Tukey-K 0.9053 
T10p 1 AgeCat*Trt Old G1 G2 -0.3 0.56 59 -0.59 0.55472 Tukey-K 0.9755
T10p 1 AgeCat*Trt Old G1 G3 -0.1 0.56 59 -0.2 0.83905 Tukey-K 0.9996 
T10p 1 AgeCat*Trt Old G1 G4 0.54 0.56 59 0.97 0.33613 Tukey-K 0.8676 
T10p 1 AgeCat*Trt Old G1 G5 -0.2 0.56 59 -0.32 0.75294 Tukey-K 0.9978
T10p 1 AgeCat*Trt Old G2 G3 0.22 0.537 59 0.407 0.68571 Tukey-K 0.9941 
T10p 1 AgeCat*Trt Old G2 G4 0.88 0.537 59 1.63 0.10836 Tukey-K 0.4844 
T10p 1 AgeCat*Trt Old G2 G5 0.16 0.537 59 0.29 0.77308 Tukey-K 0.9984 
T10p 1 AgeCat*Trt Old G3 G4 0.66 0.537 59 1.224 0.22594 Tukey-K 0.7377 
T10p 1 AgeCat*Trt Old G3 G5 -0.1 0.537 59 -0.12 0.90726 Tukey-K 1 
T10p 1 AgeCat*Trt Old G4 G5 -0.7 0.537 59 -1.34 0.18517 Tukey-K 0.6672
T10p 1 AgeCat*Trt Young G1 G2 0.27 0.62 59 0.433 0.66674 Tukey-K 0.9925 
T10p 1 AgeCat*Trt Young G1 G3 0.66 0.62 59 1.067 0.29019 Tukey-K 0.8224 
T10p 1 AgeCat*Trt Young G1 G4 0.65 0.62 59 1.051 0.29734 Tukey-K 0.8302 
T10p 1 AgeCat*Trt Young G1 G5 0.86 0.62 59 1.392 0.16901 Tukey-K 0.6348 
T10p 1 AgeCat*Trt Young G2 G3 0.39 0.62 59 0.635 0.5282 Tukey-K 0.9688 
T10p 1 AgeCat*Trt Young G2 G4 0.38 0.62 59 0.619 0.53851 Tukey-K 0.9715 
T10p 1 AgeCat*Trt Young G2 G5 0.59 0.62 59 0.96 0.34113 Tukey-K 0.8719 
T10p 1 AgeCat*Trt Young G3 G4 -0 0.62 59 -0.02 0.98742 Tukey-K 1 
T10p 1 AgeCat*Trt Young G3 G5 0.2 0.62 59 0.325 0.7462 Tukey-K 0.9975 
T10p 1 AgeCat*Trt Young G4 G5 0.21 0.62 59 0.341 0.7343 Tukey-K 0.997 
T1m 1 AgeCat*Trt Middle G1 G2 -0.1 0.56 60 -0.24 0.81252 Tukey-K 0.9993
T1m 1 AgeCat*Trt Middle G1 G3 0.18 0.56 60 0.314 0.75459 Tukey-K 0.9978 
T1m 1 AgeCat*Trt Middle G1 G4 0.41 0.56 60 0.733 0.46626 Tukey-K 0.9479 
T1m 1 AgeCat*Trt Middle G1 G5 -0.3 0.56 60 -0.61 0.54246 Tukey-K 0.9726
T1m 1 AgeCat*Trt Middle G2 G3 0.31 0.56 60 0.552 0.58282 Tukey-K 0.9812 
T1m 1 AgeCat*Trt Middle G2 G4 0.54 0.56 60 0.971 0.33521 Tukey-K 0.8669 
T1m 1 AgeCat*Trt Middle G2 G5 -0.2 0.56 60 -0.37 0.70946 Tukey-K 0.9957
T1m 1 AgeCat*Trt Middle G3 G4 0.23 0.56 60 0.419 0.67655 Tukey-K 0.9934 
T1m 1 AgeCat*Trt Middle G3 G5 -0.5 0.56 60 -0.93 0.35784 Tukey-K 0.8855
T1m 1 AgeCat*Trt Middle G4 G5 -0.8 0.56 60 -1.35 0.18342 Tukey-K 0.664 
T1m 1 AgeCat*Trt Old G1 G2 0.15 0.396 60 0.382 0.70399 Tukey-K 0.9954 
T1m 1 AgeCat*Trt Old G1 G3 0.3 0.396 60 0.758 0.4514 Tukey-K 0.9415 
T1m 1 AgeCat*Trt Old G1 G4 0.72 0.396 60 1.808 0.07568 Tukey-K 0.3789 
T1m 1 AgeCat*Trt Old G1 G5 -0.1 0.396 60 -0.18 0.85653 Tukey-K 0.9997
T1m 1 AgeCat*Trt Old G2 G3 0.15 0.396 60 0.376 0.70803 Tukey-K 0.9956 
T1m 1 AgeCat*Trt Old G2 G4 0.56 0.396 60 1.426 0.1591 Tukey-K 0.6137 
T1m 1 AgeCat*Trt Old G2 G5 -0.2 0.396 60 -0.56 0.57531 Tukey-K 0.9798
T1m 1 AgeCat*Trt Old G3 G4 0.42 0.396 60 1.05 0.29814 Tukey-K 0.8311 
T1m 1 AgeCat*Trt Old G3 G5 -0.4 0.396 60 -0.94 0.35118 Tukey-K 0.8802
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T1m 1 AgeCat*Trt Old G4 G5 -0.8 0.396 60 -1.99 0.05125 Tukey-K 0.2837
T1m 1 AgeCat*Trt Young G1 G2 -0.2 0.457 60 -0.54 0.59036 Tukey-K 0.9826
T1m 1 AgeCat*Trt Young G1 G3 0.24 0.457 60 0.523 0.60296 Tukey-K 0.9847 
T1m 1 AgeCat*Trt Young G1 G4 -0.5 0.457 60 -1.2 0.23513 Tukey-K 0.7518 
T1m 1 AgeCat*Trt Young G1 G5 -0.1 0.457 60 -0.26 0.79318 Tukey-K 0.9989
T1m 1 AgeCat*Trt Young G2 G3 0.49 0.457 60 1.064 0.29153 Tukey-K 0.824 
T1m 1 AgeCat*Trt Young G2 G4 -0.3 0.457 60 -0.66 0.51302 Tukey-K 0.9645
T1m 1 AgeCat*Trt Young G2 G5 0.13 0.457 60 0.278 0.78206 Tukey-K 0.9987 
T1m 1 AgeCat*Trt Young G3 G4 -0.8 0.457 60 -1.72 0.09019 Tukey-K 0.4284
T1m 1 AgeCat*Trt Young G3 G5 -0.4 0.457 60 -0.79 0.43481 Tukey-K 0.9336
T1m 1 AgeCat*Trt Young G4 G5 0.43 0.457 60 0.936 0.35306 Tukey-K 0.8817 
T1p 1 AgeCat*Trt Middle G1 G2 0.71 0.607 59 1.176 0.24429 Tukey-K 0.7648 
T1p 1 AgeCat*Trt Middle G1 G3 1.05 0.607 59 1.731 0.0887 Tukey-K 0.4234 
T1p 1 AgeCat*Trt Middle G1 G4 0.67 0.607 59 1.096 0.27745 Tukey-K 0.8078 
T1p 1 AgeCat*Trt Middle G1 G5 1.02 0.607 59 1.673 0.0996 Tukey-K 0.4581 
T1p 1 AgeCat*Trt Middle G2 G3 0.34 0.607 59 0.555 0.58107 Tukey-K 0.9809 
T1p 1 AgeCat*Trt Middle G2 G4 -0 0.607 59 -0.08 0.9366 Tukey-K 1 
T1p 1 AgeCat*Trt Middle G2 G5 0.3 0.607 59 0.497 0.62096 Tukey-K 0.9873 
T1p 1 AgeCat*Trt Middle G3 G4 -0.4 0.607 59 -0.63 0.52804 Tukey-K 0.9688
T1p 1 AgeCat*Trt Middle G3 G5 -0 0.607 59 -0.06 0.95413 Tukey-K 1 
T1p 1 AgeCat*Trt Middle G4 G5 0.35 0.607 59 0.577 0.56614 Tukey-K 0.9779 
T1p 1 AgeCat*Trt Old G1 G2 0.29 0.429 59 0.683 0.49738 Tukey-K 0.9594 
T1p 1 AgeCat*Trt Old G1 G3 0 0.429 59 0.003 0.9976 Tukey-K 1 
T1p 1 AgeCat*Trt Old G1 G4 0.65 0.429 59 1.516 0.13501 Tukey-K 0.5568 
T1p 1 AgeCat*Trt Old G1 G5 0.18 0.429 59 0.427 0.67118 Tukey-K 0.9929 
T1p 1 AgeCat*Trt Old G2 G3 -0.3 0.429 59 -0.68 0.49928 Tukey-K 0.9601
T1p 1 AgeCat*Trt Old G2 G4 0.36 0.429 59 0.833 0.40842 Tukey-K 0.9194 
T1p 1 AgeCat*Trt Old G2 G5 -0.1 0.429 59 -0.26 0.79869 Tukey-K 0.999 
T1p 1 AgeCat*Trt Old G3 G4 0.65 0.429 59 1.512 0.13578 Tukey-K 0.5587 
T1p 1 AgeCat*Trt Old G3 G5 0.18 0.429 59 0.424 0.67338 Tukey-K 0.9931 
T1p 1 AgeCat*Trt Old G4 G5 -0.5 0.429 59 -1.09 0.28067 Tukey-K 0.8115
T1p 1 AgeCat*Trt Young G1 G2 0.41 0.526 59 0.775 0.44139 Tukey-K 0.9368 
T1p 1 AgeCat*Trt Young G1 G3 0.24 0.526 59 0.448 0.65569 Tukey-K 0.9914 
T1p 1 AgeCat*Trt Young G1 G4 0.09 0.526 59 0.168 0.86724 Tukey-K 0.9998 
T1p 1 AgeCat*Trt Young G1 G5 0.37 0.526 59 0.705 0.4834 Tukey-K 0.9545 
T1p 1 AgeCat*Trt Young G2 G3 -0.2 0.496 59 -0.35 0.73021 Tukey-K 0.9968
T1p 1 AgeCat*Trt Young G2 G4 -0.3 0.496 59 -0.64 0.52241 Tukey-K 0.9672
T1p 1 AgeCat*Trt Young G2 G5 -0 0.496 59 -0.07 0.94129 Tukey-K 1 
T1p 1 AgeCat*Trt Young G3 G4 -0.1 0.496 59 -0.3 0.76752 Tukey-K 0.9983 
T1p 1 AgeCat*Trt Young G3 G5 0.14 0.496 59 0.273 0.78616 Tukey-K 0.9988 
T1p 1 AgeCat*Trt Young G4 G5 0.28 0.496 59 0.57 0.57116 Tukey-K 0.979 
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T2m 1 AgeCat*Trt Middle G1 G2 -0.3 0.608 60 -0.45 0.65229 Tukey-K 0.9911
T2m 1 AgeCat*Trt Middle G1 G3 0.8 0.608 60 1.312 0.19467 Tukey-K 0.6852 
T2m 1 AgeCat*Trt Middle G1 G4 0.6 0.608 60 0.991 0.3256 Tukey-K 0.8583 
T2m 1 AgeCat*Trt Middle G1 G5 Var 0.608 60 0.185 0.85376 Tukey-K 0.9997 
T2m 1 AgeCat*Trt Middle G2 G3 1.07 0.608 60 1.764 0.08276 Tukey-K 0.4036 
T2m 1 AgeCat*Trt Middle G2 G4 0.88 0.608 60 1.444 0.15395 Tukey-K 0.6022 
T2m 1 AgeCat*Trt Middle G2 G5 0.39 0.608 60 0.638 0.52592 Tukey-K 0.9682 
T2m 1 AgeCat*Trt Middle G3 G4 -0.2 0.608 60 -0.32 0.74977 Tukey-K 0.9977
T2m 1 AgeCat*Trt Middle G3 G5 -0.7 0.608 60 -1.13 0.26448 Tukey-K 0.792
T2m 1 AgeCat*Trt Middle G4 G5 -0.5 0.608 60 -0.81 0.42342 Tukey-K 0.9278
T2m 1 AgeCat*Trt Old G1 G2 -0.2 0.43 60 -0.36 0.7205 Tukey-K 0.9963 
T2m 1 AgeCat*Trt Old G1 G3 -0.1 0.43 60 -0.29 0.77052 Tukey-K 0.9983
T2m 1 AgeCat*Trt Old G1 G4 0.53 0.43 60 1.232 0.22276 Tukey-K 0.7329 
T2m 1 AgeCat*Trt Old G1 G5 -0.4 0.43 60 -0.89 0.37802 Tukey-K 0.9002
T2m 1 AgeCat*Trt Old G2 G3 0.03 0.43 60 0.066 0.94723 Tukey-K 1 
T2m 1 AgeCat*Trt Old G2 G4 0.68 0.43 60 1.591 0.11676 Tukey-K 0.5086 
T2m 1 AgeCat*Trt Old G2 G5 -0.2 0.43 60 -0.53 0.599 Tukey-K 0.9841 
T2m 1 AgeCat*Trt Old G3 G4 0.66 0.43 60 1.525 0.13251 Tukey-K 0.5506 
T2m 1 AgeCat*Trt Old G3 G5 -0.3 0.43 60 -0.6 0.55401 Tukey-K 0.9753 
T2m 1 AgeCat*Trt Old G4 G5 -0.9 0.43 60 -2.12 0.038140 Tukey-K 0.2252
T2m 1 AgeCat*Trt Young G1 G2 -1 0.497 60 -2.01 0.04883 Tukey-K 0.2734
T2m 1 AgeCat*Trt Young G1 G3 -0.4 0.497 60 -0.71 0.48019 Tukey-K 0.9533
T2m 1 AgeCat*Trt Young G1 G4 -0.7 0.497 60 -1.46 0.15052 Tukey-K 0.5943
T2m 1 AgeCat*Trt Young G1 G5 -0.7 0.497 60 -1.47 0.14672 Tukey-K 0.5855
T2m 1 AgeCat*Trt Young G2 G3 0.65 0.497 60 1.301 0.1984 Tukey-K 0.6919 
T2m 1 AgeCat*Trt Young G2 G4 0.28 0.497 60 0.555 0.58122 Tukey-K 0.981 
T2m 1 AgeCat*Trt Young G2 G5 0.27 0.497 60 0.541 0.59074 Tukey-K 0.9827 
T2m 1 AgeCat*Trt Young G3 G4 -0.4 0.497 60 -0.75 0.45865 Tukey-K 0.9447
T2m 1 AgeCat*Trt Young G3 G5 -0.4 0.497 60 -0.76 0.45033 Tukey-K 0.941
T2m 1 AgeCat*Trt Young G4 G5 -0 0.497 60 -0.01 0.98891 Tukey-K 1 
T2p 1 AgeCat*Trt Middle G1 G2 1.16 0.637 60 1.818 0.07407 Tukey-K 0.3731 
T2p 1 AgeCat*Trt Middle G1 G3 1.07 0.637 60 1.679 0.09832 Tukey-K 0.4543 
T2p 1 AgeCat*Trt Middle G1 G4 0.56 0.637 60 0.881 0.38198 Tukey-K 0.9029 
T2p 1 AgeCat*Trt Middle G1 G5 0.97 0.637 60 1.53 0.13122 Tukey-K 0.5473 
T2p 1 AgeCat*Trt Middle G2 G3 -0.1 0.637 60 -0.14 0.89012 Tukey-K 0.9999
T2p 1 AgeCat*Trt Middle G3   G4 -0.6 0.637 60 -0.94 0.35242 Tukey-K 0.8812
T2p 1 AgeCat*Trt Middle G2  G5 -0.2 0.637 60 -0.29 0.77458 Tukey-K 0.9985
T2p 1 AgeCat*Trt Middle G3  G4 -0.5 0.637 60 -0.8 0.42776 Tukey-K 0.9301 
T2p 1 AgeCat*Trt Middle G3   G5 -0.1 0.637 60 -0.15 0.8821 Tukey-K 0.9999 
T2p 1 AgeCat*Trt Middle G4 G5 0.41 0.637 60 0.649 0.5185 Tukey-K 0.9661 
T2p 1 AgeCat*Trt Old G1 G2 -0.6 0.45 60 -1.28 0.20441 Tukey-K 0.7025
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T2p 1 AgeCat*Trt Old G1 G3 -0.9 0.45 60 -2.07 0.04288 Tukey-K 0.247
T2p 1 AgeCat*Trt Old G1 G4 -0.1 0.45 60 -0.33 0.74299 Tukey-K 0.9974
T2p 1 AgeCat*Trt Old G1 G5 -0.5 0.45 60 -1.16 0.25028 Tukey-K 0.7733
T2p 1 AgeCat*Trt Old G2 G3 -0.4 0.45 60 -0.79 0.43508 Tukey-K 0.9338
T2p 1 AgeCat*Trt Old G2 G4 0.43 0.45 60 0.954 0.3441 Tukey-K 0.8745 
T2p 1 AgeCat*Trt Old G2 G5 0.06 0.45 60 0.122 0.90319 Tukey-K 0.9999 
T2p 1 AgeCat*Trt Old G3 G4 0.78 0.45 60 1.739 0.08709 Tukey-K 0.4182 
T2p 1 AgeCat*Trt Old G3 G5 0.41 0.45 60 0.908 0.36754 Tukey-K 0.8928 
T2p 1 AgeCat*Trt Old G4 G5 -0.4 0.45 60 -0.83 0.409 Tukey-K 0.9198 
T2p 1 AgeCat*Trt Young G1 G2 0.1 0.52 60 0.197 0.84482 Tukey-K 0.9997 
T2p 1 AgeCat*Trt Young G1 G3 0.11 0.52 60 0.213 0.8323 Tukey-K 0.9995 
T2p 1 AgeCat*Trt Young G1 G4 -0 0.52 60 -0.06 0.95458 Tukey-K 1 
T2p 1 AgeCat*Trt Young G1 G5 0.3 0.52 60 0.568 0.57211 Tukey-K 0.9792 
T2p 1 AgeCat*Trt Young G2 G3 0.01 0.52 60 0.016 0.98721 Tukey-K 1 
T2p 1 AgeCat*Trt Young G2 G4 -0.1 0.52 60 -0.25 0.80054 Tukey-K 0.9991
T2p 1 AgeCat*Trt Young G2 G5 0.19 0.52 60 0.371 0.71158 Tukey-K 0.9958 
T2p 1 AgeCat*Trt Young G3 G4 -0.1 0.52 60 -0.27 0.78818 Tukey-K 0.9988
T2p 1 AgeCat*Trt Young G3 G5 0.18 0.52 60 0.355 0.72354 Tukey-K 0.9965 
T2p 1 AgeCat*Trt Young G4 G5 0.33 0.52 60 0.625 0.53417 Tukey-K 0.9704 
T3m 1 AgeCat*Trt Middle G1 G2 0.02 0.63 60 0.029 0.97705 Tukey-K 1 
T3m 1 AgeCat*Trt Middle G1 G3 0.3 0.63 60 0.479 0.63389 Tukey-K 0.989 
T3m 1 AgeCat*Trt Middle G1 G4 0.71 0.63 60 1.12 0.26729 Tukey-K 0.7955 
T3m 1 AgeCat*Trt Middle G1 G5 0.3 0.63 60 0.473 0.63778 Tukey-K 0.9895 
T3m 1 AgeCat*Trt Middle G2 G3 0.28 0.63 60 0.45 0.65446 Tukey-K 0.9913 
T3m 1 AgeCat*Trt Middle G2 G4 0.69 0.63 60 1.091 0.2797 Tukey-K 0.8105 
T3m 1 AgeCat*Trt Middle G2 G5 0.28 0.63 60 0.444 0.65841 Tukey-K 0.9917 
T3m 1 AgeCat*Trt Middle G3 G4 0.4 0.63 60 0.641 0.52395 Tukey-K 0.9677 
T3m 1 AgeCat*Trt Middle G3 G5 -0 0.63 60 -0.01 0.99563 Tukey-K 1 
T3m 1 AgeCat*Trt Middle G4 G5 -0.4 0.63 60 -0.65 0.5204 Tukey-K 0.9666 
T3m 1 AgeCat*Trt Old G1 G2 0.34 0.445 60 0.773 0.44239 Tukey-K 0.9373 
T3m 1 AgeCat*Trt Old G1 G3 0.54 0.445 60 1.216 0.2288 Tukey-K 0.7422 
T3m 1 AgeCat*Trt Old G1 G4 0.69 0.445 60 1.558 0.12455 Tukey-K 0.5299 
T3m 1 AgeCat*Trt Old G1 G5 0.22 0.445 60 0.494 0.62302 Tukey-K 0.9876 
T3m 1 AgeCat*Trt Old G2 G3 0.2 0.445 60 0.443 0.65966 Tukey-K 0.9918 
T3m 1 AgeCat*Trt Old G2 G4 0.35 0.445 60 0.784 0.43585 Tukey-K 0.9341 
T3m 1 AgeCat*Trt Old G2 G5 -0.1 0.445 60 -0.28 0.78108 Tukey-K 0.9986
T3m 1 AgeCat*Trt Old G3 G4 0.15 0.445 60 0.342 0.73362 Tukey-K 0.997 
T3m 1 AgeCat*Trt Old G3 G5 -0.3 0.445 60 -0.72 0.47326 Tukey-K 0.9507
T3m 1 AgeCat*Trt Old G4 G5 -0.5 0.445 60 -1.06 0.29175 Tukey-K 0.8242
T3m 1 AgeCat*Trt Young G1 G2 -0.8 0.514 60 -1.5 0.13973 Tukey-K 0.5687 
T3m 1 AgeCat*Trt Young G1 G3 -0.4 0.514 60 -0.86 0.39057 Tukey-K 0.9086
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T3m 1 AgeCat*Trt Young G1 G4 -0.4 0.514 60 -0.78 0.43909 Tukey-K 0.9357
T3m 1 AgeCat*Trt Young G1 G5 -0.6 0.514 60 -1.25 0.21551 Tukey-K 0.7212
T3m 1 AgeCat*Trt Young G2 G3 0.32 0.514 60 0.632 0.52993 Tukey-K 0.9693 
T3m 1 AgeCat*Trt Young G2 G4 0.37 0.514 60 0.718 0.47572 Tukey-K 0.9516 
T3m 1 AgeCat*Trt Young G2 G5 0.13 0.514 60 0.245 0.80741 Tukey-K 0.9992 
T3m 1 AgeCat*Trt Young G3 G4 0.04 0.514 60 0.086 0.93181 Tukey-K 1 
T3m 1 AgeCat*Trt Young G3 G5 -0.2 0.514 60 -0.39 0.70018 Tukey-K 0.9951
T3m 1 AgeCat*Trt Young G4 G5 -0.2 0.514 60 -0.47 0.63803 Tukey-K 0.9895
T3p 1 AgeCat*Trt Middle G1 G2 0.45 0.571 60 0.791 0.43182 Tukey-K 0.9321 
T3p 1 AgeCat*Trt Middle G1 G3 1.69 0.571 60 2.957 0.00444 Tukey-K 0.0346 
T3p 1 AgeCat*Trt Middle G1 G4 0.8 0.571 60 1.403 0.16577 Tukey-K 0.6282 
T3p 1 AgeCat*Trt Middle G1 G5 1.11 0.571 60 1.936 0.05753 Tukey-K 0.3098 
T3p 1 AgeCat*Trt Middle G2 G3 1.24 0.571 60 2.166 0.03433 Tukey-K 0.2069 
T3p 1 AgeCat*Trt Middle G2 G4 0.35 0.571 60 0.612 0.54312 Tukey-K 0.9727 
T3p 1 AgeCat*Trt Middle G2 G5 0.65 0.571 60 1.145 0.25675 Tukey-K 0.782 
T3p 1 AgeCat*Trt Middle G3 G4 -0.9 0.571 60 -1.55 0.12544 Tukey-K 0.5322
T3p 1 AgeCat*Trt Middle G3 G5 -0.6 0.571 60 -1.02 0.31156 Tukey-K 0.8449
T3p 1 AgeCat*Trt Middle G4 G5 0.3 0.571 60 0.533 0.59571 Tukey-K 0.9835 
T3p 1 AgeCat*Trt Old G1 G2 -0 0.404 60 -0.03 0.97357 Tukey-K 1 
T3p 1 AgeCat*Trt Old G1 G3 -0.6 0.404 60 -1.36 0.17769 Tukey-K 0.6527
T3p 1 AgeCat*Trt Old G1 G4 0.24 0.404 60 0.607 0.54625 Tukey-K 0.9735 
T3p 1 AgeCat*Trt Old G1 G5 -0 0.404 60 -0.11 0.9149 Tukey-K 1 
T3p 1 AgeCat*Trt Old G2 G3 -0.5 0.404 60 -1.33 0.18835 Tukey-K 0.6734
T3p 1 AgeCat*Trt Old G2 G4 0.26 0.404 60 0.64 0.52455 Tukey-K 0.9678 
T3p 1 AgeCat*Trt Old G2 G5 -0 0.404 60 -0.07 0.94122 Tukey-K 1 
T3p 1 AgeCat*Trt Old G3 G4 0.8 0.404 60 1.971 0.05337 Tukey-K 0.2927 
T3p 1 AgeCat*Trt t Old G3 G5 0.51 0.404 60 1.257 0.21377 Tukey-K 0.7184 
T3p 1 AgeCat*Trt Old G4 G5 -0.3 0.404 60 -0.71 0.47791 Tukey-K 0.9525
T3p 1 AgeCat*Trt Young G1 G2 -0.2 0.466 60 -0.43 0.67235 Tukey-K 0.993 
T3p 1 AgeCat*Trt Young G1 G3 0.1 0.466 60 0.224 0.82378 Tukey-K 0.9994 
T3p 1 AgeCat*Trt Young G1 G4 0.16 0.466 60 0.351 0.72661 Tukey-K 0.9966 
T3p 1 AgeCat*Trt Young G1 G5 0.55 0.466 60 1.18 0.24256 Tukey-K 0.7625 
T3p 1 AgeCat*Trt Young G2 G3 0.3 0.466 60 0.649 0.51903 Tukey-K 0.9662 
T3p 1 AgeCat*Trt Young G2 G4 0.36 0.466 60 0.776 0.44062 Tukey-K 0.9365 
T3p 1 AgeCat*Trt Young G2 G5 0.75 0.466 60 1.605 0.11369 Tukey-K 0.5 
T3p 1 AgeCat*Trt Young G3 G4 0.06 0.466 60 0.128 0.89887 Tukey-K 0.9999 
T3p 1 AgeCat*Trt Young G3 G5 0.45 0.466 60 0.957 0.34262 Tukey-K 0.8732 
T3p 1 AgeCat*Trt Young G4 G5 0.39 0.466 60 0.829 0.41041 Tukey-K 0.9206 
T4m 1 AgeCat*Trt Middle G1 G2 -0.4 0.545 60 -0.7 0.48671 Tukey-K 0.9557 
T4m 1 AgeCat*Trt Middle G1 G3 -0.3 0.545 60 -0.49 0.62487 Tukey-K 0.9879
T4m 1 AgeCat*Trt Middle G1 G4 0.43 0.545 60 0.786 0.4351 Tukey-K 0.9338 
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T4m 1 AgeCat*Trt Middle G1 G5 -0.2 0.545 60 -0.33 0.74431 Tukey-K 0.9974
T4m 1 AgeCat*Trt Middle G2 G3 0.11 0.545 60 0.208 0.83565 Tukey-K 0.9996 
T4m 1 AgeCat*Trt Middle G2 G4 0.81 0.545 60 1.486 0.14261 Tukey-K 0.5757 
T4m 1 AgeCat*Trt Middle G2 G5 0.2 0.545 60 0.372 0.71105 Tukey-K 0.9958 
T4m 1 AgeCat*Trt Middle G3 G4 0.7 0.545 60 1.277 0.20643 Tukey-K 0.706 
T4m 1 AgeCat*Trt Middle G3 G5 0.09 0.545 60 0.164 0.87041 Tukey-K 0.9998 
T4m 1 AgeCat*Trt Middle G4 G5 -0.6 0.545 60 -1.11 0.26997 Tukey-K 0.7988
T4m 1 AgeCat*Trt Old G1 G2 0.72 0.385 60 1.878 0.0652 Tukey-K 0.34 
T4m 1 AgeCat*Trt Old G1 G3 0.42 0.385 60 1.085 0.2821 Tukey-K 0.8133 
T4m 1 AgeCat*Trt Old G1 G4 0.23 0.385 60 0.593 0.55521 Tukey-K 0.9756 
T4m 1 AgeCat*Trt Old G1 G5 0.09 0.385 60 0.245 0.80715 Tukey-K 0.9992 
T4m 1 AgeCat*Trt Old G2 G3 -0.3 0.385 60 -0.79 0.43094 Tukey-K 0.9317
T4m 1 AgeCat*Trt Old G2 G4 -0.5 0.385 60 -1.29 0.20373 Tukey-K 0.7013
T4m 1 AgeCat*Trt Old G2 G5 -0.6 0.385 60 -1.63 0.10768 Tukey-K 0.4826
T4m 1 AgeCat*Trt Old G3 G4 -0.2 0.385 60 -0.49 0.62447 Tukey-K 0.9878
T4m 1 AgeCat*Trt Old G3 G5 -0.3 0.385 60 -0.84 0.40415 Tukey-K 0.9169
T4m 1 AgeCat*Trt Old G4 G5 -0.1 0.385 60 -0.35 0.72898 Tukey-K 0.9968
T4m 1 AgeCat*Trt Young G1 G2 0.09 0.445 60 0.194 0.84671 Tukey-K 0.9997 
T4m 1 AgeCat*Trt Young G1 G3 0.2 0.445 60 0.449 0.65479 Tukey-K 0.9914 
T4m 1 AgeCat*Trt Young G1 G4 -0.3 0.445 60 -0.6 0.55119 Tukey-K 0.9747 
T4m 1 AgeCat*Trt Young G1 G5 -0.3 0.445 60 -0.6 0.54861 Tukey-K 0.9741 
T4m 1 AgeCat*Trt Young G2 G3 0.11 0.445 60 0.255 0.79944 Tukey-K 0.999 
T4m 1 AgeCat*Trt Young G2 G4 -0.4 0.445 60 -0.79 0.4306 Tukey-K 0.9315 
T4m 1 AgeCat*Trt Young G2 G5 -0.4 0.445 60 -0.8 0.42835 Tukey-K 0.9304 
T4m 1 AgeCat*Trt Young G3 G4 -0.5 0.445 60 -1.05 0.29851 Tukey-K 0.8315
T4m 1 AgeCat*Trt Young G3 G5 -0.5 0.445 60 -1.05 0.29674 Tukey-K 0.8296
T4m 1 AgeCat*Trt Young G4 G5 -0 0.445 60 -0 0.9969 Tukey-K 1 
T4p 1 AgeCat*Trt Middle G1 G2 0.58 0.801 60 0.719 0.47511 Tukey-K 0.9514 
T4p 1 AgeCat*Trt Middle G1 G3 0.63 0.801 60 0.783 0.43699 Tukey-K 0.9347 
T4p 1 AgeCat*Trt Middle G1 G4 0.57 0.801 60 0.714 0.47776 Tukey-K 0.9524 
T4p 1 AgeCat*Trt Middle G1 G5 1.21 0.801 60 1.506 0.13743 Tukey-K 0.563 
T4p 1 AgeCat*Trt Middle G2 G3 0.05 0.801 60 0.064 0.94933 Tukey-K 1 
T4p 1 AgeCat*Trt Middle G2 G4 -0 0.801 60 -0 0.99656 Tukey-K 1 
T4p 1 AgeCat*Trt Middle G2 G5 0.63 0.801 60 0.787 0.43447 Tukey-K 0.9335 
T4p 1 AgeCat*Trt Middle G3 G4 -0.1 0.801 60 -0.07 0.9459 Tukey-K 1 
T4p 1 AgeCat*Trt Middle G3 G5 0.58 0.801 60 0.723 0.47247 Tukey-K 0.9504 
T4p 1 AgeCat*Trt Middle G4 G5 0.63 0.801 60 0.791 0.43196 Tukey-K 0.9322 
T4p 1 AgeCat*Trt Old G1 G2 -0.3 0.566 60 -0.44 0.6595 Tukey-K 0.9918 
T4p 1 AgeCat*Trt Old G1 G3 -0.5 0.566 60 -0.96 0.3391 Tukey-K 0.8703 
T4p 1 AgeCat*Trt Old G1 G4 -0.3 0.566 60 -0.53 0.6015 Tukey-K 0.9845 
T4p 1 AgeCat*Trt Old G1 G5 -0.6 0.566 60 -1.07 0.28996 Tukey-K 0.8222
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T4p 1 AgeCat*Trt Old G2 G3 -0.3 0.566 60 -0.52 0.60441 Tukey-K 0.9849
T4p 1 AgeCat*Trt Old G2 G4 -0 0.566 60 -0.08 0.93475 Tukey-K 1 
T4p 1 AgeCat*Trt Old G2 G5 -0.4 0.566 60 -0.62 0.53445 Tukey-K 0.9705
T4p 1 AgeCat*Trt Old G3 G4 0.25 0.566 60 0.439 0.66252 Tukey-K 0.9921 
T4p 1 AgeCat*Trt Old G3 G5 -0.1 0.566 60 -0.1 0.91751 Tukey-K 1 
T4p 1 AgeCat*Trt Old G4 G5 -0.3 0.566 60 -0.54 0.5894 Tukey-K 0.9824 
T4p 1 AgeCat*Trt Young G1 G2 -0.1 0.654 60 -0.16 0.87354 Tukey-K 0.9998
T4p 1 AgeCat*Trt Young G1 G3 -0.1 0.654 60 -0.11 0.90933 Tukey-K 1 
T4p 1 AgeCat*Trt Young G1 G4 -0.2 0.654 60 -0.25 0.80521 Tukey-K 0.9991
T4p 1 AgeCat*Trt Young G1 G5 -0.3 0.654 60 -0.43 0.67092 Tukey-K 0.9929
T4p 1 AgeCat*Trt Young G2 G3 0.03 0.654 60 0.045 0.96388 Tukey-K 1 
T4p 1 AgeCat*Trt Young G2 G4 -0.1 0.654 60 -0.09 0.93027 Tukey-K 1 
T4p 1 AgeCat*Trt Young G2 G5 -0.2 0.654 60 -0.27 0.79028 Tukey-K 0.9988
T4p 1 AgeCat*Trt Young G3 G4 -0.1 0.654 60 -0.13 0.89436 Tukey-K 0.9999
T4p 1 AgeCat*Trt Young G3 G5 -0.2 0.654 60 -0.31 0.75566 Tukey-K 0.9979
T4p 1 AgeCat*Trt Young G4 G5 -0.1 0.654 60 -0.18 0.85833 Tukey-K 0.9998
T5m 1 AgeCat*Trt Middle G1 G2 -0.2 0.652 48 -0.27 0.79015 Tukey-K 0.9988
T5m 1 AgeCat*Trt Middle G1 G3 0.07 0.652 48 0.106 0.91576 Tukey-K 1 
T5m 1 AgeCat*Trt Middle G1 G4 0.07 0.652 48 0.106 0.91576 Tukey-K 1 
T5m 1 AgeCat*Trt Middle G1 G5 0.07 0.652 48 0.111 0.91226 Tukey-K 1 
T5m 1 AgeCat*Trt Middle G2 G3 0.24 0.652 48 0.374 0.71009 Tukey-K 0.9957 
T5m 1 AgeCat*Trt Middle G2 G4 0.24 0.652 48 0.374 0.71009 Tukey-K 0.9957 
T5m 1 AgeCat*Trt Middle G2 G5 0.25 0.652 48 0.378 0.70682 Tukey-K 0.9955 
T5m 1 AgeCat*Trt Middle G3 G4 0 0.652 48 3E-16 1 Tukey-K 1 
T5m 1 AgeCat*Trt Middle G3 G5 0 0.652 48 0.004 0.99648 Tukey-K 1 
T5m 1 AgeCat*Trt Middle G4 G5 0 0.652 48 0.004 0.99648 Tukey-K 1 
T5m 1 AgeCat*Trt Old G1 G2 -0.1 0.461 48 -0.2 0.84437 Tukey-K 0.9996 
T5m 1 AgeCat*Trt Old G1 G3 0.08 0.461 48 0.166 0.86882 Tukey-K 0.9998 
T5m 1 AgeCat*Trt Old G1 G4 0.2 0.461 48 0.442 0.66066 Tukey-K 0.9918 
T5m 1 AgeCat*Trt Old G1 G5 -0.1 0.461 48 -0.29 0.76965 Tukey-K 0.9983
T5m 1 AgeCat*Trt Old G2 G3 0.17 0.461 48 0.363 0.71789 Tukey-K 0.9961 
T5m 1 AgeCat*Trt Old G2 G4 0.29 0.461 48 0.639 0.52579 Tukey-K 0.9678 
T5m 1 AgeCat*Trt Old G2 G5 -0 0.461 48 -0.1 0.92304 Tukey-K 1 
T5m 1 AgeCat*Trt Old G3 G4 0.13 0.461 48 0.276 0.78397 Tukey-K 0.9987 
T5m 1 AgeCat*Trt Old G3 G5 -0.2 0.461 48 -0.46 0.64721 Tukey-K 0.9905
T5m 1 AgeCat*Trt Old G4 G5 -0.3 0.461 48 -0.74 0.46517 Tukey-K 0.9469
T5m 1 AgeCat*Trt Young G1 G2 0.44 0.461 48 0.963 0.34035 Tukey-K 0.8702 
T5m 1 AgeCat*Trt Young G1 G3 0.47 0.461 48 1.019 0.3134 Tukey-K 0.8455 
T5m 1 AgeCat*Trt Young G1 G4 -0.1 0.461 48 -0.17 0.8649 Tukey-K 0.9998 
T5m 1 AgeCat*Trt Young G1 G5 -0.4 0.461 48 -0.95 0.3485 Tukey-K 0.877 
162
T5m 1 AgeCat*Trt Young G2 G3 0.03 0.461 48 0.056 0.95576 Tukey-K 1 
T5m 1 AgeCat*Trt Young G2 G4 -0.5 0.461 48 -1.13 0.26238 Tukey-K 0.7877
T5m 1 AgeCat*Trt Young G2 G5 -0.9 0.461 48 -1.91 0.06214 Tukey-K 0.3262
T5m 1 AgeCat*Trt Young G3 G4 -0.5 0.461 48 -1.19 0.23995 Tukey-K 0.7571
T5m 1 AgeCat*Trt Young G3 G5 -0.9 0.461 48 -1.97 0.05515 Tukey-K 0.2981
T5m 1 AgeCat*Trt Young G4 G5 -0.4 0.461 48 -0.78 0.44173 Tukey-K 0.9364
T5p 1 AgeCat*Trt Middle G1 G2 -0.7 0.759 48 -0.98 0.33252 Tukey-K 0.8634
T5p 1 AgeCat*Trt Middle G1 G3 -0.2 0.759 48 -0.26 0.7998 Tukey-K 0.999 
T5p 1 AgeCat*Trt Middle G1 G4 -0 0.759 48 -0.06 0.9523 Tukey-K 1 
T5p 1 AgeCat*Trt Middle G1 G5 0.59 0.759 48 0.774 0.44263 Tukey-K 0.9368 
T5p 1 AgeCat*Trt Middle G2 G3 0.55 0.759 48 0.724 0.47263 Tukey-K 0.9499 
T5p 1 AgeCat*Trt Middle G2 G4 0.7 0.759 48 0.919 0.3628 Tukey-K 0.8883 
T5p 1 AgeCat*Trt Middle G2 G5 1.33 0.759 48 1.753 0.08597 Tukey-K 0.4123 
T5p 1 AgeCat*Trt Middle G3 G4 0.15 0.759 48 0.195 0.84631 Tukey-K 0.9997 
T5p 1 AgeCat*Trt Middle G3 G5 0.78 0.759 48 1.029 0.30856 Tukey-K 0.8406 
T5p 1 AgeCat*Trt Middle G4 G5 0.63 0.759 48 0.834 0.40824 Tukey-K 0.9186 
T5p 1 AgeCat*Trt Old G1 G2 -1 0.537 48 -1.95 0.05721 Tukey-K 0.3066
T5p 1 AgeCat*Trt Old G1 G3 -1 0.537 48 -1.81 0.07653 Tukey-K 0.3798
T5p 1 AgeCat*Trt Old G1 G4 -0.6 0.537 48 -1.12 0.26687 Tukey-K 0.7934
T5p 1 AgeCat*Trt Old G1 G5 -0.6 0.537 48 -1.05 0.30087 Tukey-K 0.8327
T5p 1 AgeCat*Trt Old G2 G3 0.07 0.537 48 0.138 0.89055 Tukey-K 0.9999 
T5p 1 AgeCat*Trt Old G2 G4 0.44 0.537 48 0.825 0.41336 Tukey-K 0.9215 
T5p 1 AgeCat*Trt Old G2 G5 0.48 0.537 48 0.903 0.37121 Tukey-K 0.8945 
T5p 1 AgeCat*Trt Old G3 G4 0.37 0.537 48 0.687 0.4955 Tukey-K 0.9584 
T5p 1 AgeCat*Trt Old G3 G5 0.41 0.537 48 0.764 0.44841 Tukey-K 0.9395 
T5p 1 AgeCat*Trt Old G4 G5 0.04 0.537 48 0.078 0.93854 Tukey-K 1 
T5p 1 AgeCat*Trt Young G1 G2 0.47 0.537 48 0.876 0.38523 Tukey-K 0.9042 
T5p 1 AgeCat*Trt Young G1 G3 0.26 0.537 48 0.491 0.62536 Tukey-K 0.9878 
T5p 1 AgeCat*Trt Young G1 G4 0.59 0.537 48 1.096 0.27835 Tukey-K 0.8075 
T5p 1 AgeCat*Trt Young G1 G5 0.13 0.537 48 0.235 0.81504 Tukey-K 0.9993 
T5p 1 AgeCat*Trt Young G2 G3 -0.2 0.537 48 -0.38 0.70204 Tukey-K 0.9952
T5p 1 AgeCat*Trt Young G2 G4 0.12 0.537 48 0.22 0.82669 Tukey-K 0.9995 
T5p 1 AgeCat*Trt Young G2 G5 -0.3 0.537 48 -0.64 0.52452 Tukey-K 0.9675
T5p 1 AgeCat*Trt Young G3 G4 0.32 0.537 48 0.605 0.54802 Tukey-K 0.9736 
T5p 1 AgeCat*Trt Young G3 G5 -0.1 0.537 48 -0.26 0.79888 Tukey-K 0.999 
T5p 1 AgeCat*Trt Young G4 G5 -0.5 0.537 48 -0.86 0.3934 Tukey-K 0.9095 
T6m 1 AgeCat*Trt Middle G1 G2 -0.7 1.11 56 -0.6 0.54853 Tukey-K 0.9739 
T6m 1 AgeCat*Trt Middle G1 G3 -0.8 1.11 56 -0.71 0.48014 Tukey-K 0.9531
T6m 1 AgeCat*Trt Middle G1 G4 0.23 1.11 56 0.205 0.83818 Tukey-K 0.9996 
T6m 1 AgeCat*Trt Middle G1 G5 -1 1.11 56 -0.88 0.38263 Tukey-K 0.903 
T6m 1 AgeCat*Trt Middle G2 G3 -0.1 1.132 52 -0.11 0.91666 Tukey-K 1 
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T6m 1 AgeCat*Trt Middle G2 G4 0.9 1.132 52 0.793 0.43126 Tukey-K 0.9315 
T6m 1 AgeCat*Trt Middle G2 G5 -0.3 1.132 52 -0.27 0.78744 Tukey-K 0.9988
T6m 1 AgeCat*Trt Middle G3 G4 1.02 1.132 52 0.898 0.37313 Tukey-K 0.8963 
T6m 1 AgeCat*Trt Middle G3 G5 -0.2 1.132 52 -0.17 0.86889 Tukey-K 0.9998
T6m 1 AgeCat*Trt Middle G4 G5 -1.2 1.132 52 -1.06 0.29212 Tukey-K 0.8238
T6m 1 AgeCat*Trt Old G1 G2 -0.6 0.741 52 -0.84 0.40639 Tukey-K 0.9178
T6m 1 AgeCat*Trt Old G1 G3 -0.2 0.741 52 -0.33 0.74136 Tukey-K 0.9973
T6m 1 AgeCat*Trt Old G1 G4 0.23 0.741 52 0.306 0.76051 Tukey-K 0.998 
T6m 1 AgeCat*Trt Old G1 G5 -0.7 0.741 52 -0.94 0.35123 Tukey-K 0.8797
T6m 1 AgeCat*Trt Old G2 G3 0.37 0.741 52 0.505 0.61553 Tukey-K 0.9865 
T6m 1 AgeCat*Trt Old G2 G4 0.85 0.741 52 1.143 0.25806 Tukey-K 0.7828 
T6m 1 AgeCat*Trt Old G2 G5 -0.1 0.741 52 -0.1 0.9179 Tukey-K 1 
T6m 1 AgeCat*Trt Old G3 G4 0.47 0.741 52 0.638 0.52612 Tukey-K 0.9681 
T6m 1 AgeCat*Trt Old G3 G5 -0.5 0.741 52 -0.61 0.54529 Tukey-K 0.9731
T6m 1 AgeCat*Trt Old G4 G5 -0.9 0.741 52 -1.25 0.21795 Tukey-K 0.7241
T6m 1 AgeCat*Trt Young G1 G2 -0.6 0.8 52 -0.74 0.46421 Tukey-K 0.9467
T6m 1 AgeCat*Trt Young G1 G3 0.51 0.8 52 0.637 0.52713 Tukey-K 0.9684 
T6m 1 AgeCat*Trt Young G1 G4 -0.5 0.8 52 -0.56 0.5746 Tukey-K 0.9796 
T6m 1 AgeCat*Trt Young G1 G5 0.56 0.8 52 0.698 0.48804 Tukey-K 0.956 
T6m 1 AgeCat*Trt Young G2 G3 1.1 0.8 52 1.374 0.1753 Tukey-K 0.6467 
T6m 1 AgeCat*Trt Young G2 G4 0.14 0.8 52 0.173 0.8637 Tukey-K 0.9998 
T6m 1 AgeCat*Trt Young G2 G5 1.15 0.8 52 1.436 0.15704 Tukey-K 0.6078 
T6m 1 AgeCat*Trt Young G3 G4 -1 0.8 52 -1.2 0.23498 Tukey-K 0.7505 
T6m 1 AgeCat*Trt Young G3 G5 0.05 0.8 52 0.062 0.95102 Tukey-K 1 
T6m 1 AgeCat*Trt Young G4 G5 1.01 0.8 52 1.263 0.21212 Tukey-K 0.7145 
T6p 1 AgeCat*Trt Middle G1 G2 0.88 1.035 51 0.847 0.40073 Tukey-K 0.9143 
T6p 1 AgeCat*Trt Middle G1 G3 1.5 1.035 51 1.452 0.15263 Tukey-K 0.5977 
T6p 1 AgeCat*Trt Middle G1 G4 1.49 1.035 51 1.443 0.15512 Tukey-K 0.6033 
T6p 1 AgeCat*Trt Middle G1 G5 3.09 1.035 51 2.989 0.00429 Tukey-K 0.0334 
T6p 1 AgeCat*Trt Middle G2 G3 0.63 1.035 51 0.605 0.54815 Tukey-K 0.9737 
T6p 1 AgeCat*Trt Middle G2 G4 0.62 1.035 51 0.596 0.55405 Tukey-K 0.9751 
T6p 1 AgeCat*Trt Middle G2 G5 2.22 1.035 51 2.142 0.03699 Tukey-K 0.2186 
T6p 1 AgeCat*Trt Middle G3 G4 -0 1.035 51 -0.01 0.99291 Tukey-K 1 
T6p 1 AgeCat*Trt Middle G3 G5 1.59 1.035 51 1.537 0.13038 Tukey-K 0.5436 
T6p 1 AgeCat*Trt Middle G4 G5 1.6 1.035 51 1.546 0.12821 Tukey-K 0.538 
T6p 1 AgeCat*Trt Old G1 G2 -1.2 0.677 51 -1.7 0.09514 Tukey-K 0.4428 
T6p 1 AgeCat*Trt Old G1 G3 -1.4 0.677 51 -2.1 0.04047 Tukey-K 0.2349 
T6p 1 AgeCat*Trt Old G1 G4 -0.6 0.677 51 -0.89 0.38025 Tukey-K 0.9011
T6p 1 AgeCat*Trt Old G1 G5 -1.8 0.677 51 -2.66 0.01053 Tukey-K 0.0752
T6p 1 AgeCat*Trt Old G2 G3 -0.3 0.677 51 -0.4 0.68937 Tukey-K 0.9943 
T6p 1 AgeCat*Trt Old G2 G4 0.55 0.677 51 0.815 0.41868 Tukey-K 0.9247 
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T6p 1 AgeCat*Trt Old G2 G5 -0.6 0.677 51 -0.96 0.34394 Tukey-K 0.8736
T6p 1 AgeCat*Trt Old G3 G4 0.82 0.677 51 1.217 0.22909 Tukey-K 0.7414 
T6p 1 AgeCat*Trt Old G3 G5 -0.4 0.677 51 -0.55 0.58248 Tukey-K 0.981 
T6p 1 AgeCat*Trt Old G4 G5 -1.2 0.677 51 -1.77 0.0826 Tukey-K 0.4016 
T6p 1 AgeCat*Trt Young G1 G2 -0.8 0.775 51 -1 0.32296 Tukey-K 0.855 
T6p 1 AgeCat*Trt Young G1 G3 -0.1 0.732 51 -0.15 0.87919 Tukey-K 0.9999
T6p 1 AgeCat*Trt Young G1 G4 -0.3 0.732 51 -0.35 0.72769 Tukey-K 0.9967
T6p 1 AgeCat*Trt Young G1 G5 0.02 0.732 51 0.025 0.98026 Tukey-K 1 
T6p 1 AgeCat*Trt Young G2 G3 0.66 0.775 51 0.854 0.39715 Tukey-K 0.9121 
T6p 1 AgeCat*Trt Young G2 G4 0.52 0.775 51 0.668 0.50735 Tukey-K 0.9624 
T6p 1 AgeCat*Trt Young G2 G5 0.79 0.775 51 1.021 0.31183 Tukey-K 0.8443 
T6p 1 AgeCat*Trt Young G3 G4 -0.1 0.732 51 -0.2 0.84433 Tukey-K 0.9996 
T6p 1 AgeCat*Trt Young G3 G5 0.13 0.732 51 0.178 0.85972 Tukey-K 0.9998 
T6p 1 AgeCat*Trt Young G4 G5 0.27 0.732 51 0.375 0.70922 Tukey-K 0.9957 
T7m 1 AgeCat*Trt Middle G1 G2 -0.4 0.995 60 -0.41 0.68199 Tukey-K 0.9938
T7m 1 AgeCat*Trt Middle G1 G3 -0.3 0.906 59 -0.36 0.72259 Tukey-K 0.9964
T7m 1 AgeCat*Trt Middle G1 G4 0.07 0.906 59 0.074 0.94155 Tukey-K 1 
T7m 1 AgeCat*Trt Middle G1 G5 -0.6 0.906 59 -0.72 0.47723 Tukey-K 0.9522
T7m 1 AgeCat*Trt Middle G2 G3 0.09 0.995 60 0.087 0.93112 Tukey-K 1 
T7m 1 AgeCat*Trt Middle G2 G4 0.48 0.995 60 0.479 0.63381 Tukey-K 0.989 
T7m 1 AgeCat*Trt Middle G2 G5 -0.2 0.995 60 -0.24 0.81124 Tukey-K 0.9992
T7m 1 AgeCat*Trt Middle G3 G4 0.39 0.906 59 0.43 0.66852 Tukey-K 0.9927 
T7m 1 AgeCat*Trt Middle G3 G5 -0.3 0.906 59 -0.36 0.72116 Tukey-K 0.9964
T7m 1 AgeCat*Trt Middle G4 G5 -0.7 0.906 59 -0.79 0.4333 Tukey-K 0.9328 
T7m 1 AgeCat*Trt Old G1 G2 0.73 0.641 59 1.146 0.25635 Tukey-K 0.7813 
T7m 1 AgeCat*Trt Old G1 G3 2.15 0.641 59 3.354 0.0014 Tukey-K 0.0117 
T7m 1 AgeCat*Trt Old G1 G4 1.46 0.641 59 2.278 0.02637 Tukey-K 0.1666 
T7m 1 AgeCat*Trt Old G1 G5 0.32 0.641 59 0.493 0.62387 Tukey-K 0.9877 
T7m 1 AgeCat*Trt Old G2 G3 1.41 0.641 59 2.208 0.03115 Tukey-K 0.1911 
T7m 1 AgeCat*Trt Old G2 G4 0.72 0.641 59 1.132 0.26236 Tukey-K 0.7892 
T7m 1 AgeCat*Trt Old G2 G5 -0.4 0.641 59 -0.65 0.51615 Tukey-K 0.9654
T7m 1 AgeCat*Trt Old G3 G4 -0.7 0.641 59 -1.08 0.28622 Tukey-K 0.818 
T7m 1 AgeCat*Trt Old G3 G5 -1.8 0.641 59 -2.86 0.00583 Tukey-K 0.0444
T7m 1 AgeCat*Trt Old G4 G5 -1.1 0.641 59 -1.78 0.07942 Tukey-K 0.3919
T7m 1 AgeCat*Trt Young G1 G2 0.43 0.74 59 0.577 0.56638 Tukey-K 0.978 
T7m 1 AgeCat*Trt Young G1 G3 1.04 0.74 59 1.403 0.16581 Tukey-K 0.6281 
T7m 1 AgeCat*Trt Young G1 G4 1.32 0.74 59 1.789 0.0787 Tukey-K 0.3894 
T7m 1 AgeCat*Trt Young G1 G5 0.11 0.74 59 0.146 0.8841 Tukey-K 0.9999 
T7m 1 AgeCat*Trt Young G2 G3 0.61 0.74 59 0.826 0.41185 Tukey-K 0.9214 
T7m 1 AgeCat*Trt Young G2 G4 0.9 0.74 59 1.213 0.23011 Tukey-K 0.7441 
T7m 1 AgeCat*Trt Young G2 G5 -0.3 0.74 59 -0.43 0.66859 Tukey-K 0.9927
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T7m 1 AgeCat*Trt Young G3 G4 0.29 0.74 59 0.386 0.7008 Tukey-K 0.9952 
T7m 1 AgeCat*Trt Young G3 G5 -0.9 0.74 59 -1.26 0.2138 Tukey-K 0.7183 
T7m 1 AgeCat*Trt Young G4 G5 -1.2 0.74 59 -1.64 0.10573 Tukey-K 0.4767
T7p 1 AgeCat*Trt Middle G1 G2 0.8 0.963 60 0.835 0.40709 Tukey-K 0.9187 
T7p 1 AgeCat*Trt Middle G1 G3 -0.6 0.963 60 -0.65 0.51621 Tukey-K 0.9654
T7p 1 AgeCat*Trt Middle G1 G4 -0.1 0.963 60 -0.15 0.88184 Tukey-K 0.9999
T7p 1 AgeCat*Trt Middle G1 G5 0.05 0.963 60 0.048 0.96211 Tukey-K 1 
T7p 1 AgeCat*Trt Middle G2 G3 -1.4 0.963 60 -1.49 0.142 Tukey-K 0.5742 
T7p 1 AgeCat*Trt Middle G2 G4 -0.9 0.963 60 -0.98 0.32898 Tukey-K 0.8614
T7p 1 AgeCat*Trt Middle G2 G5 -0.8 0.963 60 -0.79 0.43427 Tukey-K 0.9334
T7p 1 AgeCat*Trt Middle G3 G4 0.48 0.963 60 0.504 0.61625 Tukey-K 0.9867 
T7p 1 AgeCat*Trt Middle G3 G5 0.67 0.963 60 0.701 0.48615 Tukey-K 0.9555 
T7p 1 AgeCat*Trt Middle G4 G5 0.19 0.963 60 0.197 0.8445 Tukey-K 0.9997 
T7p 1 AgeCat*Trt Old G1 G2 -1.1 0.681 60 -1.58 0.11955 Tukey-K 0.5163
T7p 1 AgeCat*Trt Old G1 G3 0.13 0.681 60 0.185 0.85417 Tukey-K 0.9997 
T7p 1 AgeCat*Trt Old G1 G4 0.55 0.681 60 0.812 0.42008 Tukey-K 0.926 
T7p 1 AgeCat*Trt Old G1 G5 -0.3 0.681 60 -0.43 0.6713 Tukey-K 0.9929 
T7p 1 AgeCat*Trt Old G2 G3 1.2 0.681 60 1.764 0.08286 Tukey-K 0.404 
T7p 1 AgeCat*Trt Old G2 G4 1.63 0.681 60 2.391 0.01995 Tukey-K 0.1319 
T7p 1 AgeCat*Trt Old G2 G5 0.78 0.681 60 1.153 0.2536 Tukey-K 0.7778 
T7p 1 AgeCat*Trt Old G3 G4 0.43 0.681 60 0.627 0.53285 Tukey-K 0.9701 
T7p 1 AgeCat*Trt Old G3 G5 -0.4 0.681 60 -0.61 0.54347 Tukey-K 0.9728
T7p 1 AgeCat*Trt Old G4 G5 -0.8 0.681 60 -1.24 0.22042 Tukey-K 0.7291
T7p 1 AgeCat*Trt Young G1 G2 -0.7 0.786 60 -0.9 0.37231 Tukey-K 0.8962 
T7p 1 AgeCat*Trt Young G1 G3 0.22 0.786 60 0.278 0.78182 Tukey-K 0.9987 
T7p 1 AgeCat*Trt Young G1 G4 0.1 0.786 60 0.125 0.90069 Tukey-K 0.9999 
T7p 1 AgeCat*Trt Young G1 G5 -0.2 0.786 60 -0.26 0.7942 Tukey-K 0.9989 
T7p 1 AgeCat*Trt Young G2 G3 0.93 0.786 60 1.177 0.24382 Tukey-K 0.7643 
T7p 1 AgeCat*Trt Young G2 G4 0.8 0.786 60 1.024 0.30986 Tukey-K 0.8432 
T7p 1 AgeCat*Trt Young G2 G5 0.5 0.786 60 0.637 0.52664 Tukey-K 0.9684 
T7p 1 AgeCat*Trt Young G3 G4 -0.1 0.786 60 -0.15 0.87901 Tukey-K 0.9999
T7p 1 AgeCat*Trt Young G3 G5 -0.4 0.786 60 -0.54 0.59105 Tukey-K 0.9827
T7p 1 AgeCat*Trt Young G4 G5 -0.3 0.786 60 -0.39 0.69988 Tukey-K 0.9951
T8m 1 AgeCat*Trt Middle G1 G2 -1 1.06 60 -0.93 0.35752 Tukey-K 0.8852
T8m 1 AgeCat*Trt Middle G1 G3 -0.8 1.06 60 -0.77 0.44418 Tukey-K 0.9382
T8m 1 AgeCat*Trt Middle G1 G4 0.51 1.06 60 0.483 0.63068 Tukey-K 0.9886 
T8m 1 AgeCat*Trt Middle G1 G5 0.15 1.06 60 0.142 0.88734 Tukey-K 0.9999 
T8m 1 AgeCat*Trt Middle G2 G3 0.17 1.06 60 0.157 0.87578 Tukey-K 0.9999 
T8m 1 AgeCat*Trt Middle G2 G4 1.49 1.06 60 1.41 0.16356 Tukey-K 0.6234 
T8m 1 AgeCat*Trt Middle G2 G5 1.13 1.06 60 1.07 0.28912 Tukey-K 0.8213 
T8m 1 AgeCat*Trt Middle G3 G4 1.33 1.06 60 1.253 0.21489 Tukey-K 0.7202 
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T8m 1 AgeCat*Trt Middle G3 G5 0.97 1.06 60 0.913 0.36515 Tukey-K 0.891 
T8m 1 AgeCat*Trt Middle G4 G5 -0.4 1.06 60 -0.34 0.73432 Tukey-K 0.997 
T8m 1 AgeCat*Trt Old G1 G2 0.69 0.749 60 0.919 0.36162 Tukey-K 0.8884 
T8m 1 AgeCat*Trt Old G1 G3 0.99 0.749 60 1.321 0.19166 Tukey-K 0.6796 
T8m 1 AgeCat*Trt Old G1 G4 -0 0.749 60 -0.01 0.99058 Tukey-K 1 
T8m 1 AgeCat*Trt Old G1 G5 0.39 0.749 60 0.525 0.60153 Tukey-K 0.9845 
T8m 1 AgeCat*Trt Old G2 G3 0.3 0.749 60 0.401 0.68966 Tukey-K 0.9944 
T8m 1 AgeCat*Trt Old G2 G4 -0.7 0.749 60 -0.93 0.3555 Tukey-K 0.8837 
T8m 1 AgeCat*Trt Old G2 G5 -0.3 0.749 60 -0.39 0.69474 Tukey-K 0.9948
T8m 1 AgeCat*Trt Old G3 G4 -1 0.749 60 -1.33 0.18776 Tukey-K 0.6723
T8m 1 AgeCat*Trt Old G3 G5 -0.6 0.749 60 -0.8 0.42941 Tukey-K 0.9309 
T8m 1 AgeCat*Trt Old G4 G5 0.4 0.749 60 0.537 0.59336 Tukey-K 0.9831 
T8m 1 AgeCat*Trt Young G1 G2 0.57 0.865 60 0.655 0.51522 Tukey-K 0.9651 
T8m 1 AgeCat*Trt Young G1 G3 0.73 0.865 60 0.845 0.40135 Tukey-K 0.9153 
T8m 1 AgeCat*Trt Young G1 G4 1.18 0.865 60 1.362 0.1782 Tukey-K 0.6537 
T8m 1 AgeCat*Trt Young G1 G5 -0.1 0.865 60 -0.14 0.88923 Tukey-K 0.9999
T8m 1 AgeCat*Trt Young G2 G3 0.16 0.865 60 0.191 0.84948 Tukey-K 0.9997 
T8m 1 AgeCat*Trt Young G2 G4 0.61 0.865 60 0.708 0.48188 Tukey-K 0.954 
T8m 1 AgeCat*Trt Young G2 G5 -0.7 0.865 60 -0.79 0.43005 Tukey-K 0.9312
T8m 1 AgeCat*Trt Young G3 G4 0.45 0.865 60 0.517 0.607 Tukey-K 0.9853 
T8m 1 AgeCat*Trt Young G3 G5 -0.9 0.865 60 -0.99 0.32854 Tukey-K 0.861 
T8m 1 AgeCat*Trt Young G4 G5 -1.3 0.865 60 -1.5 0.1383 Tukey-K 0.5652 
T8p 1 AgeCat*Trt Middle G1 G2 -0.2 0.915 60 -0.19 0.85295 Tukey-K 0.9997
T8p 1 AgeCat*Trt Middle G1 G3 -1.5 0.915 60 -1.68 0.09813 Tukey-K 0.4538
T8p 1 AgeCat*Trt Middle G1 G4 0.33 0.915 60 0.362 0.71859 Tukey-K 0.9962 
T8p 1 AgeCat*Trt Middle G1 G5 0.51 0.915 60 0.555 0.58086 Tukey-K 0.9809 
T8p 1 AgeCat*Trt Middle G2 G3 -1.4 0.915 60 -1.49 0.14042 Tukey-K 0.5704
T8p 1 AgeCat*Trt Middle G2 G4 0.5 0.915 60 0.548 0.58559 Tukey-K 0.9818 
T8p 1 AgeCat*Trt Middle G2 G5 0.68 0.915 60 0.741 0.4614 Tukey-K 0.9458 
T8p 1 AgeCat*Trt Middle G3 G4 1.87 0.915 60 2.042 0.04554 Tukey-K 0.259 
T8p 1 AgeCat*Trt Middle G3 G5 2.04 0.915 60 2.235 0.02913 Tukey-K 0.181 
T8p 1 AgeCat*Trt Middle G4 G5 0.18 0.915 60 0.193 0.84753 Tukey-K 0.9997 
T8p 1 AgeCat*Trt Old G1 G2 -0.3 0.647 60 -0.5 0.61722 Tukey-K 0.9868 
T8p 1 AgeCat*Trt Old G1 G3 -1.2 0.647 60 -1.87 0.06642 Tukey-K 0.3447
T8p 1 AgeCat*Trt Old G1 G4 0.08 0.647 60 0.118 0.90681 Tukey-K 1 
T8p 1 AgeCat*Trt Old G1 G5 -0 0.647 60 -0.08 0.93885 Tukey-K 1 
T8p 1 AgeCat*Trt Old G2 G3 -0.9 0.647 60 -1.37 0.17666 Tukey-K 0.6507
T8p 1 AgeCat*Trt Old G2 G4 0.4 0.647 60 0.62 0.53762 Tukey-K 0.9713 
T8p 1 AgeCat*Trt Old G2 G5 0.28 0.647 60 0.425 0.67209 Tukey-K 0.993 
T8p 1 AgeCat*Trt Old G3 G4 1.29 0.647 60 1.987 0.05147 Tukey-K 0.2847 
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T8p 1 AgeCat*Trt Old G3 G5 1.16 0.647 60 1.793 0.07808 Tukey-K 0.3874 
T8p 1 AgeCat*Trt Old G4 G5 -0.1 0.647 60 -0.19 0.84636 Tukey-K 0.9997
T8p 1 AgeCat*Trt Young G1 G2 0.66 0.747 60 0.882 0.3812 Tukey-K 0.9024 
T8p 1 AgeCat*Trt Young G1 G3 0.33 0.747 60 0.439 0.66226 Tukey-K 0.9921 
T8p 1 AgeCat*Trt Young G1 G4 0.22 0.747 60 0.301 0.76483 Tukey-K 0.9982 
T8p 1 AgeCat*Trt Young G1 G5 0.19 0.747 60 0.25 0.80326 Tukey-K 0.9991 
T8p 1 AgeCat*Trt Young G2 G3 -0.3 0.747 60 -0.44 0.6592 Tukey-K 0.9918 
T8p 1 AgeCat*Trt Young G2 G4 -0.4 0.747 60 -0.58 0.56296 Tukey-K 0.9773
T8p 1 AgeCat*Trt Young G2 G5 -0.5 0.747 60 -0.63 0.52982 Tukey-K 0.9693
T8p 1 AgeCat*Trt Young G3 G4 -0.1 0.747 60 -0.14 0.89034 Tukey-K 0.9999
T8p 1 AgeCat*Trt Young G3 G5 -0.1 0.747 60 -0.19 0.85094 Tukey-K 0.9997
T8p 1 AgeCat*Trt Young G4 G5 -0 0.747 60 -0.05 0.96007 Tukey-K 1 
T9m 1 AgeCat*Trt Middle G1 G2 -0.4 0.693 60 -0.54 0.59379 Tukey-K 0.9832
T9m 1 AgeCat*Trt Middle G1 G3 -0.4 0.693 60 -0.56 0.58014 Tukey-K 0.9807
T9m 1 AgeCat*Trt Middle G1 G4 1.04 0.693 60 1.505 0.1376 Tukey-K 0.5634 
T9m 1 AgeCat*Trt Middle G1 G5 -0.8 0.693 60 -1.22 0.22774 Tukey-K 0.7406
T9m 1 AgeCat*Trt Middle G2 G3 -0 0.693 60 -0.02 0.98411 Tukey-K 1 
T9m 1 AgeCat*Trt Middle G2 G4 1.41 0.693 60 2.041 0.04565 Tukey-K 0.2595 
T9m 1 AgeCat*Trt Middle G2 G5 -0.5 0.693 60 -0.68 0.49758 Tukey-K 0.9595
T9m 1 AgeCat*Trt Middle G3 G4 1.43 0.693 60 2.061 0.04363 Tukey-K 0.2505 
T9m 1 AgeCat*Trt Middle G3 G5 -0.5 0.693 60 -0.66 0.51022 Tukey-K 0.9636
T9m 1 AgeCat*Trt Middle G4 G5 -1.9 0.693 60 -2.72 0.00845 Tukey-K 0.0622
T9m 1 AgeCat*Trt Old G1 G2 0.23 0.49 60 0.466 0.64306 Tukey-K 0.9901 
T9m 1 AgeCat*Trt Old G1 G3 0.34 0.49 60 0.701 0.48609 Tukey-K 0.9555 
T9m 1 AgeCat*Trt Old G1 G4 0.6 0.49 60 1.226 0.22488 Tukey-K 0.7362 
T9m 1 AgeCat*Trt Old G1 G5 0.3 0.49 60 0.615 0.54079 Tukey-K 0.9721 
T9m 1 AgeCat*Trt Old G2 G3 0.12 0.49 60 0.235 0.81493 Tukey-K 0.9993 
T9m 1 AgeCat*Trt Old G2 G4 0.37 0.49 60 0.761 0.44992 Tukey-K 0.9408 
T9m 1 AgeCat*Trt Old G2 G5 0.07 0.49 60 0.149 0.88177 Tukey-K 0.9999 
T9m 1 AgeCat*Trt Old G3 G4 0.26 0.49 60 0.525 0.60122 Tukey-K 0.9844 
T9m 1 AgeCat*Trt Old G3 G5 -0 0.49 60 -0.09 0.93197 Tukey-K 1 
T9m 1 AgeCat*Trt Old G4 G5 -0.3 0.49 60 -0.61 0.5434 Tukey-K 0.9728 
T9m 1 AgeCat*Trt Young G1 G2 0.35 0.566 60 0.62 0.53762 Tukey-K 0.9713 
T9m 1 AgeCat*Trt Young G1 G3 0.6 0.566 60 1.069 0.28957 Tukey-K 0.8218 
T9m 1 AgeCat*Trt Young G1 G4 -0.3 0.566 60 -0.51 0.60925 Tukey-K 0.9857
T9m 1 AgeCat*Trt Young G1 G5 -0.2 0.566 60 -0.31 0.75552 Tukey-K 0.9979
T9m 1 AgeCat*Trt Young G2 G3 0.25 0.566 60 0.449 0.65539 Tukey-K 0.9914 
T9m 1 AgeCat*Trt Young G2 G4 -0.6 0.566 60 -1.13 0.26138 Tukey-K 0.788 
T9m 1 AgeCat*Trt Young G2 G5 -0.5 0.566 60 -0.93 0.35467 Tukey-K 0.883 
T9m 1 AgeCat*Trt Young G3 G4 -0.9 0.566 60 -1.58 0.11882 Tukey-K 0.5143
T9m 1 AgeCat*Trt Young G3 G5 -0.8 0.566 60 -1.38 0.17231 Tukey-K 0.6418
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T9m 1 AgeCat*Trt Young G4 G5 0.11 0.566 60 0.201 0.84134 Tukey-K 0.9996 
T9p 1 AgeCat*Trt Middle G1 G2 -0.4 0.951 60 -0.39 0.69892 Tukey-K 0.995 
T9p 1 AgeCat*Trt Middle G1 G3 -0.9 0.951 60 -0.91 0.36893 Tukey-K 0.8938
T9p 1 AgeCat*Trt Middle G1 G4 -0.2 0.951 60 -0.16 0.87467 Tukey-K 0.9999
T9p 1 AgeCat*Trt Middle G1 G5 0.33 0.951 60 0.347 0.72968 Tukey-K 0.9968 
T9p 1 AgeCat*Trt Middle G2 G3 -0.5 0.951 60 -0.52 0.6073 Tukey-K 0.9854 
T9p 1 AgeCat*Trt Middle G2 G4 0.22 0.951 60 0.23 0.81869 Tukey-K 0.9994 
T9p 1 AgeCat*Trt Middle G2 G5 0.7 0.951 60 0.736 0.46472 Tukey-K 0.9472 
T9p 1 AgeCat*Trt Middle G3 G4 0.71 0.951 60 0.747 0.45805 Tukey-K 0.9444 
T9p 1 AgeCat*Trt Middle G3 G5 1.19 0.951 60 1.252 0.21526 Tukey-K 0.7208 
T9p 1 AgeCat*Trt Middle G4 G5 0.48 0.951 60 0.506 0.61501 Tukey-K 0.9865 
T9p 1 AgeCat*Trt Old G1 G2 -0.8 0.672 60 -1.19 0.23779 Tukey-K 0.7556
T9p 1 AgeCat*Trt Old G1 G3 -0.3 0.672 60 -0.43 0.66891 Tukey-K 0.9927
T9p 1 AgeCat*Trt Old G1 G4 0.33 0.672 60 0.484 0.63046 Tukey-K 0.9886 
T9p 1 AgeCat*Trt Old G1 G5 0.51 0.672 60 0.76 0.45005 Tukey-K 0.9409 
T9p 1 AgeCat*Trt Old G2 G3 0.51 0.672 60 0.763 0.44865 Tukey-K 0.9402 
T9p 1 AgeCat*Trt Old G2 G4 1.13 0.672 60 1.676 0.09894 Tukey-K 0.4563 
T9p 1 AgeCat*Trt Old G2 G5 1.31 0.672 60 1.953 0.05552 Tukey-K 0.3016 
T9p 1 AgeCat*Trt Old G3 G4 0.61 0.672 60 0.913 0.36473 Tukey-K 0.8907 
T9p 1 AgeCat*Trt Old G3 G5 0.8 0.672 60 1.19 0.23871 Tukey-K 0.757 
T9p 1 AgeCat*Trt Old G4 G5 0.19 0.672 60 0.277 0.78293 Tukey-K 0.9987 
T9p 1 AgeCat*Trt Young G1 G2 -0 0.776 60 -0.06 0.95126 Tukey-K 1 
T9p 1 AgeCat*Trt Young G1 G3 -0.3 0.776 60 -0.35 0.73086 Tukey-K 0.9969
T9p 1 AgeCat*Trt Young G1 G4 0.41 0.776 60 0.523 0.60314 Tukey-K 0.9847 
T9p 1 AgeCat*Trt Young G1 G5 -0.7 0.776 60 -0.92 0.36282 Tukey-K 0.8893
T9p 1 AgeCat*Trt Young G2 G3 -0.2 0.776 60 -0.28 0.77723 Tukey-K 0.9985
T9p 1 AgeCat*Trt Young G2 G4 0.45 0.776 60 0.584 0.56138 Tukey-K 0.977 
T9p 1 AgeCat*Trt Young G2 G5 -0.7 0.776 60 -0.86 0.39562 Tukey-K 0.9117
T9p 1 AgeCat*Trt Young G3 G4 0.67 0.776 60 0.868 0.38872 Tukey-K 0.9074 
T9p 1 AgeCat*Trt Young G3 G5 -0.4 0.776 60 -0.57 0.56987 Tukey-K 0.9787
T9p 1 AgeCat*Trt Young G4 G5 -1.1 0.776 60 -1.44 0.15517 Tukey-K 0.6049
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SUM STATS: 
GAVE THE VALUES THAT WE NEED TO PLOTED WITH STANDARED ERROR 
- Back trans formed means can be substantially lower than the means in the original scale,
particularly when transformation is log
Transformation: adding a constant is required to take logs when there are zero’s in the data 
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SUM STATS 
Var AgeCat Trt n mean_Y sd_Y SE_Y mean_logY sd_logY SE_logY 
T10m Middle G1 4 0.6086 0.2757 0.1379 -0.59 0.5353 0.2677 
T10m Middle G2 4 0.6959 0.5016 0.2508 -0.57 0.7489 0.3745 
T10m Middle G3 4 0.7848 0.8599 0.4299 -0.72 1.1725 0.5862 
T10m Middle G4 4 0.4226 0.4414 0.2207 -1.21 0.9221 0.4611 
T10m Middle G5 4 0.9513 0.7054 0.3527 -0.34 0.9799 0.4899 
T10m Old G1 8 3.4713 4.8926 1.7298 0.631 1.1473 0.4056 
T10m Old G2 8 1.9068 2.9553 1.0449 -0.7 2.7561 0.9744 
T10m Old G3 8 2.8869 6.2794 2.2201 -0.97 3.0594 1.0817 
T10m Old G4 8 4.0258 9.1323 3.2288 -0.78 2.9343 1.0374 
T10m Old G5 8 4.2961 10.092 3.5681 -0.68 2.8982 1.0247 
T10m Young G1 6 3.2545 3.8733 1.5813 0.413 1.5365 0.6273 
T10m Young G2 6 1.836 1.8812 0.768 0.002 1.387 0.5662 
T10m Young G3 6 1.2564 1.3201 0.5389 -0.38 1.3688 0.5588 
T10m Young G4 6 1.5273 1.507 0.6152 -0.07 1.1443 0.4672 
T10m Young G5 6 2.3776 2.8053 1.1452 0.112 1.4293 0.5835 
T10p Middle G1 4 1.9015 1.9917 0.9959 0.267 0.9755 0.4877 
T10p Middle G2 4 5.1492 8.2997 4.1499 0.583 1.6502 0.8251 
T10p Middle G3 4 1.1028 0.6761 0.3381 -0.02 0.5436 0.2718 
T10p Middle G4 4 2.1512 1.5657 0.7829 0.548 0.784 0.392 
T10p Middle G5 4 1.8189 1.7703 0.8851 -0.12 1.6226 0.8113 
T10p Old G1 7 1.8769 1.7452 0.6596 0.154 1.2004 0.4537 
T10p Old G2 8 12.985 29.331 10.37 0.695 1.9537 0.6907 
T10p Old G3 8 12.468 30.472 10.774 0.476 1.9675 0.6956 
T10p Old G4 8 1.3931 1.5098 0.5338 -0.18 1.082 0.3826 
T10p Old G5 8 12.761 22.265 7.872 0.539 2.2399 0.7919 
T10p Young G1 6 2.6641 4.4624 1.8218 -0.28 1.9959 0.8148 
T10p Young G2 6 0.7213 0.3955 0.1615 -0.55 0.874 0.3568 
T10p Young G3 6 0.5543 0.329 0.1343 -0.94 1.1861 0.4842 
T10p Young G4 6 0.5518 0.2681 0.1095 -0.93 1.243 0.5074 
T10p Young G5 6 0.5691 0.5202 0.2124 -1.15 1.3431 0.5483 
T1m Middle G1 4 1.4394 1.3081 0.6541 0.0026 1.02 0.51 
T1m Middle G2 4 1.6605 1.7848 0.8924 0.136 0.9413 0.4707 
T1m Middle G3 4 1.6846 1.463 0.7315 -0.17 1.7698 0.8849 
T1m Middle G4 4 1.435 1.9386 0.9693 -0.41 1.4761 0.738 
T1m Middle G5 4 1.7384 1.0182 0.5091 0.346 0.8395 0.4198 
T1m Old G1 8 1.556 2.0663 0.7305 -0.199 1.2514 0.4424 
T1m Old G2 8 0.8906 0.6482 0.2292 -0.35 0.746 0.2637 
T1m Old G3 8 0.8256 0.6114 0.2161 -0.5 0.9015 0.3187 
T1m Old G4 8 0.6369 0.5313 0.1878 -0.91 1.1609 0.4104 
T1m Old G5 8 1.7706 2.5111 0.8878 -0.13 1.2509 0.4423 
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T1m Young G1 6 1.95 2.913 1.1892 0.032 1.0944 0.4468 
T1m Young G2 6 1.5712 1.1161 0.4556 0.28 0.6149 0.251 
T1m Young G3 6 0.9101 0.3996 0.1631 -0.21 0.5669 0.2314 
T1m Young G4 6 2.6444 2.6136 1.067 0.581 0.9826 0.4012 
T1m Young G5 6 1.8646 1.5972 0.6521 0.152 1.3066 0.5334 
T1p Middle G1 4 2.4276 2.3606 1.1803 0.424 1.184 0.592 
T1p Middle G2 4 0.9628 0.7186 0.3593 -0.29 0.8809 0.4405 
T1p Middle G3 4 0.7572 0.585 0.2925 -0.63 1.0763 0.5382 
T1p Middle G4 4 0.967 0.6588 0.3294 -0.24 0.7724 0.3862 
T1p Middle G5 4 1.0003 1.117 0.5585 -0.59 1.3408 0.6704 
T1p Old G1 8 3.4957 7.2361 2.5584 -0.05 1.5816 0.5592 
T1p Old G2 8 2.784 5.8565 2.0706 -0.34 1.6748 0.5921 
T1p Old G3 8 1.6201 2.3484 0.8303 -0.05 0.9653 0.3413 
T1p Old G4 8 0.921 0.8663 0.3063 -0.7 1.4705 0.5199 
T1p Old G5 8 1.3765 1.3353 0.4721 -0.23 1.3619 0.4815 
T1p Young G1 5 1.7273 1.4999 0.6708 0.177 0.9982 0.4464 
T1p Young G2 6 4.4525 7.9066 3.2279 0.378 1.5109 0.6168 
T1p Young G3 6 6.5568 13.707 5.5959 0.55 1.4719 0.6009 
T1p Young G4 6 15.42 34.492 14.081 0.697 1.9951 0.8145 
T1p Young G5 6 18.184 42.65 17.412 0.415 2.153 0.879 
T2m Middle G1 4 2.2436 2.3226 1.1613 0.235 1.367 0.6835 
T2m Middle G2 4 2.0207 1.5519 0.7759 0.51 0.693 0.3465 
T2m Middle G3 4 0.8261 0.6356 0.3178 -0.56 1.1707 0.5854 
T2m Middle G4 4 0.9173 0.6789 0.3394 -0.37 0.9277 0.4638 
T2m Middle G5 4 1.3583 0.9094 0.4547 0.122 0.7209 0.3605 
T2m Old G1 8 1.0978 1.0548 0.3729 -0.47 1.3461 0.4759 
T2m Old G2 8 0.9113 0.684 0.2418 -0.32 0.7286 0.2576 
T2m Old G3 8 0.9313 0.7725 0.2731 -0.35 0.7868 0.2782 
T2m Old G4 8 0.4148 0.2117 0.0748 -1 0.561 0.1984 
T2m Old G5 8 3.5746 8.2617 2.921 -0.09 1.4141 0.5 
T2m Young G1 6 2.9873 5.3324 2.1769 -0.05 1.7342 0.708 
T2m Young G2 6 3.1379 2.1546 0.8796 0.949 0.6828 0.2787 
T2m Young G3 6 1.7748 1.2556 0.5126 0.303 0.917 0.3744 
T2m Young G4 6 2.712 2.2205 0.9065 0.674 0.9384 0.3831 
T2m Young G5 6 2.7179 1.9331 0.7892 0.68 1.029 0.4201 
T2p Middle G1 4 1.7821 1.5526 0.7763 0.149 1.1533 0.5766 
T2p Middle G2 4 0.6143 0.5085 0.2542 -1.01 1.4706 0.7353 
T2p Middle G3 4 0.8881 0.9809 0.4904 -0.92 1.8389 0.9194 
T2p Middle G4 4 0.8844 0.7857 0.3928 -0.41 0.867 0.4335 
T2p Middle G5 4 0.7825 0.9049 0.4525 -0.83 1.3416 0.6708 
T2p Old G1 8 5.4255 13.008 4.5991 -0.44 2.1423 0.7574 
T2p Old G2 8 3.342 6.8895 2.4358 0.142 1.3373 0.4728 
T2p Old G3 8 4.0305 7.3766 2.608 0.496 1.2928 0.4571 
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T2p Old G4 8 1.494 2.1132 0.7471 -0.29 1.2524 0.4428 
T2p Old G5 8 2.3041 2.3095 0.8165 0.087 1.613 0.5703 
T2p Young G1 6 9.4224 14.244 5.8151 0.849 1.9146 0.7816 
T2p Young G2 6 9.0677 15.899 6.4909 0.747 1.8616 0.76 
T2p Young G3 6 3.926 4.5053 1.8393 0.738 1.2301 0.5022 
T2p Young G4 6 7.1101 9.8837 4.035 0.879 1.6611 0.6781 
T2p Young G5 6 5.6778 7.9088 3.2288 0.553 1.7279 0.7054 
T3m Middle G1 4 2.6864 2.3218 1.1609 0.578 1.1194 0.5597 
T3m Middle G2 4 2.5317 2.6569 1.3285 0.56 0.9611 0.4806 
T3m Middle G3 4 3.2546 3.1048 1.5524 0.276 2.1465 1.0732 
T3m Middle G4 4 1.4107 1.5771 0.7886 -0.13 1.1108 0.5554 
T3m Middle G5 4 2.1661 2.5001 1.2501 0.28 1.1521 0.576 
T3m Old G1 8 2.2298 2.8312 1.001 0.086 1.4593 0.5159 
T3m Old G2 8 1.1474 0.9394 0.3321 -0.26 1.0455 0.3696 
T3m Old G3 8 0.9162 0.6214 0.2197 -0.46 1.0691 0.378 
T3m Old G4 8 0.8304 0.6578 0.2326 -0.61 1.1283 0.3989 
T3m Old G5 8 2.9351 5.0638 1.7903 -0.13 1.7127 0.6055 
T3m Young G1 6 5.3772 9.9352 4.056 0.116 2.0977 0.8564 
T3m Young G2 6 4.053 4.9756 2.0313 0.885 1.0392 0.4242 
T3m Young G3 6 2.5174 1.8254 0.7452 0.561 1.0981 0.4483 
T3m Young G4 6 2.7737 1.7832 0.728 0.516 1.5036 0.6138 
T3m Young G5 6 3.3229 3.0062 1.2273 0.76 1.1616 0.4742 
T3p Middle G1 4 2.5481 1.9064 0.9532 0.688 0.8428 0.4214 
T3p Middle G2 4 1.7141 1.5873 0.7936 0.236 0.8901 0.445 
T3p Middle G3 4 0.7838 0.9234 0.4617 -1 1.688 0.844 
T3p Middle G4 4 1.8043 2.4085 1.2043 -0.11 1.3991 0.6995 
T3p Middle G5 4 1.2521 1.4068 0.7034 -0.42 1.4169 0.7085 
T3p Old G1 8 5.1572 11.351 4.0132 -0.08 1.8278 0.6462 
T3p Old G2 8 2.9249 6.0713 2.1465 -0.06 1.4193 0.5018 
T3p Old G3 8 3.8544 6.696 2.3674 0.474 1.2842 0.454 
T3p Old G4 8 1.8278 3.2053 1.1333 -0.32 1.3872 0.4905 
T3p Old G5 8 1.9506 2.4779 0.8761 -0.03 1.3974 0.494 
T3p Young G1 6 7.649 16.273 6.6432 0.569 1.5819 0.6458 
T3p Young G2 6 6.8758 12.049 4.9189 0.767 1.5702 0.641 
T3p Young G3 6 5.4369 10.99 4.4865 0.464 1.4415 0.5885 
T3p Young G4 6 5.1402 10.085 4.1173 0.405 1.5202 0.6206 
T3p Young G5 6 8.6649 19.81 8.0874 0.018 2.0075 0.8196 
T4m Middle G1 4 0.9391 0.5648 0.2824 -0.21 0.6339 0.317 
T4m Middle G2 4 1.2734 0.5155 0.2577 0.173 0.4375 0.2187 
T4m Middle G3 4 1.3225 0.9107 0.4554 0.06 0.794 0.397 
T4m Middle G4 4 0.615 0.3269 0.1635 -0.64 0.6897 0.3449 
T4m Middle G5 4 1.0611 0.4682 0.2341 -0.03 0.5136 0.2568 
T4m Old G1 8 2.7906 4.0831 1.4436 0.209 1.3853 0.4898 
173 
T4m Old G2 8 1.5349 2.5776 0.9113 -0.51 1.4939 0.5282 
T4m Old G3 8 1.1804 1.0605 0.3749 -0.21 0.9874 0.3491 
T4m Old G4 8 2.4215 3.6892 1.3043 -0.02 1.3657 0.4829 
T4m Old G5 8 2.5391 4.219 1.4916 0.115 1.2917 0.4567 
T4m Young G1 6 1.5825 1.6153 0.6594 0.105 0.8898 0.3632 
T4m Young G2 6 1.3598 1.3084 0.5342 0.019 0.7835 0.3199 
T4m Young G3 6 1.1994 0.9578 0.391 -0.09 0.8292 0.3385 
T4m Young G4 6 1.6322 0.7807 0.3187 0.372 0.5619 0.2294 
T4m Young G5 6 1.9721 1.7956 0.733 0.374 0.8597 0.351 
T4p Middle G1 4 1.4034 0.6328 0.3164 0.259 0.4676 0.2338 
T4p Middle G2 4 0.9256 0.6238 0.3119 -0.32 0.8813 0.4406 
T4p Middle G3 4 0.8488 0.5227 0.2614 -0.37 0.8202 0.4101 
T4p Middle G4 4 0.8546 0.5444 0.2722 -0.31 0.65 0.325 
T4p Middle G5 4 0.4694 0.2916 0.1458 -0.95 0.7677 0.3839 
T4p Old G1 8 3.5892 5.5263 1.9538 -0.54 2.9954 1.059 
T4p Old G2 8 1.2462 1.5193 0.5371 -0.29 1.0989 0.3885 
T4p Old G3 8 1.3579 1.2579 0.4448 0.004 0.7892 0.279 
T4p Old G4 8 0.9759 0.5564 0.1967 -0.24 0.8307 0.2937 
T4p Old G5 8 2.1293 2.8488 1.0072 0.063 1.3188 0.4663 
T4p Young G1 6 9.1608 20.083 8.1989 0.413 1.8445 0.753 
T4p Young G2 6 6.2849 12.249 5.0007 0.518 1.6303 0.6656 
T4p Young G3 6 6.1322 12.572 5.1326 0.488 1.531 0.625 
T4p Young G4 6 7.01 13.633 5.5656 0.575 1.7242 0.7039 
T4p Young G5 6 11.555 23.372 9.5417 0.693 2.0363 0.8313 
T5m Middle G1 3 4.1685 5.8714 3.3899 0.626 1.5364 0.887 
T5m Middle G2 3 3.7708 3.9714 2.2929 0.8 1.3876 0.8011 
T5m Middle G3 3 3.5822 3.7801 2.1824 0.556 1.7716 1.0228 
T5m Middle G4 3 3.0265 3.6796 2.1244 0.556 1.2854 0.7421 
T5m Middle G5 3 3.1872 3.4184 1.9736 0.553 1.5343 0.8858 
T5m Old G1 6 4.2134 5.7112 2.3316 0.582 1.4951 0.6104 
T5m Old G2 6 6.0108 8.8038 3.5941 0.673 1.7627 0.7196 
T5m Old G3 6 2.6293 2.5192 1.0285 0.505 1.1308 0.4616 
T5m Old G4 6 3.5388 3.4782 1.42 0.378 1.8189 0.7426 
T5m Old G5 6 10.789 15.975 6.5219 0.718 2.4405 0.9963 
T5m Young G1 6 1.8931 1.5676 0.64 -0.21 2.1507 0.878 
T5m Young G2 6 1.3249 1.0099 0.4123 -0.66 2.4096 0.9837 
T5m Young G3 6 1.4188 1.4228 0.5808 -0.68 2.3211 0.9476 
T5m Young G4 6 1.9508 1.5157 0.6188 -0.13 2.0914 0.8538 
T5m Young G5 6 2.6708 1.6021 0.654 0.225 2.1808 0.8903 
T5p Middle G1 3 0.9315 0.5336 0.3081 -0.22 0.7258 0.4191 
T5p Middle G2 3 2.0844 1.6407 0.9472 0.521 0.8034 0.4638 
T5p Middle G3 3 1.96 2.6293 1.518 -0.03 1.4407 0.8318 
T5p Middle G4 3 0.9771 0.5384 0.3108 -0.18 0.7434 0.4292 
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T5p Middle G5 3 0.5004 0.3118 0.18 -0.81 0.5718 0.3301 
T5p Old G1 6 3.1066 3.8926 1.5891 0.126 1.9163 0.7823 
T5p Old G2 6 12.698 24.211 9.8841 1.172 1.6823 0.6868 
T5p Old G3 6 22.521 43.758 17.864 1.098 2.4033 0.9811 
T5p Old G4 6 2.4962 1.7336 0.7077 0.729 0.6484 0.2647 
T5p Old G5 6 17.253 38.92 15.889 0.688 2.1411 0.8741 
T5p Young G1 6 1.411 1.0248 0.4184 -0.31 1.812 0.7398 
T5p Young G2 6 0.8666 0.5751 0.2348 -0.78 1.847 0.754 
T5p Young G3 6 1.3326 1.2393 0.5059 -0.57 2.1004 0.8575 
T5p Young G4 6 0.9161 0.7085 0.2893 -0.89 2.1688 0.8854 
T5p Young G5 6 1.2841 1.3206 0.5391 -0.43 1.4871 0.6071 
T6m Middle G1 4 1.2275 1.3888 0.6944 -0.29 1.1711 0.5855 
T6m Middle G2 3 1.9326 0.3738 0.2158 0.645 0.2067 0.1193 
T6m Middle G3 3 3.4844 2.6835 1.5493 0.764 1.4741 0.8511 
T6m Middle G4 3 1.012 0.7204 0.4159 -0.25 0.9924 0.573 
T6m Middle G5 3 2.8971 1.7514 1.0112 0.952 0.5623 0.3247 
T6m Old G1 7 1.6815 1.8773 0.7096 0.007 1.1173 0.4223 
T6m Old G2 7 13.636 30.156 11.398 0.628 2.3132 0.8743 
T6m Old G3 7 11.275 26.145 9.8819 0.253 2.4702 0.9337 
T6m Old G4 7 25.749 65.095 24.603 -0.22 3.2973 1.2463 
T6m Old G5 7 233.84 589.98 222.99 0.704 4.4493 1.6817 
T6m Young G1 6 4.6975 4.3684 1.7834 1.028 1.2639 0.516 
T6m Young G2 6 6.5898 5.807 2.3707 1.618 0.7735 0.3158 
T6m Young G3 6 4.4263 4.8791 1.9919 0.518 1.8793 0.7672 
T6m Young G4 6 14.307 26.714 10.906 1.48 1.5778 0.6441 
T6m Young G5 6 16.345 34.431 14.056 0.469 2.5101 1.0248 
T6p Middle G1 3 6.7043 7.9098 4.5667 1.424 1.1627 0.6713 
T6p Middle G2 3 1.9609 1.1478 0.6627 0.548 0.6299 0.3637 
T6p Middle G3 3 2.4548 3.5291 2.0375 -0.08 1.8078 1.0438 
T6p Middle G4 3 2.0087 1.6855 0.9731 -0.07 1.996 1.1524 
T6p Middle G5 3 1.5183 2.5623 1.4793 -1.67 2.7458 1.5853 
T6p Old G1 7 2.5617 2.8083 1.0614 0.037 1.7579 0.6644 
T6p Old G2 7 16.392 32.141 12.148 1.189 1.9749 0.7464 
T6p Old G3 7 54.479 98.114 37.084 1.462 2.8642 1.0825 
T6p Old G4 7 60.48 150.26 56.793 0.637 3.0872 1.1668 
T6p Old G5 7 216.95 526.67 199.06 1.836 3.1395 1.1866 
T6p Young G1 6 5.0019 10.711 4.3726 0.116 1.5982 0.6525 
T6p Young G2 5 6.498 6.7021 2.9973 1.057 1.6876 0.7547 
T6p Young G3 6 5.2806 10.099 4.1228 0.228 1.8091 0.7385 
T6p Young G4 6 4.9603 8.3847 3.423 0.373 1.6715 0.6824 
T6p Young G5 6 4.1164 7.6693 3.131 0.098 1.8075 0.7379 
T7m Middle G1 4 1.3708 0.9449 0.4725 0.168 0.5933 0.2966 
T7m Middle G2 4 3.3834 4.8413 2.4206 0.828 1.6011 0.9244 
175 
T7m Middle G3 4 3.8196 3.9737 1.9868 0.491 1.7337 0.8668 
T7m Middle G4 4 2.0127 2.0397 1.0199 0.101 1.3986 0.6993 
T7m Middle G5 4 3.4043 2.9301 1.4651 0.816 1.1397 0.5698 
T7m Old G1 8 4.5137 7.0197 2.4819 0.595 1.534 0.5423 
T7m Old G2 8 2.4673 2.4891 0.88 -0.14 2.2123 0.7822 
T7m Old G3 8 1.7041 2.6606 0.9407 -1.55 3.4585 1.2228 
T7m Old G4 8 1.9803 2.5301 0.8945 -0.86 2.6848 0.9492 
T7m Old G5 8 23.275 59.591 21.068 0.279 2.9728 1.0511 
T7m Young G1 6 10.428 15.871 6.4791 1.398 1.7444 0.7122 
T7m Young G2 6 6.3734 6.8565 2.7991 0.971 1.764 0.7201 
T7m Young G3 6 2.8707 2.9613 1.209 0.36 1.5191 0.6202 
T7m Young G4 6 1.7423 1.523 0.6218 0.074 1.3256 0.5412 
T7m Young G5 6 12.922 20.872 8.5209 1.289 2.2152 0.9043 
T7p Middle G1 4 2.298 2.2132 1.1066 0.463 0.9989 0.4995 
T7p Middle G2 4 1.3873 1.6726 0.8363 -0.34 1.4502 0.7251 
T7p Middle G3 4 3.6825 2.7318 1.3659 1.092 0.7524 0.3762 
T7p Middle G4 4 2.5254 2.6044 1.3022 0.607 0.8544 0.4272 
T7p Middle G5 4 2.3933 2.5135 1.2568 0.417 1.1611 0.5806 
T7p Old G1 8 8.6271 15.933 5.633 0.315 2.6261 0.9285 
T7p Old G2 8 49.592 126.11 44.587 1.39 2.3608 0.8347 
T7p Old G3 8 5.7751 11.09 3.9209 0.19 2.2791 0.8058 
T7p Old G4 8 2.0915 2.9784 1.053 -0.24 1.6638 0.5882 
T7p Old G5 8 114.39 280.89 99.31 0.605 3.5218 1.2451 
T7p Young G1 6 2.2702 4.139 1.6897 -0.14 1.3164 0.5374 
T7p Young G2 6 8.425 17.203 7.0229 0.566 1.7988 0.7343 
T7p Young G3 6 0.858 0.4907 0.2003 -0.36 0.7884 0.3219 
T7p Young G4 6 0.9058 0.4909 0.2004 -0.24 0.5986 0.2444 
T7p Young G5 6 3.7538 7.0146 2.8637 0.066 1.7742 0.7243 
T8m Middle G1 4 1.0465 0.8372 0.4186 -0.36 1.2336 0.6168 
T8m Middle G2 4 4.2651 3.3483 1.6741 0.621 2.1295 1.0648 
T8m Middle G3 4 4.6722 5.7161 2.858 0.455 2.2906 1.1453 
T8m Middle G4 4 1.002 1.1753 0.5877 -0.87 1.8328 0.9164 
T8m Middle G5 4 2.3847 3.6441 1.822 -0.51 2.3299 1.165 
T8m Old G1 8 1.8621 1.9957 0.7056 0.175 1.0014 0.354 
T8m Old G2 8 3.6468 3.9372 1.392 -0.51 3.0764 1.0877 
T8m Old G3 8 28.172 72.771 25.729 -0.81 4.5469 1.6076 
T8m Old G4 8 29.404 76.656 27.102 0.184 3.2735 1.1573 
T8m Old G5 8 14.569 37.326 13.197 -0.22 3.0152 1.066 
T8m Young G1 6 2.4065 1.8751 0.7655 -0.09 2.363 0.9647 
T8m Young G2 6 1.4699 1.3092 0.5345 -0.66 2.3045 0.9408 
T8m Young G3 6 1.1874 1.143 0.4666 -0.82 2.3078 0.9421 
T8m Young G4 6 0.7452 0.7102 0.2899 -1.27 2.1725 0.8869 
T8m Young G5 6 2.6568 3.1499 1.286 0.029 1.7187 0.7016 
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T8p Middle G1 4 2.433 1.9244 0.9622 0.586 0.967 0.4835 
T8p Middle G2 4 4.2684 6.0273 3.0137 0.756 1.2873 0.6436 
T8p Middle G3 4 10.44 7.7946 3.8973 2.123 0.7975 0.3987 
T8p Middle G4 4 1.7434 1.724 0.862 0.255 0.8378 0.4189 
T8p Middle G5 4 5.3354 9.6273 4.8136 0.078 2.0653 1.0326 
T8p Old G1 8 5.6282 8.214 2.9041 0.709 1.6513 0.5838 
T8p Old G2 8 41.576 111.02 39.252 1.034 2.1323 0.7539 
T8p Old G3 8 782.55 2201.1 778.2 1.919 2.963 1.0476 
T8p Old G4 8 4.5177 6.6334 2.3453 0.633 1.5163 0.5361 
T8p Old G5 8 31.998 77.482 27.394 0.759 2.3372 0.8263 
T8p Young G1 6 1.83 2.4954 1.0188 -0.83 2.2424 0.9154 
T8p Young G2 6 0.5121 0.4136 0.1688 -1.49 1.9427 0.7931 
T8p Young G3 6 0.5765 0.3981 0.1625 -1.15 1.6862 0.6884 
T8p Young G4 6 1.1134 1.3909 0.5678 -1.05 2.3114 0.9436 
T8p Young G5 6 0.6732 0.5319 0.2171 -1.01 1.5308 0.6249 
T9m Middle G1 4 3.3886 3.6082 1.8041 0.398 1.8094 0.9047 
T9m Middle G2 4 5.6796 6.5639 3.2819 0.77 2.0622 1.0311 
T9m Middle G3 4 5.9089 6.6743 3.3372 0.784 2.1949 1.0975 
T9m Middle G4 4 0.8646 0.6881 0.3441 -0.64 1.4106 0.7053 
T9m Middle G5 4 7.5983 5.6894 2.8447 1.243 2.0803 1.0402 
T9m Old G1 8 2.0821 1.9997 0.707 0.144 1.4263 0.5043 
T9m Old G2 8 4.1108 5.644 1.9955 -0.08 2.2807 0.8064 
T9m Old G3 8 4.625 10.196 3.6047 -0.2 2.0619 0.729 
T9m Old G4 8 5.2745 12.442 4.3989 -0.46 2.3532 0.832 
T9m Old G5 8 1.961 3.1735 1.122 -0.16 1.3284 0.4697 
T9m Young G1 6 1.4183 1.6875 0.6889 -0.36 1.5726 0.642 
T9m Young G2 6 1.6956 1.4186 0.5791 -0.71 2.5036 1.0221 
T9m Young G3 6 1.1232 1.1572 0.4724 -0.97 2.1096 0.8612 
T9m Young G4 6 2.4256 4.3129 1.7607 -0.07 1.355 0.5532 
T9m Young G5 6 3.3318 4.9496 2.0207 -0.18 2.0903 0.8534 
T9p Middle G1 4 2.6681 3.0022 1.5011 0.475 1.1701 0.5851 
T9p Middle G2 4 4.7105 5.7533 2.8767 0.844 1.4534 0.7267 
T9p Middle G3 4 5.591 5.3328 2.6664 1.336 1.0401 0.5201 
T9p Middle G4 4 4.113 6.2473 3.1236 0.625 1.3348 0.6674 
T9p Middle G5 4 3.7173 5.8541 2.9271 0.145 1.826 0.913 
T9p Old G1 8 15.86 21.659 7.6576 0.655 2.8929 1.0228 
T9p Old G2 8 90.754 240.22 84.93 1.457 2.6993 0.9544 
T9p Old G3 8 230.55 642.41 227.13 0.944 3.055 1.0801 
T9p Old G4 8 8.0346 13.538 4.7863 0.33 2.6724 0.9448 
T9p Old G5 8 25.797 68.815 24.33 0.144 2.5202 0.891 
T9p Young G1 6 1.1306 2.3697 0.9674 -1.64 2 0.8165 
T9p Young G2 6 0.4911 0.5266 0.215 -1.59 1.8491 0.7549 
T9p Young G3 6 1.1929 2.3028 0.9401 -1.37 2.104 0.8589 
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T9p Young G4 6 0.3334 0.3514 0.1435 -2.04 1.9112 0.7803 
T9p Young G5 6 0.5787 0.399 0.1629 -0.92 1.1909 0.4862 
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APPENDIX III:  PEARSON CORRELATION COEFFICIENTS BETWEEN THE TEN 
GENES 








T8; IGF-1,  
T9; GLUT4 
T10; IR  
KEY:  Treatments (G) 
G0: Control  
G1: Insulin 





m: minus (without FBS and glucose) 







Table: shows the Spearman Correlation Coefficients between ten genes (T1; AMPKα1, 
T2;AMPKα2,T3; AMPKβ1,T4; AMPKβ2, T5;AMPKγ1,T6; AMPKγ1, T7;AMPKγ3, T8;IGF-1, 
T9;GLUT4, and T10;IR). Were m; minus (without FBS and glucose). 
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Table 4 
Table : shows the Pearson Correlation Coefficients between ten genes (T1; AMPKα1, 
T2;AMPKα2,T3; AMPKβ1,T4; AMPKβ2, T5;AMPKγ1,T6; AMPKγ1, T7;AMPKγ3, T8;IGF-1, 
T9;GLUT4, and T10;IR). Were P; Plus FBS and glucose. The underlined in red indicate a 
positive significant correlation between changes in expression of the two genes being compared. 
183 
Table 5 
